data_2m1r_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m1r _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -154.74 -43.95 0.09 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -166.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.8 p -38.05 169.66 0.0 OUTLIER 'General case' 0 C--N 1.348 0.54 0 C-N-CA 126.385 1.874 . . . . 0.0 114.414 169.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.0 mt -70.69 -6.16 35.14 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 113.399 -1.728 . . . . 0.0 110.12 168.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 93.8 m -96.15 -14.22 22.96 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 123.423 0.689 . . . . 0.0 111.738 173.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.6 p80 46.08 52.16 10.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.912 2.085 . . . . 0.0 112.406 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -169.01 141.47 2.66 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.482 1.513 . . . . 0.0 108.018 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.44 174.87 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.475 1.51 . . . . 0.0 110.51 176.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.1 t 66.69 60.89 0.55 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.701 2.0 . . . . 0.0 113.429 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.51 120.11 1.77 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.98 2.112 . . . . 0.0 107.881 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.44 -151.2 43.5 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 122.613 1.118 . . . . 0.0 111.49 -172.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.58 169.26 10.47 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.388 1.875 . . . . 0.0 111.255 170.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -136.89 162.26 33.73 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.913 1.285 . . . . 0.0 111.677 -169.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 11.2 tt -138.0 -139.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 169.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 147.47 132.22 2.23 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 125.79 1.662 . . . . 0.0 111.57 -169.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 41.4 t -64.25 123.9 20.32 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.81 -0.48 3.03 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.365 1.466 . . . . 0.0 113.686 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -70.25 117.31 53.35 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.67 4.16 5.84 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.301 2.667 . . . . 0.0 113.168 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -117.37 7.63 12.87 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.85 1.66 . . . . 0.0 110.456 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.1 t -58.33 127.23 31.08 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 123.192 0.597 . . . . 0.0 109.736 170.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 70.5 m -77.01 5.95 7.17 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.538 1.535 . . . . 0.0 113.304 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.9 mm -132.58 -35.53 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 126.082 1.753 . . . . 0.0 109.95 -173.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.44 -42.9 0.55 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.512 2.725 . . . . 0.0 115.333 169.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.42 149.71 51.09 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.4 1.88 . . . . 0.0 108.431 -175.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -149.42 149.31 30.62 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -73.4 149.63 42.35 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.62 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.95 -3.59 0.81 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.985 1.714 . . . . 0.0 112.394 168.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.45 -3.74 8.35 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.674 1.59 . . . . 0.0 112.462 172.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.9 m -71.62 -7.47 48.0 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.06 0.845 . . . . 0.0 111.281 166.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -134.71 -4.63 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 126.853 2.061 . . . . 0.0 111.591 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.97 31.11 74.7 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.904 1.24 . . . . 0.0 113.272 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 4.6 mt . . . . . 0 C--N 1.343 0.291 0 C-N-CA 124.338 1.055 . . . . 0.0 112.584 -174.27 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.419 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 79.2 t90 . . . . . 0 CA--C 1.538 0.499 0 CA-C-O 121.203 0.525 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -141.68 140.45 33.2 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.076 1.35 . . . . 0.0 109.283 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.419 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 15.0 p -66.67 165.32 25.84 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 123.467 0.707 . . . . 0.0 112.198 177.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.06 35.23 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.97 3.113 . . . . 0.0 113.08 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -137.95 -38.37 0.57 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.445 1.498 . . . . 0.0 109.764 169.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.443 -0.82 0 C-N-CA 126.756 2.022 . . . . 0.0 111.805 171.702 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 47.2 p . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -155.04 -45.39 0.08 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -168.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.7 p -38.01 169.66 0.0 OUTLIER 'General case' 0 C--N 1.348 0.54 0 C-N-CA 126.429 1.892 . . . . 0.0 114.269 168.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.49 -6.3 35.07 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 113.452 -1.703 . . . . 0.0 110.199 168.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 89.5 m -97.34 -14.17 21.44 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 123.812 0.845 . . . . 0.0 111.805 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.5 p80 45.06 51.85 8.67 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.109 2.164 . . . . 0.0 112.842 -173.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -167.34 139.24 3.23 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 125.762 1.625 . . . . 0.0 107.94 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.95 172.32 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.307 1.443 . . . . 0.0 111.058 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.0 t 65.44 63.47 0.63 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.833 2.053 . . . . 0.0 112.792 -173.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.07 112.55 1.34 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.555 1.942 . . . . 0.0 108.45 -175.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.01 -161.65 24.18 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-O 123.283 1.49 . . . . 0.0 113.124 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.6 pm0 -68.26 143.79 55.12 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.155 2.182 . . . . 0.0 111.128 169.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.4 mtm -147.09 155.11 41.91 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.38 1.872 . . . . 0.0 110.289 -167.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 9.2 tp -139.02 -138.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.409 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 150.91 131.23 1.8 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 126.152 1.834 . . . . 0.0 112.301 -169.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 42.2 t -63.05 121.71 14.27 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.259 1.023 . . . . 0.0 108.559 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.85 1.4 1.89 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.384 1.474 . . . . 0.0 113.868 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -69.94 117.89 58.2 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.474 1.11 . . . . 0.0 108.072 168.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.35 6.21 4.13 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.305 2.67 . . . . 0.0 113.234 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -120.89 9.22 10.6 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.817 1.647 . . . . 0.0 110.482 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 45.1 t -59.23 128.63 38.08 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.316 0.646 . . . . 0.0 110.116 171.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 44.0 m -76.14 2.99 11.5 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.59 1.556 . . . . 0.0 113.542 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.8 mm -133.78 -35.33 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.925 1.69 . . . . 0.0 109.966 -170.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.91 -39.53 0.45 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 128.422 2.689 . . . . 0.0 115.454 169.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.87 148.95 51.32 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.305 1.842 . . . . 0.0 108.74 -174.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -150.06 146.02 26.71 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.4 -1.334 . . . . 0.0 107.4 -175.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -72.23 151.43 42.87 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.721 0.772 . . . . 0.0 111.043 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.33 -4.31 0.82 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.352 1.461 . . . . 0.0 113.06 167.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.33 -3.6 8.93 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.305 1.442 . . . . 0.0 112.544 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 20.6 m -72.43 -6.0 40.51 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.114 0.87 . . . . 0.0 111.715 167.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 10.9 p -135.4 -4.95 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 126.29 1.836 . . . . 0.0 111.797 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.34 35.77 90.71 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.667 1.127 . . . . 0.0 112.924 -173.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--N 1.343 0.304 0 C-N-CA 124.358 1.063 . . . . 0.0 111.493 -175.846 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.402 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 84.5 t90 . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 120.971 0.415 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -138.82 139.87 38.35 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.153 0.981 . . . . 0.0 109.587 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.402 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 13.9 p -65.7 163.43 35.03 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.436 0.695 . . . . 0.0 111.658 174.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.41 28.66 0.27 Allowed 'Trans proline' 0 CA--C 1.548 1.198 0 C-N-CA 124.013 3.142 . . . . 0.0 113.694 -178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -136.02 -32.95 0.86 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.555 1.542 . . . . 0.0 110.422 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.443 -0.795 0 C-N-CA 126.556 1.942 . . . . 0.0 111.727 169.693 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.3 p . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -155.15 -46.53 0.08 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.8 p -37.46 169.54 0.0 OUTLIER 'General case' 0 C--N 1.351 0.637 0 C-N-CA 126.665 1.986 . . . . 0.0 114.593 169.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.4 -6.23 34.06 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 113.311 -1.768 . . . . 0.0 110.08 168.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 86.6 m -97.46 -14.41 21.17 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 123.841 0.856 . . . . 0.0 111.776 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.2 p80 45.67 52.16 9.62 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.236 2.214 . . . . 0.0 112.807 -173.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -169.5 140.53 2.26 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.678 1.591 . . . . 0.0 107.906 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.07 173.37 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.219 1.407 . . . . 0.0 111.168 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.2 t 66.33 61.68 0.58 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.983 2.113 . . . . 0.0 113.537 -175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -161.98 114.1 1.72 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.39 1.876 . . . . 0.0 108.548 -175.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 62.12 -164.03 24.4 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-O 123.084 1.38 . . . . 0.0 112.702 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -66.14 147.18 53.72 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 112.405 -1.898 . . . . 0.0 110.92 169.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 75.7 mtm -146.33 154.26 41.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.939 1.696 . . . . 0.0 110.045 -168.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.6 tp -138.56 -139.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.357 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 149.8 131.0 1.87 Allowed Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 126.203 1.859 . . . . 0.0 112.289 -169.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.83 123.53 18.7 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.295 1.038 . . . . 0.0 108.557 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.05 -2.16 2.58 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.153 1.381 . . . . 0.0 113.467 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -69.64 117.38 52.63 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 168.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.5 4.93 5.09 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.131 2.554 . . . . 0.0 113.166 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -118.58 8.24 11.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.954 1.702 . . . . 0.0 110.416 174.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 50.0 t -58.25 127.6 32.95 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.181 0.593 . . . . 0.0 109.897 170.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.7 t -74.69 2.87 8.93 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.576 1.55 . . . . 0.0 113.444 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.6 mm -132.96 -34.96 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 126.072 1.749 . . . . 0.0 109.931 -171.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.34 -39.31 0.44 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.186 2.595 . . . . 0.0 115.52 169.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.82 149.81 50.41 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.403 1.881 . . . . 0.0 108.929 -174.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -149.5 146.37 27.36 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 -176.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -70.36 149.81 46.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.548 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -60.75 -4.9 1.07 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.977 1.311 . . . . 0.0 113.237 168.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -120.62 -2.05 9.97 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.732 1.213 . . . . 0.0 112.543 170.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 16.9 m -73.11 -5.65 40.46 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.933 0.788 . . . . 0.0 111.507 167.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 p -135.7 -13.41 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 126.853 2.061 . . . . 0.0 112.323 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 75.77 37.98 37.96 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.562 1.077 . . . . 0.0 112.922 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 18.3 mt . . . . . 0 N--CA 1.466 0.343 0 C-N-CA 123.92 0.888 . . . . 0.0 110.159 174.905 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.416 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 83.3 t90 . . . . . 0 CA--C 1.537 0.45 0 CA-C-O 121.185 0.517 . . . . 0.0 109.995 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -139.54 139.73 36.95 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.351 1.06 . . . . 0.0 109.377 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.416 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 14.2 p -66.36 166.69 15.84 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.96 0.904 . . . . 0.0 112.401 176.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.67 36.79 0.4 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.914 3.076 . . . . 0.0 112.985 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -139.96 -39.62 0.45 Allowed 'General case' 0 C--N 1.344 0.366 0 C-N-CA 125.336 1.455 . . . . 0.0 109.582 168.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.441 -0.899 0 C-N-CA 126.722 2.009 . . . . 0.0 112.038 173.017 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -154.93 -37.89 0.09 Allowed 'General case' 0 C--N 1.349 0.56 0 CA-C-O 116.027 -1.939 . . . . 0.0 115.042 -168.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.459 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.7 OUTLIER -52.88 172.61 0.05 OUTLIER 'General case' 0 C--N 1.358 0.938 0 CA-C-N 122.002 2.183 . . . . 0.0 112.245 170.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.5 mt -63.24 -5.09 2.96 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.749 1.619 . . . . 0.0 111.24 172.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.2 m -99.21 -12.12 20.71 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 126.105 1.762 . . . . 0.0 112.585 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.0 p80 46.04 50.02 11.86 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 126.678 1.991 . . . . 0.0 111.894 -174.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -165.2 148.12 8.13 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.931 1.293 . . . . 0.0 107.901 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.0 173.66 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 126.958 2.103 . . . . 0.0 110.78 176.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.9 t 65.19 63.93 0.64 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.85 2.06 . . . . 0.0 113.067 -174.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.59 112.23 0.92 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.324 1.85 . . . . 0.0 109.034 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 60.1 -160.65 21.05 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 123.09 1.383 . . . . 0.0 112.982 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -66.11 143.29 57.4 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 112.253 -1.973 . . . . 0.0 111.097 169.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.0 mtm -149.04 154.05 38.75 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.752 2.021 . . . . 0.0 109.095 -168.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 6.2 tt -142.04 -136.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -171.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 149.42 132.05 2.03 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 125.482 1.515 . . . . 0.0 112.867 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.47 120.91 12.0 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.473 1.109 . . . . 0.0 108.548 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.3 -1.52 2.42 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.522 1.529 . . . . 0.0 113.561 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -69.54 116.4 42.62 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 169.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -77.17 9.43 2.79 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.28 2.653 . . . . 0.0 113.066 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -123.29 7.46 9.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.978 1.711 . . . . 0.0 110.172 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.7 t -61.21 130.98 48.92 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 118.402 0.546 . . . . 0.0 109.768 171.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 38.0 m -74.92 6.22 4.3 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.564 1.545 . . . . 0.0 113.589 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.9 mm -135.76 -37.19 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 126.369 1.867 . . . . 0.0 109.83 -170.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.11 -41.99 0.52 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.313 2.645 . . . . 0.0 115.523 170.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . 0.459 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -127.85 148.56 50.47 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.334 1.854 . . . . 0.0 108.644 -177.05 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.425 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 76.5 m-85 -149.19 155.97 41.44 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -174.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -83.76 142.72 30.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.38 -9.06 2.05 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.549 1.54 . . . . 0.0 112.913 170.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -115.47 -6.29 12.27 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.527 1.131 . . . . 0.0 112.394 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.8 m -80.13 -0.09 34.45 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 168.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.29 -8.8 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 126.852 2.061 . . . . 0.0 111.638 171.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.17 36.46 63.91 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.547 1.07 . . . . 0.0 113.06 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 32.0 mt . . . . . 0 CA--C 1.538 0.508 0 CA-C-N 118.287 1.043 . . . . 0.0 110.613 171.139 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.4 t90 . . . . . 0 CA--C 1.538 0.493 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -139.83 141.85 36.66 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.064 0.945 . . . . 0.0 109.409 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.1 p -66.08 163.62 36.21 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.876 0.87 . . . . 0.0 111.724 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.53 32.92 0.32 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 123.986 3.124 . . . . 0.0 113.087 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -135.64 -39.11 0.72 Allowed 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.45 1.5 . . . . 0.0 109.67 170.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.442 -0.864 0 C-N-CA 126.919 2.088 . . . . 0.0 112.222 170.869 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -156.06 -38.19 0.08 Allowed 'General case' 0 C--N 1.35 0.626 0 CA-C-O 115.956 -1.973 . . . . 0.0 115.563 -168.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.45 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.9 OUTLIER -52.99 174.15 0.04 OUTLIER 'General case' 0 C--N 1.359 0.991 0 CA-C-N 122.069 2.213 . . . . 0.0 112.027 172.06 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.0 mt -62.98 -5.07 2.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.641 1.577 . . . . 0.0 111.339 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 69.6 m -100.0 -12.28 19.88 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 126.069 1.748 . . . . 0.0 112.675 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.8 p80 45.36 50.1 10.09 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.775 2.03 . . . . 0.0 112.008 -174.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -164.62 148.57 9.21 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 125.219 1.408 . . . . 0.0 107.67 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.69 174.01 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 127.131 2.172 . . . . 0.0 110.871 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.1 t 63.26 63.04 0.93 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.688 1.995 . . . . 0.0 112.904 -174.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.36 108.32 1.07 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.574 1.95 . . . . 0.0 108.332 -174.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 62.04 -164.38 23.22 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 123.278 1.488 . . . . 0.0 112.798 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.413 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.8 pm0 -65.25 150.17 48.69 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.314 2.246 . . . . 0.0 111.577 169.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 76.8 mtm -149.55 159.71 44.08 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.903 1.681 . . . . 0.0 110.684 -167.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 6.8 tp -138.34 -133.8 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.117 0.967 . . . . 0.0 109.302 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 221' ' ' TRP . . . 145.62 132.73 2.47 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 126.447 1.975 . . . . 0.0 113.242 -169.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.521 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 8.8 t -65.11 124.12 21.29 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.63 4.18 0.62 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.129 1.372 . . . . 0.0 113.104 173.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.65 112.04 5.01 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 128.51 2.724 . . . . 0.0 107.797 167.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -78.55 11.9 2.31 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.372 2.715 . . . . 0.0 112.955 -176.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -129.24 8.46 5.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.114 1.766 . . . . 0.0 109.807 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 12.2 t -57.3 116.7 3.46 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-O 121.767 0.794 . . . . 0.0 111.62 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 68.7 m -79.59 6.58 10.18 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.181 1.792 . . . . 0.0 112.48 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.5 mm -123.08 -36.99 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 126.547 1.939 . . . . 0.0 108.92 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . 0.254 0.1 OUTLIER 67.26 -23.98 0.11 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 129.093 2.957 . . . . 0.0 116.494 169.226 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . 0.45 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.6 OUTLIER -147.59 149.85 33.33 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.662 1.585 . . . . 0.0 109.152 -179.129 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.422 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 87.0 m-85 -147.44 157.2 43.48 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.293 1.037 . . . . 0.0 108.299 -177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -83.19 143.13 30.68 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.33 0.585 . . . . 0.0 110.142 -174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.51 -4.45 0.4 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.924 2.09 . . . . 0.0 114.039 170.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.47 -9.15 8.01 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.317 1.447 . . . . 0.0 112.276 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 10.3 m -77.45 -1.65 31.38 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.029 0.831 . . . . 0.0 112.769 168.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 12.7 p -132.04 -1.42 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 126.923 2.089 . . . . 0.0 110.92 171.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 63.6 32.56 84.58 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.25 1.405 . . . . 0.0 113.297 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.1 mt . . . . . 0 C--N 1.344 0.368 0 CA-C-N 117.999 0.9 . . . . 0.0 112.276 -172.955 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.439 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 90.3 t90 . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.521 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 97.5 m-85 -139.4 141.35 37.54 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.726 0.81 . . . . 0.0 110.698 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.439 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 29.1 p -65.75 160.27 62.72 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.519 0.727 . . . . 0.0 111.685 174.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.33 28.4 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.275 3.317 . . . . 0.0 113.327 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -133.58 -35.66 0.99 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.344 1.858 . . . . 0.0 109.637 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.447 -0.611 0 C-N-CA 126.099 1.76 . . . . 0.0 110.969 168.972 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -157.47 -43.42 0.07 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -168.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.1 p -39.62 170.2 0.0 OUTLIER 'General case' 0 C--N 1.349 0.57 0 C-N-CA 126.364 1.866 . . . . 0.0 114.379 169.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.3 mt -70.96 -6.63 40.16 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 113.31 -1.768 . . . . 0.0 110.131 168.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 97.4 m -96.29 -13.67 23.18 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 123.472 0.709 . . . . 0.0 111.755 174.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.7 p80 46.34 52.4 10.64 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.773 2.029 . . . . 0.0 112.607 -173.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -171.56 140.36 1.36 Allowed 'General case' 0 C--N 1.346 0.455 0 C-N-CA 126.004 1.721 . . . . 0.0 108.083 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.5 t -122.33 171.17 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.506 1.522 . . . . 0.0 111.179 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 52.8 m 67.17 64.31 0.44 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.983 2.113 . . . . 0.0 113.405 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -160.14 112.48 2.04 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.661 1.984 . . . . 0.0 108.024 -176.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 68.19 -123.19 17.12 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -170.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.35 167.59 12.6 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.003 2.121 . . . . 0.0 110.982 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -138.26 156.17 47.93 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.178 0.991 . . . . 0.0 111.23 -169.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 8.1 tt -134.53 -139.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 173.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 148.04 132.97 2.26 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 125.35 1.453 . . . . 0.0 112.648 -169.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.9 t -66.13 122.94 18.55 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.83 -2.19 3.58 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.504 1.522 . . . . 0.0 113.553 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -67.15 117.12 43.09 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 124.3 1.04 . . . . 0.0 108.33 168.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.65 5.42 4.81 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.229 2.619 . . . . 0.0 113.147 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -118.09 6.88 12.1 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.934 1.694 . . . . 0.0 110.428 174.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 45.9 t -58.88 127.54 32.73 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 121.234 0.54 . . . . 0.0 109.875 170.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 67.9 m -78.64 6.82 7.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.56 1.544 . . . . 0.0 113.336 -176.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.7 mt -133.76 -33.58 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.124 1.77 . . . . 0.0 110.261 -176.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.98 -39.42 0.45 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.869 2.468 . . . . 0.0 115.168 170.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.27 148.68 52.72 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.524 1.93 . . . . 0.0 108.719 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -147.17 150.16 34.39 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -72.34 148.55 45.22 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.41 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -60.54 -5.87 1.4 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.342 1.457 . . . . 0.0 112.336 167.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -119.78 -2.01 10.45 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.925 1.29 . . . . 0.0 112.478 171.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.3 m -73.48 -5.24 38.81 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.907 0.776 . . . . 0.0 111.078 166.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 14.2 p -134.6 -10.17 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.766 2.026 . . . . 0.0 112.211 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.58 36.59 62.32 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.619 1.104 . . . . 0.0 113.354 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 11.0 mt . . . . . 0 CA--C 1.537 0.45 0 CA-C-N 118.514 1.157 . . . . 0.0 111.603 173.729 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.401 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 91.2 t90 . . . . . 0 CA--C 1.539 0.526 0 CA-C-O 121.427 0.632 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -140.5 141.96 35.32 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.129 1.372 . . . . 0.0 108.897 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.401 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 16.9 p -68.82 164.06 49.95 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.896 -0.573 . . . . 0.0 112.005 174.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.45 34.1 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 124.148 3.232 . . . . 0.0 113.203 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -135.84 -36.97 0.75 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 125.793 1.637 . . . . 0.0 109.757 171.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.5 m . . . . . 0 N--CA 1.442 -0.865 0 C-N-CA 126.797 2.039 . . . . 0.0 112.091 171.755 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -156.29 -44.31 0.07 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -169.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.3 p -40.58 169.92 0.0 OUTLIER 'General case' 0 C--N 1.349 0.555 0 C-N-CA 126.139 1.775 . . . . 0.0 114.158 169.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.9 mt -71.48 -6.32 39.61 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 113.233 -1.803 . . . . 0.0 110.07 168.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 95.1 m -96.02 -13.54 23.66 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 123.455 0.702 . . . . 0.0 111.808 174.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.1 p80 46.28 53.75 9.16 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.804 2.042 . . . . 0.0 112.609 -173.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -171.78 141.38 1.41 Allowed 'General case' 0 C--N 1.346 0.441 0 C-N-CA 125.707 1.603 . . . . 0.0 108.221 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.99 170.5 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.36 1.464 . . . . 0.0 110.906 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.9 t 67.8 65.91 0.37 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.026 2.13 . . . . 0.0 113.165 -174.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.89 111.88 1.16 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.732 2.013 . . . . 0.0 107.733 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.16 -134.97 36.85 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -169.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.52 169.33 8.88 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.91 2.084 . . . . 0.0 111.252 177.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -137.8 159.86 40.83 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.478 1.111 . . . . 0.0 111.596 -168.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 5.6 tp -134.76 -138.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 170.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 149.47 131.87 2.0 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 126.024 1.773 . . . . 0.0 112.132 -169.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 43.7 t -63.42 125.43 24.15 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.217 1.007 . . . . 0.0 108.675 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.97 -3.43 3.48 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.824 1.25 . . . . 0.0 113.709 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -70.48 117.18 52.63 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 124.242 1.017 . . . . 0.0 108.659 169.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -76.82 4.22 5.86 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.261 2.641 . . . . 0.0 113.16 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -115.99 6.3 14.1 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.85 1.66 . . . . 0.0 110.463 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 49.9 t -58.72 128.3 36.5 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.019 0.528 . . . . 0.0 109.975 170.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.2 m -74.38 2.83 8.5 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.727 1.611 . . . . 0.0 113.689 -176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.8 mt -133.18 -33.66 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.186 1.794 . . . . 0.0 110.175 -173.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.89 -38.1 0.41 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.796 2.438 . . . . 0.0 115.226 170.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -132.06 148.51 52.5 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.618 1.967 . . . . 0.0 108.751 -174.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -148.35 149.47 31.85 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -73.94 150.7 40.66 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.244 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -59.66 -4.25 0.63 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.84 1.656 . . . . 0.0 113.252 167.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.79 -2.84 8.26 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.326 1.45 . . . . 0.0 112.609 171.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.1 m -71.9 -7.88 51.1 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.112 0.869 . . . . 0.0 111.612 167.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.0 p -133.94 -4.45 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 125.958 1.703 . . . . 0.0 111.765 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.18 33.55 78.67 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.605 1.098 . . . . 0.0 113.012 -174.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.5 mt . . . . . 0 C--N 1.343 0.311 0 C-N-CA 124.437 1.095 . . . . 0.0 112.096 -174.368 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 81.1 t90 . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -138.64 138.26 37.67 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.187 0.995 . . . . 0.0 108.728 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.7 p -64.82 166.78 10.95 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.965 0.906 . . . . 0.0 112.171 176.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.4 36.01 0.37 Allowed 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 123.861 3.041 . . . . 0.0 113.095 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -138.68 -39.51 0.51 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 125.473 1.509 . . . . 0.0 109.329 169.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.442 -0.837 0 C-N-CA 126.979 2.112 . . . . 0.0 112.393 172.184 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.8 p . . . . . 0 C--O 1.235 0.305 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -155.89 -44.91 0.08 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.7 p -39.83 170.32 0.0 OUTLIER 'General case' 0 C--N 1.348 0.522 0 C-N-CA 126.408 1.883 . . . . 0.0 114.001 168.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.68 -6.97 41.1 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.527 -1.67 . . . . 0.0 110.127 168.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 89.2 m -97.13 -14.16 21.68 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 123.859 0.864 . . . . 0.0 111.763 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.5 p80 45.57 52.48 9.23 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.082 2.153 . . . . 0.0 112.883 -173.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.15 139.79 2.3 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 126.043 1.737 . . . . 0.0 108.439 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.437 HG11 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -122.6 -174.82 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.878 1.671 . . . . 0.0 109.752 176.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.437 ' H ' HG11 ' A' ' 204' ' ' VAL 0.277 59.7 p 59.87 53.98 4.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.124 2.17 . . . . 0.0 114.571 -174.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.75 121.05 5.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.7 2.0 . . . . 0.0 109.1 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 57.54 -113.46 4.6 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.616 1.579 . . . . 0.0 111.188 -174.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.76 168.56 18.82 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.346 2.259 . . . . 0.0 111.41 -174.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -138.57 159.76 41.3 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.802 0.841 . . . . 0.0 113.036 -167.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 5.7 tp -134.8 -137.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 168.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 147.71 131.53 2.13 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 125.555 1.55 . . . . 0.0 112.03 -170.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 53.3 t -64.75 119.49 10.69 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -67.38 1.28 2.31 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.432 1.493 . . . . 0.0 113.747 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -67.0 118.0 51.15 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.22 6.23 4.05 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.28 2.654 . . . . 0.0 113.191 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -119.66 7.64 11.1 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.821 1.648 . . . . 0.0 110.575 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 47.5 t -59.34 130.26 46.04 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 123.286 0.634 . . . . 0.0 110.3 172.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.0 m -76.2 1.48 15.77 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.56 1.544 . . . . 0.0 113.671 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 26.2 mt -134.94 -34.34 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.029 1.731 . . . . 0.0 110.285 -171.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.7 -39.77 0.44 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.71 2.404 . . . . 0.0 115.011 170.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.27 147.73 52.62 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.523 1.929 . . . . 0.0 108.42 -174.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -147.76 147.79 30.26 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -71.45 150.97 44.42 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.204 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.96 -1.33 0.64 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.589 1.556 . . . . 0.0 113.41 168.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -126.95 1.3 6.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.756 1.222 . . . . 0.0 112.28 169.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.1 m -72.28 -9.42 58.45 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.793 0.724 . . . . 0.0 111.608 167.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.1 p -135.07 -10.83 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 124.696 1.198 . . . . 0.0 113.046 170.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.49 38.37 8.98 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.615 1.102 . . . . 0.0 113.888 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.344 0.366 0 CA-C-N 118.69 1.245 . . . . 0.0 110.764 173.154 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.453 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 87.5 t90 . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 121.075 0.464 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -139.25 141.25 37.83 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 124.854 1.262 . . . . 0.0 109.471 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.453 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 15.9 p -67.87 163.68 47.61 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.49 0.716 . . . . 0.0 112.288 176.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.54 34.14 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 124.056 3.171 . . . . 0.0 113.458 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -137.32 -35.92 0.67 Allowed 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.45 1.5 . . . . 0.0 110.076 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.442 -0.86 0 C-N-CA 126.556 1.942 . . . . 0.0 111.808 169.972 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 81.1 p . . . . . 0 CA--C 1.534 0.329 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -156.58 -48.59 0.07 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -174.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.8 p -38.62 171.28 0.0 OUTLIER 'General case' 0 C--N 1.351 0.663 0 C-N-CA 126.803 2.041 . . . . 0.0 114.633 169.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.9 mt -70.38 -7.24 41.39 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 113.458 -1.701 . . . . 0.0 110.021 168.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 94.6 m -96.43 -13.71 22.96 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 123.546 0.738 . . . . 0.0 111.852 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.3 p80 46.01 51.04 11.16 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.306 2.242 . . . . 0.0 113.101 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -169.66 142.05 2.45 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 125.854 1.662 . . . . 0.0 107.897 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.1 t -123.65 174.09 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.666 1.587 . . . . 0.0 110.733 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 50.0 m 67.48 57.84 0.55 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.719 2.007 . . . . 0.0 113.114 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -158.66 109.4 2.09 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.298 2.239 . . . . 0.0 106.945 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.77 -159.74 45.55 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-O 122.814 1.23 . . . . 0.0 110.757 -168.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.43 170.58 14.34 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.375 1.87 . . . . 0.0 112.075 171.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -140.23 159.73 41.53 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.921 1.289 . . . . 0.0 112.137 -169.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . 0.258 9.1 tp -132.19 -138.42 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 146.94 136.45 2.85 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 126.454 1.978 . . . . 0.0 112.308 -169.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.488 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 7.5 t -65.75 127.68 32.92 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.755 -0.723 . . . . 0.0 109.748 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.72 -8.27 1.98 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.343 1.457 . . . . 0.0 113.75 171.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -57.55 110.16 2.29 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 128.163 2.585 . . . . 0.0 108.288 169.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -78.61 10.91 2.64 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.42 2.747 . . . . 0.0 112.758 -175.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -129.22 9.9 5.73 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.279 1.832 . . . . 0.0 109.603 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 21.9 t -55.38 117.46 3.57 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-O 121.781 0.801 . . . . 0.0 111.66 175.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 85.7 p -74.49 1.94 10.73 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.94 2.096 . . . . 0.0 113.265 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.8 mm -123.67 -36.54 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.37 1.868 . . . . 0.0 108.957 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.03 -30.15 0.21 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 128.207 2.603 . . . . 0.0 115.195 169.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -144.24 149.81 36.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.689 1.596 . . . . 0.0 109.435 -175.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -148.21 149.67 32.36 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -72.88 149.86 43.13 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.192 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -59.36 -4.76 0.63 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.57 1.548 . . . . 0.0 113.473 167.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.65 -4.23 8.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.215 1.406 . . . . 0.0 112.638 171.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 14.6 m -72.8 -5.34 37.35 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.002 0.819 . . . . 0.0 111.359 167.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.5 p -136.56 -5.22 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 126.479 1.911 . . . . 0.0 111.931 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.8 35.86 91.46 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.802 1.191 . . . . 0.0 113.023 -175.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.5 mt . . . . . 0 C--N 1.344 0.334 0 C-N-CA 123.968 0.907 . . . . 0.0 111.281 -176.642 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.8 t90 . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.488 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 91.3 m-85 -138.44 138.42 38.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.716 0.807 . . . . 0.0 110.249 -176.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 31.5 p -64.03 162.48 30.36 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 123.675 0.79 . . . . 0.0 111.622 172.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.82 28.95 0.24 Allowed 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 124.028 3.152 . . . . 0.0 113.59 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -133.61 -36.85 0.95 Allowed 'General case' 0 C--N 1.343 0.326 0 C-N-CA 125.794 1.638 . . . . 0.0 109.702 173.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.447 -0.615 0 C-N-CA 126.325 1.85 . . . . 0.0 111.863 169.341 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.98 -49.48 0.09 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -168.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.9 p -41.65 170.33 0.0 OUTLIER 'General case' 0 C--N 1.349 0.58 0 C-N-CA 125.892 1.677 . . . . 0.0 114.165 169.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.7 mt -71.1 -6.86 42.48 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.925 168.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 93.7 m -95.62 -13.6 24.2 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.513 0.725 . . . . 0.0 111.797 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.0 p80 46.83 52.94 10.92 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.031 2.132 . . . . 0.0 112.85 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -173.16 139.73 0.82 Allowed 'General case' 0 C--N 1.345 0.391 0 C-N-CA 125.878 1.671 . . . . 0.0 108.498 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.482 HG11 ' H ' ' A' ' 205' ' ' SER . 0.5 OUTLIER -114.29 -173.18 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 125.605 1.562 . . . . 0.0 110.665 175.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.482 ' H ' HG11 ' A' ' 204' ' ' VAL 0.254 97.5 p 53.12 64.29 1.91 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.812 2.445 . . . . 0.0 114.771 -174.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.08 112.07 1.54 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.894 2.078 . . . . 0.0 108.011 -177.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 63.65 -133.72 41.25 Favored Glycine 0 C--N 1.339 0.75 0 C-N-CA 124.497 1.046 . . . . 0.0 110.546 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.08 169.05 9.21 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 127.248 2.219 . . . . 0.0 111.42 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -138.66 159.51 41.92 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.251 1.02 . . . . 0.0 112.209 -168.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 5.8 tp -133.44 -138.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 169.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 148.32 131.25 2.04 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 125.597 1.57 . . . . 0.0 112.507 -170.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 45.9 t -63.94 121.39 13.99 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.24 2.11 1.79 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.436 1.494 . . . . 0.0 113.699 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -70.94 118.01 61.43 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.378 1.071 . . . . 0.0 108.146 168.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -76.33 4.58 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.185 2.59 . . . . 0.0 113.273 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -116.21 6.41 13.87 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.717 1.607 . . . . 0.0 110.508 174.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 46.5 t -59.14 129.13 40.64 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 123.118 0.567 . . . . 0.0 109.924 171.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 11.0 t -73.27 -1.44 17.87 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.922 1.689 . . . . 0.0 113.455 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.6 mt -132.76 -33.84 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.968 1.707 . . . . 0.0 110.449 -170.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.68 -38.9 0.43 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 127.47 2.308 . . . . 0.0 114.985 171.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -132.49 148.29 52.39 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.497 1.919 . . . . 0.0 109.03 -173.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -148.85 149.95 32.17 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -74.17 151.08 40.09 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.369 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -59.28 -5.12 0.66 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.766 1.626 . . . . 0.0 113.259 167.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.04 -3.58 8.56 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.294 1.438 . . . . 0.0 112.581 171.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 15.5 m -72.8 -6.9 47.92 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.04 0.836 . . . . 0.0 111.739 167.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.35 -5.6 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.864 1.666 . . . . 0.0 111.817 172.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.51 34.82 80.03 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.726 1.155 . . . . 0.0 112.8 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--N 1.343 0.324 0 C-N-CA 124.327 1.051 . . . . 0.0 111.771 -174.599 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.414 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 88.8 t90 . . . . . 0 CA--C 1.539 0.538 0 CA-C-O 120.975 0.417 . . . . 0.0 109.99 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -138.63 140.46 38.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.201 1.0 . . . . 0.0 109.584 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.414 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 15.2 p -66.73 165.24 26.69 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.73 0.812 . . . . 0.0 112.06 175.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.47 33.03 0.29 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 124.024 3.149 . . . . 0.0 113.482 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -136.02 -40.31 0.68 Allowed 'General case' 0 C--N 1.345 0.404 0 C-N-CA 125.068 1.347 . . . . 0.0 109.674 169.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.442 -0.856 0 C-N-CA 126.736 2.014 . . . . 0.0 111.705 171.803 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 63.6 p . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -155.26 -42.26 0.08 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 115.705 -2.093 . . . . 0.0 115.099 -173.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.451 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.7 OUTLIER -52.01 173.64 0.03 OUTLIER 'General case' 0 C--N 1.359 0.985 0 CA-C-N 122.223 2.283 . . . . 0.0 112.572 172.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.6 mt -62.83 -6.13 3.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.559 1.543 . . . . 0.0 111.243 172.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 92.4 m -99.29 -11.87 20.86 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 126.298 1.839 . . . . 0.0 112.762 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.7 p80 45.36 48.61 10.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.406 2.283 . . . . 0.0 112.342 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -162.91 147.99 11.78 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.367 1.467 . . . . 0.0 107.539 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.1 t -135.19 171.72 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 127.388 2.275 . . . . 0.0 110.323 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.3 t 61.36 64.52 1.07 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.61 1.964 . . . . 0.0 112.987 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.86 108.11 1.14 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.48 1.912 . . . . 0.0 108.374 -174.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 59.69 -160.22 19.8 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-O 123.271 1.484 . . . . 0.0 112.631 -174.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -64.17 148.94 48.85 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.959 2.104 . . . . 0.0 111.621 169.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.8 mtm -150.94 156.17 40.62 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.653 1.981 . . . . 0.0 109.492 -168.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 7.2 tp -140.53 -135.56 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 148.78 133.89 2.32 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 126.054 1.788 . . . . 0.0 112.444 -171.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 50.4 t -64.63 126.58 28.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.168 -1.016 . . . . 0.0 109.013 175.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.91 -7.33 2.33 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -69.61 114.73 26.57 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 119.496 1.044 . . . . 0.0 108.593 171.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -78.45 6.04 5.08 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.418 2.745 . . . . 0.0 112.948 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -118.95 5.58 11.38 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.952 1.701 . . . . 0.0 109.987 174.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . 0.4 ' HG ' ' H ' ' A' ' 219' ' ' ILE . 48.2 t -59.39 131.07 49.87 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 118.487 0.585 . . . . 0.0 109.844 170.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.0 m -74.11 6.31 3.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.725 1.61 . . . . 0.0 113.417 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.4 ' H ' ' HG ' ' A' ' 217' ' ' CYS . 34.0 mm -135.75 -38.15 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 126.54 1.936 . . . . 0.0 109.62 -170.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.86 -43.2 0.53 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.525 2.73 . . . . 0.0 115.511 171.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . 0.451 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -126.02 148.51 49.28 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.566 1.946 . . . . 0.0 108.625 -177.373 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.438 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 74.0 m-85 -149.11 155.31 40.52 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -173.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -83.97 145.1 28.72 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.559 0.695 . . . . 0.0 110.628 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.34 -3.94 1.08 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.005 1.722 . . . . 0.0 113.979 171.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.86 -4.22 7.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.546 1.138 . . . . 0.0 112.185 172.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.3 m -77.44 -3.03 38.3 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.036 0.835 . . . . 0.0 113.02 168.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.2 p -135.02 -6.11 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.789 1.235 . . . . 0.0 112.259 169.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.77 40.88 20.71 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.59 1.091 . . . . 0.0 113.723 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.7 mt . . . . . 0 N--CA 1.468 0.432 0 CA-C-N 118.517 1.158 . . . . 0.0 110.221 172.064 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 89.1 t90 . . . . . 0 CA--C 1.537 0.444 0 CA-C-O 120.956 0.408 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -140.98 141.99 34.35 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.297 1.039 . . . . 0.0 109.646 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.0 p -70.02 166.02 37.21 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.485 0.714 . . . . 0.0 111.896 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -73.1 32.48 0.31 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.028 3.152 . . . . 0.0 113.383 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -136.29 -36.74 0.72 Allowed 'General case' 0 C--N 1.344 0.34 0 C-N-CA 125.161 1.385 . . . . 0.0 109.845 171.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 37.5 m . . . . . 0 N--CA 1.44 -0.947 0 C-N-CA 126.779 2.032 . . . . 0.0 111.961 172.3 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.9 p . . . . . 0 N--CA 1.465 0.275 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -154.69 -40.47 0.09 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 115.884 -2.007 . . . . 0.0 115.319 -171.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.47 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.8 OUTLIER -53.43 173.64 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 122.312 2.324 . . . . 0.0 112.213 170.59 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.6 mt -62.44 -7.66 4.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.671 1.588 . . . . 0.0 111.232 171.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 67.6 m -95.75 -12.9 24.67 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 126.062 1.745 . . . . 0.0 112.753 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.5 p80 45.2 49.03 10.02 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.339 2.256 . . . . 0.0 112.232 -173.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -164.27 147.94 9.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.217 1.407 . . . . 0.0 108.147 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.422 HG11 ' H ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -127.45 -169.93 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 127.202 2.201 . . . . 0.0 109.285 174.479 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.422 ' H ' HG11 ' A' ' 204' ' ' VAL . 89.8 p 49.24 58.04 5.83 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.893 2.077 . . . . 0.0 114.324 -174.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.15 100.77 2.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.845 2.058 . . . . 0.0 109.295 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 68.95 -96.78 0.47 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.615 1.578 . . . . 0.0 111.5 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.17 169.47 17.8 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.148 1.779 . . . . 0.0 111.977 -169.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -146.0 161.23 40.57 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.42 1.088 . . . . 0.0 112.073 -169.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 4.6 tp -133.31 -134.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 168.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 146.25 133.15 2.46 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 125.493 1.52 . . . . 0.0 111.923 -170.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.51 121.17 14.29 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.374 -0.913 . . . . 0.0 109.082 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -71.78 7.2 1.61 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.51 1.524 . . . . 0.0 113.602 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -71.73 120.2 78.6 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.469 1.107 . . . . 0.0 108.402 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -75.7 6.61 3.58 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.333 2.689 . . . . 0.0 113.361 177.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -119.68 7.67 11.09 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.785 1.634 . . . . 0.0 110.648 174.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.76 129.23 40.44 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 123.438 0.695 . . . . 0.0 110.226 173.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.1 m -81.17 3.45 23.58 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.281 1.432 . . . . 0.0 113.363 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 78.7 mt -134.71 -33.72 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.614 1.565 . . . . 0.0 110.364 -169.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER 73.06 -46.05 0.64 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 128.78 2.832 . . . . 0.0 115.235 170.341 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . 0.47 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.3 OUTLIER -125.44 149.12 48.5 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.588 1.555 . . . . 0.0 109.24 -175.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.43 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 82.6 m-85 -149.69 157.88 43.65 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.945 1.298 . . . . 0.0 108.832 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -89.11 144.6 26.01 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.378 0.609 . . . . 0.0 111.174 -172.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -56.57 -8.24 0.53 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.421 2.288 . . . . 0.0 114.245 169.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.86 -7.69 8.43 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.827 1.251 . . . . 0.0 112.297 174.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 10.6 m -77.28 -3.15 38.4 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.044 0.838 . . . . 0.0 112.938 168.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 12.7 p -131.11 -0.44 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 126.091 1.757 . . . . 0.0 110.857 169.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.46 29.33 74.97 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.208 1.385 . . . . 0.0 113.174 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 C--N 1.342 0.272 0 C-N-CA 124.307 1.043 . . . . 0.0 112.362 -171.509 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.1 t90 . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -139.82 142.43 36.64 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.012 0.925 . . . . 0.0 110.096 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.0 p -70.83 164.96 51.36 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.574 0.75 . . . . 0.0 111.347 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -73.76 31.5 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.047 3.165 . . . . 0.0 113.096 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -136.18 -36.85 0.73 Allowed 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.386 1.474 . . . . 0.0 109.937 176.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.443 -0.815 0 C-N-CA 127.354 2.262 . . . . 0.0 112.011 173.675 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 78.5 p . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -156.83 -39.0 0.07 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 115.901 -2.0 . . . . 0.0 115.194 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.462 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.7 OUTLIER -52.86 173.79 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 122.218 2.281 . . . . 0.0 112.438 171.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.6 mt -62.88 -6.71 4.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.691 1.596 . . . . 0.0 111.216 171.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.8 m -98.53 -11.31 22.35 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 126.14 1.776 . . . . 0.0 112.712 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.2 p80 45.75 48.92 11.63 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.401 2.28 . . . . 0.0 112.424 -174.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -163.76 148.97 10.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.457 1.503 . . . . 0.0 107.548 176.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.1 t -133.83 172.03 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 127.225 2.21 . . . . 0.0 110.635 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.2 t 64.66 61.53 0.82 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.869 2.068 . . . . 0.0 113.3 -174.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.82 111.07 1.52 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.396 1.878 . . . . 0.0 108.558 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.5 -163.18 23.44 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-O 123.171 1.428 . . . . 0.0 112.575 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -65.61 147.27 53.68 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 112.233 -1.983 . . . . 0.0 111.1 169.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.8 mtm -148.98 153.71 38.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.208 1.803 . . . . 0.0 109.743 -168.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.9 tp -137.96 -134.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.346 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -173.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 149.35 132.06 2.03 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 126.232 1.872 . . . . 0.0 112.788 -169.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 47.6 t -64.35 125.35 24.31 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.29 -0.955 . . . . 0.0 108.678 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.8 -0.32 2.14 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.484 1.514 . . . . 0.0 113.245 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -72.97 116.83 54.39 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 124.501 1.121 . . . . 0.0 108.466 168.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.02 4.21 5.97 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.288 2.658 . . . . 0.0 113.217 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -114.78 5.01 15.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.766 1.626 . . . . 0.0 110.526 174.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.98 130.13 45.52 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 122.987 0.515 . . . . 0.0 110.4 171.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.0 m -74.03 1.62 10.59 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.785 1.634 . . . . 0.0 113.868 -176.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 19.1 mt -134.07 -32.82 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 126.091 1.756 . . . . 0.0 110.359 -172.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.77 -37.51 0.38 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 128.366 2.666 . . . . 0.0 115.78 172.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . 0.462 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.5 OUTLIER -130.14 148.77 52.02 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.371 1.868 . . . . 0.0 108.985 -176.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.442 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 82.5 m-85 -147.27 155.12 41.77 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.849 0.86 . . . . 0.0 108.868 -175.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -82.05 143.19 31.71 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.922 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -58.97 -7.27 1.0 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.789 1.636 . . . . 0.0 113.827 170.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -118.83 -5.26 10.63 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.412 1.085 . . . . 0.0 112.417 172.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.0 m -78.55 -0.77 30.95 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.903 0.774 . . . . 0.0 112.855 168.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.0 -9.67 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.845 2.058 . . . . 0.0 111.943 173.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 73.14 36.98 55.93 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.575 1.084 . . . . 0.0 112.993 -177.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 CA--C 1.533 0.319 0 CA-C-N 117.854 0.827 . . . . 0.0 109.919 175.344 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 89.6 t90 . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -139.76 141.66 36.82 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.313 1.045 . . . . 0.0 109.491 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.1 p -67.2 165.58 26.92 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 123.586 0.755 . . . . 0.0 112.109 174.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -72.97 34.84 0.33 Allowed 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.978 3.119 . . . . 0.0 113.274 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -139.11 -37.45 0.51 Allowed 'General case' 0 C--N 1.343 0.324 0 C-N-CA 125.02 1.328 . . . . 0.0 110.275 169.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.442 -0.868 0 C-N-CA 126.934 2.094 . . . . 0.0 112.025 172.999 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.4 p . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -156.49 -37.98 0.08 Allowed 'General case' 0 C--N 1.35 0.625 0 CA-C-O 115.728 -2.082 . . . . 0.0 115.958 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.468 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 1.1 t -53.65 174.11 0.05 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 122.49 2.405 . . . . 0.0 111.851 170.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.1 mt -62.33 -7.29 4.12 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.953 1.701 . . . . 0.0 111.283 170.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 69.7 m -97.11 -12.4 23.19 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.989 1.716 . . . . 0.0 112.711 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.4 p80 45.32 49.33 10.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.173 2.189 . . . . 0.0 112.437 -173.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -164.02 148.06 9.97 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.417 1.487 . . . . 0.0 107.864 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.86 176.1 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 127.179 2.192 . . . . 0.0 110.81 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.0 t 63.69 61.85 0.96 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.692 1.997 . . . . 0.0 112.803 -175.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.96 110.08 1.22 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.334 1.853 . . . . 0.0 109.001 -173.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 60.06 -158.78 24.9 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-O 123.21 1.45 . . . . 0.0 113.247 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -65.49 145.17 56.45 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.098 2.159 . . . . 0.0 111.317 169.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.3 mtm -151.52 156.68 41.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.294 1.838 . . . . 0.0 109.863 -168.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 7.5 tp -138.03 -133.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 124.258 1.023 . . . . 0.0 109.204 -175.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 146.37 136.08 2.85 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 126.466 1.984 . . . . 0.0 113.285 -169.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 7.0 t -65.14 125.62 25.55 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 114.622 -0.789 . . . . 0.0 109.324 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.2 0.29 0.65 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.589 1.156 . . . . 0.0 112.758 170.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -63.49 111.4 5.07 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 127.783 2.433 . . . . 0.0 107.844 167.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -78.58 11.5 2.44 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.374 2.716 . . . . 0.0 113.031 -176.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -129.23 9.04 5.61 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.161 1.784 . . . . 0.0 109.787 174.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 25.8 t -55.58 124.11 16.25 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.636 0.732 . . . . 0.0 112.403 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 15.8 m -74.34 1.14 12.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.703 2.001 . . . . 0.0 113.271 -177.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 12.5 mt -131.48 -34.55 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 126.382 1.873 . . . . 0.0 109.574 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.13 -25.3 0.16 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 128.017 2.527 . . . . 0.0 115.78 169.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . 0.468 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.6 OUTLIER -143.6 148.06 35.31 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.855 1.662 . . . . 0.0 109.178 -178.433 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.422 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 90.6 m-85 -145.96 155.87 43.13 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.168 0.987 . . . . 0.0 108.825 -177.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -80.91 143.16 32.86 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.901 -175.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.99 -2.4 0.41 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.297 1.839 . . . . 0.0 114.12 171.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.61 -7.59 7.42 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.26 1.424 . . . . 0.0 112.166 172.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.6 m -77.27 -2.16 33.35 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.154 0.888 . . . . 0.0 112.678 168.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.77 -5.59 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 127.444 2.298 . . . . 0.0 111.266 172.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.34 36.58 91.85 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.894 1.235 . . . . 0.0 112.885 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 N--CA 1.465 0.307 0 C-N-CA 123.727 0.811 . . . . 0.0 111.452 -178.166 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 85.0 t90 . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.52 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 71.8 m-85 -134.77 135.97 42.25 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.831 0.852 . . . . 0.0 110.655 -176.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 31.2 p -65.96 164.42 28.55 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.311 1.044 . . . . 0.0 112.237 172.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.88 30.84 0.25 Allowed 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.244 3.296 . . . . 0.0 113.664 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -133.67 -36.4 0.96 Allowed 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.545 1.538 . . . . 0.0 110.041 170.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.444 -0.74 0 C-N-CA 126.158 1.783 . . . . 0.0 112.156 169.853 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 82.0 p . . . . . 0 C--O 1.233 0.235 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -156.55 -46.56 0.07 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 117.861 -1.066 . . . . 0.0 113.804 -175.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.8 p -39.38 170.05 0.0 OUTLIER 'General case' 0 C--N 1.349 0.578 0 C-N-CA 126.375 1.87 . . . . 0.0 114.064 168.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -71.08 -6.74 41.44 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.118 168.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 95.7 m -95.89 -14.31 23.26 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 123.633 0.773 . . . . 0.0 111.792 174.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.1 p80 46.25 52.34 10.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.304 2.242 . . . . 0.0 112.899 -173.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -170.36 141.62 2.03 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 126.091 1.756 . . . . 0.0 107.95 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.6 t -126.47 171.11 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 125.488 1.515 . . . . 0.0 111.18 -176.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 43.2 m 68.72 62.81 0.33 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.267 2.227 . . . . 0.0 113.387 -177.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.65 113.45 1.29 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.595 1.958 . . . . 0.0 108.531 -174.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 63.26 -168.68 20.12 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-O 122.708 1.171 . . . . 0.0 112.06 -173.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -69.02 150.53 47.55 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 113.273 -1.463 . . . . 0.0 110.651 168.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.9 mtm -143.63 152.57 41.53 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.929 1.692 . . . . 0.0 109.824 -166.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.6 tp -135.5 -138.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.304 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 151.86 132.4 1.85 Allowed Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 125.906 1.717 . . . . 0.0 112.151 -169.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 40.7 t -63.61 125.55 24.63 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 114.074 -1.063 . . . . 0.0 108.249 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -68.9 6.16 0.96 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.54 1.136 . . . . 0.0 113.559 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -74.42 114.11 30.47 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 166.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -77.65 9.11 3.06 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.328 2.685 . . . . 0.0 113.059 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -124.21 8.74 8.55 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.888 1.675 . . . . 0.0 110.248 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . 0.433 ' HG ' ' H ' ' A' ' 219' ' ' ILE . 49.6 t -60.6 129.97 44.23 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 118.306 0.503 . . . . 0.0 109.924 172.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -73.59 4.36 5.05 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.755 1.622 . . . . 0.0 113.404 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.433 ' H ' ' HG ' ' A' ' 217' ' ' CYS . 34.2 mt -132.54 -35.17 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 126.268 1.827 . . . . 0.0 109.938 -175.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.7 -38.72 0.43 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.762 2.425 . . . . 0.0 115.27 170.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.43 148.67 52.67 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.899 2.08 . . . . 0.0 108.646 -174.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -148.62 146.72 28.35 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -73.22 149.61 42.7 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.793 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -60.29 -6.28 1.43 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.74 1.216 . . . . 0.0 113.641 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -120.36 -0.56 10.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.33 1.052 . . . . 0.0 112.611 170.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.5 m -72.61 -5.99 41.11 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.901 0.773 . . . . 0.0 111.301 166.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.1 p -137.48 -12.48 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.765 2.026 . . . . 0.0 112.388 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.97 38.84 55.62 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.348 0.975 . . . . 0.0 112.86 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 15.8 mt . . . . . 0 N--CA 1.467 0.415 0 CA-C-N 117.82 0.81 . . . . 0.0 109.796 175.142 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.422 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 88.9 t90 . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -140.12 143.21 36.11 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.2 1.0 . . . . 0.0 108.755 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.422 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 17.1 p -68.12 163.37 51.99 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-O 118.808 -0.615 . . . . 0.0 111.633 177.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.25 33.81 0.32 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.965 3.11 . . . . 0.0 112.891 178.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -138.26 -35.7 0.61 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 125.988 1.715 . . . . 0.0 109.964 173.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.443 -0.818 0 C-N-CA 126.774 2.03 . . . . 0.0 111.591 170.324 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.6 p . . . . . 0 CA--C 1.532 0.282 0 CA-C-O 118.616 -0.707 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -156.28 -38.91 0.08 Allowed 'General case' 0 C--N 1.35 0.623 0 CA-C-O 115.764 -2.065 . . . . 0.0 115.725 -174.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.471 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.8 OUTLIER -53.1 174.2 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 122.449 2.386 . . . . 0.0 112.145 172.035 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.0 mt -62.65 -6.3 3.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.734 1.614 . . . . 0.0 111.275 170.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 82.6 m -99.32 -12.1 20.63 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 126.193 1.797 . . . . 0.0 112.699 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.0 p80 45.19 49.03 10.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.189 2.196 . . . . 0.0 112.357 -174.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -164.15 148.16 9.8 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 125.572 1.549 . . . . 0.0 108.045 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.26 175.51 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 127.244 2.218 . . . . 0.0 110.253 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 16.8 t 61.93 63.1 1.15 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.377 1.871 . . . . 0.0 113.292 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -161.12 112.58 1.81 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.333 1.853 . . . . 0.0 109.165 -173.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.48 -110.02 3.24 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 125.232 1.396 . . . . 0.0 109.872 -172.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.14 165.9 24.64 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.84 2.056 . . . . 0.0 111.332 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -138.72 157.16 46.62 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.742 1.217 . . . . 0.0 111.063 -168.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 9.5 tt -134.48 -136.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 147.59 132.08 2.2 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 125.167 1.365 . . . . 0.0 113.113 -170.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.5 t -65.86 123.44 19.81 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.9 0.88 . . . . 0.0 108.777 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.34 -1.8 3.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.71 1.604 . . . . 0.0 113.574 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -66.93 116.29 33.97 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 168.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.93 5.15 5.15 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.409 2.739 . . . . 0.0 113.009 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -117.69 6.16 12.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.902 1.681 . . . . 0.0 110.424 174.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 41.8 t -59.01 130.23 46.03 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 122.973 0.509 . . . . 0.0 110.378 172.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.3 t -76.07 3.21 10.92 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.732 1.613 . . . . 0.0 113.617 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 19.6 mt -134.42 -35.02 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.995 1.718 . . . . 0.0 110.279 -172.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.22 -40.95 0.49 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.992 2.517 . . . . 0.0 115.38 172.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . 0.471 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.5 OUTLIER -126.56 147.67 49.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.135 1.774 . . . . 0.0 108.837 -177.683 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.428 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 80.9 m-85 -146.89 157.48 43.66 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.39 1.076 . . . . 0.0 108.794 -175.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -84.16 141.82 30.78 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.793 -175.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.73 -8.55 1.35 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.574 1.949 . . . . 0.0 113.096 169.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -118.01 -7.06 10.91 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.823 1.249 . . . . 0.0 112.189 174.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 4.6 m -77.9 -2.1 35.09 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.94 0.791 . . . . 0.0 112.306 168.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 14.3 p -130.86 -6.31 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 126.955 2.102 . . . . 0.0 111.481 173.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.67 35.32 89.65 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.735 1.16 . . . . 0.0 113.176 -176.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.7 mt . . . . . 0 CA--C 1.536 0.419 0 CA-C-N 118.366 1.083 . . . . 0.0 111.315 175.999 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.442 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 91.4 t90 . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 121.245 0.545 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -139.02 141.13 38.29 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.864 1.266 . . . . 0.0 109.125 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.442 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 17.6 p -66.88 162.87 48.85 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.302 0.641 . . . . 0.0 112.071 173.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -73.63 35.99 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 124.006 3.137 . . . . 0.0 112.888 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -138.46 -35.68 0.59 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.868 1.667 . . . . 0.0 109.935 170.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.444 -0.763 0 C-N-CA 126.424 1.89 . . . . 0.0 111.832 169.98 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.8 p . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -155.42 -47.14 0.08 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -173.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.8 p -38.6 170.11 0.0 OUTLIER 'General case' 0 C--N 1.351 0.635 0 C-N-CA 126.557 1.943 . . . . 0.0 114.607 169.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.3 mt -70.57 -6.7 38.44 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 113.32 -1.764 . . . . 0.0 110.044 168.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.9 m -96.77 -14.18 22.13 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 123.646 0.778 . . . . 0.0 111.784 174.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.8 p80 45.46 52.27 9.16 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.224 2.21 . . . . 0.0 112.915 -173.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -169.9 140.7 2.1 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.934 1.694 . . . . 0.0 108.269 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.0 174.1 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.675 1.59 . . . . 0.0 110.634 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.7 t 66.36 62.05 0.57 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.721 2.009 . . . . 0.0 113.413 -174.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.75 110.87 1.98 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.174 1.79 . . . . 0.0 108.977 -175.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 66.81 -109.51 2.95 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 125.283 1.421 . . . . 0.0 110.438 -172.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.61 168.64 19.35 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.123 2.169 . . . . 0.0 111.139 -174.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -140.35 158.89 43.33 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.719 0.808 . . . . 0.0 112.748 -168.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 7.2 tp -133.18 -138.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.401 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 145.43 134.6 2.73 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 126.165 1.84 . . . . 0.0 111.714 -169.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 41.4 t -63.18 126.38 27.21 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.75 -4.29 3.0 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.376 1.47 . . . . 0.0 113.545 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -71.72 118.85 70.32 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.458 1.103 . . . . 0.0 109.071 169.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.36 3.76 6.02 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.362 2.708 . . . . 0.0 113.283 176.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -115.04 6.11 15.14 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.912 1.685 . . . . 0.0 110.495 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 50.8 t -58.18 128.37 36.78 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 123.174 0.59 . . . . 0.0 109.905 171.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.9 t -74.14 1.74 10.52 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.7 1.6 . . . . 0.0 113.442 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.5 mm -134.33 -35.08 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.848 1.659 . . . . 0.0 110.126 -170.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.92 -38.34 0.4 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.117 2.567 . . . . 0.0 115.201 169.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.8 148.91 48.92 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.936 1.694 . . . . 0.0 109.168 -174.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -149.15 148.13 29.28 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -72.15 150.89 43.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.264 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -59.03 -4.6 0.51 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.884 1.674 . . . . 0.0 113.027 166.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.86 -3.69 8.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.237 1.415 . . . . 0.0 112.647 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 18.8 m -72.92 -6.2 43.59 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.107 0.867 . . . . 0.0 111.645 167.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.22 -4.76 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 126.179 1.792 . . . . 0.0 111.709 172.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.69 32.57 74.56 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.753 1.168 . . . . 0.0 113.117 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 C--N 1.344 0.342 0 C-N-CA 124.375 1.07 . . . . 0.0 112.048 -175.011 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.402 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 90.1 t90 . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.413 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 93.3 m-85 -140.49 140.89 35.39 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.826 0.851 . . . . 0.0 109.506 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.402 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 6.0 p -70.16 167.36 25.91 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.118 0.967 . . . . 0.0 112.174 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -69.59 9.32 0.58 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 123.463 2.776 . . . . 0.0 114.42 -176.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -133.41 27.03 4.11 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.188 1.795 . . . . 0.0 111.504 176.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 3.7 t . . . . . 0 CA--C 1.536 0.425 0 C-N-CA 126.11 1.764 . . . . 0.0 110.768 -173.996 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.7 p . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -156.41 -37.92 0.08 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 115.935 -1.983 . . . . 0.0 115.759 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.46 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.9 OUTLIER -53.82 174.11 0.05 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 122.352 2.342 . . . . 0.0 111.97 169.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.3 mt -62.52 -7.46 4.66 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.869 1.668 . . . . 0.0 111.278 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 67.0 m -96.62 -12.54 23.8 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.943 1.697 . . . . 0.0 112.68 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.8 p80 45.16 49.27 9.83 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.262 2.225 . . . . 0.0 112.371 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -163.92 148.29 10.24 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.352 1.461 . . . . 0.0 107.825 175.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.66 174.48 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 127.274 2.23 . . . . 0.0 110.796 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.0 t 63.64 62.04 0.96 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.653 1.981 . . . . 0.0 112.727 -174.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.88 108.74 1.16 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.546 1.938 . . . . 0.0 108.716 -173.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 60.48 -160.14 24.17 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-O 123.296 1.498 . . . . 0.0 113.172 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -65.6 147.24 53.72 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.337 2.255 . . . . 0.0 111.63 170.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.6 mtm -150.57 158.83 44.6 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.186 1.794 . . . . 0.0 110.218 -168.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 9.2 tp -139.35 -133.87 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.247 1.019 . . . . 0.0 109.219 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 147.29 136.01 2.75 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 126.456 1.979 . . . . 0.0 113.14 -169.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.509 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 7.1 t -64.59 124.98 23.27 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 114.642 -0.779 . . . . 0.0 109.124 177.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.45 1.59 0.52 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.631 1.173 . . . . 0.0 113.105 170.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -63.73 111.65 5.69 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 127.622 2.369 . . . . 0.0 107.951 167.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -78.7 11.46 2.49 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.455 2.77 . . . . 0.0 112.916 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -128.95 9.08 5.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.087 1.755 . . . . 0.0 109.798 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 20.8 t -56.65 123.21 14.1 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-O 121.542 0.687 . . . . 0.0 112.131 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 39.7 m -74.5 0.35 15.03 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.537 1.935 . . . . 0.0 113.321 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 14.5 mt -129.14 -34.76 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.436 1.894 . . . . 0.0 109.425 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.75 -25.63 0.15 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.144 2.578 . . . . 0.0 115.77 169.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . 0.46 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.6 OUTLIER -142.45 148.59 38.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.957 1.703 . . . . 0.0 109.041 -177.503 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.421 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 91.0 m-85 -147.03 156.61 43.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.095 0.958 . . . . 0.0 108.511 -177.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -82.74 143.58 30.78 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.43 0.633 . . . . 0.0 110.203 -175.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.17 -4.36 0.51 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.675 1.99 . . . . 0.0 114.056 170.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.1 -8.92 7.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.364 1.466 . . . . 0.0 112.215 173.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.5 m -76.68 -2.57 33.53 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.102 0.865 . . . . 0.0 112.81 168.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.2 p -131.43 -1.62 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 126.675 1.99 . . . . 0.0 110.931 170.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 62.45 34.12 88.43 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.112 1.339 . . . . 0.0 113.003 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.5 mt . . . . . 0 C--N 1.343 0.309 0 CA-C-N 117.859 0.829 . . . . 0.0 111.524 -174.018 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 86.7 t90 . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.509 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 88.7 m-85 -135.92 136.65 40.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.942 0.897 . . . . 0.0 110.592 -176.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 30.6 p -69.8 164.53 50.35 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 124.259 1.023 . . . . 0.0 112.163 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.28 28.85 0.26 Allowed 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 124.352 3.368 . . . . 0.0 113.817 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -132.15 -30.22 1.56 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.722 2.009 . . . . 0.0 110.079 174.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.443 -0.794 0 C-N-CA 127.301 2.24 . . . . 0.0 112.312 169.88 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.8 p . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -155.34 -44.47 0.08 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.8 p -38.86 169.84 0.0 OUTLIER 'General case' 0 C--N 1.349 0.578 0 C-N-CA 126.299 1.839 . . . . 0.0 114.257 168.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.6 mt -71.05 -6.34 38.28 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 113.417 -1.72 . . . . 0.0 110.129 168.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 86.9 m -96.69 -14.2 22.24 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 123.617 0.767 . . . . 0.0 111.819 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.9 p80 45.87 52.7 9.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.21 2.204 . . . . 0.0 112.779 -173.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.42 140.39 2.27 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 125.818 1.647 . . . . 0.0 107.958 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.4 t -129.34 171.02 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.368 1.467 . . . . 0.0 111.069 -176.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.8 t 67.04 64.75 0.44 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.033 2.133 . . . . 0.0 113.048 -174.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.15 113.63 1.21 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.468 1.907 . . . . 0.0 108.48 -175.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.36 -162.68 23.8 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 123.181 1.434 . . . . 0.0 112.769 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -67.61 145.05 55.23 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 112.223 -1.988 . . . . 0.0 110.829 169.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.4 mtm -146.45 152.89 39.75 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.166 1.787 . . . . 0.0 109.858 -168.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 9.7 tp -138.98 -137.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.36 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 -174.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 152.92 133.01 1.83 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 125.938 1.732 . . . . 0.0 112.375 -169.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 43.9 t -63.08 124.39 21.03 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.081 -1.059 . . . . 0.0 108.395 175.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.63 4.87 1.22 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.353 1.461 . . . . 0.0 113.426 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -74.95 114.59 36.35 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 167.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.31 9.07 2.97 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.384 2.722 . . . . 0.0 113.009 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -123.89 8.76 8.74 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.798 1.639 . . . . 0.0 110.34 175.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . 0.437 ' HG ' ' H ' ' A' ' 219' ' ' ILE . 48.9 t -60.79 130.88 48.69 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 118.293 0.497 . . . . 0.0 109.951 172.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.5 t -73.48 3.86 5.55 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.794 1.638 . . . . 0.0 113.578 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.437 ' H ' ' HG ' ' A' ' 217' ' ' CYS . 30.7 mt -132.96 -34.61 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 126.274 1.829 . . . . 0.0 110.035 -175.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.79 -39.54 0.45 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.624 2.369 . . . . 0.0 115.415 170.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -130.7 148.6 52.5 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.923 2.089 . . . . 0.0 108.371 -174.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -148.63 145.9 27.97 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -175.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -71.64 149.78 45.25 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.634 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.38 -6.04 1.39 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.742 1.217 . . . . 0.0 113.389 168.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -121.66 0.1 9.79 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.454 1.102 . . . . 0.0 112.588 170.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.1 m -72.1 -6.77 44.87 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.946 0.794 . . . . 0.0 111.252 166.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.12 -12.67 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 126.376 1.87 . . . . 0.0 112.627 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.22 36.61 34.44 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.422 1.011 . . . . 0.0 113.113 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 17.0 mt . . . . . 0 CA--C 1.535 0.376 0 C-N-CA 124.309 1.044 . . . . 0.0 109.838 174.003 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.404 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 87.4 t90 . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 121.196 0.522 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -140.08 140.01 36.01 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.204 1.001 . . . . 0.0 109.093 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.404 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 16.6 p -68.94 164.69 44.84 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 123.614 0.765 . . . . 0.0 112.187 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.47 35.3 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.291 3.327 . . . . 0.0 113.071 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -139.55 -28.65 0.76 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.622 1.569 . . . . 0.0 111.032 169.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.441 -0.885 0 C-N-CA 127.521 2.328 . . . . 0.0 112.18 178.149 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -155.55 -41.53 0.08 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -166.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.7 p -38.56 170.15 0.0 OUTLIER 'General case' 0 C--N 1.347 0.49 0 C-N-CA 126.392 1.877 . . . . 0.0 113.973 168.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.1 mt -70.68 -6.17 35.17 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.149 168.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 93.4 m -96.38 -14.14 22.7 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 123.659 0.784 . . . . 0.0 111.705 174.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.2 p80 46.38 50.92 12.06 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.903 2.081 . . . . 0.0 112.388 -174.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -168.26 141.63 3.16 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 125.068 1.347 . . . . 0.0 108.035 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -124.84 -177.39 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.618 1.567 . . . . 0.0 110.293 177.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 10.6 t 62.16 57.59 1.99 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.294 2.238 . . . . 0.0 114.449 -169.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . 0.421 ' H ' ' CE ' ' A' ' 209' ' ' MET . 0.1 OUTLIER -164.04 113.85 1.24 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.574 1.95 . . . . 0.0 109.834 -177.008 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 66.09 -174.23 21.72 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 122.888 1.271 . . . . 0.0 114.099 176.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -62.05 151.3 35.78 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.474 1.91 . . . . 0.0 111.846 169.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' MET . . . . . 0.421 ' CE ' ' H ' ' A' ' 206' ' ' TYR . 26.0 mtt -145.14 160.6 41.18 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.625 1.17 . . . . 0.0 112.724 -166.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . 0.265 9.6 tp -138.33 -139.21 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.406 ' CA ' ' HA ' ' A' ' 221' ' ' TRP . . . 145.73 135.22 2.78 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 126.486 1.993 . . . . 0.0 111.787 -168.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 6.6 t -65.1 123.18 18.83 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 124.447 0.734 . . . . 0.0 109.208 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.68 1.99 0.52 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.851 1.26 . . . . 0.0 113.11 171.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -62.59 112.43 6.57 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.903 2.481 . . . . 0.0 107.658 166.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -78.28 12.17 2.15 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.363 2.709 . . . . 0.0 112.953 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -129.8 9.49 5.42 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.081 1.752 . . . . 0.0 109.811 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 15.4 t -57.88 117.89 4.76 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-O 121.647 0.737 . . . . 0.0 111.669 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.7 t -74.49 -2.37 25.34 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.571 1.948 . . . . 0.0 112.571 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.0 mm -117.6 -37.03 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.041 1.736 . . . . 0.0 109.05 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.51 -30.26 0.21 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.25 2.62 . . . . 0.0 115.462 168.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . 0.406 ' HA ' ' CA ' ' A' ' 211' ' ' GLY . 0.0 OUTLIER -144.46 150.15 37.16 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.19 1.796 . . . . 0.0 109.03 -174.576 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -148.12 148.17 30.32 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -71.57 150.41 44.75 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.413 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -60.16 -4.61 0.84 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.904 1.281 . . . . 0.0 113.595 168.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -120.87 -2.5 9.77 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.765 1.226 . . . . 0.0 112.485 170.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 21.2 m -73.36 -5.05 37.2 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.863 0.756 . . . . 0.0 111.606 167.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.5 p -138.91 -9.4 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 126.986 2.114 . . . . 0.0 112.187 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.0 37.13 60.49 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.409 1.004 . . . . 0.0 112.941 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 24.6 mt . . . . . 0 N--CA 1.467 0.396 0 CA-C-N 117.819 0.81 . . . . 0.0 109.909 175.287 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 78.9 t90 . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . 0.508 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 75.1 m-85 -133.03 135.81 45.62 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.926 0.89 . . . . 0.0 110.298 -176.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.401 ' C ' ' H ' ' A' ' 241' ' ' ARG . 30.8 p -65.6 163.08 37.23 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 123.821 0.848 . . . . 0.0 111.599 170.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.28 28.85 0.26 Allowed 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 124.31 3.34 . . . . 0.0 113.529 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.401 ' H ' ' C ' ' A' ' 239' ' ' CYS . 84.2 mtt-85 -134.17 -34.85 0.95 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.694 1.998 . . . . 0.0 109.377 177.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.447 -0.616 0 C-N-CA 126.602 1.961 . . . . 0.0 112.104 169.349 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 55.3 p . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -155.45 -38.5 0.09 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 115.739 -2.077 . . . . 0.0 115.92 -168.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.476 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.8 OUTLIER -53.48 174.29 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 122.551 2.432 . . . . 0.0 112.169 170.554 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.0 mt -62.47 -6.74 3.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.607 1.563 . . . . 0.0 111.212 171.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 89.1 m -98.22 -12.53 21.56 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 126.186 1.794 . . . . 0.0 112.71 179.29 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.8 p80 44.97 48.29 9.39 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.219 2.208 . . . . 0.0 112.368 -173.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -162.94 147.16 11.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.461 1.504 . . . . 0.0 108.047 176.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.62 175.44 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 127.157 2.183 . . . . 0.0 110.109 178.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.6 t 59.82 65.91 1.06 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.347 1.859 . . . . 0.0 112.824 -174.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.62 102.89 1.36 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.344 1.858 . . . . 0.0 109.163 -173.561 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 68.45 -98.4 0.52 Allowed Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.386 1.47 . . . . 0.0 110.392 -172.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.26 170.67 15.55 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.401 1.88 . . . . 0.0 111.731 -174.036 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -143.97 160.19 41.26 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.903 1.281 . . . . 0.0 111.364 -169.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 4.6 tp -133.42 -135.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.372 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 169.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 148.19 133.7 2.35 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 125.434 1.493 . . . . 0.0 112.478 -172.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 53.6 t -64.89 119.32 10.46 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.366 -0.917 . . . . 0.0 109.055 174.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -70.01 5.28 1.66 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.695 1.598 . . . . 0.0 113.874 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -68.8 119.78 71.58 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 168.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.95 5.88 4.16 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.317 2.678 . . . . 0.0 113.312 178.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.86 6.06 12.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.657 1.583 . . . . 0.0 110.608 174.216 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 42.5 t -60.53 129.06 39.7 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 123.584 0.753 . . . . 0.0 110.442 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.2 m -79.91 4.47 16.66 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.496 1.518 . . . . 0.0 113.333 -176.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.6 mm -135.1 -36.27 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.787 1.635 . . . . 0.0 110.348 -169.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.45 -41.65 0.51 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.84 2.856 . . . . 0.0 115.201 170.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . 0.476 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -129.08 148.09 50.99 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.738 1.615 . . . . 0.0 109.276 -176.057 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.42 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 81.4 m-85 -149.38 157.54 43.4 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 124.94 1.296 . . . . 0.0 108.84 -175.193 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -88.24 144.11 26.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.304 0.573 . . . . 0.0 111.098 -171.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -57.43 -7.2 0.56 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.292 2.237 . . . . 0.0 114.265 170.078 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.22 -8.29 8.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.029 1.332 . . . . 0.0 112.207 174.228 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 10.0 m -77.11 -2.51 34.63 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.07 0.85 . . . . 0.0 112.87 168.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 12.9 p -131.72 -2.03 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 126.435 1.894 . . . . 0.0 111.116 170.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.2 34.38 89.77 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.938 1.256 . . . . 0.0 112.894 -177.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.2 mt . . . . . 0 C--N 1.342 0.266 0 C-N-CA 124.183 0.993 . . . . 0.0 111.919 -174.299 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.5 t90 . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -140.67 141.78 34.99 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.275 1.03 . . . . 0.0 110.348 178.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.7 p -70.37 165.61 42.9 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.082 0.953 . . . . 0.0 111.731 174.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.47 29.32 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.994 3.13 . . . . 0.0 113.569 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -135.58 -33.8 0.86 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.664 1.586 . . . . 0.0 110.091 174.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.44 -0.959 0 C-N-CA 126.554 1.941 . . . . 0.0 111.99 170.381 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 57.6 p . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -156.33 -39.95 0.08 Allowed 'General case' 0 C--N 1.353 0.735 0 CA-C-O 115.621 -2.133 . . . . 0.0 115.207 -169.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 222' ' ' PHE . 0.7 OUTLIER -51.53 175.47 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 122.01 2.186 . . . . 0.0 112.953 176.538 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.9 -5.11 3.92 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.082 -1.417 . . . . 0.0 111.21 170.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 88.6 m -99.32 -15.95 18.63 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 125.976 1.711 . . . . 0.0 112.548 176.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 51.12 46.82 25.9 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.723 2.009 . . . . 0.0 111.628 -177.142 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -164.51 147.27 8.85 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.764 1.626 . . . . 0.0 107.621 179.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.432 HG11 ' H ' ' A' ' 205' ' ' SER . 0.5 OUTLIER -132.35 -178.14 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 127.355 2.262 . . . . 0.0 109.553 175.654 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.432 ' H ' HG11 ' A' ' 204' ' ' VAL . 8.2 t 60.16 58.32 2.69 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.93 1.692 . . . . 0.0 113.08 -172.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.89 114.48 2.58 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.944 2.098 . . . . 0.0 109.122 -175.202 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.86 -109.34 2.48 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 125.571 1.558 . . . . 0.0 110.827 -175.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.78 169.11 18.36 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.627 1.971 . . . . 0.0 111.546 -173.618 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -141.69 161.26 38.38 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.146 0.978 . . . . 0.0 112.627 -167.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 7.5 tp -135.78 -135.32 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 168.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 145.61 130.47 2.2 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 125.559 1.552 . . . . 0.0 112.096 -170.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 41.0 t -63.82 122.66 16.97 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.78 -2.12 2.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.692 1.597 . . . . 0.0 113.506 -179.216 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -69.25 116.25 40.39 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.277 1.031 . . . . 0.0 108.518 168.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -78.08 8.58 3.44 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.036 2.491 . . . . 0.0 112.916 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -121.37 6.4 10.15 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.727 1.611 . . . . 0.0 110.145 174.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.9 t -60.98 129.95 43.96 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 118.683 0.674 . . . . 0.0 109.589 171.124 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.3 t -74.94 6.31 4.22 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.708 1.603 . . . . 0.0 113.188 -176.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.3 mm -134.45 -36.81 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 126.134 1.774 . . . . 0.0 109.776 -171.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . 0.251 0.0 OUTLIER 71.06 -43.88 0.57 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.355 2.662 . . . . 0.0 115.497 169.737 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . 0.453 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -125.33 148.77 48.6 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.469 1.908 . . . . 0.0 108.511 -178.383 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.455 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 72.9 m-85 -147.89 154.51 40.48 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.147 0.979 . . . . 0.0 108.804 -175.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -84.58 144.08 28.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.447 0.641 . . . . 0.0 110.499 -175.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -57.0 -7.12 0.43 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.363 2.265 . . . . 0.0 114.413 169.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.58 -8.02 8.55 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.877 1.271 . . . . 0.0 112.184 173.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 14.4 m -77.61 -2.26 34.95 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.088 0.858 . . . . 0.0 113.051 168.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.5 p -129.53 -4.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 126.447 1.899 . . . . 0.0 111.039 169.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.29 35.4 91.48 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.938 1.256 . . . . 0.0 112.82 -175.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.4 mt . . . . . 0 C--N 1.343 0.287 0 C-N-CA 123.863 0.865 . . . . 0.0 111.326 -176.385 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 87.2 t90 . . . . . 0 CA--C 1.54 0.565 0 CA-C-O 121.319 0.581 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -139.29 139.1 37.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.312 1.445 . . . . 0.0 108.375 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 13.4 p -68.2 165.87 29.7 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 123.143 0.577 . . . . 0.0 111.9 172.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.26 31.6 0.31 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.327 3.351 . . . . 0.0 113.389 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -136.36 -37.81 0.69 Allowed 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.494 1.517 . . . . 0.0 109.816 169.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.441 -0.91 0 C-N-CA 126.565 1.946 . . . . 0.0 112.721 173.761 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -156.17 -45.61 0.08 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -168.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.0 p -40.25 170.28 0.0 OUTLIER 'General case' 0 C--N 1.349 0.586 0 C-N-CA 126.091 1.757 . . . . 0.0 114.252 169.136 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -71.3 -6.14 37.63 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.137 168.327 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 95.1 m -97.03 -13.36 22.32 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 123.499 0.72 . . . . 0.0 111.776 175.021 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.9 p80 46.37 53.38 9.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.862 2.065 . . . . 0.0 112.755 -174.006 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -171.0 142.12 1.79 Allowed 'General case' 0 C--N 1.347 0.474 0 C-N-CA 125.652 1.581 . . . . 0.0 108.114 177.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.1 t -123.79 168.92 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 125.606 1.562 . . . . 0.0 110.933 177.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 10.5 t 70.81 61.06 0.19 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.144 2.178 . . . . 0.0 113.389 -176.248 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -162.72 108.95 1.2 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.986 2.115 . . . . 0.0 107.403 -176.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.44 -168.94 29.89 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 122.643 1.135 . . . . 0.0 110.761 -168.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -72.79 164.3 26.78 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.06 1.344 . . . . 0.0 111.978 169.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -138.54 155.46 48.36 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.693 1.597 . . . . 0.0 110.652 -169.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.0 tp -131.6 -139.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 149.11 130.76 1.91 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 125.812 1.673 . . . . 0.0 112.428 -169.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 40.6 t -62.73 123.19 17.78 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.468 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.1 0.18 1.4 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.027 1.331 . . . . 0.0 113.529 -179.332 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -70.4 115.05 30.93 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 167.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.56 9.14 3.02 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.304 2.669 . . . . 0.0 113.017 -179.412 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -124.02 8.29 8.65 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.988 1.715 . . . . 0.0 110.206 175.178 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . 0.424 ' HG ' ' H ' ' A' ' 219' ' ' ILE . 48.7 t -60.45 129.23 40.56 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 118.605 0.639 . . . . 0.0 109.558 170.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -73.4 3.41 6.01 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.999 1.72 . . . . 0.0 113.368 -175.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.424 ' H ' ' HG ' ' A' ' 217' ' ' CYS . 26.6 mt -132.01 -34.22 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 126.37 1.868 . . . . 0.0 109.965 -175.414 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.99 -37.35 0.39 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.357 2.263 . . . . 0.0 115.76 170.341 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -132.58 148.57 52.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.864 2.065 . . . . 0.0 108.785 -174.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -148.02 148.52 30.79 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -177.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -73.02 150.15 42.65 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.895 178.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -60.96 -4.27 0.98 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.369 1.467 . . . . 0.0 113.417 167.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.2 -1.63 9.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.771 1.228 . . . . 0.0 112.558 170.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.4 m -72.43 -7.48 50.04 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.96 0.8 . . . . 0.0 111.296 167.031 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 2.8 p -134.38 -13.98 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 127.283 2.233 . . . . 0.0 112.016 179.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.86 37.46 44.36 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.592 1.091 . . . . 0.0 112.934 -176.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 20.6 mt . . . . . 0 N--CA 1.467 0.413 0 C-N-CA 123.732 0.813 . . . . 0.0 110.235 176.172 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.434 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 88.3 t90 . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.282 0.563 . . . . 0.0 109.702 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.01 142.13 34.28 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.337 1.055 . . . . 0.0 109.199 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.434 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 2.4 p -63.03 165.37 10.45 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 123.72 0.808 . . . . 0.0 112.026 175.582 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.95 23.96 0.34 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.543 2.828 . . . . 0.0 113.643 -173.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -134.54 -33.07 0.99 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 125.687 1.595 . . . . 0.0 110.472 174.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.443 -0.782 0 C-N-CA 126.72 2.008 . . . . 0.0 111.533 169.315 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -154.72 -47.43 0.09 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -173.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.8 p -38.29 169.62 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 0 C-N-CA 126.401 1.881 . . . . 0.0 114.444 168.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.72 -6.69 39.23 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.198 168.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 89.7 m -96.08 -14.51 22.84 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 123.602 0.761 . . . . 0.0 111.71 174.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.2 p80 45.73 52.85 9.24 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.211 2.204 . . . . 0.0 112.759 -173.382 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.17 140.88 2.47 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 125.866 1.666 . . . . 0.0 107.889 179.178 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.4 t -129.2 172.72 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.336 1.454 . . . . 0.0 111.051 -176.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.0 t 66.16 60.73 0.63 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.769 2.027 . . . . 0.0 113.208 -174.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.02 112.52 1.83 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.566 1.946 . . . . 0.0 108.318 -175.218 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.85 -163.45 24.42 Favored Glycine 0 C--N 1.34 0.759 0 CA-C-O 123.314 1.508 . . . . 0.0 112.931 -176.503 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.6 pm0 -67.88 146.13 53.94 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.028 2.131 . . . . 0.0 111.074 169.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.0 mtm -146.85 155.58 42.44 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.198 1.799 . . . . 0.0 110.461 -167.078 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 8.2 tp -138.89 -138.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.41 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -175.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 152.22 133.93 2.02 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 126.239 1.876 . . . . 0.0 112.46 -169.61 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.25 123.59 20.36 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 114.179 -1.011 . . . . 0.0 109.398 177.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.19 0.14 2.18 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.314 1.846 . . . . 0.0 114.86 178.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -68.44 118.91 64.35 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.57 1.148 . . . . 0.0 108.592 169.627 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.26 7.27 3.43 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.413 2.742 . . . . 0.0 113.242 178.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -123.04 9.84 9.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.044 1.738 . . . . 0.0 110.358 174.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 42.6 t -58.65 128.87 39.34 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 123.494 0.718 . . . . 0.0 110.607 173.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.6 t -78.19 1.44 21.41 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.668 1.587 . . . . 0.0 113.072 -177.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.4 mm -132.7 -36.2 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 125.484 1.513 . . . . 0.0 110.375 -169.432 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.9 -39.16 0.42 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.415 2.686 . . . . 0.0 115.63 170.526 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.16 149.07 51.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.176 1.791 . . . . 0.0 108.803 -174.569 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -149.34 147.01 27.82 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -176.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -73.11 150.49 42.2 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.771 0.796 . . . . 0.0 111.189 178.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -60.52 -4.02 0.81 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.374 1.47 . . . . 0.0 113.304 168.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.12 -2.03 8.18 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.074 1.35 . . . . 0.0 112.556 171.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.2 m -71.34 -8.11 51.57 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.043 0.838 . . . . 0.0 111.394 167.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.7 p -136.02 -4.1 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.084 1.753 . . . . 0.0 111.863 174.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 69.3 30.24 71.61 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.848 1.213 . . . . 0.0 112.909 -175.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 C--N 1.343 0.291 0 C-N-CA 124.662 1.185 . . . . 0.0 112.043 -172.264 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 82.2 t90 . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -139.59 136.4 34.35 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.638 0.775 . . . . 0.0 110.03 -177.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 10.8 p -66.95 164.07 38.31 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.125 0.97 . . . . 0.0 111.871 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -72.49 22.69 0.28 Allowed 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 123.94 3.094 . . . . 0.0 114.054 -177.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 -134.21 6.19 3.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.441 1.497 . . . . 0.0 112.027 172.097 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.438 -1.029 0 C-N-CA 128.128 2.571 . . . . 0.0 110.01 -175.487 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 73.8 p . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -155.12 -44.7 0.08 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -175.457 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.8 p -39.23 170.2 0.0 OUTLIER 'General case' 0 C--N 1.35 0.615 0 C-N-CA 126.273 1.829 . . . . 0.0 114.216 168.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.89 -6.62 39.7 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 113.425 -1.716 . . . . 0.0 110.115 168.172 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 85.3 m -96.79 -14.22 22.09 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 123.7 0.8 . . . . 0.0 111.725 174.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.9 p80 45.73 53.18 8.95 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.138 2.175 . . . . 0.0 112.811 -173.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.74 140.77 2.18 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 125.858 1.663 . . . . 0.0 107.911 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.93 170.04 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.364 1.465 . . . . 0.0 111.105 -175.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.1 t 65.89 66.1 0.51 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.083 2.153 . . . . 0.0 113.09 -174.609 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.24 111.3 1.08 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.566 1.946 . . . . 0.0 108.336 -175.496 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.47 -163.45 22.6 Favored Glycine 0 C--N 1.34 0.778 0 CA-C-O 123.254 1.474 . . . . 0.0 112.592 -174.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -65.71 149.06 50.74 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 112.237 -1.981 . . . . 0.0 111.193 169.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.0 mtm -147.41 156.9 43.31 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.138 1.775 . . . . 0.0 110.067 -167.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 4.9 tp -141.01 -138.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.369 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 151.49 132.88 1.94 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 126.11 1.814 . . . . 0.0 112.629 -169.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 46.6 t -64.35 125.64 25.26 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.064 0.946 . . . . 0.0 108.814 177.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.08 -2.74 2.16 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.533 1.533 . . . . 0.0 114.068 178.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -70.44 116.08 41.47 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 124.136 0.975 . . . . 0.0 108.387 169.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -76.99 4.4 5.79 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.315 2.677 . . . . 0.0 113.103 179.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -117.49 7.09 12.63 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.896 1.678 . . . . 0.0 110.36 174.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.7 t -58.42 127.82 34.04 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 123.113 0.565 . . . . 0.0 110.005 170.459 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.8 t -74.5 2.48 9.52 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.796 1.639 . . . . 0.0 113.207 -176.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 30.2 mt -132.19 -33.78 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.069 1.748 . . . . 0.0 110.247 -173.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.69 -37.64 0.4 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.006 2.522 . . . . 0.0 115.305 170.313 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.06 148.96 52.2 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 126.777 2.031 . . . . 0.0 108.677 -174.032 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -148.44 146.62 28.5 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -176.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -70.63 150.61 45.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.942 0.877 . . . . 0.0 110.884 178.183 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -60.63 -5.06 1.09 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.073 1.349 . . . . 0.0 113.727 168.3 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.47 -0.84 9.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.656 1.182 . . . . 0.0 112.372 170.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.8 m -71.69 -7.19 46.46 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.892 0.769 . . . . 0.0 111.531 167.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 p -137.39 -11.51 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.809 1.244 . . . . 0.0 113.269 173.037 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 80.39 41.28 11.74 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.514 1.054 . . . . 0.0 113.54 -175.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 24.0 mt . . . . . 0 N--CA 1.472 0.637 0 CA-C-N 118.295 1.047 . . . . 0.0 111.439 171.476 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.408 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 88.9 t90 . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 121.211 0.529 . . . . 0.0 110.305 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -141.06 139.78 34.13 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.184 0.994 . . . . 0.0 109.2 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.408 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 14.5 p -66.69 165.11 27.38 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.674 0.789 . . . . 0.0 111.957 177.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.5 31.93 0.28 Allowed 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.908 3.072 . . . . 0.0 113.413 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -135.97 -38.09 0.72 Allowed 'General case' 0 C--N 1.345 0.373 0 C-N-CA 125.584 1.554 . . . . 0.0 109.689 171.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 26.6 m . . . . . 0 N--CA 1.441 -0.899 0 C-N-CA 126.585 1.954 . . . . 0.0 111.888 171.811 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -154.8 -43.62 0.09 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.71 1.204 . . . . 0.0 110.536 -174.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 64.8 mtt 33.4 62.38 1.62 Allowed Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 128.155 2.582 . . . . 0.0 114.413 169.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -67.49 160.59 47.21 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.369 2.712 . . . . 0.0 112.159 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.9 p -138.2 0.68 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.268 1.427 . . . . 0.0 111.539 -175.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -51.73 -44.56 90.8 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.987 1.715 . . . . 0.0 113.303 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.46 111.48 3.32 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 121.89 1.727 . . . . 0.0 109.302 169.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -73.29 -7.21 50.57 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.03 0.932 . . . . 0.0 112.601 173.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -145.6 72.51 14.04 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.571 1.548 . . . . 0.0 108.366 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.21 159.12 37.21 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.609 2.872 . . . . 0.0 111.107 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 64.14 147.0 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.327 2.251 . . . . 0.0 112.272 -171.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -154.74 -43.95 0.09 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -166.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.8 p -38.05 169.66 0.0 OUTLIER 'General case' 0 C--N 1.348 0.54 0 C-N-CA 126.385 1.874 . . . . 0.0 114.414 169.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.0 mt -70.69 -6.16 35.14 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 113.399 -1.728 . . . . 0.0 110.12 168.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 93.8 m -96.15 -14.22 22.96 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 123.423 0.689 . . . . 0.0 111.738 173.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.6 p80 46.08 52.16 10.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.912 2.085 . . . . 0.0 112.406 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -169.01 141.47 2.66 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.482 1.513 . . . . 0.0 108.018 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.44 174.87 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.475 1.51 . . . . 0.0 110.51 176.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.1 t 66.69 60.89 0.55 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.701 2.0 . . . . 0.0 113.429 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.51 120.11 1.77 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.98 2.112 . . . . 0.0 107.881 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.44 -151.2 43.5 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 122.613 1.118 . . . . 0.0 111.49 -172.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.58 169.26 10.47 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.388 1.875 . . . . 0.0 111.255 170.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -136.89 162.26 33.73 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.913 1.285 . . . . 0.0 111.677 -169.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 11.2 tt -138.0 -139.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 169.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 147.47 132.22 2.23 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 125.79 1.662 . . . . 0.0 111.57 -169.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 41.4 t -64.25 123.9 20.32 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.81 -0.48 3.03 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.365 1.466 . . . . 0.0 113.686 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -70.25 117.31 53.35 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.67 4.16 5.84 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.301 2.667 . . . . 0.0 113.168 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -117.37 7.63 12.87 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.85 1.66 . . . . 0.0 110.456 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.1 t -58.33 127.23 31.08 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 123.192 0.597 . . . . 0.0 109.736 170.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 70.5 m -77.01 5.95 7.17 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.538 1.535 . . . . 0.0 113.304 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.9 mm -132.58 -35.53 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 126.082 1.753 . . . . 0.0 109.95 -173.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.44 -42.9 0.55 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.512 2.725 . . . . 0.0 115.333 169.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.42 149.71 51.09 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.4 1.88 . . . . 0.0 108.431 -175.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -149.42 149.31 30.62 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -73.4 149.63 42.35 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.62 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.95 -3.59 0.81 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.985 1.714 . . . . 0.0 112.394 168.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.45 -3.74 8.35 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.674 1.59 . . . . 0.0 112.462 172.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.9 m -71.62 -7.47 48.0 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.06 0.845 . . . . 0.0 111.281 166.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -134.71 -4.63 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 126.853 2.061 . . . . 0.0 111.591 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.97 31.11 74.7 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.904 1.24 . . . . 0.0 113.272 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 4.6 mt -62.48 -52.95 61.48 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.338 1.055 . . . . 0.0 112.584 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.5 m 63.87 -17.42 0.07 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.699 2.0 . . . . 0.0 114.411 -173.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 82.8 p -143.64 164.74 29.56 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.268 1.827 . . . . 0.0 110.327 -175.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -70.18 123.13 88.26 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.029 173.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.62 -55.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.567 2.178 . . . . 0.0 111.594 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 4.3 ttp85 -175.31 -176.6 0.93 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.654 1.981 . . . . 0.0 109.403 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -78.32 17.73 6.08 Favored Glycine 0 CA--C 1.539 1.567 0 CA-C-O 118.821 -0.988 . . . . 0.0 113.639 169.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -159.3 120.52 3.27 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 125.401 1.48 . . . . 0.0 108.063 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.419 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 79.2 t90 -138.74 163.66 31.6 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.358 1.863 . . . . 0.0 110.777 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -141.68 140.45 33.2 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.076 1.35 . . . . 0.0 109.283 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.419 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 15.0 p -66.67 165.32 25.84 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 123.467 0.707 . . . . 0.0 112.198 177.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.06 35.23 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.97 3.113 . . . . 0.0 113.08 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -137.95 -38.37 0.57 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.445 1.498 . . . . 0.0 109.764 169.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 28.7 m -70.81 -35.57 72.58 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.756 2.022 . . . . 0.0 111.805 171.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 t -77.35 -27.43 52.66 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.175 1.39 . . . . 0.0 112.082 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -66.33 -24.77 66.58 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.015 0.926 . . . . 0.0 112.431 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.26 -19.55 64.73 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.831 1.252 . . . . 0.0 113.1 176.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.63 72.3 1.39 Allowed 'General case' 0 C--N 1.347 0.476 0 C-N-CA 125.401 1.48 . . . . 0.0 109.655 177.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -82.67 91.7 7.03 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.986 1.314 . . . . 0.0 108.611 170.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.69 27.33 3.66 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.109 1.764 . . . . 0.0 112.18 -175.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? . . . . . 0 C--O 1.25 1.097 0 C-N-CA 130.901 3.68 . . . . 0.0 109.502 -175.898 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 55.4 40.3 31.34 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.377 1.471 . . . . 0.0 113.355 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 94.4 mtp -132.23 81.33 61.49 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.407 1.483 . . . . 0.0 109.351 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -74.55 86.49 1.34 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.034 3.156 . . . . 0.0 110.016 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 10.8 p -136.08 55.85 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.991 1.316 . . . . 0.0 110.067 -173.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -49.72 -45.27 79.18 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 116.932 -1.509 . . . . 0.0 113.878 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.16 91.26 1.04 Allowed 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.811 2.341 . . . . 0.0 110.611 172.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -150.49 57.93 0.94 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.891 1.276 . . . . 0.0 109.6 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -133.02 70.15 78.61 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.858 1.263 . . . . 0.0 109.739 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.96 105.35 1.34 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.898 3.065 . . . . 0.0 110.329 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 47.2 p -146.06 139.46 26.07 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.423 1.889 . . . . 0.0 108.121 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -155.04 -45.39 0.08 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -168.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.7 p -38.01 169.66 0.0 OUTLIER 'General case' 0 C--N 1.348 0.54 0 C-N-CA 126.429 1.892 . . . . 0.0 114.269 168.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.49 -6.3 35.07 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 113.452 -1.703 . . . . 0.0 110.199 168.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 89.5 m -97.34 -14.17 21.44 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 123.812 0.845 . . . . 0.0 111.805 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.5 p80 45.06 51.85 8.67 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.109 2.164 . . . . 0.0 112.842 -173.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -167.34 139.24 3.23 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 125.762 1.625 . . . . 0.0 107.94 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.95 172.32 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.307 1.443 . . . . 0.0 111.058 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.0 t 65.44 63.47 0.63 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.833 2.053 . . . . 0.0 112.792 -173.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.07 112.55 1.34 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.555 1.942 . . . . 0.0 108.45 -175.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.01 -161.65 24.18 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-O 123.283 1.49 . . . . 0.0 113.124 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.6 pm0 -68.26 143.79 55.12 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.155 2.182 . . . . 0.0 111.128 169.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.4 mtm -147.09 155.11 41.91 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.38 1.872 . . . . 0.0 110.289 -167.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 9.2 tp -139.02 -138.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.409 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 150.91 131.23 1.8 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 126.152 1.834 . . . . 0.0 112.301 -169.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 42.2 t -63.05 121.71 14.27 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.259 1.023 . . . . 0.0 108.559 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.85 1.4 1.89 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.384 1.474 . . . . 0.0 113.868 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -69.94 117.89 58.2 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.474 1.11 . . . . 0.0 108.072 168.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.35 6.21 4.13 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.305 2.67 . . . . 0.0 113.234 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -120.89 9.22 10.6 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.817 1.647 . . . . 0.0 110.482 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 45.1 t -59.23 128.63 38.08 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.316 0.646 . . . . 0.0 110.116 171.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 44.0 m -76.14 2.99 11.5 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.59 1.556 . . . . 0.0 113.542 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.8 mm -133.78 -35.33 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.925 1.69 . . . . 0.0 109.966 -170.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.91 -39.53 0.45 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 128.422 2.689 . . . . 0.0 115.454 169.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.87 148.95 51.32 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.305 1.842 . . . . 0.0 108.74 -174.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -150.06 146.02 26.71 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.4 -1.334 . . . . 0.0 107.4 -175.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -72.23 151.43 42.87 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.721 0.772 . . . . 0.0 111.043 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.33 -4.31 0.82 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.352 1.461 . . . . 0.0 113.06 167.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.33 -3.6 8.93 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.305 1.442 . . . . 0.0 112.544 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 20.6 m -72.43 -6.0 40.51 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.114 0.87 . . . . 0.0 111.715 167.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 10.9 p -135.4 -4.95 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 126.29 1.836 . . . . 0.0 111.797 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.34 35.77 90.71 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.667 1.127 . . . . 0.0 112.924 -173.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.7 mt -64.82 -51.3 62.87 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 124.358 1.063 . . . . 0.0 111.493 -175.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 18.0 m 62.16 -10.42 0.08 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.132 2.173 . . . . 0.0 114.738 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 11.1 t -149.59 170.0 19.67 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.049 1.739 . . . . 0.0 110.191 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -62.9 127.15 90.24 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.838 1.255 . . . . 0.0 109.943 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.1 168.46 20.49 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.381 2.72 . . . . 0.0 112.114 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -71.03 170.73 12.21 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.159 0.983 . . . . 0.0 110.218 168.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -57.24 152.39 25.17 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.186 0.898 . . . . 0.0 113.368 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 46.6 tttp 40.3 74.84 0.09 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.375 2.27 . . . . 0.0 113.395 -172.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.402 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 84.5 t90 -76.33 159.03 30.92 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.811 0.845 . . . . 0.0 110.113 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -138.82 139.87 38.35 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.153 0.981 . . . . 0.0 109.587 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.402 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 13.9 p -65.7 163.43 35.03 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.436 0.695 . . . . 0.0 111.658 174.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.41 28.66 0.27 Allowed 'Trans proline' 0 CA--C 1.548 1.198 0 C-N-CA 124.013 3.142 . . . . 0.0 113.694 -178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -136.02 -32.95 0.86 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.555 1.542 . . . . 0.0 110.422 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 15.8 m -74.83 -35.29 62.42 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 126.556 1.942 . . . . 0.0 111.727 169.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 10.1 t -76.17 -12.24 60.07 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.215 1.406 . . . . 0.0 112.863 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -61.99 -25.5 67.67 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.206 1.402 . . . . 0.0 112.312 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -51.88 -29.93 21.87 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.197 1.799 . . . . 0.0 114.4 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 39.16 54.59 2.18 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.175 2.19 . . . . 0.0 113.662 170.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -76.6 71.15 3.19 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.878 1.671 . . . . 0.0 111.104 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -146.96 35.18 0.91 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.336 1.455 . . . . 0.0 110.817 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt . . . . . 0 C--O 1.251 1.167 0 CA-C-O 117.533 -1.222 . . . . 0.0 110.112 175.007 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 60.4 ttm . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -144.35 157.95 43.99 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.262 1.025 . . . . 0.0 110.695 -168.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 27.2 ttt -148.25 83.45 7.17 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.506 1.122 . . . . 0.0 108.828 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -79.9 24.04 0.65 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.614 3.543 . . . . 0.0 112.865 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 14.9 p -130.05 51.8 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.483 1.513 . . . . 0.0 110.492 -169.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.537 ' H ' ' HD2' ' A' ' 193' ' ' PRO . 27.4 m-20 -131.83 -46.5 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 116.595 -1.669 . . . . 0.0 112.764 174.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.537 ' HD2' ' H ' ' A' ' 192' ' ' ASP . 89.3 Cg_endo -77.56 93.66 1.08 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.433 2.089 . . . . 0.0 110.419 177.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -142.23 -15.82 0.76 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -172.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -77.61 121.28 84.08 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 119.61 1.095 . . . . 0.0 109.933 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -82.41 165.0 16.6 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.308 2.672 . . . . 0.0 111.614 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.3 p -143.13 144.55 32.26 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.647 1.579 . . . . 0.0 108.865 -174.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -155.15 -46.53 0.08 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.8 p -37.46 169.54 0.0 OUTLIER 'General case' 0 C--N 1.351 0.637 0 C-N-CA 126.665 1.986 . . . . 0.0 114.593 169.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.4 -6.23 34.06 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 113.311 -1.768 . . . . 0.0 110.08 168.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 86.6 m -97.46 -14.41 21.17 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 123.841 0.856 . . . . 0.0 111.776 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.2 p80 45.67 52.16 9.62 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.236 2.214 . . . . 0.0 112.807 -173.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -169.5 140.53 2.26 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.678 1.591 . . . . 0.0 107.906 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.07 173.37 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.219 1.407 . . . . 0.0 111.168 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.2 t 66.33 61.68 0.58 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.983 2.113 . . . . 0.0 113.537 -175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -161.98 114.1 1.72 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.39 1.876 . . . . 0.0 108.548 -175.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 62.12 -164.03 24.4 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-O 123.084 1.38 . . . . 0.0 112.702 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -66.14 147.18 53.72 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 112.405 -1.898 . . . . 0.0 110.92 169.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 75.7 mtm -146.33 154.26 41.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.939 1.696 . . . . 0.0 110.045 -168.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.6 tp -138.56 -139.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.357 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 149.8 131.0 1.87 Allowed Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 126.203 1.859 . . . . 0.0 112.289 -169.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.83 123.53 18.7 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.295 1.038 . . . . 0.0 108.557 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.05 -2.16 2.58 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.153 1.381 . . . . 0.0 113.467 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -69.64 117.38 52.63 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 168.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.5 4.93 5.09 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.131 2.554 . . . . 0.0 113.166 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -118.58 8.24 11.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.954 1.702 . . . . 0.0 110.416 174.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 50.0 t -58.25 127.6 32.95 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.181 0.593 . . . . 0.0 109.897 170.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.7 t -74.69 2.87 8.93 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.576 1.55 . . . . 0.0 113.444 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.6 mm -132.96 -34.96 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 126.072 1.749 . . . . 0.0 109.931 -171.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.34 -39.31 0.44 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.186 2.595 . . . . 0.0 115.52 169.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.82 149.81 50.41 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.403 1.881 . . . . 0.0 108.929 -174.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -149.5 146.37 27.36 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 -176.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -70.36 149.81 46.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.548 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -60.75 -4.9 1.07 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.977 1.311 . . . . 0.0 113.237 168.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -120.62 -2.05 9.97 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.732 1.213 . . . . 0.0 112.543 170.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 16.9 m -73.11 -5.65 40.46 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.933 0.788 . . . . 0.0 111.507 167.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 p -135.7 -13.41 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 126.853 2.061 . . . . 0.0 112.323 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 75.77 37.98 37.96 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.562 1.077 . . . . 0.0 112.922 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 18.3 mt -69.42 106.05 2.81 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.92 0.888 . . . . 0.0 110.159 174.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 37.5 m -69.82 -25.38 63.74 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.661 1.184 . . . . 0.0 111.631 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 13.7 t -151.34 178.01 9.7 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.568 1.547 . . . . 0.0 110.09 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -59.91 129.01 87.68 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.995 1.318 . . . . 0.0 110.091 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.65 169.63 21.44 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.174 2.583 . . . . 0.0 111.717 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -74.96 169.82 17.21 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.948 169.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -59.93 155.16 30.91 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 123.339 0.495 . . . . 0.0 112.375 176.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.6 tptp 51.54 60.97 3.48 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.393 1.477 . . . . 0.0 112.096 -173.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.416 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 83.3 t90 -73.8 157.83 35.69 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.346 0.658 . . . . 0.0 109.995 174.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -139.54 139.73 36.95 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.351 1.06 . . . . 0.0 109.377 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.416 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 14.2 p -66.36 166.69 15.84 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.96 0.904 . . . . 0.0 112.401 176.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.67 36.79 0.4 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.914 3.076 . . . . 0.0 112.985 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -139.96 -39.62 0.45 Allowed 'General case' 0 C--N 1.344 0.366 0 C-N-CA 125.336 1.455 . . . . 0.0 109.582 168.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.1 m -71.28 -34.28 70.53 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.722 2.009 . . . . 0.0 112.038 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.0 t -77.93 -33.17 51.83 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.529 1.131 . . . . 0.0 111.376 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -62.63 -25.64 68.21 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 124.808 1.243 . . . . 0.0 112.497 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -49.95 -46.25 52.05 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.875 2.07 . . . . 0.0 112.56 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -157.89 78.08 0.83 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.707 0.803 . . . . 0.0 109.989 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -69.99 93.25 0.77 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.442 1.097 . . . . 0.0 109.288 171.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -132.43 47.95 2.46 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.059 1.744 . . . . 0.0 109.365 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt . . . . . 0 C--O 1.249 1.079 0 C-N-CA 126.5 1.92 . . . . 0.0 111.424 179.611 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -144.41 141.15 29.45 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.94 0.896 . . . . 0.0 110.171 -168.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 25.9 mmt -143.31 69.28 17.71 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.3 1.44 . . . . 0.0 109.258 -178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.38 111.25 2.24 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.33 2.686 . . . . 0.0 110.042 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 5.8 p -148.17 3.76 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 124.465 1.106 . . . . 0.0 112.266 -170.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -137.61 91.97 13.52 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.225 1.41 . . . . 0.0 108.654 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.53 132.8 16.52 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.034 2.49 . . . . 0.0 110.556 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -135.37 29.76 3.29 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.133 1.373 . . . . 0.0 110.709 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -31.93 99.22 0.13 Allowed Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 129.896 3.278 . . . . 0.0 113.701 -172.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -87.48 164.58 8.03 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.2 3.267 . . . . 0.0 112.219 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.7 p 66.17 142.78 0.03 OUTLIER 'General case' 0 C--N 1.347 0.475 0 C-N-CA 127.693 2.397 . . . . 0.0 112.62 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -154.93 -37.89 0.09 Allowed 'General case' 0 C--N 1.349 0.56 0 CA-C-O 116.027 -1.939 . . . . 0.0 115.042 -168.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.459 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.7 OUTLIER -52.88 172.61 0.05 OUTLIER 'General case' 0 C--N 1.358 0.938 0 CA-C-N 122.002 2.183 . . . . 0.0 112.245 170.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.5 mt -63.24 -5.09 2.96 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.749 1.619 . . . . 0.0 111.24 172.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.2 m -99.21 -12.12 20.71 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 126.105 1.762 . . . . 0.0 112.585 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.0 p80 46.04 50.02 11.86 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 126.678 1.991 . . . . 0.0 111.894 -174.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -165.2 148.12 8.13 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.931 1.293 . . . . 0.0 107.901 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.0 173.66 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 126.958 2.103 . . . . 0.0 110.78 176.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.9 t 65.19 63.93 0.64 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.85 2.06 . . . . 0.0 113.067 -174.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.59 112.23 0.92 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.324 1.85 . . . . 0.0 109.034 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 60.1 -160.65 21.05 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 123.09 1.383 . . . . 0.0 112.982 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -66.11 143.29 57.4 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 112.253 -1.973 . . . . 0.0 111.097 169.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.0 mtm -149.04 154.05 38.75 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.752 2.021 . . . . 0.0 109.095 -168.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 6.2 tt -142.04 -136.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -171.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 149.42 132.05 2.03 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 125.482 1.515 . . . . 0.0 112.867 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.47 120.91 12.0 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.473 1.109 . . . . 0.0 108.548 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.3 -1.52 2.42 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.522 1.529 . . . . 0.0 113.561 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -69.54 116.4 42.62 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 169.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -77.17 9.43 2.79 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.28 2.653 . . . . 0.0 113.066 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -123.29 7.46 9.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.978 1.711 . . . . 0.0 110.172 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.7 t -61.21 130.98 48.92 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 118.402 0.546 . . . . 0.0 109.768 171.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 38.0 m -74.92 6.22 4.3 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.564 1.545 . . . . 0.0 113.589 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.9 mm -135.76 -37.19 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 126.369 1.867 . . . . 0.0 109.83 -170.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.11 -41.99 0.52 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.313 2.645 . . . . 0.0 115.523 170.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . 0.459 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -127.85 148.56 50.47 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.334 1.854 . . . . 0.0 108.644 -177.05 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.425 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 76.5 m-85 -149.19 155.97 41.44 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -174.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -83.76 142.72 30.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.38 -9.06 2.05 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.549 1.54 . . . . 0.0 112.913 170.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -115.47 -6.29 12.27 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.527 1.131 . . . . 0.0 112.394 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.8 m -80.13 -0.09 34.45 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 168.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.29 -8.8 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 126.852 2.061 . . . . 0.0 111.638 171.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.17 36.46 63.91 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.547 1.07 . . . . 0.0 113.06 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 32.0 mt -67.59 157.82 33.52 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.287 1.043 . . . . 0.0 110.613 171.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 27.8 m -136.73 -19.12 1.37 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.382 1.473 . . . . 0.0 110.752 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 13.8 t -149.2 170.54 18.21 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.198 1.799 . . . . 0.0 108.944 169.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -63.05 119.92 56.55 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 124.165 0.986 . . . . 0.0 109.649 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.27 174.26 12.37 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.105 2.537 . . . . 0.0 111.532 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -65.99 162.94 18.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.682 0.793 . . . . 0.0 110.118 169.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -61.8 164.67 21.36 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.944 0.783 . . . . 0.0 113.185 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 15.8 tptp 52.91 57.5 6.29 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.298 1.439 . . . . 0.0 112.149 -172.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -73.41 158.36 35.14 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.746 0.819 . . . . 0.0 109.8 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -139.83 141.85 36.66 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.064 0.945 . . . . 0.0 109.409 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.1 p -66.08 163.62 36.21 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.876 0.87 . . . . 0.0 111.724 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.53 32.92 0.32 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 123.986 3.124 . . . . 0.0 113.087 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -135.64 -39.11 0.72 Allowed 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.45 1.5 . . . . 0.0 109.67 170.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 28.2 m -70.98 -31.68 68.29 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.919 2.088 . . . . 0.0 112.222 170.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 8.1 t -83.51 -34.85 25.23 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.093 1.357 . . . . 0.0 110.858 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -21.26 66.34 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.502 1.121 . . . . 0.0 112.979 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.33 -14.87 13.08 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.071 1.748 . . . . 0.0 113.158 172.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.91 26.13 4.63 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.602 1.561 . . . . 0.0 111.065 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt 51.24 64.74 1.72 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.454 1.902 . . . . 0.0 112.305 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -140.89 114.29 8.71 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 126.003 1.721 . . . . 0.0 106.417 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 27.0 tptp . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.408 1.483 . . . . 0.0 110.582 -170.851 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 89.5 mtp . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 57.25 -167.64 0.12 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.746 1.618 . . . . 0.0 112.802 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 13.8 ptm -89.13 110.16 36.21 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.601 1.16 . . . . 0.0 109.441 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -75.97 -35.77 2.33 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.501 2.134 . . . . 0.0 112.043 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 6.3 p -156.55 10.5 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 126.213 1.805 . . . . 0.0 110.996 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 34.3 t70 50.86 64.39 8.29 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 125.576 1.55 . . . . 0.0 111.325 -167.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.33 105.68 1.78 Allowed 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.397 2.731 . . . . 0.0 110.491 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -79.56 -6.11 56.34 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.494 1.117 . . . . 0.0 113.046 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -144.24 69.47 15.92 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.486 1.115 . . . . 0.0 109.999 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.88 162.39 41.2 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.377 2.718 . . . . 0.0 111.291 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.7 p 64.88 142.31 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.578 2.351 . . . . 0.0 112.871 -174.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -156.06 -38.19 0.08 Allowed 'General case' 0 C--N 1.35 0.626 0 CA-C-O 115.956 -1.973 . . . . 0.0 115.563 -168.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.45 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.9 OUTLIER -52.99 174.15 0.04 OUTLIER 'General case' 0 C--N 1.359 0.991 0 CA-C-N 122.069 2.213 . . . . 0.0 112.027 172.06 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.0 mt -62.98 -5.07 2.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.641 1.577 . . . . 0.0 111.339 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 69.6 m -100.0 -12.28 19.88 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 126.069 1.748 . . . . 0.0 112.675 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.8 p80 45.36 50.1 10.09 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.775 2.03 . . . . 0.0 112.008 -174.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -164.62 148.57 9.21 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 125.219 1.408 . . . . 0.0 107.67 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.69 174.01 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 127.131 2.172 . . . . 0.0 110.871 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.1 t 63.26 63.04 0.93 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.688 1.995 . . . . 0.0 112.904 -174.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.36 108.32 1.07 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.574 1.95 . . . . 0.0 108.332 -174.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 62.04 -164.38 23.22 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 123.278 1.488 . . . . 0.0 112.798 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.413 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.8 pm0 -65.25 150.17 48.69 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.314 2.246 . . . . 0.0 111.577 169.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 76.8 mtm -149.55 159.71 44.08 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.903 1.681 . . . . 0.0 110.684 -167.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 6.8 tp -138.34 -133.8 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.117 0.967 . . . . 0.0 109.302 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 221' ' ' TRP . . . 145.62 132.73 2.47 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 126.447 1.975 . . . . 0.0 113.242 -169.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.521 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 8.8 t -65.11 124.12 21.29 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.63 4.18 0.62 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.129 1.372 . . . . 0.0 113.104 173.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.65 112.04 5.01 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 128.51 2.724 . . . . 0.0 107.797 167.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -78.55 11.9 2.31 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.372 2.715 . . . . 0.0 112.955 -176.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -129.24 8.46 5.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.114 1.766 . . . . 0.0 109.807 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 12.2 t -57.3 116.7 3.46 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-O 121.767 0.794 . . . . 0.0 111.62 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 68.7 m -79.59 6.58 10.18 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.181 1.792 . . . . 0.0 112.48 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.5 mm -123.08 -36.99 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 126.547 1.939 . . . . 0.0 108.92 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . 0.254 0.1 OUTLIER 67.26 -23.98 0.11 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 129.093 2.957 . . . . 0.0 116.494 169.226 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . 0.45 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.6 OUTLIER -147.59 149.85 33.33 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.662 1.585 . . . . 0.0 109.152 -179.129 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.422 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 87.0 m-85 -147.44 157.2 43.48 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.293 1.037 . . . . 0.0 108.299 -177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -83.19 143.13 30.68 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.33 0.585 . . . . 0.0 110.142 -174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.51 -4.45 0.4 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.924 2.09 . . . . 0.0 114.039 170.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.47 -9.15 8.01 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.317 1.447 . . . . 0.0 112.276 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 10.3 m -77.45 -1.65 31.38 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.029 0.831 . . . . 0.0 112.769 168.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 12.7 p -132.04 -1.42 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 126.923 2.089 . . . . 0.0 110.92 171.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 63.6 32.56 84.58 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.25 1.405 . . . . 0.0 113.297 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.1 mt -66.93 -53.71 29.22 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 117.999 0.9 . . . . 0.0 112.276 -172.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . 0.272 2.4 t 45.39 12.66 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 127.964 2.505 . . . . 0.0 115.637 -169.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 60.5 p -152.24 158.48 42.89 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.096 2.158 . . . . 0.0 109.422 -175.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -69.29 125.01 91.66 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 170.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.01 -66.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.722 2.281 . . . . 0.0 111.352 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.426 ' HG2' ' H ' ' A' ' 235' ' ' GLY . 37.2 ttt-85 -174.88 -173.77 0.73 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.889 2.476 . . . . 0.0 107.554 -177.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 234' ' ' ARG . . . -77.08 16.06 5.98 Favored Glycine 0 CA--C 1.54 1.641 0 CA-C-O 119.036 -0.869 . . . . 0.0 112.944 168.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -159.68 120.48 3.12 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 126.008 1.723 . . . . 0.0 107.948 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.439 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 90.3 t90 -136.43 162.56 32.72 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.733 2.013 . . . . 0.0 109.989 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.521 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 97.5 m-85 -139.4 141.35 37.54 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.726 0.81 . . . . 0.0 110.698 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.439 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 29.1 p -65.75 160.27 62.72 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.519 0.727 . . . . 0.0 111.685 174.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.33 28.4 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.275 3.317 . . . . 0.0 113.327 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -133.58 -35.66 0.99 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.344 1.858 . . . . 0.0 109.637 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 1.4 m -72.53 -38.89 67.9 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.099 1.76 . . . . 0.0 110.969 168.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.3 t -76.32 -27.33 56.49 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.971 1.308 . . . . 0.0 111.564 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -64.41 -29.55 70.61 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.125 0.97 . . . . 0.0 112.273 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.91 -16.27 28.21 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.405 1.882 . . . . 0.0 113.165 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 37.8 ttt85 -127.85 21.88 6.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.867 1.667 . . . . 0.0 111.144 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 10.4 mtpm? -133.81 57.99 1.79 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.997 1.719 . . . . 0.0 109.603 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 59.3 mtmt -75.28 76.95 2.39 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.268 1.427 . . . . 0.0 107.849 169.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt . . . . . 0 C--O 1.252 1.194 0 C-N-CA 127.008 2.123 . . . . 0.0 109.749 -167.695 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 11.4 tmm? . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -144.24 -42.88 0.26 Allowed 'General case' 0 CA--C 1.534 0.337 0 O-C-N 124.017 0.823 . . . . 0.0 111.105 -169.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 43.5 tpp -155.08 67.19 5.12 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.826 1.25 . . . . 0.0 108.994 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.91 1.97 8.05 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 124.214 3.276 . . . . 0.0 114.777 -169.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.58 98.08 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.465 1.506 . . . . 0.0 111.041 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -73.65 129.29 85.59 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.842 1.257 . . . . 0.0 110.503 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.16 148.58 27.45 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.443 2.762 . . . . 0.0 111.531 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -89.19 22.43 2.83 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.881 1.272 . . . . 0.0 112.158 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -138.83 75.36 36.51 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.017 1.327 . . . . 0.0 109.642 -172.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.53 143.27 51.37 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.701 2.267 . . . . 0.0 110.801 176.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.3 p 61.58 149.41 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.06 2.544 . . . . 0.0 113.826 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -157.47 -43.42 0.07 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -168.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.1 p -39.62 170.2 0.0 OUTLIER 'General case' 0 C--N 1.349 0.57 0 C-N-CA 126.364 1.866 . . . . 0.0 114.379 169.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.3 mt -70.96 -6.63 40.16 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 113.31 -1.768 . . . . 0.0 110.131 168.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 97.4 m -96.29 -13.67 23.18 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 123.472 0.709 . . . . 0.0 111.755 174.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.7 p80 46.34 52.4 10.64 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.773 2.029 . . . . 0.0 112.607 -173.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -171.56 140.36 1.36 Allowed 'General case' 0 C--N 1.346 0.455 0 C-N-CA 126.004 1.721 . . . . 0.0 108.083 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.5 t -122.33 171.17 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.506 1.522 . . . . 0.0 111.179 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 52.8 m 67.17 64.31 0.44 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.983 2.113 . . . . 0.0 113.405 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -160.14 112.48 2.04 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.661 1.984 . . . . 0.0 108.024 -176.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 68.19 -123.19 17.12 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -170.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.35 167.59 12.6 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.003 2.121 . . . . 0.0 110.982 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -138.26 156.17 47.93 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.178 0.991 . . . . 0.0 111.23 -169.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 8.1 tt -134.53 -139.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 173.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 148.04 132.97 2.26 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 125.35 1.453 . . . . 0.0 112.648 -169.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.9 t -66.13 122.94 18.55 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.83 -2.19 3.58 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.504 1.522 . . . . 0.0 113.553 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -67.15 117.12 43.09 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 124.3 1.04 . . . . 0.0 108.33 168.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.65 5.42 4.81 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.229 2.619 . . . . 0.0 113.147 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -118.09 6.88 12.1 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.934 1.694 . . . . 0.0 110.428 174.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 45.9 t -58.88 127.54 32.73 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 121.234 0.54 . . . . 0.0 109.875 170.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 67.9 m -78.64 6.82 7.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.56 1.544 . . . . 0.0 113.336 -176.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.7 mt -133.76 -33.58 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.124 1.77 . . . . 0.0 110.261 -176.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.98 -39.42 0.45 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.869 2.468 . . . . 0.0 115.168 170.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.27 148.68 52.72 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.524 1.93 . . . . 0.0 108.719 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -147.17 150.16 34.39 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -72.34 148.55 45.22 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.41 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -60.54 -5.87 1.4 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.342 1.457 . . . . 0.0 112.336 167.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -119.78 -2.01 10.45 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.925 1.29 . . . . 0.0 112.478 171.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.3 m -73.48 -5.24 38.81 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.907 0.776 . . . . 0.0 111.078 166.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 14.2 p -134.6 -10.17 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.766 2.026 . . . . 0.0 112.211 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.58 36.59 62.32 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.619 1.104 . . . . 0.0 113.354 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 11.0 mt -65.85 158.63 27.36 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.514 1.157 . . . . 0.0 111.603 173.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.3 t -139.84 -3.57 1.44 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.738 1.615 . . . . 0.0 111.808 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 9.9 t -151.12 166.23 31.43 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 126.017 1.727 . . . . 0.0 109.484 175.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -82.33 116.21 62.35 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.093 0.957 . . . . 0.0 109.106 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.12 166.36 27.97 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.166 2.578 . . . . 0.0 111.093 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 32.8 mtp-105 -140.25 164.48 29.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.559 1.143 . . . . 0.0 110.56 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 89.59 -76.05 1.78 Allowed Glycine 0 C--N 1.34 0.768 0 N-CA-C 109.181 -1.567 . . . . 0.0 109.181 -172.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -170.46 153.17 4.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 127.298 2.239 . . . . 0.0 107.334 169.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.401 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 91.2 t90 -119.34 163.14 17.61 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.916 2.086 . . . . 0.0 110.306 177.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -140.5 141.96 35.32 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.129 1.372 . . . . 0.0 108.897 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.401 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 16.9 p -68.82 164.06 49.95 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.896 -0.573 . . . . 0.0 112.005 174.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.45 34.1 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 124.148 3.232 . . . . 0.0 113.203 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -135.84 -36.97 0.75 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 125.793 1.637 . . . . 0.0 109.757 171.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.5 m -73.89 -33.83 64.19 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.797 2.039 . . . . 0.0 112.091 171.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 13.7 t -87.49 -16.47 34.64 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.628 1.171 . . . . 0.0 112.172 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -64.66 -21.75 66.81 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.976 1.311 . . . . 0.0 112.674 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -46.84 -36.87 7.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.05 1.74 . . . . 0.0 113.127 170.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 11.4 ttt85 -133.05 16.54 4.17 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.832 1.253 . . . . 0.0 112.117 -173.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -134.45 79.51 1.81 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 126.192 1.797 . . . . 0.0 107.045 172.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -142.32 36.98 1.52 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.649 1.98 . . . . 0.0 110.669 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--O 1.251 1.172 0 C-N-CA 126.532 1.933 . . . . 0.0 111.676 -179.6 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -63.48 123.29 18.39 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.413 1.085 . . . . 0.0 110.425 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.54 ' H ' ' HD2' ' A' ' 190' ' ' PRO . 63.5 mtt -145.44 -48.71 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 116.574 -1.679 . . . . 0.0 112.48 -175.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.54 ' HD2' ' H ' ' A' ' 189' ' ' MET . 61.7 Cg_endo -73.21 -38.93 2.4 Favored 'Trans proline' 0 C--N 1.357 1.0 0 CA-C-N 122.35 1.875 . . . . 0.0 111.956 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . 0.28 2.1 p 46.82 13.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 129.945 3.298 . . . . 0.0 117.782 169.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.535 ' H ' ' HD2' ' A' ' 193' ' ' PRO . 23.9 m-20 -143.44 -49.33 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.703 0 CA-C-O 116.697 -1.621 . . . . 0.0 113.58 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.535 ' HD2' ' H ' ' A' ' 192' ' ' ASP . 60.5 Cg_endo -72.11 138.87 31.58 Favored 'Trans proline' 0 C--N 1.355 0.908 0 CA-C-N 122.47 1.918 . . . . 0.0 110.933 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -153.13 35.92 0.47 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.645 1.178 . . . . 0.0 110.724 -173.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -136.65 77.18 46.23 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.81 1.244 . . . . 0.0 109.597 -172.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.47 151.99 59.79 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.337 2.692 . . . . 0.0 111.464 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.2 p 62.43 147.73 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.946 2.498 . . . . 0.0 113.151 -173.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -156.29 -44.31 0.07 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -169.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.3 p -40.58 169.92 0.0 OUTLIER 'General case' 0 C--N 1.349 0.555 0 C-N-CA 126.139 1.775 . . . . 0.0 114.158 169.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.9 mt -71.48 -6.32 39.61 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 113.233 -1.803 . . . . 0.0 110.07 168.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 95.1 m -96.02 -13.54 23.66 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 123.455 0.702 . . . . 0.0 111.808 174.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.1 p80 46.28 53.75 9.16 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.804 2.042 . . . . 0.0 112.609 -173.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -171.78 141.38 1.41 Allowed 'General case' 0 C--N 1.346 0.441 0 C-N-CA 125.707 1.603 . . . . 0.0 108.221 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.99 170.5 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.36 1.464 . . . . 0.0 110.906 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.9 t 67.8 65.91 0.37 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.026 2.13 . . . . 0.0 113.165 -174.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.89 111.88 1.16 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.732 2.013 . . . . 0.0 107.733 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.16 -134.97 36.85 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -169.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.52 169.33 8.88 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.91 2.084 . . . . 0.0 111.252 177.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -137.8 159.86 40.83 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.478 1.111 . . . . 0.0 111.596 -168.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 5.6 tp -134.76 -138.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 170.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 149.47 131.87 2.0 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 126.024 1.773 . . . . 0.0 112.132 -169.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 43.7 t -63.42 125.43 24.15 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.217 1.007 . . . . 0.0 108.675 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.97 -3.43 3.48 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.824 1.25 . . . . 0.0 113.709 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -70.48 117.18 52.63 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 124.242 1.017 . . . . 0.0 108.659 169.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -76.82 4.22 5.86 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.261 2.641 . . . . 0.0 113.16 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -115.99 6.3 14.1 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.85 1.66 . . . . 0.0 110.463 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 49.9 t -58.72 128.3 36.5 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.019 0.528 . . . . 0.0 109.975 170.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.2 m -74.38 2.83 8.5 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.727 1.611 . . . . 0.0 113.689 -176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.8 mt -133.18 -33.66 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.186 1.794 . . . . 0.0 110.175 -173.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.89 -38.1 0.41 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.796 2.438 . . . . 0.0 115.226 170.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -132.06 148.51 52.5 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.618 1.967 . . . . 0.0 108.751 -174.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -148.35 149.47 31.85 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -73.94 150.7 40.66 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.244 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -59.66 -4.25 0.63 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.84 1.656 . . . . 0.0 113.252 167.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.79 -2.84 8.26 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.326 1.45 . . . . 0.0 112.609 171.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.1 m -71.9 -7.88 51.1 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.112 0.869 . . . . 0.0 111.612 167.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.0 p -133.94 -4.45 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 125.958 1.703 . . . . 0.0 111.765 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.18 33.55 78.67 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.605 1.098 . . . . 0.0 113.012 -174.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.5 mt -65.18 -50.51 65.65 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.437 1.095 . . . . 0.0 112.096 -174.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . 0.277 1.7 t 47.45 6.09 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 128.678 2.791 . . . . 0.0 116.585 -171.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 76.3 p -148.14 165.96 29.31 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.703 2.001 . . . . 0.0 109.818 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -65.4 127.83 93.27 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.644 -0.693 . . . . 0.0 109.305 171.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -80.68 173.31 12.32 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.336 2.691 . . . . 0.0 112.578 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 54.4 mmm-85 -67.22 160.96 25.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.478 1.111 . . . . 0.0 109.418 167.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -61.09 152.86 39.65 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 173.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt 50.99 62.96 2.44 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.07 1.348 . . . . 0.0 111.279 -171.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 81.1 t90 -75.36 153.21 37.91 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 113.641 -1.618 . . . . 0.0 109.287 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -138.64 138.26 37.67 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.187 0.995 . . . . 0.0 108.728 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.7 p -64.82 166.78 10.95 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.965 0.906 . . . . 0.0 112.171 176.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.4 36.01 0.37 Allowed 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 123.861 3.041 . . . . 0.0 113.095 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -138.68 -39.51 0.51 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 125.473 1.509 . . . . 0.0 109.329 169.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 33.9 m -72.13 -29.04 63.67 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.979 2.112 . . . . 0.0 112.393 172.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 69.2 m -73.73 -36.6 65.19 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.833 1.253 . . . . 0.0 110.962 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -70.07 -12.18 61.42 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.231 1.012 . . . . 0.0 112.893 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -54.07 -66.93 0.31 Allowed 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 127.158 2.183 . . . . 0.0 111.448 172.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.93 21.52 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.59 1.556 . . . . 0.0 111.001 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -130.63 75.54 1.66 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.424 1.49 . . . . 0.0 109.992 -167.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp 70.97 105.76 0.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.496 2.318 . . . . 0.0 111.204 -174.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt . . . . . 0 C--O 1.25 1.086 0 C-N-CA 125.963 1.705 . . . . 0.0 108.772 178.715 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.6 153.57 15.21 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.697 1.199 . . . . 0.0 110.046 -170.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 27.7 ttt -156.88 82.85 3.19 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.596 1.159 . . . . 0.0 108.398 175.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -71.83 125.36 10.97 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.811 2.34 . . . . 0.0 110.353 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.23 25.54 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 125.342 1.457 . . . . 0.0 109.182 176.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -55.69 -46.32 99.75 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 117.256 -1.354 . . . . 0.0 112.061 174.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.75 111.7 3.35 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.19 1.927 . . . . 0.0 109.192 168.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -149.78 31.13 0.72 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.45 1.1 . . . . 0.0 110.907 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -135.99 72.22 61.36 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 125.056 1.342 . . . . 0.0 109.107 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.14 111.24 2.83 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.728 2.952 . . . . 0.0 110.416 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.8 p -146.68 138.29 24.48 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.821 1.648 . . . . 0.0 108.846 -174.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -155.89 -44.91 0.08 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.7 p -39.83 170.32 0.0 OUTLIER 'General case' 0 C--N 1.348 0.522 0 C-N-CA 126.408 1.883 . . . . 0.0 114.001 168.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.68 -6.97 41.1 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.527 -1.67 . . . . 0.0 110.127 168.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 89.2 m -97.13 -14.16 21.68 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 123.859 0.864 . . . . 0.0 111.763 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.5 p80 45.57 52.48 9.23 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.082 2.153 . . . . 0.0 112.883 -173.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.15 139.79 2.3 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 126.043 1.737 . . . . 0.0 108.439 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.437 HG11 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -122.6 -174.82 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.878 1.671 . . . . 0.0 109.752 176.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.437 ' H ' HG11 ' A' ' 204' ' ' VAL 0.277 59.7 p 59.87 53.98 4.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.124 2.17 . . . . 0.0 114.571 -174.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.75 121.05 5.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.7 2.0 . . . . 0.0 109.1 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 57.54 -113.46 4.6 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.616 1.579 . . . . 0.0 111.188 -174.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.76 168.56 18.82 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.346 2.259 . . . . 0.0 111.41 -174.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -138.57 159.76 41.3 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.802 0.841 . . . . 0.0 113.036 -167.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 5.7 tp -134.8 -137.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 168.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 147.71 131.53 2.13 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 125.555 1.55 . . . . 0.0 112.03 -170.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 53.3 t -64.75 119.49 10.69 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -67.38 1.28 2.31 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.432 1.493 . . . . 0.0 113.747 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -67.0 118.0 51.15 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.22 6.23 4.05 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.28 2.654 . . . . 0.0 113.191 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -119.66 7.64 11.1 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.821 1.648 . . . . 0.0 110.575 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 47.5 t -59.34 130.26 46.04 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 123.286 0.634 . . . . 0.0 110.3 172.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.0 m -76.2 1.48 15.77 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.56 1.544 . . . . 0.0 113.671 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 26.2 mt -134.94 -34.34 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.029 1.731 . . . . 0.0 110.285 -171.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.7 -39.77 0.44 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.71 2.404 . . . . 0.0 115.011 170.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.27 147.73 52.62 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.523 1.929 . . . . 0.0 108.42 -174.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -147.76 147.79 30.26 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -71.45 150.97 44.42 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.204 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.96 -1.33 0.64 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.589 1.556 . . . . 0.0 113.41 168.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -126.95 1.3 6.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.756 1.222 . . . . 0.0 112.28 169.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.1 m -72.28 -9.42 58.45 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.793 0.724 . . . . 0.0 111.608 167.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.1 p -135.07 -10.83 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 124.696 1.198 . . . . 0.0 113.046 170.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.49 38.37 8.98 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.615 1.102 . . . . 0.0 113.888 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 68.3 mt -65.8 112.64 3.83 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.69 1.245 . . . . 0.0 110.764 173.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.3 t -78.5 -20.96 49.65 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.967 0.907 . . . . 0.0 111.567 169.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 8.9 t -156.87 176.04 13.28 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.605 1.562 . . . . 0.0 110.193 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -65.31 120.27 66.26 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.402 1.081 . . . . 0.0 109.192 175.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.74 -50.74 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.741 2.294 . . . . 0.0 111.543 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -173.76 -178.83 1.65 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.114 2.165 . . . . 0.0 108.452 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -82.44 18.19 15.72 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.43 1.014 . . . . 0.0 112.278 167.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -154.71 112.81 3.49 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 125.93 1.692 . . . . 0.0 108.186 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.453 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 87.5 t90 -139.32 164.15 30.59 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.568 1.947 . . . . 0.0 110.429 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -139.25 141.25 37.83 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 124.854 1.262 . . . . 0.0 109.471 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.453 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 15.9 p -67.87 163.68 47.61 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.49 0.716 . . . . 0.0 112.288 176.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.54 34.14 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 124.056 3.171 . . . . 0.0 113.458 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -137.32 -35.92 0.67 Allowed 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.45 1.5 . . . . 0.0 110.076 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 24.3 m -72.8 -32.48 65.58 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.556 1.942 . . . . 0.0 111.808 169.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.4 t -82.19 -16.36 49.96 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.777 1.631 . . . . 0.0 112.586 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -68.26 -32.17 72.16 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.81 0.844 . . . . 0.0 111.34 173.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.75 167.13 7.82 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.788 1.635 . . . . 0.0 111.212 169.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 56.6 ttt-85 58.99 41.27 21.25 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.358 1.463 . . . . 0.0 112.12 175.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -66.45 94.27 0.27 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 125.9 1.68 . . . . 0.0 108.989 171.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 49.3 tptt 57.66 109.33 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.182 2.593 . . . . 0.0 112.742 -170.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm . . . . . 0 C--O 1.251 1.136 0 C-N-CA 125.18 1.392 . . . . 0.0 107.412 169.57 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 52.12 65.15 1.59 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.385 1.474 . . . . 0.0 112.046 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 66.6 mtt -126.99 79.2 73.25 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.39 1.476 . . . . 0.0 110.138 -170.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.48 155.57 66.48 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.127 2.552 . . . . 0.0 111.031 173.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 86.7 t -143.36 133.43 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.204 1.402 . . . . 0.0 107.417 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -143.55 153.18 58.25 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.812 1.245 . . . . 0.0 110.699 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -80.45 35.76 0.59 Allowed 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 125.024 3.816 . . . . 0.0 111.951 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -135.14 37.14 3.0 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.605 1.562 . . . . 0.0 110.961 -169.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.48 130.19 89.81 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.489 1.116 . . . . 0.0 110.734 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.22 116.89 4.89 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.241 2.627 . . . . 0.0 110.762 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 81.1 p -147.66 136.0 21.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.815 1.646 . . . . 0.0 108.661 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -156.58 -48.59 0.07 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -174.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.8 p -38.62 171.28 0.0 OUTLIER 'General case' 0 C--N 1.351 0.663 0 C-N-CA 126.803 2.041 . . . . 0.0 114.633 169.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.9 mt -70.38 -7.24 41.39 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 113.458 -1.701 . . . . 0.0 110.021 168.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 94.6 m -96.43 -13.71 22.96 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 123.546 0.738 . . . . 0.0 111.852 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.3 p80 46.01 51.04 11.16 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.306 2.242 . . . . 0.0 113.101 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -169.66 142.05 2.45 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 125.854 1.662 . . . . 0.0 107.897 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.1 t -123.65 174.09 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.666 1.587 . . . . 0.0 110.733 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 50.0 m 67.48 57.84 0.55 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.719 2.007 . . . . 0.0 113.114 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -158.66 109.4 2.09 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.298 2.239 . . . . 0.0 106.945 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.77 -159.74 45.55 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-O 122.814 1.23 . . . . 0.0 110.757 -168.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.43 170.58 14.34 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.375 1.87 . . . . 0.0 112.075 171.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -140.23 159.73 41.53 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.921 1.289 . . . . 0.0 112.137 -169.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . 0.258 9.1 tp -132.19 -138.42 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 146.94 136.45 2.85 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 126.454 1.978 . . . . 0.0 112.308 -169.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.488 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 7.5 t -65.75 127.68 32.92 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.755 -0.723 . . . . 0.0 109.748 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.42 ' HB3' ' HZ1' ' A' ' 236' ' ' LYS . 1.4 m-20 -59.72 -8.27 1.98 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.343 1.457 . . . . 0.0 113.75 171.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -57.55 110.16 2.29 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 128.163 2.585 . . . . 0.0 108.288 169.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -78.61 10.91 2.64 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.42 2.747 . . . . 0.0 112.758 -175.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -129.22 9.9 5.73 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.279 1.832 . . . . 0.0 109.603 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 21.9 t -55.38 117.46 3.57 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-O 121.781 0.801 . . . . 0.0 111.66 175.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 85.7 p -74.49 1.94 10.73 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.94 2.096 . . . . 0.0 113.265 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.8 mm -123.67 -36.54 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.37 1.868 . . . . 0.0 108.957 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.03 -30.15 0.21 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 128.207 2.603 . . . . 0.0 115.195 169.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -144.24 149.81 36.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.689 1.596 . . . . 0.0 109.435 -175.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -148.21 149.67 32.36 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -72.88 149.86 43.13 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.192 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -59.36 -4.76 0.63 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.57 1.548 . . . . 0.0 113.473 167.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.65 -4.23 8.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.215 1.406 . . . . 0.0 112.638 171.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 14.6 m -72.8 -5.34 37.35 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.002 0.819 . . . . 0.0 111.359 167.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.5 p -136.56 -5.22 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 126.479 1.911 . . . . 0.0 111.931 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.8 35.86 91.46 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.802 1.191 . . . . 0.0 113.023 -175.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.5 mt -67.14 -53.51 29.96 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 123.968 0.907 . . . . 0.0 111.281 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 22.9 m 61.31 -12.21 0.05 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.286 2.234 . . . . 0.0 114.587 -173.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.6 p -143.56 165.39 27.71 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.851 1.66 . . . . 0.0 110.598 -174.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -66.08 126.7 92.38 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 123.968 0.907 . . . . 0.0 109.91 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.51 177.17 9.06 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.529 2.819 . . . . 0.0 111.879 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -65.3 174.89 1.89 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.423 1.089 . . . . 0.0 111.115 169.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.5 7.57 1.94 Allowed Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.08 1.324 . . . . 0.0 115.321 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.42 ' HZ1' ' HB3' ' A' ' 213' ' ' ASP . 10.2 mmtm -148.33 115.07 6.02 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 126.969 2.108 . . . . 0.0 106.762 173.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -126.8 155.9 42.12 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.276 1.83 . . . . 0.0 109.429 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.488 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 91.3 m-85 -138.44 138.42 38.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.716 0.807 . . . . 0.0 110.249 -176.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 31.5 p -64.03 162.48 30.36 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 123.675 0.79 . . . . 0.0 111.622 172.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.82 28.95 0.24 Allowed 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 124.028 3.152 . . . . 0.0 113.59 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -133.61 -36.85 0.95 Allowed 'General case' 0 C--N 1.343 0.326 0 C-N-CA 125.794 1.638 . . . . 0.0 109.702 173.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 2.5 m -71.87 -35.99 69.96 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.325 1.85 . . . . 0.0 111.863 169.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 27.4 t -75.5 -31.07 60.05 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.835 1.254 . . . . 0.0 110.977 174.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -28.73 68.66 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.841 1.256 . . . . 0.0 111.489 175.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.86 -22.5 59.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.578 1.551 . . . . 0.0 112.911 173.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 53.2 ttt85 26.56 71.61 0.04 OUTLIER 'General case' 0 C--N 1.35 0.597 0 C-N-CA 129.412 3.085 . . . . 0.0 114.166 169.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -80.89 -171.5 3.21 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.342 1.457 . . . . 0.0 110.558 -171.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -81.77 76.29 8.68 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.531 1.932 . . . . 0.0 109.469 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 23.4 tptm . . . . . 0 C--O 1.25 1.109 0 C-N-CA 126.962 2.105 . . . . 0.0 111.324 -172.131 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 97.9 mtp . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 63.15 120.79 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.692 2.397 . . . . 0.0 113.699 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 27.5 ttt -150.29 76.72 8.43 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.147 0.979 . . . . 0.0 109.946 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.71 149.72 61.27 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.952 2.435 . . . . 0.0 110.832 173.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.58 9.94 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 125.073 1.349 . . . . 0.0 110.256 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -54.92 -44.46 99.52 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.796 1.639 . . . . 0.0 113.55 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -81.41 73.35 5.94 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 123.232 2.622 . . . . 0.0 109.101 169.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -66.33 -15.9 63.62 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.873 1.269 . . . . 0.0 114.401 -170.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.3 125.68 91.42 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.32 1.048 . . . . 0.0 110.428 178.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.72 153.38 43.24 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.302 2.668 . . . . 0.0 111.703 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.7 p 58.64 144.27 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.866 2.866 . . . . 0.0 113.477 -172.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.98 -49.48 0.09 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -168.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.9 p -41.65 170.33 0.0 OUTLIER 'General case' 0 C--N 1.349 0.58 0 C-N-CA 125.892 1.677 . . . . 0.0 114.165 169.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.7 mt -71.1 -6.86 42.48 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.925 168.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 93.7 m -95.62 -13.6 24.2 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.513 0.725 . . . . 0.0 111.797 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.0 p80 46.83 52.94 10.92 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.031 2.132 . . . . 0.0 112.85 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -173.16 139.73 0.82 Allowed 'General case' 0 C--N 1.345 0.391 0 C-N-CA 125.878 1.671 . . . . 0.0 108.498 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.482 HG11 ' H ' ' A' ' 205' ' ' SER . 0.5 OUTLIER -114.29 -173.18 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 125.605 1.562 . . . . 0.0 110.665 175.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.482 ' H ' HG11 ' A' ' 204' ' ' VAL 0.254 97.5 p 53.12 64.29 1.91 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.812 2.445 . . . . 0.0 114.771 -174.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.08 112.07 1.54 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.894 2.078 . . . . 0.0 108.011 -177.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 63.65 -133.72 41.25 Favored Glycine 0 C--N 1.339 0.75 0 C-N-CA 124.497 1.046 . . . . 0.0 110.546 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.08 169.05 9.21 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 127.248 2.219 . . . . 0.0 111.42 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -138.66 159.51 41.92 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.251 1.02 . . . . 0.0 112.209 -168.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 5.8 tp -133.44 -138.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 169.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 148.32 131.25 2.04 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 125.597 1.57 . . . . 0.0 112.507 -170.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 45.9 t -63.94 121.39 13.99 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.24 2.11 1.79 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.436 1.494 . . . . 0.0 113.699 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -70.94 118.01 61.43 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.378 1.071 . . . . 0.0 108.146 168.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -76.33 4.58 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.185 2.59 . . . . 0.0 113.273 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -116.21 6.41 13.87 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.717 1.607 . . . . 0.0 110.508 174.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 46.5 t -59.14 129.13 40.64 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 123.118 0.567 . . . . 0.0 109.924 171.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 11.0 t -73.27 -1.44 17.87 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.922 1.689 . . . . 0.0 113.455 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.6 mt -132.76 -33.84 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.968 1.707 . . . . 0.0 110.449 -170.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.68 -38.9 0.43 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 127.47 2.308 . . . . 0.0 114.985 171.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -132.49 148.29 52.39 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.497 1.919 . . . . 0.0 109.03 -173.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -148.85 149.95 32.17 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -74.17 151.08 40.09 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.369 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -59.28 -5.12 0.66 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.766 1.626 . . . . 0.0 113.259 167.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.04 -3.58 8.56 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.294 1.438 . . . . 0.0 112.581 171.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 15.5 m -72.8 -6.9 47.92 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.04 0.836 . . . . 0.0 111.739 167.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.35 -5.6 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.864 1.666 . . . . 0.0 111.817 172.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.51 34.82 80.03 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.726 1.155 . . . . 0.0 112.8 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.3 mt -66.18 -50.46 63.81 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 124.327 1.051 . . . . 0.0 111.771 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 16.9 m 61.81 -8.87 0.09 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.072 2.149 . . . . 0.0 114.612 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 12.1 t -150.1 176.78 10.51 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.839 1.656 . . . . 0.0 110.39 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -71.83 129.22 88.49 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.316 1.046 . . . . 0.0 109.728 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.22 176.55 9.6 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.468 2.779 . . . . 0.0 111.95 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -69.21 171.26 8.68 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.016 0.927 . . . . 0.0 109.992 167.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -58.58 153.66 28.13 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 123.565 0.602 . . . . 0.0 112.348 172.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 45.4 tttp 42.86 71.72 0.21 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.825 2.05 . . . . 0.0 113.498 -172.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.414 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 88.8 t90 -76.86 160.3 29.35 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.95 0.9 . . . . 0.0 109.99 174.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -138.63 140.46 38.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.201 1.0 . . . . 0.0 109.584 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.414 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 15.2 p -66.73 165.24 26.69 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.73 0.812 . . . . 0.0 112.06 175.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.47 33.03 0.29 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 124.024 3.149 . . . . 0.0 113.482 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -136.02 -40.31 0.68 Allowed 'General case' 0 C--N 1.345 0.404 0 C-N-CA 125.068 1.347 . . . . 0.0 109.674 169.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.3 m -68.38 -36.94 79.9 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.736 2.014 . . . . 0.0 111.705 171.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.8 t -80.52 -31.77 37.02 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.325 1.45 . . . . 0.0 111.384 175.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -36.56 84.07 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.528 1.131 . . . . 0.0 111.182 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.82 -16.96 54.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.704 1.602 . . . . 0.0 113.388 176.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 41.0 ttt-85 -137.0 35.37 2.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.019 1.328 . . . . 0.0 110.586 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.19 95.86 0.43 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.325 1.85 . . . . 0.0 109.736 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 85.3 tttt 58.08 93.47 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.861 2.464 . . . . 0.0 112.328 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt . . . . . 0 C--O 1.249 1.043 0 C-N-CA 125.942 1.697 . . . . 0.0 109.702 176.835 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -80.27 143.52 33.61 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.658 0.783 . . . . 0.0 111.147 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -130.24 68.82 81.61 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.541 1.536 . . . . 0.0 109.064 -177.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.84 -23.32 6.9 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.505 2.803 . . . . 0.0 113.889 -171.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 11.7 t -142.82 56.7 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.45 1.5 . . . . 0.0 107.32 -175.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -144.53 157.11 56.33 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.161 1.385 . . . . 0.0 110.253 -169.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -70.2 157.45 59.49 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.056 2.504 . . . . 0.0 112.108 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -100.8 34.27 2.52 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.289 1.436 . . . . 0.0 110.385 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -135.07 75.54 60.23 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.275 1.43 . . . . 0.0 109.161 -171.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.26 116.1 4.46 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.614 2.876 . . . . 0.0 110.635 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 63.6 p -147.68 137.62 22.82 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.104 1.762 . . . . 0.0 108.474 -174.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -155.26 -42.26 0.08 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 115.705 -2.093 . . . . 0.0 115.099 -173.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.451 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.7 OUTLIER -52.01 173.64 0.03 OUTLIER 'General case' 0 C--N 1.359 0.985 0 CA-C-N 122.223 2.283 . . . . 0.0 112.572 172.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.6 mt -62.83 -6.13 3.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.559 1.543 . . . . 0.0 111.243 172.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 92.4 m -99.29 -11.87 20.86 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 126.298 1.839 . . . . 0.0 112.762 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.7 p80 45.36 48.61 10.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.406 2.283 . . . . 0.0 112.342 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -162.91 147.99 11.78 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.367 1.467 . . . . 0.0 107.539 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.1 t -135.19 171.72 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 127.388 2.275 . . . . 0.0 110.323 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.3 t 61.36 64.52 1.07 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.61 1.964 . . . . 0.0 112.987 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.86 108.11 1.14 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.48 1.912 . . . . 0.0 108.374 -174.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 59.69 -160.22 19.8 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-O 123.271 1.484 . . . . 0.0 112.631 -174.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -64.17 148.94 48.85 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.959 2.104 . . . . 0.0 111.621 169.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.8 mtm -150.94 156.17 40.62 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.653 1.981 . . . . 0.0 109.492 -168.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 7.2 tp -140.53 -135.56 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 148.78 133.89 2.32 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 126.054 1.788 . . . . 0.0 112.444 -171.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 50.4 t -64.63 126.58 28.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.168 -1.016 . . . . 0.0 109.013 175.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.91 -7.33 2.33 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -69.61 114.73 26.57 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 119.496 1.044 . . . . 0.0 108.593 171.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -78.45 6.04 5.08 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.418 2.745 . . . . 0.0 112.948 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -118.95 5.58 11.38 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.952 1.701 . . . . 0.0 109.987 174.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . 0.4 ' HG ' ' H ' ' A' ' 219' ' ' ILE . 48.2 t -59.39 131.07 49.87 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 118.487 0.585 . . . . 0.0 109.844 170.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.0 m -74.11 6.31 3.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.725 1.61 . . . . 0.0 113.417 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.4 ' H ' ' HG ' ' A' ' 217' ' ' CYS . 34.0 mm -135.75 -38.15 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 126.54 1.936 . . . . 0.0 109.62 -170.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.86 -43.2 0.53 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.525 2.73 . . . . 0.0 115.511 171.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . 0.451 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -126.02 148.51 49.28 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.566 1.946 . . . . 0.0 108.625 -177.373 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.438 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 74.0 m-85 -149.11 155.31 40.52 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -173.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -83.97 145.1 28.72 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.559 0.695 . . . . 0.0 110.628 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.34 -3.94 1.08 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.005 1.722 . . . . 0.0 113.979 171.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.86 -4.22 7.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.546 1.138 . . . . 0.0 112.185 172.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.3 m -77.44 -3.03 38.3 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.036 0.835 . . . . 0.0 113.02 168.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.2 p -135.02 -6.11 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.789 1.235 . . . . 0.0 112.259 169.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.77 40.88 20.71 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.59 1.091 . . . . 0.0 113.723 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.7 mt -67.76 103.07 1.33 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.517 1.158 . . . . 0.0 110.221 172.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.7 t -71.19 -21.07 62.2 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.813 0.845 . . . . 0.0 111.76 169.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 14.3 t -155.99 172.75 17.86 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.933 1.693 . . . . 0.0 110.1 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -63.45 120.96 66.99 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.47 1.108 . . . . 0.0 108.776 174.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.45 -58.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.615 2.21 . . . . 0.0 111.478 -169.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -172.39 -176.17 1.52 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.771 2.028 . . . . 0.0 108.571 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -78.27 23.05 2.88 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.419 1.009 . . . . 0.0 112.702 168.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -157.3 114.33 3.03 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 125.781 1.633 . . . . 0.0 108.697 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -141.52 160.4 40.23 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.148 1.779 . . . . 0.0 110.347 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -140.98 141.99 34.35 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.297 1.039 . . . . 0.0 109.646 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.0 p -70.02 166.02 37.21 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.485 0.714 . . . . 0.0 111.896 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -73.1 32.48 0.31 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.028 3.152 . . . . 0.0 113.383 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -136.29 -36.74 0.72 Allowed 'General case' 0 C--N 1.344 0.34 0 C-N-CA 125.161 1.385 . . . . 0.0 109.845 171.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 37.5 m -75.4 -33.45 60.98 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 126.779 2.032 . . . . 0.0 111.961 172.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 10.1 t -80.96 -20.77 41.23 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.466 1.506 . . . . 0.0 111.993 175.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -62.16 -38.28 88.45 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.182 1.393 . . . . 0.0 112.312 -174.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.07 -46.11 89.08 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.748 1.619 . . . . 0.0 111.993 176.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 51.46 21.18 1.16 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.19 2.196 . . . . 0.0 115.211 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm 47.63 55.37 8.49 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.586 1.555 . . . . 0.0 111.382 -169.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -142.44 42.57 1.62 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.141 1.376 . . . . 0.0 110.555 -170.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt . . . . . 0 C--O 1.253 1.25 0 C-N-CA 124.837 1.255 . . . . 0.0 111.415 175.796 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.2 ptp . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -145.14 146.03 31.62 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.379 1.072 . . . . 0.0 109.997 -171.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 8.9 tmm? -153.99 98.8 2.58 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.95 152.99 37.06 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.036 2.491 . . . . 0.0 111.806 -176.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.3 t -89.92 84.2 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 174.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.55 153.07 79.0 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.749 1.22 . . . . 0.0 111.32 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.6 128.68 19.55 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.05 2.5 . . . . 0.0 111.151 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -73.88 -8.65 56.89 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.532 1.133 . . . . 0.0 112.988 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -145.23 74.94 14.05 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.298 1.439 . . . . 0.0 108.779 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.74 112.44 3.49 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.865 3.043 . . . . 0.0 110.261 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.9 p -147.46 136.49 22.25 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.53 1.532 . . . . 0.0 109.155 -172.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -154.69 -40.47 0.09 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 115.884 -2.007 . . . . 0.0 115.319 -171.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.47 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.8 OUTLIER -53.43 173.64 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 122.312 2.324 . . . . 0.0 112.213 170.59 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.6 mt -62.44 -7.66 4.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.671 1.588 . . . . 0.0 111.232 171.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 67.6 m -95.75 -12.9 24.67 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 126.062 1.745 . . . . 0.0 112.753 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.5 p80 45.2 49.03 10.02 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.339 2.256 . . . . 0.0 112.232 -173.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -164.27 147.94 9.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.217 1.407 . . . . 0.0 108.147 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.422 HG11 ' H ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -127.45 -169.93 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 127.202 2.201 . . . . 0.0 109.285 174.479 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.422 ' H ' HG11 ' A' ' 204' ' ' VAL . 89.8 p 49.24 58.04 5.83 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.893 2.077 . . . . 0.0 114.324 -174.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.15 100.77 2.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.845 2.058 . . . . 0.0 109.295 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 68.95 -96.78 0.47 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.615 1.578 . . . . 0.0 111.5 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.17 169.47 17.8 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.148 1.779 . . . . 0.0 111.977 -169.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -146.0 161.23 40.57 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.42 1.088 . . . . 0.0 112.073 -169.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 4.6 tp -133.31 -134.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 168.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 146.25 133.15 2.46 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 125.493 1.52 . . . . 0.0 111.923 -170.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.51 121.17 14.29 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.374 -0.913 . . . . 0.0 109.082 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -71.78 7.2 1.61 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.51 1.524 . . . . 0.0 113.602 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -71.73 120.2 78.6 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.469 1.107 . . . . 0.0 108.402 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -75.7 6.61 3.58 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.333 2.689 . . . . 0.0 113.361 177.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -119.68 7.67 11.09 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.785 1.634 . . . . 0.0 110.648 174.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.76 129.23 40.44 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 123.438 0.695 . . . . 0.0 110.226 173.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.1 m -81.17 3.45 23.58 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.281 1.432 . . . . 0.0 113.363 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 78.7 mt -134.71 -33.72 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.614 1.565 . . . . 0.0 110.364 -169.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER 73.06 -46.05 0.64 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 128.78 2.832 . . . . 0.0 115.235 170.341 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . 0.47 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.3 OUTLIER -125.44 149.12 48.5 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.588 1.555 . . . . 0.0 109.24 -175.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.43 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 82.6 m-85 -149.69 157.88 43.65 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.945 1.298 . . . . 0.0 108.832 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -89.11 144.6 26.01 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.378 0.609 . . . . 0.0 111.174 -172.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -56.57 -8.24 0.53 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.421 2.288 . . . . 0.0 114.245 169.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.86 -7.69 8.43 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.827 1.251 . . . . 0.0 112.297 174.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 10.6 m -77.28 -3.15 38.4 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.044 0.838 . . . . 0.0 112.938 168.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 12.7 p -131.11 -0.44 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 126.091 1.757 . . . . 0.0 110.857 169.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.46 29.33 74.97 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.208 1.385 . . . . 0.0 113.174 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.6 mt -64.59 -48.53 74.61 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.307 1.043 . . . . 0.0 112.362 -171.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.4 m 63.65 -13.63 0.08 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.878 2.071 . . . . 0.0 114.118 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.8 p -144.73 168.99 18.88 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.18 1.792 . . . . 0.0 110.361 -173.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -67.25 128.82 93.83 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-O 118.373 -0.822 . . . . 0.0 108.804 170.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -73.53 -67.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.599 2.199 . . . . 0.0 111.749 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 24.9 ttp85 -173.1 -173.99 1.0 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.63 1.972 . . . . 0.0 108.666 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -75.62 6.53 31.26 Favored Glycine 0 CA--C 1.539 1.567 0 CA-C-O 118.731 -1.039 . . . . 0.0 113.875 169.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -158.04 119.85 3.63 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 125.175 1.39 . . . . 0.0 108.593 175.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.1 t90 -136.2 160.0 40.03 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.08 2.152 . . . . 0.0 109.852 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -139.82 142.43 36.64 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.012 0.925 . . . . 0.0 110.096 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.0 p -70.83 164.96 51.36 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.574 0.75 . . . . 0.0 111.347 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -73.76 31.5 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.047 3.165 . . . . 0.0 113.096 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -136.18 -36.85 0.73 Allowed 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.386 1.474 . . . . 0.0 109.937 176.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 18.8 m -79.21 -30.83 43.5 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 127.354 2.262 . . . . 0.0 112.011 173.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 17.9 t -74.62 -19.24 60.37 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.653 1.181 . . . . 0.0 112.303 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 21.9 tm0? -55.85 -35.9 66.96 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.59 1.556 . . . . 0.0 112.754 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.58 -31.54 62.28 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.543 1.537 . . . . 0.0 113.118 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -116.74 33.42 5.6 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.486 1.514 . . . . 0.0 111.524 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -121.18 32.11 6.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.45 1.5 . . . . 0.0 111.045 178.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -80.49 38.53 0.43 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.112 1.765 . . . . 0.0 111.294 169.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt . . . . . 0 C--O 1.25 1.117 0 C-N-CA 127.097 2.159 . . . . 0.0 111.135 -169.169 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 99.0 mmm . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -144.3 30.71 1.25 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.433 1.093 . . . . 0.0 111.366 -167.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 23.9 ptm -133.67 54.68 13.31 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.416 1.087 . . . . 0.0 113.585 -169.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -68.86 138.47 40.86 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.387 2.058 . . . . 0.0 110.348 170.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 91.0 t -144.64 119.47 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -147.39 147.57 28.67 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.491 1.116 . . . . 0.0 110.404 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -81.74 46.18 2.16 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 125.133 3.889 . . . . 0.0 110.954 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -129.51 -0.87 4.97 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.968 1.307 . . . . 0.0 113.312 -168.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -70.91 125.8 92.05 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 118.857 0.753 . . . . 0.0 110.129 175.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.09 128.77 11.68 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.052 2.501 . . . . 0.0 110.362 174.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 78.5 p -149.27 135.31 18.98 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.615 1.566 . . . . 0.0 108.735 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -156.83 -39.0 0.07 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 115.901 -2.0 . . . . 0.0 115.194 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.462 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.7 OUTLIER -52.86 173.79 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 122.218 2.281 . . . . 0.0 112.438 171.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.6 mt -62.88 -6.71 4.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.691 1.596 . . . . 0.0 111.216 171.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.8 m -98.53 -11.31 22.35 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 126.14 1.776 . . . . 0.0 112.712 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.2 p80 45.75 48.92 11.63 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.401 2.28 . . . . 0.0 112.424 -174.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -163.76 148.97 10.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.457 1.503 . . . . 0.0 107.548 176.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.1 t -133.83 172.03 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 127.225 2.21 . . . . 0.0 110.635 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.2 t 64.66 61.53 0.82 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.869 2.068 . . . . 0.0 113.3 -174.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.82 111.07 1.52 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.396 1.878 . . . . 0.0 108.558 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.5 -163.18 23.44 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-O 123.171 1.428 . . . . 0.0 112.575 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -65.61 147.27 53.68 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 112.233 -1.983 . . . . 0.0 111.1 169.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.8 mtm -148.98 153.71 38.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.208 1.803 . . . . 0.0 109.743 -168.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.9 tp -137.96 -134.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.346 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -173.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 149.35 132.06 2.03 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 126.232 1.872 . . . . 0.0 112.788 -169.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 47.6 t -64.35 125.35 24.31 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.29 -0.955 . . . . 0.0 108.678 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.8 -0.32 2.14 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.484 1.514 . . . . 0.0 113.245 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -72.97 116.83 54.39 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 124.501 1.121 . . . . 0.0 108.466 168.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.02 4.21 5.97 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.288 2.658 . . . . 0.0 113.217 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -114.78 5.01 15.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.766 1.626 . . . . 0.0 110.526 174.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.98 130.13 45.52 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 122.987 0.515 . . . . 0.0 110.4 171.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.0 m -74.03 1.62 10.59 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.785 1.634 . . . . 0.0 113.868 -176.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 19.1 mt -134.07 -32.82 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 126.091 1.756 . . . . 0.0 110.359 -172.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.77 -37.51 0.38 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 128.366 2.666 . . . . 0.0 115.78 172.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . 0.462 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.5 OUTLIER -130.14 148.77 52.02 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.371 1.868 . . . . 0.0 108.985 -176.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.442 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 82.5 m-85 -147.27 155.12 41.77 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.849 0.86 . . . . 0.0 108.868 -175.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -82.05 143.19 31.71 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.922 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -58.97 -7.27 1.0 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.789 1.636 . . . . 0.0 113.827 170.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -118.83 -5.26 10.63 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.412 1.085 . . . . 0.0 112.417 172.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.0 m -78.55 -0.77 30.95 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.903 0.774 . . . . 0.0 112.855 168.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.0 -9.67 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.845 2.058 . . . . 0.0 111.943 173.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 73.14 36.98 55.93 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.575 1.084 . . . . 0.0 112.993 -177.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 21.9 mt -70.3 104.37 2.65 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.854 0.827 . . . . 0.0 109.919 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 71.0 p -73.81 -18.7 60.92 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.224 1.01 . . . . 0.0 112.446 172.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 55.5 p -147.56 167.38 24.68 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.546 1.938 . . . . 0.0 109.616 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -59.95 129.07 87.81 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.781 0.833 . . . . 0.0 110.081 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.51 166.24 30.41 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.043 2.496 . . . . 0.0 112.042 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -73.84 166.35 23.49 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.45 1.1 . . . . 0.0 109.605 169.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -60.8 158.06 29.5 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 123.3 0.476 . . . . 0.0 112.5 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? 52.74 63.84 2.08 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.135 1.374 . . . . 0.0 111.568 -173.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -84.79 159.57 20.42 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.018 1.327 . . . . 0.0 109.468 172.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -139.76 141.66 36.82 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.313 1.045 . . . . 0.0 109.491 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.1 p -67.2 165.58 26.92 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 123.586 0.755 . . . . 0.0 112.109 174.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -72.97 34.84 0.33 Allowed 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.978 3.119 . . . . 0.0 113.274 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -139.11 -37.45 0.51 Allowed 'General case' 0 C--N 1.343 0.324 0 C-N-CA 125.02 1.328 . . . . 0.0 110.275 169.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 19.7 m -72.47 -35.15 68.14 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.934 2.094 . . . . 0.0 112.025 172.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 t -73.11 -34.0 65.89 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.585 1.154 . . . . 0.0 111.201 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -64.96 -30.14 71.11 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.216 1.407 . . . . 0.0 111.68 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.62 -9.82 39.44 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.213 1.805 . . . . 0.0 113.622 175.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 33.9 ttt85 -143.36 30.71 1.38 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.248 1.019 . . . . 0.0 112.018 -170.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 10.8 mtpm? -68.18 96.52 0.64 Allowed 'General case' 0 C--N 1.344 0.336 0 C-N-CA 125.339 1.456 . . . . 0.0 110.229 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -132.31 36.65 3.59 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.222 1.809 . . . . 0.0 110.114 175.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? . . . . . 0 C--O 1.25 1.123 0 C-N-CA 125.791 1.636 . . . . 0.0 109.524 174.654 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 1.2 tmt? . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -157.86 153.0 25.65 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.803 1.241 . . . . 0.0 109.445 176.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 21.0 ptt? -155.99 62.58 3.14 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.324 1.45 . . . . 0.0 110.126 -176.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.3 -40.75 1.5 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.27 2.647 . . . . 0.0 113.565 -169.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . 0.264 9.9 p 44.93 135.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 130.857 3.663 . . . . 0.0 116.576 -175.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -142.65 150.63 54.69 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.841 1.257 . . . . 0.0 110.514 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.76 -40.51 3.7 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.178 2.585 . . . . 0.0 112.327 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 59.5 t30 47.74 27.72 1.14 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.662 1.985 . . . . 0.0 114.228 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -127.47 83.69 65.38 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.657 1.183 . . . . 0.0 110.41 -171.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.84 131.72 17.45 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.413 2.742 . . . . 0.0 111.026 175.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.4 p -149.54 138.42 21.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.964 1.706 . . . . 0.0 108.786 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -156.49 -37.98 0.08 Allowed 'General case' 0 C--N 1.35 0.625 0 CA-C-O 115.728 -2.082 . . . . 0.0 115.958 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.468 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 1.1 t -53.65 174.11 0.05 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 122.49 2.405 . . . . 0.0 111.851 170.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.1 mt -62.33 -7.29 4.12 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.953 1.701 . . . . 0.0 111.283 170.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 69.7 m -97.11 -12.4 23.19 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.989 1.716 . . . . 0.0 112.711 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.4 p80 45.32 49.33 10.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.173 2.189 . . . . 0.0 112.437 -173.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -164.02 148.06 9.97 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.417 1.487 . . . . 0.0 107.864 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.86 176.1 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 127.179 2.192 . . . . 0.0 110.81 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.0 t 63.69 61.85 0.96 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.692 1.997 . . . . 0.0 112.803 -175.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.96 110.08 1.22 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.334 1.853 . . . . 0.0 109.001 -173.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 60.06 -158.78 24.9 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-O 123.21 1.45 . . . . 0.0 113.247 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -65.49 145.17 56.45 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.098 2.159 . . . . 0.0 111.317 169.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.3 mtm -151.52 156.68 41.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.294 1.838 . . . . 0.0 109.863 -168.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 7.5 tp -138.03 -133.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 124.258 1.023 . . . . 0.0 109.204 -175.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 146.37 136.08 2.85 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 126.466 1.984 . . . . 0.0 113.285 -169.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 7.0 t -65.14 125.62 25.55 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 114.622 -0.789 . . . . 0.0 109.324 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.2 0.29 0.65 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.589 1.156 . . . . 0.0 112.758 170.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -63.49 111.4 5.07 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 127.783 2.433 . . . . 0.0 107.844 167.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -78.58 11.5 2.44 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.374 2.716 . . . . 0.0 113.031 -176.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -129.23 9.04 5.61 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.161 1.784 . . . . 0.0 109.787 174.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 25.8 t -55.58 124.11 16.25 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.636 0.732 . . . . 0.0 112.403 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 15.8 m -74.34 1.14 12.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.703 2.001 . . . . 0.0 113.271 -177.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 12.5 mt -131.48 -34.55 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 126.382 1.873 . . . . 0.0 109.574 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.13 -25.3 0.16 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 128.017 2.527 . . . . 0.0 115.78 169.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . 0.468 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.6 OUTLIER -143.6 148.06 35.31 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.855 1.662 . . . . 0.0 109.178 -178.433 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.422 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 90.6 m-85 -145.96 155.87 43.13 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.168 0.987 . . . . 0.0 108.825 -177.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -80.91 143.16 32.86 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.901 -175.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.99 -2.4 0.41 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.297 1.839 . . . . 0.0 114.12 171.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.61 -7.59 7.42 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.26 1.424 . . . . 0.0 112.166 172.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.6 m -77.27 -2.16 33.35 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.154 0.888 . . . . 0.0 112.678 168.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.77 -5.59 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 127.444 2.298 . . . . 0.0 111.266 172.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.34 36.58 91.85 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.894 1.235 . . . . 0.0 112.885 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 231' ' ' THR . 11.8 mt -64.9 -58.64 5.62 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.727 0.811 . . . . 0.0 111.452 -178.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 25.7 m 62.26 -22.22 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.229 2.211 . . . . 0.0 114.58 -172.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' THR . . . . . 0.402 ' H ' ' C ' ' A' ' 229' ' ' LEU . 71.1 p -142.01 157.79 44.52 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.687 1.995 . . . . 0.0 109.528 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -65.18 127.19 92.63 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 123.557 0.743 . . . . 0.0 110.986 -173.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.81 174.44 12.58 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.449 2.766 . . . . 0.0 112.091 176.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -69.05 168.71 13.28 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.949 0.9 . . . . 0.0 109.593 167.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -61.03 161.12 25.26 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 123.224 0.44 . . . . 0.0 112.354 173.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.6 tptp 54.7 56.09 7.15 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.102 1.361 . . . . 0.0 112.645 -173.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -74.46 156.11 37.3 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.44 0.696 . . . . 0.0 109.22 172.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.52 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 71.8 m-85 -134.77 135.97 42.25 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.831 0.852 . . . . 0.0 110.655 -176.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 31.2 p -65.96 164.42 28.55 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.311 1.044 . . . . 0.0 112.237 172.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.88 30.84 0.25 Allowed 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.244 3.296 . . . . 0.0 113.664 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -133.67 -36.4 0.96 Allowed 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.545 1.538 . . . . 0.0 110.041 170.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 3.6 m -71.78 -38.19 70.36 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.158 1.783 . . . . 0.0 112.156 169.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 17.6 t -81.39 -27.99 34.55 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.826 1.251 . . . . 0.0 111.155 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -65.21 -31.62 72.89 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.451 1.5 . . . . 0.0 111.46 173.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.74 -27.48 68.76 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.9 1.68 . . . . 0.0 112.584 175.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 64.2 ttt-85 33.79 70.47 0.12 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 128.407 2.683 . . . . 0.0 114.049 172.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -70.66 -175.43 1.07 Allowed 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.458 1.903 . . . . 0.0 111.066 -176.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -79.22 34.58 0.25 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.645 2.378 . . . . 0.0 111.531 169.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 83.8 tttt . . . . . 0 C--O 1.252 1.21 0 C-N-CA 127.493 2.317 . . . . 0.0 110.806 -168.479 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 66.7 ttp . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -73.5 -48.66 31.57 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.739 0.816 . . . . 0.0 111.403 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 14.0 tpt 19.79 68.79 0.25 Allowed Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 129.233 3.013 . . . . 0.0 114.305 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.06 -41.9 2.39 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.681 2.254 . . . . 0.0 112.809 -170.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . 0.259 1.3 p 49.19 145.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 130.656 3.582 . . . . 0.0 115.727 -174.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 29.3 t70 43.12 76.81 0.49 Allowed Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 126.518 1.927 . . . . 0.0 112.599 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -65.48 136.08 45.13 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.951 2.434 . . . . 0.0 111.626 -172.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -132.75 19.13 4.21 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.385 1.474 . . . . 0.0 111.078 -176.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -57.3 129.72 80.02 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.278 1.431 . . . . 0.0 111.766 -171.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.07 118.07 5.44 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.147 2.565 . . . . 0.0 110.261 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 82.0 p -149.24 132.13 16.11 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.751 1.62 . . . . 0.0 108.409 176.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -156.55 -46.56 0.07 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 117.861 -1.066 . . . . 0.0 113.804 -175.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.8 p -39.38 170.05 0.0 OUTLIER 'General case' 0 C--N 1.349 0.578 0 C-N-CA 126.375 1.87 . . . . 0.0 114.064 168.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -71.08 -6.74 41.44 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.118 168.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 95.7 m -95.89 -14.31 23.26 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 123.633 0.773 . . . . 0.0 111.792 174.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.1 p80 46.25 52.34 10.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.304 2.242 . . . . 0.0 112.899 -173.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -170.36 141.62 2.03 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 126.091 1.756 . . . . 0.0 107.95 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.6 t -126.47 171.11 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 125.488 1.515 . . . . 0.0 111.18 -176.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 43.2 m 68.72 62.81 0.33 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.267 2.227 . . . . 0.0 113.387 -177.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.65 113.45 1.29 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.595 1.958 . . . . 0.0 108.531 -174.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 63.26 -168.68 20.12 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-O 122.708 1.171 . . . . 0.0 112.06 -173.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -69.02 150.53 47.55 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 113.273 -1.463 . . . . 0.0 110.651 168.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.9 mtm -143.63 152.57 41.53 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.929 1.692 . . . . 0.0 109.824 -166.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.6 tp -135.5 -138.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.304 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 151.86 132.4 1.85 Allowed Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 125.906 1.717 . . . . 0.0 112.151 -169.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 40.7 t -63.61 125.55 24.63 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 114.074 -1.063 . . . . 0.0 108.249 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -68.9 6.16 0.96 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.54 1.136 . . . . 0.0 113.559 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -74.42 114.11 30.47 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 166.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -77.65 9.11 3.06 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.328 2.685 . . . . 0.0 113.059 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -124.21 8.74 8.55 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.888 1.675 . . . . 0.0 110.248 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . 0.433 ' HG ' ' H ' ' A' ' 219' ' ' ILE . 49.6 t -60.6 129.97 44.23 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 118.306 0.503 . . . . 0.0 109.924 172.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -73.59 4.36 5.05 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.755 1.622 . . . . 0.0 113.404 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.433 ' H ' ' HG ' ' A' ' 217' ' ' CYS . 34.2 mt -132.54 -35.17 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 126.268 1.827 . . . . 0.0 109.938 -175.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.7 -38.72 0.43 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.762 2.425 . . . . 0.0 115.27 170.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.43 148.67 52.67 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.899 2.08 . . . . 0.0 108.646 -174.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -148.62 146.72 28.35 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -73.22 149.61 42.7 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.793 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -60.29 -6.28 1.43 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.74 1.216 . . . . 0.0 113.641 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -120.36 -0.56 10.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.33 1.052 . . . . 0.0 112.611 170.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.5 m -72.61 -5.99 41.11 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.901 0.773 . . . . 0.0 111.301 166.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.1 p -137.48 -12.48 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.765 2.026 . . . . 0.0 112.388 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.97 38.84 55.62 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.348 0.975 . . . . 0.0 112.86 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.7 111.12 3.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 117.82 0.81 . . . . 0.0 109.796 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 73.6 p -78.04 -15.69 58.7 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.44 1.096 . . . . 0.0 112.565 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 15.1 t -155.59 172.29 18.53 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.759 1.623 . . . . 0.0 109.822 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -66.74 127.04 93.27 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 124.599 1.16 . . . . 0.0 109.948 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.04 170.65 19.66 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.149 2.566 . . . . 0.0 112.121 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 50.6 ttp85 -63.71 168.87 4.47 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.208 1.403 . . . . 0.0 111.15 172.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -60.92 -1.5 2.02 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.92 1.724 . . . . 0.0 116.169 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -139.3 116.95 11.45 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.744 1.618 . . . . 0.0 107.361 169.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.422 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 88.9 t90 -130.57 156.17 45.28 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.54 2.336 . . . . 0.0 109.245 176.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -140.12 143.21 36.11 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.2 1.0 . . . . 0.0 108.755 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.422 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 17.1 p -68.12 163.37 51.99 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-O 118.808 -0.615 . . . . 0.0 111.633 177.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.25 33.81 0.32 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.965 3.11 . . . . 0.0 112.891 178.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -138.26 -35.7 0.61 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 125.988 1.715 . . . . 0.0 109.964 173.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 15.7 m -75.36 -35.8 61.07 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.774 2.03 . . . . 0.0 111.591 170.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 8.2 t -81.36 -5.97 58.42 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.272 1.429 . . . . 0.0 112.781 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -73.49 -40.18 64.3 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.962 0.905 . . . . 0.0 111.497 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -58.3 -47.74 82.7 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.868 1.667 . . . . 0.0 111.85 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 50.09 32.91 6.29 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.553 1.941 . . . . 0.0 114.822 170.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 56.3 tttm 50.45 56.46 7.92 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.081 1.753 . . . . 0.0 111.593 -174.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -138.7 30.76 2.3 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.119 1.368 . . . . 0.0 111.695 -172.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 83.4 tttt . . . . . 0 C--O 1.252 1.205 0 C-N-CA 127.65 2.38 . . . . 0.0 112.647 178.439 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 58.0 tpp . . . . . 0 N--CA 1.475 0.805 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -81.68 17.28 1.5 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.51 1.524 . . . . 0.0 113.024 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 25.5 ttt -57.73 -46.92 99.71 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-O 116.856 -1.545 . . . . 0.0 113.816 -177.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -75.63 142.5 26.07 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.042 1.828 . . . . 0.0 110.032 169.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 88.8 t -66.86 -52.96 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.621 0.769 . . . . 0.0 110.185 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -166.62 -55.39 0.01 OUTLIER Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.942 1.697 . . . . 0.0 110.145 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -72.97 131.58 17.07 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.045 1.83 . . . . 0.0 110.638 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -156.85 23.67 0.32 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.765 1.226 . . . . 0.0 111.178 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.85 118.22 27.4 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.445 1.498 . . . . 0.0 111.535 -172.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -88.54 26.23 0.59 Allowed 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 124.119 3.212 . . . . 0.0 113.557 -173.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.6 p -141.75 140.07 32.99 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.954 1.702 . . . . 0.0 109.361 -173.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -156.28 -38.91 0.08 Allowed 'General case' 0 C--N 1.35 0.623 0 CA-C-O 115.764 -2.065 . . . . 0.0 115.725 -174.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.471 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.8 OUTLIER -53.1 174.2 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 122.449 2.386 . . . . 0.0 112.145 172.035 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.0 mt -62.65 -6.3 3.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.734 1.614 . . . . 0.0 111.275 170.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 82.6 m -99.32 -12.1 20.63 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 126.193 1.797 . . . . 0.0 112.699 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.0 p80 45.19 49.03 10.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.189 2.196 . . . . 0.0 112.357 -174.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -164.15 148.16 9.8 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 125.572 1.549 . . . . 0.0 108.045 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.26 175.51 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 127.244 2.218 . . . . 0.0 110.253 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 16.8 t 61.93 63.1 1.15 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.377 1.871 . . . . 0.0 113.292 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -161.12 112.58 1.81 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.333 1.853 . . . . 0.0 109.165 -173.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.48 -110.02 3.24 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 125.232 1.396 . . . . 0.0 109.872 -172.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.14 165.9 24.64 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.84 2.056 . . . . 0.0 111.332 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -138.72 157.16 46.62 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.742 1.217 . . . . 0.0 111.063 -168.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 9.5 tt -134.48 -136.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 147.59 132.08 2.2 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 125.167 1.365 . . . . 0.0 113.113 -170.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.5 t -65.86 123.44 19.81 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.9 0.88 . . . . 0.0 108.777 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.34 -1.8 3.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.71 1.604 . . . . 0.0 113.574 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -66.93 116.29 33.97 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 168.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.93 5.15 5.15 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.409 2.739 . . . . 0.0 113.009 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -117.69 6.16 12.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.902 1.681 . . . . 0.0 110.424 174.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 41.8 t -59.01 130.23 46.03 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 122.973 0.509 . . . . 0.0 110.378 172.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.3 t -76.07 3.21 10.92 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.732 1.613 . . . . 0.0 113.617 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 19.6 mt -134.42 -35.02 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.995 1.718 . . . . 0.0 110.279 -172.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.22 -40.95 0.49 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.992 2.517 . . . . 0.0 115.38 172.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . 0.471 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.5 OUTLIER -126.56 147.67 49.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.135 1.774 . . . . 0.0 108.837 -177.683 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.428 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 80.9 m-85 -146.89 157.48 43.66 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.39 1.076 . . . . 0.0 108.794 -175.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -84.16 141.82 30.78 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.793 -175.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.73 -8.55 1.35 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.574 1.949 . . . . 0.0 113.096 169.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -118.01 -7.06 10.91 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.823 1.249 . . . . 0.0 112.189 174.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 4.6 m -77.9 -2.1 35.09 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.94 0.791 . . . . 0.0 112.306 168.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 14.3 p -130.86 -6.31 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 126.955 2.102 . . . . 0.0 111.481 173.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.67 35.32 89.65 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.735 1.16 . . . . 0.0 113.176 -176.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.7 mt -66.29 155.54 36.91 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.366 1.083 . . . . 0.0 111.315 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 90.6 m -134.46 -12.58 2.37 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.758 1.623 . . . . 0.0 110.924 -176.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 9.9 t -148.49 165.09 32.22 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 125.649 1.579 . . . . 0.0 109.859 174.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -79.63 119.51 77.1 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.33 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.06 172.14 16.67 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.434 2.756 . . . . 0.0 111.46 176.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -146.11 153.54 40.8 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.066 0.946 . . . . 0.0 109.897 174.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 109.56 -82.55 0.3 Allowed Glycine 0 C--N 1.338 0.686 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -175.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -168.92 139.56 2.38 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.732 2.013 . . . . 0.0 107.491 168.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.442 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 91.4 t90 -106.35 162.65 13.5 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.277 1.831 . . . . 0.0 110.256 177.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -139.02 141.13 38.29 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.864 1.266 . . . . 0.0 109.125 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.442 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 17.6 p -66.88 162.87 48.85 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.302 0.641 . . . . 0.0 112.071 173.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -73.63 35.99 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 124.006 3.137 . . . . 0.0 112.888 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -138.46 -35.68 0.59 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.868 1.667 . . . . 0.0 109.935 170.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 17.6 m -72.34 -34.87 68.36 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.424 1.89 . . . . 0.0 111.832 169.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 10.5 t -80.33 -14.92 57.97 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.086 1.354 . . . . 0.0 112.873 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -67.11 -19.51 65.64 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.81 0.844 . . . . 0.0 113.006 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -58.76 -27.26 64.8 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.504 1.922 . . . . 0.0 113.82 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 40.2 mtp180 -136.01 43.44 2.54 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.388 1.075 . . . . 0.0 111.345 -170.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -68.45 86.94 0.3 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.319 1.848 . . . . 0.0 110.917 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -135.5 28.08 3.36 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.901 1.68 . . . . 0.0 111.21 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? . . . . . 0 C--O 1.251 1.171 0 C-N-CA 127.481 2.313 . . . . 0.0 111.502 -169.803 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 68.4 mtt . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -66.48 143.75 56.9 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.493 1.117 . . . . 0.0 110.843 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 73.3 mtm -142.7 73.56 19.5 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 124.883 1.273 . . . . 0.0 108.975 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -78.94 21.93 0.7 Allowed 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 124.678 3.586 . . . . 0.0 113.418 -175.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.7 t -128.53 40.26 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.378 1.471 . . . . 0.0 109.319 -171.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -142.52 151.5 57.71 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.502 1.521 . . . . 0.0 110.132 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.45 126.45 13.53 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.315 2.677 . . . . 0.0 110.81 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -153.77 35.74 0.45 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.577 1.151 . . . . 0.0 110.809 -174.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -135.24 80.29 47.22 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.885 1.274 . . . . 0.0 109.391 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.02 126.96 11.66 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.504 2.803 . . . . 0.0 111.115 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.8 p -147.43 141.66 26.19 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.078 1.751 . . . . 0.0 108.841 -174.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -155.42 -47.14 0.08 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -173.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.8 p -38.6 170.11 0.0 OUTLIER 'General case' 0 C--N 1.351 0.635 0 C-N-CA 126.557 1.943 . . . . 0.0 114.607 169.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.3 mt -70.57 -6.7 38.44 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 113.32 -1.764 . . . . 0.0 110.044 168.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.9 m -96.77 -14.18 22.13 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 123.646 0.778 . . . . 0.0 111.784 174.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.8 p80 45.46 52.27 9.16 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.224 2.21 . . . . 0.0 112.915 -173.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -169.9 140.7 2.1 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.934 1.694 . . . . 0.0 108.269 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.0 174.1 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.675 1.59 . . . . 0.0 110.634 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.7 t 66.36 62.05 0.57 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.721 2.009 . . . . 0.0 113.413 -174.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.75 110.87 1.98 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.174 1.79 . . . . 0.0 108.977 -175.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 66.81 -109.51 2.95 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 125.283 1.421 . . . . 0.0 110.438 -172.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.61 168.64 19.35 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.123 2.169 . . . . 0.0 111.139 -174.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -140.35 158.89 43.33 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.719 0.808 . . . . 0.0 112.748 -168.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 7.2 tp -133.18 -138.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.401 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 145.43 134.6 2.73 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 126.165 1.84 . . . . 0.0 111.714 -169.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 41.4 t -63.18 126.38 27.21 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.75 -4.29 3.0 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.376 1.47 . . . . 0.0 113.545 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -71.72 118.85 70.32 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.458 1.103 . . . . 0.0 109.071 169.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.36 3.76 6.02 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.362 2.708 . . . . 0.0 113.283 176.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -115.04 6.11 15.14 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.912 1.685 . . . . 0.0 110.495 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 50.8 t -58.18 128.37 36.78 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 123.174 0.59 . . . . 0.0 109.905 171.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.9 t -74.14 1.74 10.52 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.7 1.6 . . . . 0.0 113.442 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.5 mm -134.33 -35.08 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.848 1.659 . . . . 0.0 110.126 -170.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.92 -38.34 0.4 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.117 2.567 . . . . 0.0 115.201 169.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.8 148.91 48.92 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.936 1.694 . . . . 0.0 109.168 -174.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -149.15 148.13 29.28 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -72.15 150.89 43.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.264 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -59.03 -4.6 0.51 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.884 1.674 . . . . 0.0 113.027 166.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.86 -3.69 8.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.237 1.415 . . . . 0.0 112.647 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 18.8 m -72.92 -6.2 43.59 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.107 0.867 . . . . 0.0 111.645 167.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.22 -4.76 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 126.179 1.792 . . . . 0.0 111.709 172.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.69 32.57 74.56 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.753 1.168 . . . . 0.0 113.117 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.6 mt -66.53 -51.07 60.6 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.375 1.07 . . . . 0.0 112.048 -175.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . 0.278 2.6 t 46.69 8.98 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 128.549 2.74 . . . . 0.0 116.263 -169.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 75.1 p -147.4 162.97 37.92 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.319 1.848 . . . . 0.0 110.228 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -68.13 121.61 80.78 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 124.103 0.961 . . . . 0.0 109.259 172.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.64 164.38 20.9 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.229 2.619 . . . . 0.0 112.042 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -67.09 159.4 28.89 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.76 0.824 . . . . 0.0 109.77 169.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -57.9 155.14 21.52 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.836 0.731 . . . . 0.0 112.883 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt 53.06 64.77 1.73 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.341 1.456 . . . . 0.0 111.56 -170.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.402 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 90.1 t90 -81.83 152.7 26.78 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 113.168 -1.833 . . . . 0.0 109.044 169.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.413 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 93.3 m-85 -140.49 140.89 35.39 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.826 0.851 . . . . 0.0 109.506 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.402 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 6.0 p -70.16 167.36 25.91 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.118 0.967 . . . . 0.0 112.174 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -69.59 9.32 0.58 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 123.463 2.776 . . . . 0.0 114.42 -176.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -133.41 27.03 4.11 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.188 1.795 . . . . 0.0 111.504 176.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 3.7 t -152.16 -32.26 0.14 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.11 1.764 . . . . 0.0 110.768 -173.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 76.0 p -70.32 -29.98 66.84 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.395 1.478 . . . . 0.0 112.2 170.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -67.61 -34.23 76.58 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.385 1.474 . . . . 0.0 112.294 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -57.02 -50.9 71.31 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.867 1.667 . . . . 0.0 111.888 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 52.22 27.95 5.14 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.648 1.979 . . . . 0.0 114.823 172.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt 47.72 43.76 17.06 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.069 1.748 . . . . 0.0 111.691 -171.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.1 tptm 59.84 118.62 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.326 2.65 . . . . 0.0 112.042 -167.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? . . . . . 0 C--O 1.251 1.161 0 CA-C-O 116.427 -1.749 . . . . 0.0 107.313 170.387 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -68.68 156.63 37.85 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.937 0.895 . . . . 0.0 111.465 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 64.6 mtt -139.17 74.47 35.99 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.675 1.59 . . . . 0.0 108.191 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.56 164.18 36.56 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.639 2.893 . . . . 0.0 112.35 -174.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.472 HG11 ' H ' ' A' ' 192' ' ' ASP . 0.6 OUTLIER -141.07 -173.25 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 125.953 1.701 . . . . 0.0 107.961 -176.127 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.472 ' H ' HG11 ' A' ' 191' ' ' VAL . 26.1 m-20 68.33 154.71 0.14 Allowed Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 128.183 2.593 . . . . 0.0 112.916 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.43 144.88 63.11 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.635 2.224 . . . . 0.0 111.403 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -65.8 -19.57 65.94 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.623 1.169 . . . . 0.0 112.824 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -144.94 83.1 9.6 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.949 1.3 . . . . 0.0 108.452 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.09 121.16 7.99 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.275 2.65 . . . . 0.0 110.48 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.7 p -148.81 135.55 19.73 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.909 1.684 . . . . 0.0 108.615 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -156.41 -37.92 0.08 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 115.935 -1.983 . . . . 0.0 115.759 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.46 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.9 OUTLIER -53.82 174.11 0.05 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 122.352 2.342 . . . . 0.0 111.97 169.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.3 mt -62.52 -7.46 4.66 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.869 1.668 . . . . 0.0 111.278 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 67.0 m -96.62 -12.54 23.8 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.943 1.697 . . . . 0.0 112.68 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.8 p80 45.16 49.27 9.83 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.262 2.225 . . . . 0.0 112.371 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -163.92 148.29 10.24 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.352 1.461 . . . . 0.0 107.825 175.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.66 174.48 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 127.274 2.23 . . . . 0.0 110.796 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.0 t 63.64 62.04 0.96 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.653 1.981 . . . . 0.0 112.727 -174.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.88 108.74 1.16 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.546 1.938 . . . . 0.0 108.716 -173.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 60.48 -160.14 24.17 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-O 123.296 1.498 . . . . 0.0 113.172 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -65.6 147.24 53.72 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.337 2.255 . . . . 0.0 111.63 170.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.6 mtm -150.57 158.83 44.6 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.186 1.794 . . . . 0.0 110.218 -168.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 9.2 tp -139.35 -133.87 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.247 1.019 . . . . 0.0 109.219 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 147.29 136.01 2.75 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 126.456 1.979 . . . . 0.0 113.14 -169.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.509 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 7.1 t -64.59 124.98 23.27 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 114.642 -0.779 . . . . 0.0 109.124 177.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.45 1.59 0.52 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.631 1.173 . . . . 0.0 113.105 170.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -63.73 111.65 5.69 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 127.622 2.369 . . . . 0.0 107.951 167.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -78.7 11.46 2.49 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.455 2.77 . . . . 0.0 112.916 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -128.95 9.08 5.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.087 1.755 . . . . 0.0 109.798 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 20.8 t -56.65 123.21 14.1 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-O 121.542 0.687 . . . . 0.0 112.131 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 39.7 m -74.5 0.35 15.03 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.537 1.935 . . . . 0.0 113.321 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 14.5 mt -129.14 -34.76 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.436 1.894 . . . . 0.0 109.425 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.75 -25.63 0.15 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.144 2.578 . . . . 0.0 115.77 169.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . 0.46 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.6 OUTLIER -142.45 148.59 38.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.957 1.703 . . . . 0.0 109.041 -177.503 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.421 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 91.0 m-85 -147.03 156.61 43.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.095 0.958 . . . . 0.0 108.511 -177.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -82.74 143.58 30.78 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.43 0.633 . . . . 0.0 110.203 -175.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.17 -4.36 0.51 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.675 1.99 . . . . 0.0 114.056 170.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.1 -8.92 7.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.364 1.466 . . . . 0.0 112.215 173.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.5 m -76.68 -2.57 33.53 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.102 0.865 . . . . 0.0 112.81 168.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.2 p -131.43 -1.62 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 126.675 1.99 . . . . 0.0 110.931 170.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 62.45 34.12 88.43 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.112 1.339 . . . . 0.0 113.003 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.76 -53.76 41.97 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 117.859 0.829 . . . . 0.0 111.524 -174.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 36.1 p 48.67 10.32 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.976 2.51 . . . . 0.0 116.118 -173.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 11.0 t -156.84 165.05 37.32 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 125.829 1.652 . . . . 0.0 110.328 174.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -61.27 118.54 37.62 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.84 1.656 . . . . 0.0 108.756 177.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.58 169.76 21.58 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.393 2.729 . . . . 0.0 113.194 -174.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.53 172.31 4.24 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.267 1.027 . . . . 0.0 110.239 168.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -60.42 148.29 44.34 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.374 0.512 . . . . 0.0 111.974 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 46.1 tttp 43.93 82.13 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.284 2.234 . . . . 0.0 113.845 -175.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 86.7 t90 -81.55 157.53 24.75 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.039 0.935 . . . . 0.0 109.66 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.509 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 88.7 m-85 -135.92 136.65 40.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.942 0.897 . . . . 0.0 110.592 -176.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 30.6 p -69.8 164.53 50.35 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 124.259 1.023 . . . . 0.0 112.163 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.28 28.85 0.26 Allowed 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 124.352 3.368 . . . . 0.0 113.817 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -132.15 -30.22 1.56 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.722 2.009 . . . . 0.0 110.079 174.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 2.0 m -81.49 -31.0 33.1 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.301 2.24 . . . . 0.0 112.312 169.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.5 t -70.09 -19.54 63.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.216 1.406 . . . . 0.0 112.393 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.52 -38.48 91.15 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.945 1.298 . . . . 0.0 111.1 170.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' A' ' 246' ' ' ARG . 0.9 OUTLIER -71.83 179.77 3.02 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.919 1.688 . . . . 0.0 112.114 173.327 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.443 ' H ' ' CD ' ' A' ' 245' ' ' GLU . 32.4 ttm105 55.12 64.29 1.84 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.228 1.811 . . . . 0.0 111.258 -176.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -80.94 -156.3 0.13 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.556 1.942 . . . . 0.0 109.721 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.24 126.09 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 128.488 2.715 . . . . 0.0 111.565 -173.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' A' ' 249' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.062 0 C-N-CA 127.917 2.487 . . . . 0.0 112.902 -174.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 33.3 t70 62.64 159.49 0.07 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.044 2.137 . . . . 0.0 113.425 -170.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.0 ttt -152.08 89.56 3.96 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.254 1.422 . . . . 0.0 107.997 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.0 156.74 59.57 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.977 2.452 . . . . 0.0 111.486 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.0 -34.79 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.405 1.082 . . . . 0.0 111.616 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 28.4 t70 40.75 73.57 0.85 Allowed Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 126.368 1.867 . . . . 0.0 112.469 -171.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -67.23 88.6 0.32 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 124.304 3.336 . . . . 0.0 109.54 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -152.9 48.69 0.72 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.847 1.659 . . . . 0.0 109.054 -167.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -118.61 91.47 42.01 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.098 1.359 . . . . 0.0 109.159 -171.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.33 141.61 29.02 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.092 2.528 . . . . 0.0 110.856 177.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.8 p -148.47 141.17 24.54 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.996 1.718 . . . . 0.0 108.789 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -155.34 -44.47 0.08 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.8 p -38.86 169.84 0.0 OUTLIER 'General case' 0 C--N 1.349 0.578 0 C-N-CA 126.299 1.839 . . . . 0.0 114.257 168.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.6 mt -71.05 -6.34 38.28 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 113.417 -1.72 . . . . 0.0 110.129 168.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 86.9 m -96.69 -14.2 22.24 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 123.617 0.767 . . . . 0.0 111.819 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.9 p80 45.87 52.7 9.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.21 2.204 . . . . 0.0 112.779 -173.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.42 140.39 2.27 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 125.818 1.647 . . . . 0.0 107.958 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.4 t -129.34 171.02 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.368 1.467 . . . . 0.0 111.069 -176.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.8 t 67.04 64.75 0.44 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.033 2.133 . . . . 0.0 113.048 -174.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.15 113.63 1.21 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.468 1.907 . . . . 0.0 108.48 -175.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.36 -162.68 23.8 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 123.181 1.434 . . . . 0.0 112.769 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -67.61 145.05 55.23 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 112.223 -1.988 . . . . 0.0 110.829 169.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.4 mtm -146.45 152.89 39.75 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.166 1.787 . . . . 0.0 109.858 -168.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 9.7 tp -138.98 -137.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.36 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 -174.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 152.92 133.01 1.83 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 125.938 1.732 . . . . 0.0 112.375 -169.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 43.9 t -63.08 124.39 21.03 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.081 -1.059 . . . . 0.0 108.395 175.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.63 4.87 1.22 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.353 1.461 . . . . 0.0 113.426 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -74.95 114.59 36.35 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 167.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.31 9.07 2.97 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.384 2.722 . . . . 0.0 113.009 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -123.89 8.76 8.74 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.798 1.639 . . . . 0.0 110.34 175.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . 0.437 ' HG ' ' H ' ' A' ' 219' ' ' ILE . 48.9 t -60.79 130.88 48.69 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 118.293 0.497 . . . . 0.0 109.951 172.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.5 t -73.48 3.86 5.55 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.794 1.638 . . . . 0.0 113.578 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.437 ' H ' ' HG ' ' A' ' 217' ' ' CYS . 30.7 mt -132.96 -34.61 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 126.274 1.829 . . . . 0.0 110.035 -175.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.79 -39.54 0.45 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.624 2.369 . . . . 0.0 115.415 170.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -130.7 148.6 52.5 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.923 2.089 . . . . 0.0 108.371 -174.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -148.63 145.9 27.97 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -175.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -71.64 149.78 45.25 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.634 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.38 -6.04 1.39 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.742 1.217 . . . . 0.0 113.389 168.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -121.66 0.1 9.79 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.454 1.102 . . . . 0.0 112.588 170.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.1 m -72.1 -6.77 44.87 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.946 0.794 . . . . 0.0 111.252 166.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.12 -12.67 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 126.376 1.87 . . . . 0.0 112.627 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.22 36.61 34.44 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.422 1.011 . . . . 0.0 113.113 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 17.0 mt -68.62 104.3 1.93 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.309 1.044 . . . . 0.0 109.838 174.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.7 t -71.89 -17.82 62.09 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.46 1.104 . . . . 0.0 112.575 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 14.1 t -152.66 174.56 13.83 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.679 1.592 . . . . 0.0 110.017 176.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -65.98 131.03 94.48 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.457 1.103 . . . . 0.0 110.085 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.26 176.94 9.42 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.38 2.72 . . . . 0.0 112.011 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -61.66 170.94 1.72 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.924 1.29 . . . . 0.0 111.677 171.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -68.21 8.77 1.86 Allowed Glycine 0 CA--C 1.539 1.546 0 C-N-CA 125.281 1.42 . . . . 0.0 115.063 177.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -150.46 112.33 4.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.165 1.386 . . . . 0.0 107.443 170.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.404 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 87.4 t90 -128.07 157.82 39.66 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.226 1.81 . . . . 0.0 109.745 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -140.08 140.01 36.01 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.204 1.001 . . . . 0.0 109.093 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.404 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 16.6 p -68.94 164.69 44.84 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 123.614 0.765 . . . . 0.0 112.187 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.47 35.3 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.291 3.327 . . . . 0.0 113.071 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -139.55 -28.65 0.76 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.622 1.569 . . . . 0.0 111.032 169.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 7.5 m -88.27 -29.63 20.26 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 127.521 2.328 . . . . 0.0 112.18 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 16.1 t -73.41 -20.11 60.82 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.133 0.973 . . . . 0.0 112.159 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 17.0 mp0 -69.9 -25.67 63.8 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.453 1.501 . . . . 0.0 112.078 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -11.81 31.64 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.739 1.616 . . . . 0.0 113.253 172.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -130.84 31.77 4.45 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.691 1.597 . . . . 0.0 110.967 -175.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -63.77 93.93 0.09 Allowed 'General case' 0 C--N 1.345 0.38 0 C-N-CA 125.731 1.612 . . . . 0.0 109.819 169.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -137.81 68.19 1.41 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.288 2.235 . . . . 0.0 106.827 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt . . . . . 0 C--O 1.251 1.17 0 C-N-CA 126.882 2.073 . . . . 0.0 110.15 -168.347 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 119.255 -0.402 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -148.17 158.38 44.04 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.861 1.265 . . . . 0.0 110.463 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -156.39 99.19 2.11 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 124.271 1.028 . . . . 0.0 108.619 175.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.68 132.9 16.41 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.722 2.281 . . . . 0.0 109.269 169.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.9 t -83.64 -89.5 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -154.87 -54.3 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 125.487 1.515 . . . . 0.0 111.399 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.89 -40.96 0.34 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 CA-C-N 122.037 1.763 . . . . 0.0 113.18 -175.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 47.13 32.88 2.17 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.519 1.528 . . . . 0.0 112.871 -169.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -128.04 84.58 62.87 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.172 1.389 . . . . 0.0 109.907 -169.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -81.81 164.7 18.03 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 124.377 3.385 . . . . 0.0 111.889 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.1 p 64.54 144.44 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.869 2.467 . . . . 0.0 112.472 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -155.55 -41.53 0.08 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -166.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.7 p -38.56 170.15 0.0 OUTLIER 'General case' 0 C--N 1.347 0.49 0 C-N-CA 126.392 1.877 . . . . 0.0 113.973 168.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.1 mt -70.68 -6.17 35.17 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.149 168.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 93.4 m -96.38 -14.14 22.7 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 123.659 0.784 . . . . 0.0 111.705 174.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.2 p80 46.38 50.92 12.06 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.903 2.081 . . . . 0.0 112.388 -174.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -168.26 141.63 3.16 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 125.068 1.347 . . . . 0.0 108.035 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -124.84 -177.39 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.618 1.567 . . . . 0.0 110.293 177.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 10.6 t 62.16 57.59 1.99 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.294 2.238 . . . . 0.0 114.449 -169.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . 0.421 ' H ' ' CE ' ' A' ' 209' ' ' MET . 0.1 OUTLIER -164.04 113.85 1.24 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.574 1.95 . . . . 0.0 109.834 -177.008 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 66.09 -174.23 21.72 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 122.888 1.271 . . . . 0.0 114.099 176.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -62.05 151.3 35.78 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.474 1.91 . . . . 0.0 111.846 169.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' MET . . . . . 0.421 ' CE ' ' H ' ' A' ' 206' ' ' TYR . 26.0 mtt -145.14 160.6 41.18 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.625 1.17 . . . . 0.0 112.724 -166.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . 0.265 9.6 tp -138.33 -139.21 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.406 ' CA ' ' HA ' ' A' ' 221' ' ' TRP . . . 145.73 135.22 2.78 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 126.486 1.993 . . . . 0.0 111.787 -168.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 6.6 t -65.1 123.18 18.83 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 124.447 0.734 . . . . 0.0 109.208 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.68 1.99 0.52 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.851 1.26 . . . . 0.0 113.11 171.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -62.59 112.43 6.57 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.903 2.481 . . . . 0.0 107.658 166.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -78.28 12.17 2.15 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.363 2.709 . . . . 0.0 112.953 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -129.8 9.49 5.42 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.081 1.752 . . . . 0.0 109.811 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 15.4 t -57.88 117.89 4.76 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-O 121.647 0.737 . . . . 0.0 111.669 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.7 t -74.49 -2.37 25.34 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.571 1.948 . . . . 0.0 112.571 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.0 mm -117.6 -37.03 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.041 1.736 . . . . 0.0 109.05 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.51 -30.26 0.21 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.25 2.62 . . . . 0.0 115.462 168.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . 0.406 ' HA ' ' CA ' ' A' ' 211' ' ' GLY . 0.0 OUTLIER -144.46 150.15 37.16 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.19 1.796 . . . . 0.0 109.03 -174.576 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -148.12 148.17 30.32 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -71.57 150.41 44.75 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.413 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -60.16 -4.61 0.84 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.904 1.281 . . . . 0.0 113.595 168.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -120.87 -2.5 9.77 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.765 1.226 . . . . 0.0 112.485 170.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 21.2 m -73.36 -5.05 37.2 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.863 0.756 . . . . 0.0 111.606 167.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.5 p -138.91 -9.4 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 126.986 2.114 . . . . 0.0 112.187 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.0 37.13 60.49 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.409 1.004 . . . . 0.0 112.941 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 24.6 mt -68.05 111.27 4.35 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 117.819 0.81 . . . . 0.0 109.909 175.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 66.9 p -79.85 -13.6 59.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.268 1.027 . . . . 0.0 112.525 173.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 14.3 t -158.27 172.83 17.66 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.337 1.455 . . . . 0.0 110.493 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.92 115.7 30.89 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.739 1.616 . . . . 0.0 109.065 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.3 170.42 20.04 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.366 2.711 . . . . 0.0 112.822 -173.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -63.87 165.87 8.1 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.874 0.87 . . . . 0.0 110.898 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -58.87 160.08 16.05 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.117 0.865 . . . . 0.0 113.159 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 43.5 tttp 45.88 69.42 0.46 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.474 1.91 . . . . 0.0 113.164 -170.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -75.7 156.7 34.47 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.97 0.908 . . . . 0.0 109.255 173.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . 0.508 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 75.1 m-85 -133.03 135.81 45.62 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.926 0.89 . . . . 0.0 110.298 -176.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.401 ' C ' ' H ' ' A' ' 241' ' ' ARG . 30.8 p -65.6 163.08 37.23 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 123.821 0.848 . . . . 0.0 111.599 170.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.28 28.85 0.26 Allowed 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 124.31 3.34 . . . . 0.0 113.529 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.401 ' H ' ' C ' ' A' ' 239' ' ' CYS . 84.2 mtt-85 -134.17 -34.85 0.95 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.694 1.998 . . . . 0.0 109.377 177.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 1.5 m -74.87 -33.42 62.08 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.602 1.961 . . . . 0.0 112.104 169.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.5 t -67.02 -33.38 75.43 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.964 0.906 . . . . 0.0 111.148 173.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 16.9 tm0? -68.93 -37.52 78.95 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.346 1.059 . . . . 0.0 111.247 173.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.11 -30.0 65.94 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.633 1.573 . . . . 0.0 112.968 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 35.71 61.56 0.7 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.516 2.727 . . . . 0.0 114.491 168.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -79.37 64.03 4.15 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.406 1.082 . . . . 0.0 111.668 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt 46.53 53.91 9.32 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.771 2.028 . . . . 0.0 112.703 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.089 0 C-N-CA 126.485 1.914 . . . . 0.0 110.651 -174.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 73.5 mtm . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -128.34 103.01 6.92 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 124.25 1.02 . . . . 0.0 109.427 -170.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.2 ttt -150.13 81.58 6.77 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.939 1.295 . . . . 0.0 108.433 179.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.47 78.81 2.93 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 124.348 3.365 . . . . 0.0 110.663 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 97.1 t -137.56 -40.48 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.667 1.587 . . . . 0.0 109.332 -175.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -71.16 151.65 94.65 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.475 1.11 . . . . 0.0 110.745 172.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.64 135.43 33.22 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.096 2.531 . . . . 0.0 110.724 177.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -152.23 34.62 0.52 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.476 1.111 . . . . 0.0 110.825 -173.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -135.63 73.91 60.51 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 124.75 1.22 . . . . 0.0 109.747 -175.036 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.11 102.23 1.32 Allowed 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.861 3.041 . . . . 0.0 110.465 177.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 55.3 p -144.45 137.58 27.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.939 1.696 . . . . 0.0 108.603 -174.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -155.45 -38.5 0.09 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 115.739 -2.077 . . . . 0.0 115.92 -168.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.476 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.8 OUTLIER -53.48 174.29 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 122.551 2.432 . . . . 0.0 112.169 170.554 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.0 mt -62.47 -6.74 3.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.607 1.563 . . . . 0.0 111.212 171.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 89.1 m -98.22 -12.53 21.56 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 126.186 1.794 . . . . 0.0 112.71 179.29 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.8 p80 44.97 48.29 9.39 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.219 2.208 . . . . 0.0 112.368 -173.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -162.94 147.16 11.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.461 1.504 . . . . 0.0 108.047 176.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.62 175.44 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 127.157 2.183 . . . . 0.0 110.109 178.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.6 t 59.82 65.91 1.06 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.347 1.859 . . . . 0.0 112.824 -174.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.62 102.89 1.36 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.344 1.858 . . . . 0.0 109.163 -173.561 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 68.45 -98.4 0.52 Allowed Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.386 1.47 . . . . 0.0 110.392 -172.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.26 170.67 15.55 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.401 1.88 . . . . 0.0 111.731 -174.036 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -143.97 160.19 41.26 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.903 1.281 . . . . 0.0 111.364 -169.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 4.6 tp -133.42 -135.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.372 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 169.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 148.19 133.7 2.35 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 125.434 1.493 . . . . 0.0 112.478 -172.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 53.6 t -64.89 119.32 10.46 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.366 -0.917 . . . . 0.0 109.055 174.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -70.01 5.28 1.66 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.695 1.598 . . . . 0.0 113.874 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -68.8 119.78 71.58 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 168.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.95 5.88 4.16 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.317 2.678 . . . . 0.0 113.312 178.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.86 6.06 12.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.657 1.583 . . . . 0.0 110.608 174.216 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 42.5 t -60.53 129.06 39.7 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 123.584 0.753 . . . . 0.0 110.442 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.2 m -79.91 4.47 16.66 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.496 1.518 . . . . 0.0 113.333 -176.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.6 mm -135.1 -36.27 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.787 1.635 . . . . 0.0 110.348 -169.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.45 -41.65 0.51 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.84 2.856 . . . . 0.0 115.201 170.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . 0.476 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -129.08 148.09 50.99 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.738 1.615 . . . . 0.0 109.276 -176.057 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.42 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 81.4 m-85 -149.38 157.54 43.4 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 124.94 1.296 . . . . 0.0 108.84 -175.193 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -88.24 144.11 26.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.304 0.573 . . . . 0.0 111.098 -171.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -57.43 -7.2 0.56 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.292 2.237 . . . . 0.0 114.265 170.078 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.22 -8.29 8.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.029 1.332 . . . . 0.0 112.207 174.228 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 10.0 m -77.11 -2.51 34.63 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.07 0.85 . . . . 0.0 112.87 168.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 12.9 p -131.72 -2.03 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 126.435 1.894 . . . . 0.0 111.116 170.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.2 34.38 89.77 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.938 1.256 . . . . 0.0 112.894 -177.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.2 mt -66.34 -52.33 48.17 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.183 0.993 . . . . 0.0 111.919 -174.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 17.5 m 61.92 -9.83 0.08 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.82 2.048 . . . . 0.0 114.47 -175.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 13.0 t -150.0 173.27 14.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.85 1.66 . . . . 0.0 110.659 178.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -68.3 125.39 91.54 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.773 1.229 . . . . 0.0 109.487 177.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.7 -69.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.539 2.159 . . . . 0.0 110.755 177.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 -175.96 176.14 1.84 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.897 2.879 . . . . 0.0 107.074 -176.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -72.67 15.28 2.24 Favored Glycine 0 CA--C 1.541 1.709 0 CA-C-O 118.935 -0.925 . . . . 0.0 113.374 168.182 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt -152.67 112.73 3.99 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 125.806 1.642 . . . . 0.0 108.99 176.204 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.5 t90 -140.83 162.47 35.35 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.581 2.352 . . . . 0.0 109.832 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -140.67 141.78 34.99 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.275 1.03 . . . . 0.0 110.348 178.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.7 p -70.37 165.61 42.9 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.082 0.953 . . . . 0.0 111.731 174.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.47 29.32 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.994 3.13 . . . . 0.0 113.569 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -135.58 -33.8 0.86 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.664 1.586 . . . . 0.0 110.091 174.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.9 m -78.28 -31.78 49.14 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 126.554 1.941 . . . . 0.0 111.99 170.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.8 t -71.67 -24.94 61.92 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.2 1.4 . . . . 0.0 112.085 175.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 17.8 tm0? -62.62 -35.27 79.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.483 1.113 . . . . 0.0 111.913 176.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -52.06 -42.49 63.19 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.242 1.817 . . . . 0.0 112.966 -178.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.8 111.23 3.7 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.994 1.318 . . . . 0.0 107.516 174.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -128.06 -153.94 0.6 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.358 1.863 . . . . 0.0 108.742 -170.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -108.35 33.0 4.39 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.683 1.593 . . . . 0.0 110.849 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 65.2 tttm . . . . . 0 C--O 1.25 1.099 0 C-N-CA 126.224 1.81 . . . . 0.0 109.245 178.376 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 18.3 ptp . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -145.55 135.99 24.12 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.094 0.958 . . . . 0.0 109.725 -168.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 48.8 ttm 35.11 62.86 2.2 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 127.082 2.153 . . . . 0.0 113.541 -176.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.17 112.3 2.72 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.185 2.59 . . . . 0.0 110.162 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 95.4 t -140.68 92.83 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.2 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 -178.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -137.6 63.82 41.83 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.919 1.288 . . . . 0.0 109.332 -170.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.71 145.99 71.4 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.319 2.679 . . . . 0.0 111.754 -175.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -148.3 45.21 1.06 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.939 1.296 . . . . 0.0 109.734 -179.108 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -129.87 70.09 81.91 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.474 1.509 . . . . 0.0 108.854 -179.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.3 165.96 25.05 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.55 2.833 . . . . 0.0 111.507 176.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 57.6 p -137.07 142.52 42.38 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.283 1.433 . . . . 0.0 110.709 -167.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -156.33 -39.95 0.08 Allowed 'General case' 0 C--N 1.353 0.735 0 CA-C-O 115.621 -2.133 . . . . 0.0 115.207 -169.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 222' ' ' PHE . 0.7 OUTLIER -51.53 175.47 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 122.01 2.186 . . . . 0.0 112.953 176.538 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.9 -5.11 3.92 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.082 -1.417 . . . . 0.0 111.21 170.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 88.6 m -99.32 -15.95 18.63 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 125.976 1.711 . . . . 0.0 112.548 176.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 51.12 46.82 25.9 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.723 2.009 . . . . 0.0 111.628 -177.142 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -164.51 147.27 8.85 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.764 1.626 . . . . 0.0 107.621 179.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.432 HG11 ' H ' ' A' ' 205' ' ' SER . 0.5 OUTLIER -132.35 -178.14 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 127.355 2.262 . . . . 0.0 109.553 175.654 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.432 ' H ' HG11 ' A' ' 204' ' ' VAL . 8.2 t 60.16 58.32 2.69 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.93 1.692 . . . . 0.0 113.08 -172.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.89 114.48 2.58 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.944 2.098 . . . . 0.0 109.122 -175.202 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.86 -109.34 2.48 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 125.571 1.558 . . . . 0.0 110.827 -175.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.78 169.11 18.36 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.627 1.971 . . . . 0.0 111.546 -173.618 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -141.69 161.26 38.38 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.146 0.978 . . . . 0.0 112.627 -167.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 7.5 tp -135.78 -135.32 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 168.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 145.61 130.47 2.2 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 125.559 1.552 . . . . 0.0 112.096 -170.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 41.0 t -63.82 122.66 16.97 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.78 -2.12 2.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.692 1.597 . . . . 0.0 113.506 -179.216 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -69.25 116.25 40.39 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.277 1.031 . . . . 0.0 108.518 168.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -78.08 8.58 3.44 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.036 2.491 . . . . 0.0 112.916 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -121.37 6.4 10.15 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.727 1.611 . . . . 0.0 110.145 174.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.9 t -60.98 129.95 43.96 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 118.683 0.674 . . . . 0.0 109.589 171.124 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.3 t -74.94 6.31 4.22 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.708 1.603 . . . . 0.0 113.188 -176.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.3 mm -134.45 -36.81 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 126.134 1.774 . . . . 0.0 109.776 -171.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . 0.251 0.0 OUTLIER 71.06 -43.88 0.57 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.355 2.662 . . . . 0.0 115.497 169.737 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . 0.453 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -125.33 148.77 48.6 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.469 1.908 . . . . 0.0 108.511 -178.383 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.455 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 72.9 m-85 -147.89 154.51 40.48 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.147 0.979 . . . . 0.0 108.804 -175.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -84.58 144.08 28.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.447 0.641 . . . . 0.0 110.499 -175.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -57.0 -7.12 0.43 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.363 2.265 . . . . 0.0 114.413 169.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.58 -8.02 8.55 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.877 1.271 . . . . 0.0 112.184 173.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 14.4 m -77.61 -2.26 34.95 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.088 0.858 . . . . 0.0 113.051 168.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.5 p -129.53 -4.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 126.447 1.899 . . . . 0.0 111.039 169.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.29 35.4 91.48 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.938 1.256 . . . . 0.0 112.82 -175.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.4 mt -66.84 -54.21 24.77 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.863 0.865 . . . . 0.0 111.326 -176.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 21.8 m 61.2 -11.22 0.06 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.929 2.091 . . . . 0.0 114.338 -174.138 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.7 p -143.97 167.04 23.29 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.33 1.852 . . . . 0.0 110.027 -175.088 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -64.7 126.45 90.9 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 123.789 0.836 . . . . 0.0 109.995 177.342 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.3 169.95 19.33 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.371 2.714 . . . . 0.0 112.138 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 31.1 ttt85 -67.84 158.06 33.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.87 0.868 . . . . 0.0 109.477 168.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -58.5 152.82 29.55 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 123.504 0.574 . . . . 0.0 113.171 -178.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? 50.68 68.86 0.71 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.176 1.79 . . . . 0.0 111.533 -174.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -76.42 162.98 27.4 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.799 1.239 . . . . 0.0 110.241 177.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -139.29 139.1 37.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.312 1.445 . . . . 0.0 108.375 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 13.4 p -68.2 165.87 29.7 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 123.143 0.577 . . . . 0.0 111.9 172.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.26 31.6 0.31 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.327 3.351 . . . . 0.0 113.389 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -136.36 -37.81 0.69 Allowed 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.494 1.517 . . . . 0.0 109.816 169.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 18.3 m -72.03 -26.48 62.23 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 126.565 1.946 . . . . 0.0 112.721 173.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.465 ' HA ' ' HE ' ' A' ' 246' ' ' ARG . 3.2 t -96.25 -17.45 20.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.511 1.125 . . . . 0.0 112.388 172.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -65.33 -36.7 84.85 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.113 0.965 . . . . 0.0 111.666 -175.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.36 -12.53 59.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.449 1.099 . . . . 0.0 113.569 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.465 ' HE ' ' HA ' ' A' ' 243' ' ' SER . 35.1 mtm180 -87.13 54.93 3.34 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.883 1.273 . . . . 0.0 110.768 -173.737 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -85.28 -142.68 0.09 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.478 1.911 . . . . 0.0 110.001 -175.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -126.79 87.08 2.6 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.21 1.804 . . . . 0.0 108.068 -179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.251 1.162 0 C-N-CA 126.116 1.766 . . . . 0.0 109.012 -176.808 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 66.4 ttp . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -145.47 -43.51 0.22 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.491 0.717 . . . . 0.0 111.795 -169.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.52 157.58 16.82 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.74 1.216 . . . . 0.0 111.005 -176.405 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.18 50.72 3.15 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 124.892 3.728 . . . . 0.0 112.088 -179.433 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.8 t -121.34 90.99 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.671 1.189 . . . . 0.0 108.376 -175.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -153.64 -52.03 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.655 1.582 . . . . 0.0 110.652 176.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.04 161.28 32.89 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.28 1.986 . . . . 0.0 111.716 174.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -76.78 5.57 7.5 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.166 1.386 . . . . 0.0 113.51 178.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -138.57 75.02 38.78 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.801 1.24 . . . . 0.0 110.035 -173.166 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.78 160.13 46.88 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.528 2.819 . . . . 0.0 111.424 174.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.7 p 62.48 143.78 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.247 2.619 . . . . 0.0 113.285 -173.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -156.17 -45.61 0.08 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -168.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.0 p -40.25 170.28 0.0 OUTLIER 'General case' 0 C--N 1.349 0.586 0 C-N-CA 126.091 1.757 . . . . 0.0 114.252 169.136 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -71.3 -6.14 37.63 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.137 168.327 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 95.1 m -97.03 -13.36 22.32 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 123.499 0.72 . . . . 0.0 111.776 175.021 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.9 p80 46.37 53.38 9.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.862 2.065 . . . . 0.0 112.755 -174.006 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -171.0 142.12 1.79 Allowed 'General case' 0 C--N 1.347 0.474 0 C-N-CA 125.652 1.581 . . . . 0.0 108.114 177.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.1 t -123.79 168.92 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 125.606 1.562 . . . . 0.0 110.933 177.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 10.5 t 70.81 61.06 0.19 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.144 2.178 . . . . 0.0 113.389 -176.248 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -162.72 108.95 1.2 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.986 2.115 . . . . 0.0 107.403 -176.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.44 -168.94 29.89 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 122.643 1.135 . . . . 0.0 110.761 -168.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -72.79 164.3 26.78 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.06 1.344 . . . . 0.0 111.978 169.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -138.54 155.46 48.36 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.693 1.597 . . . . 0.0 110.652 -169.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.0 tp -131.6 -139.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 149.11 130.76 1.91 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 125.812 1.673 . . . . 0.0 112.428 -169.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 40.6 t -62.73 123.19 17.78 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.468 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.1 0.18 1.4 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.027 1.331 . . . . 0.0 113.529 -179.332 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -70.4 115.05 30.93 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 167.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.56 9.14 3.02 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.304 2.669 . . . . 0.0 113.017 -179.412 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -124.02 8.29 8.65 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.988 1.715 . . . . 0.0 110.206 175.178 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . 0.424 ' HG ' ' H ' ' A' ' 219' ' ' ILE . 48.7 t -60.45 129.23 40.56 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 118.605 0.639 . . . . 0.0 109.558 170.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -73.4 3.41 6.01 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.999 1.72 . . . . 0.0 113.368 -175.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.424 ' H ' ' HG ' ' A' ' 217' ' ' CYS . 26.6 mt -132.01 -34.22 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 126.37 1.868 . . . . 0.0 109.965 -175.414 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.99 -37.35 0.39 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.357 2.263 . . . . 0.0 115.76 170.341 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -132.58 148.57 52.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.864 2.065 . . . . 0.0 108.785 -174.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -148.02 148.52 30.79 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -177.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -73.02 150.15 42.65 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.895 178.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -60.96 -4.27 0.98 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.369 1.467 . . . . 0.0 113.417 167.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.2 -1.63 9.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.771 1.228 . . . . 0.0 112.558 170.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.4 m -72.43 -7.48 50.04 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.96 0.8 . . . . 0.0 111.296 167.031 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 2.8 p -134.38 -13.98 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 127.283 2.233 . . . . 0.0 112.016 179.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.86 37.46 44.36 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.592 1.091 . . . . 0.0 112.934 -176.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 20.6 mt -66.76 111.05 3.51 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.732 0.813 . . . . 0.0 110.235 176.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 26.3 m -72.12 -27.32 62.55 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.511 1.125 . . . . 0.0 111.464 174.355 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 14.5 t -153.25 175.4 13.11 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.704 1.602 . . . . 0.0 110.065 177.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -61.62 126.39 86.7 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 124.814 1.246 . . . . 0.0 110.256 -177.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.73 170.2 20.57 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.111 2.541 . . . . 0.0 111.967 179.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 68.0 mtm180 -69.98 169.79 12.61 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.936 0.894 . . . . 0.0 110.181 169.058 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -60.41 159.2 25.73 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.276 0.465 . . . . 0.0 112.308 172.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 15.0 tptp 51.99 57.38 6.56 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.192 1.397 . . . . 0.0 112.363 -172.264 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.434 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 88.3 t90 -74.97 159.64 31.54 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.611 0.764 . . . . 0.0 109.702 171.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.01 142.13 34.28 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.337 1.055 . . . . 0.0 109.199 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.434 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 2.4 p -63.03 165.37 10.45 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 123.72 0.808 . . . . 0.0 112.026 175.582 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.95 23.96 0.34 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.543 2.828 . . . . 0.0 113.643 -173.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -134.54 -33.07 0.99 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 125.687 1.595 . . . . 0.0 110.472 174.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.6 m -71.9 -36.5 70.03 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.72 2.008 . . . . 0.0 111.533 169.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 21.2 t -73.13 -19.4 61.14 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.758 1.623 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -60.59 -24.84 65.78 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -178.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -50.58 -46.47 57.8 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.209 1.804 . . . . 0.0 112.438 177.085 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -144.92 81.57 1.65 Allowed 'General case' 0 C--N 1.343 0.295 0 C-N-CA 125.688 1.595 . . . . 0.0 107.344 171.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -75.59 24.5 0.11 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.749 1.62 . . . . 0.0 114.408 -169.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -80.14 61.27 3.92 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.845 1.658 . . . . 0.0 109.682 169.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.131 0 C-N-CA 126.619 1.968 . . . . 0.0 110.227 -176.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 97.8 mtp . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 62.93 147.63 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.515 2.326 . . . . 0.0 113.806 -173.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 78.0 mtm -151.59 154.92 33.86 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.029 1.332 . . . . 0.0 110.344 -177.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -71.59 168.78 22.68 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.617 2.878 . . . . 0.0 111.835 170.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.8 p -108.32 -4.1 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.275 1.43 . . . . 0.0 111.87 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -57.23 -43.97 99.45 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-O 117.119 -1.42 . . . . 0.0 113.214 170.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.74 165.64 29.83 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.358 2.039 . . . . 0.0 111.499 170.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 52.66 56.08 8.14 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.42 1.488 . . . . 0.0 112.016 -177.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -126.12 84.32 61.75 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.479 1.511 . . . . 0.0 108.619 -176.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.09 120.41 6.31 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.831 3.021 . . . . 0.0 111.178 -175.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.1 p -147.24 140.51 25.33 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.903 1.681 . . . . 0.0 108.722 -176.471 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -154.72 -47.43 0.09 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -173.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.8 p -38.29 169.62 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 0 C-N-CA 126.401 1.881 . . . . 0.0 114.444 168.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.72 -6.69 39.23 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.198 168.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 89.7 m -96.08 -14.51 22.84 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 123.602 0.761 . . . . 0.0 111.71 174.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.2 p80 45.73 52.85 9.24 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.211 2.204 . . . . 0.0 112.759 -173.382 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.17 140.88 2.47 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 125.866 1.666 . . . . 0.0 107.889 179.178 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.4 t -129.2 172.72 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.336 1.454 . . . . 0.0 111.051 -176.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.0 t 66.16 60.73 0.63 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.769 2.027 . . . . 0.0 113.208 -174.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.02 112.52 1.83 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.566 1.946 . . . . 0.0 108.318 -175.218 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.85 -163.45 24.42 Favored Glycine 0 C--N 1.34 0.759 0 CA-C-O 123.314 1.508 . . . . 0.0 112.931 -176.503 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.6 pm0 -67.88 146.13 53.94 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.028 2.131 . . . . 0.0 111.074 169.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.0 mtm -146.85 155.58 42.44 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.198 1.799 . . . . 0.0 110.461 -167.078 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 8.2 tp -138.89 -138.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.41 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -175.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 152.22 133.93 2.02 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 126.239 1.876 . . . . 0.0 112.46 -169.61 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.25 123.59 20.36 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 114.179 -1.011 . . . . 0.0 109.398 177.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.19 0.14 2.18 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.314 1.846 . . . . 0.0 114.86 178.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -68.44 118.91 64.35 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.57 1.148 . . . . 0.0 108.592 169.627 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.26 7.27 3.43 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.413 2.742 . . . . 0.0 113.242 178.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -123.04 9.84 9.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.044 1.738 . . . . 0.0 110.358 174.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 42.6 t -58.65 128.87 39.34 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 123.494 0.718 . . . . 0.0 110.607 173.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.6 t -78.19 1.44 21.41 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.668 1.587 . . . . 0.0 113.072 -177.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.4 mm -132.7 -36.2 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 125.484 1.513 . . . . 0.0 110.375 -169.432 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.9 -39.16 0.42 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.415 2.686 . . . . 0.0 115.63 170.526 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.16 149.07 51.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.176 1.791 . . . . 0.0 108.803 -174.569 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -149.34 147.01 27.82 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -176.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -73.11 150.49 42.2 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.771 0.796 . . . . 0.0 111.189 178.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -60.52 -4.02 0.81 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.374 1.47 . . . . 0.0 113.304 168.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.12 -2.03 8.18 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.074 1.35 . . . . 0.0 112.556 171.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.2 m -71.34 -8.11 51.57 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.043 0.838 . . . . 0.0 111.394 167.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.7 p -136.02 -4.1 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.084 1.753 . . . . 0.0 111.863 174.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 69.3 30.24 71.61 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.848 1.213 . . . . 0.0 112.909 -175.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.89 -47.93 83.78 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.662 1.185 . . . . 0.0 112.043 -172.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 m 64.4 -18.83 0.07 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.379 2.272 . . . . 0.0 114.755 -179.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 74.8 p -143.84 163.64 32.79 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.926 1.69 . . . . 0.0 110.605 -173.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -64.23 119.94 60.32 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 124.939 1.295 . . . . 0.0 108.925 177.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.31 166.86 28.52 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.213 2.609 . . . . 0.0 113.019 -175.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -67.39 170.98 6.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.216 1.006 . . . . 0.0 111.242 171.209 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -49.64 114.34 2.28 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.483 1.516 . . . . 0.0 112.416 -179.564 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 49.0 mttm 58.54 124.17 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 128.33 2.652 . . . . 0.0 114.1 -169.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -116.88 153.88 31.76 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.394 1.877 . . . . 0.0 109.652 175.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -139.59 136.4 34.35 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.638 0.775 . . . . 0.0 110.03 -177.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 10.8 p -66.95 164.07 38.31 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.125 0.97 . . . . 0.0 111.871 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -72.49 22.69 0.28 Allowed 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 123.94 3.094 . . . . 0.0 114.054 -177.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 -134.21 6.19 3.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.441 1.497 . . . . 0.0 112.027 172.097 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 5.2 m -128.96 -28.78 2.37 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 128.128 2.571 . . . . 0.0 110.01 -175.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 88.8 p -79.25 -29.77 42.81 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 124.688 1.195 . . . . 0.0 111.549 172.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -72.99 -38.34 66.69 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 125.017 1.327 . . . . 0.0 111.028 179.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -58.43 -40.96 83.94 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 126.439 1.896 . . . . 0.0 111.856 173.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 54.52 23.6 4.71 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.35 1.86 . . . . 0.0 114.31 172.423 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 51.1 tttm 46.59 55.01 8.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.227 1.811 . . . . 0.0 111.915 -172.05 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -130.7 35.69 3.98 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.027 1.331 . . . . 0.0 111.617 -169.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 83.7 tttt . . . . . 0 C--O 1.252 1.19 0 C-N-CA 127.157 2.183 . . . . 0.0 112.653 176.442 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -59.56 157.03 12.24 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.46 1.504 . . . . 0.0 112.02 170.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 94.4 mtp -140.4 72.4 31.61 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 124.705 1.202 . . . . 0.0 109.727 -173.181 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.38 152.83 71.31 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.329 2.686 . . . . 0.0 111.491 177.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.82 64.62 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.065 1.346 . . . . 0.0 107.987 -175.554 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.44 -48.97 85.72 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-O 117.286 -1.34 . . . . 0.0 112.778 173.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.85 -179.14 5.1 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.782 2.322 . . . . 0.0 111.3 171.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 61.2 t30 57.85 61.66 2.32 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.266 1.427 . . . . 0.0 112.273 178.135 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -114.82 98.38 49.74 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.943 1.297 . . . . 0.0 108.324 177.234 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.73 132.1 16.77 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.225 2.617 . . . . 0.0 111.24 -178.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 73.8 p -149.22 140.16 22.87 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.112 1.765 . . . . 0.0 108.914 -174.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -155.12 -44.7 0.08 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -175.457 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.8 p -39.23 170.2 0.0 OUTLIER 'General case' 0 C--N 1.35 0.615 0 C-N-CA 126.273 1.829 . . . . 0.0 114.216 168.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.89 -6.62 39.7 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 113.425 -1.716 . . . . 0.0 110.115 168.172 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 85.3 m -96.79 -14.22 22.09 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 123.7 0.8 . . . . 0.0 111.725 174.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.9 p80 45.73 53.18 8.95 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.138 2.175 . . . . 0.0 112.811 -173.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.74 140.77 2.18 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 125.858 1.663 . . . . 0.0 107.911 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.93 170.04 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.364 1.465 . . . . 0.0 111.105 -175.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.1 t 65.89 66.1 0.51 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.083 2.153 . . . . 0.0 113.09 -174.609 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.24 111.3 1.08 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.566 1.946 . . . . 0.0 108.336 -175.496 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.47 -163.45 22.6 Favored Glycine 0 C--N 1.34 0.778 0 CA-C-O 123.254 1.474 . . . . 0.0 112.592 -174.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -65.71 149.06 50.74 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 112.237 -1.981 . . . . 0.0 111.193 169.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.0 mtm -147.41 156.9 43.31 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.138 1.775 . . . . 0.0 110.067 -167.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 4.9 tp -141.01 -138.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.369 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 151.49 132.88 1.94 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 126.11 1.814 . . . . 0.0 112.629 -169.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 46.6 t -64.35 125.64 25.26 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.064 0.946 . . . . 0.0 108.814 177.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.08 -2.74 2.16 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.533 1.533 . . . . 0.0 114.068 178.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -70.44 116.08 41.47 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 124.136 0.975 . . . . 0.0 108.387 169.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -76.99 4.4 5.79 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.315 2.677 . . . . 0.0 113.103 179.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -117.49 7.09 12.63 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.896 1.678 . . . . 0.0 110.36 174.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.7 t -58.42 127.82 34.04 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 123.113 0.565 . . . . 0.0 110.005 170.459 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.8 t -74.5 2.48 9.52 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.796 1.639 . . . . 0.0 113.207 -176.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 30.2 mt -132.19 -33.78 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.069 1.748 . . . . 0.0 110.247 -173.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.69 -37.64 0.4 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.006 2.522 . . . . 0.0 115.305 170.313 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.06 148.96 52.2 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 126.777 2.031 . . . . 0.0 108.677 -174.032 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -148.44 146.62 28.5 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -176.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -70.63 150.61 45.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.942 0.877 . . . . 0.0 110.884 178.183 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -60.63 -5.06 1.09 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.073 1.349 . . . . 0.0 113.727 168.3 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.47 -0.84 9.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.656 1.182 . . . . 0.0 112.372 170.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.8 m -71.69 -7.19 46.46 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.892 0.769 . . . . 0.0 111.531 167.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 p -137.39 -11.51 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.809 1.244 . . . . 0.0 113.269 173.037 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 80.39 41.28 11.74 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.514 1.054 . . . . 0.0 113.54 -175.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 24.0 mt -65.98 160.88 22.64 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.295 1.047 . . . . 0.0 111.439 171.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 87.8 m -136.39 -16.81 1.57 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.986 1.714 . . . . 0.0 111.001 178.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 10.0 t -148.42 169.53 20.01 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.129 1.771 . . . . 0.0 109.368 174.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -65.84 122.86 82.98 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 174.277 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -73.43 164.3 35.46 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.823 2.349 . . . . 0.0 111.293 177.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 24.8 mtp-105 -142.33 161.76 37.19 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.117 1.367 . . . . 0.0 109.763 -178.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 73.09 22.24 79.17 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-O 118.929 -0.928 . . . . 0.0 113.444 -177.071 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? 72.2 126.54 0.03 OUTLIER 'General case' 0 C--N 1.346 0.42 0 C-N-CA 128.441 2.696 . . . . 0.0 111.821 -173.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.408 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 88.9 t90 -99.77 158.34 15.86 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.333 1.453 . . . . 0.0 110.305 178.607 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -141.06 139.78 34.13 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.184 0.994 . . . . 0.0 109.2 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.408 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 14.5 p -66.69 165.11 27.38 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.674 0.789 . . . . 0.0 111.957 177.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.5 31.93 0.28 Allowed 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.908 3.072 . . . . 0.0 113.413 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -135.97 -38.09 0.72 Allowed 'General case' 0 C--N 1.345 0.373 0 C-N-CA 125.584 1.554 . . . . 0.0 109.689 171.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 26.6 m -71.96 -34.61 69.11 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.585 1.954 . . . . 0.0 111.888 171.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 15.9 t -85.27 -21.39 29.05 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.061 1.344 . . . . 0.0 112.117 175.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.86 -33.72 76.23 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.896 1.278 . . . . 0.0 111.287 -179.299 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.81 -33.14 55.16 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.069 1.747 . . . . 0.0 113.343 178.16 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 33.35 63.48 0.35 Allowed 'General case' 0 C--N 1.345 0.412 0 C-N-CA 128.971 2.908 . . . . 0.0 113.917 169.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -81.44 56.27 2.88 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.365 1.066 . . . . 0.0 110.77 176.609 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -155.66 126.94 7.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 127.423 2.289 . . . . 0.0 106.852 177.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt . . . . . 0 C--O 1.25 1.117 0 CA-C-O 116.736 -1.602 . . . . 0.0 109.493 -172.712 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -154.74 -43.95 0.09 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -166.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.499 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -38.05 169.66 0.0 OUTLIER 'General case' 0 C--N 1.348 0.54 0 C-N-CA 126.385 1.874 . . . . 0.0 114.414 169.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.0 mt -70.69 -6.16 35.14 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 113.399 -1.728 . . . . 0.0 110.12 168.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.499 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 93.8 m -96.15 -14.22 22.96 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 123.423 0.689 . . . . 0.0 111.738 173.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.6 p80 46.08 52.16 10.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.912 2.085 . . . . 0.0 112.406 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -169.01 141.47 2.66 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.482 1.513 . . . . 0.0 108.018 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -124.44 174.87 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.475 1.51 . . . . 0.0 110.51 176.76 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.503 ' H ' HG12 ' A' ' 204' ' ' VAL . 7.1 t 66.69 60.89 0.55 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.701 2.0 . . . . 0.0 113.429 -173.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.51 120.11 1.77 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.98 2.112 . . . . 0.0 107.881 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.44 -151.2 43.5 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 122.613 1.118 . . . . 0.0 111.49 -172.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.58 169.26 10.47 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.388 1.875 . . . . 0.0 111.255 170.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -136.89 162.26 33.73 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.913 1.285 . . . . 0.0 111.677 -169.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 11.2 tt -138.0 -139.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 169.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 147.47 132.22 2.23 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 125.79 1.662 . . . . 0.0 111.57 -169.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 41.4 t -64.25 123.9 20.32 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.81 -0.48 3.03 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.365 1.466 . . . . 0.0 113.686 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -70.25 117.31 53.35 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.67 4.16 5.84 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.301 2.667 . . . . 0.0 113.168 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -117.37 7.63 12.87 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.85 1.66 . . . . 0.0 110.456 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.1 t -58.33 127.23 31.08 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 123.192 0.597 . . . . 0.0 109.736 170.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 70.5 m -77.01 5.95 7.17 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.538 1.535 . . . . 0.0 113.304 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.9 mm -132.58 -35.53 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 126.082 1.753 . . . . 0.0 109.95 -173.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.44 -42.9 0.55 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.512 2.725 . . . . 0.0 115.333 169.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.443 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -129.42 149.71 51.09 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.4 1.88 . . . . 0.0 108.431 -175.564 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -149.42 149.31 30.62 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -73.4 149.63 42.35 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.62 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.95 -3.59 0.81 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.985 1.714 . . . . 0.0 112.394 168.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.45 -3.74 8.35 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.674 1.59 . . . . 0.0 112.462 172.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.9 m -71.62 -7.47 48.0 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.06 0.845 . . . . 0.0 111.281 166.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -134.71 -4.63 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 126.853 2.061 . . . . 0.0 111.591 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.97 31.11 74.7 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.904 1.24 . . . . 0.0 113.272 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 4.6 mt . . . . . 0 C--N 1.343 0.291 0 C-N-CA 124.338 1.055 . . . . 0.0 112.584 -174.27 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 79.2 t90 . . . . . 0 CA--C 1.538 0.499 0 CA-C-O 121.203 0.525 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -141.68 140.45 33.2 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.076 1.35 . . . . 0.0 109.283 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.0 p -66.67 165.32 25.84 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 123.467 0.707 . . . . 0.0 112.198 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.06 35.23 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.97 3.113 . . . . 0.0 113.08 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -137.95 -38.37 0.57 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.445 1.498 . . . . 0.0 109.764 169.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.443 -0.82 0 C-N-CA 126.756 2.022 . . . . 0.0 111.805 171.702 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 47.2 p . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -155.04 -45.39 0.08 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -168.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.505 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.7 p -38.01 169.66 0.0 OUTLIER 'General case' 0 C--N 1.348 0.54 0 C-N-CA 126.429 1.892 . . . . 0.0 114.269 168.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.49 -6.3 35.07 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 113.452 -1.703 . . . . 0.0 110.199 168.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.505 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 89.5 m -97.34 -14.17 21.44 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 123.812 0.845 . . . . 0.0 111.805 174.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.5 p80 45.06 51.85 8.67 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.109 2.164 . . . . 0.0 112.842 -173.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -167.34 139.24 3.23 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 125.762 1.625 . . . . 0.0 107.94 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 205' ' ' SER . 1.3 t -129.95 172.32 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.307 1.443 . . . . 0.0 111.058 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.524 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.0 t 65.44 63.47 0.63 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.833 2.053 . . . . 0.0 112.792 -173.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.07 112.55 1.34 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.555 1.942 . . . . 0.0 108.45 -175.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.01 -161.65 24.18 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-O 123.283 1.49 . . . . 0.0 113.124 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.526 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.6 pm0 -68.26 143.79 55.12 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.155 2.182 . . . . 0.0 111.128 169.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.4 mtm -147.09 155.11 41.91 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.38 1.872 . . . . 0.0 110.289 -167.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.426 HG13 ' H ' ' A' ' 211' ' ' GLY . 9.2 tp -139.02 -138.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.409 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -175.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 150.91 131.23 1.8 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 126.152 1.834 . . . . 0.0 112.301 -169.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 42.2 t -63.05 121.71 14.27 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.259 1.023 . . . . 0.0 108.559 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.85 1.4 1.89 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.384 1.474 . . . . 0.0 113.868 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -69.94 117.89 58.2 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.474 1.11 . . . . 0.0 108.072 168.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.35 6.21 4.13 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.305 2.67 . . . . 0.0 113.234 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -120.89 9.22 10.6 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.817 1.647 . . . . 0.0 110.482 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 45.1 t -59.23 128.63 38.08 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.316 0.646 . . . . 0.0 110.116 171.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 44.0 m -76.14 2.99 11.5 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.59 1.556 . . . . 0.0 113.542 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.8 mm -133.78 -35.33 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.925 1.69 . . . . 0.0 109.966 -170.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.91 -39.53 0.45 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 128.422 2.689 . . . . 0.0 115.454 169.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.478 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.0 OUTLIER -133.87 148.95 51.32 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.305 1.842 . . . . 0.0 108.74 -174.158 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -150.06 146.02 26.71 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.4 -1.334 . . . . 0.0 107.4 -175.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -72.23 151.43 42.87 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.721 0.772 . . . . 0.0 111.043 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.33 -4.31 0.82 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.352 1.461 . . . . 0.0 113.06 167.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.33 -3.6 8.93 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.305 1.442 . . . . 0.0 112.544 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 20.6 m -72.43 -6.0 40.51 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.114 0.87 . . . . 0.0 111.715 167.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 10.9 p -135.4 -4.95 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 126.29 1.836 . . . . 0.0 111.797 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.34 35.77 90.71 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.667 1.127 . . . . 0.0 112.924 -173.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--N 1.343 0.304 0 C-N-CA 124.358 1.063 . . . . 0.0 111.493 -175.846 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 84.5 t90 . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 120.971 0.415 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -138.82 139.87 38.35 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.153 0.981 . . . . 0.0 109.587 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 13.9 p -65.7 163.43 35.03 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.436 0.695 . . . . 0.0 111.658 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.41 28.66 0.27 Allowed 'Trans proline' 0 CA--C 1.548 1.198 0 C-N-CA 124.013 3.142 . . . . 0.0 113.694 -178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -136.02 -32.95 0.86 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.555 1.542 . . . . 0.0 110.422 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.443 -0.795 0 C-N-CA 126.556 1.942 . . . . 0.0 111.727 169.693 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.3 p . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -155.15 -46.53 0.08 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.506 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -37.46 169.54 0.0 OUTLIER 'General case' 0 C--N 1.351 0.637 0 C-N-CA 126.665 1.986 . . . . 0.0 114.593 169.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.4 -6.23 34.06 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 113.311 -1.768 . . . . 0.0 110.08 168.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.506 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 86.6 m -97.46 -14.41 21.17 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 123.841 0.856 . . . . 0.0 111.776 174.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.2 p80 45.67 52.16 9.62 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.236 2.214 . . . . 0.0 112.807 -173.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -169.5 140.53 2.26 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.678 1.591 . . . . 0.0 107.906 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 205' ' ' SER . 1.5 t -127.07 173.37 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.219 1.407 . . . . 0.0 111.168 -175.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.537 ' H ' HG12 ' A' ' 204' ' ' VAL . 13.2 t 66.33 61.68 0.58 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.983 2.113 . . . . 0.0 113.537 -175.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -161.98 114.1 1.72 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.39 1.876 . . . . 0.0 108.548 -175.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 62.12 -164.03 24.4 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-O 123.084 1.38 . . . . 0.0 112.702 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.9 pm0 -66.14 147.18 53.72 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 112.405 -1.898 . . . . 0.0 110.92 169.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 75.7 mtm -146.33 154.26 41.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.939 1.696 . . . . 0.0 110.045 -168.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.6 tp -138.56 -139.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.357 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 149.8 131.0 1.87 Allowed Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 126.203 1.859 . . . . 0.0 112.289 -169.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.83 123.53 18.7 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.295 1.038 . . . . 0.0 108.557 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.05 -2.16 2.58 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.153 1.381 . . . . 0.0 113.467 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -69.64 117.38 52.63 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 168.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.5 4.93 5.09 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.131 2.554 . . . . 0.0 113.166 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -118.58 8.24 11.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.954 1.702 . . . . 0.0 110.416 174.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 50.0 t -58.25 127.6 32.95 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.181 0.593 . . . . 0.0 109.897 170.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.7 t -74.69 2.87 8.93 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.576 1.55 . . . . 0.0 113.444 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.6 mm -132.96 -34.96 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 126.072 1.749 . . . . 0.0 109.931 -171.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.34 -39.31 0.44 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.186 2.595 . . . . 0.0 115.52 169.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.472 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.0 OUTLIER -134.82 149.81 50.41 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.403 1.881 . . . . 0.0 108.929 -174.771 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -149.5 146.37 27.36 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 -176.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -70.36 149.81 46.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.548 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -60.75 -4.9 1.07 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.977 1.311 . . . . 0.0 113.237 168.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -120.62 -2.05 9.97 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.732 1.213 . . . . 0.0 112.543 170.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 16.9 m -73.11 -5.65 40.46 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.933 0.788 . . . . 0.0 111.507 167.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 p -135.7 -13.41 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 126.853 2.061 . . . . 0.0 112.323 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 75.77 37.98 37.96 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.562 1.077 . . . . 0.0 112.922 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 18.3 mt . . . . . 0 N--CA 1.466 0.343 0 C-N-CA 123.92 0.888 . . . . 0.0 110.159 174.905 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 83.3 t90 . . . . . 0 CA--C 1.537 0.45 0 CA-C-O 121.185 0.517 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -139.54 139.73 36.95 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.351 1.06 . . . . 0.0 109.377 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.2 p -66.36 166.69 15.84 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.96 0.904 . . . . 0.0 112.401 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.67 36.79 0.4 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.914 3.076 . . . . 0.0 112.985 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -139.96 -39.62 0.45 Allowed 'General case' 0 C--N 1.344 0.366 0 C-N-CA 125.336 1.455 . . . . 0.0 109.582 168.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.441 -0.899 0 C-N-CA 126.722 2.009 . . . . 0.0 112.038 173.017 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -154.93 -37.89 0.09 Allowed 'General case' 0 C--N 1.349 0.56 0 CA-C-O 116.027 -1.939 . . . . 0.0 115.042 -168.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.7 OUTLIER -52.88 172.61 0.05 OUTLIER 'General case' 0 C--N 1.358 0.938 0 CA-C-N 122.002 2.183 . . . . 0.0 112.245 170.541 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.5 mt -63.24 -5.09 2.96 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.749 1.619 . . . . 0.0 111.24 172.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.2 m -99.21 -12.12 20.71 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 126.105 1.762 . . . . 0.0 112.585 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.0 p80 46.04 50.02 11.86 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 126.678 1.991 . . . . 0.0 111.894 -174.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -165.2 148.12 8.13 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.931 1.293 . . . . 0.0 107.901 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 205' ' ' SER . 0.5 OUTLIER -132.0 173.66 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 126.958 2.103 . . . . 0.0 110.78 176.534 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.508 ' H ' HG12 ' A' ' 204' ' ' VAL . 7.9 t 65.19 63.93 0.64 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.85 2.06 . . . . 0.0 113.067 -174.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.59 112.23 0.92 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.324 1.85 . . . . 0.0 109.034 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 60.1 -160.65 21.05 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 123.09 1.383 . . . . 0.0 112.982 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -66.11 143.29 57.4 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 112.253 -1.973 . . . . 0.0 111.097 169.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.0 mtm -149.04 154.05 38.75 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.752 2.021 . . . . 0.0 109.095 -168.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 211' ' ' GLY . 6.2 tt -142.04 -136.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -171.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 149.42 132.05 2.03 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 125.482 1.515 . . . . 0.0 112.867 -170.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.47 120.91 12.0 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.473 1.109 . . . . 0.0 108.548 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.3 -1.52 2.42 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.522 1.529 . . . . 0.0 113.561 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -69.54 116.4 42.62 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 169.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -77.17 9.43 2.79 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.28 2.653 . . . . 0.0 113.066 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -123.29 7.46 9.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.978 1.711 . . . . 0.0 110.172 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.7 t -61.21 130.98 48.92 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 118.402 0.546 . . . . 0.0 109.768 171.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 38.0 m -74.92 6.22 4.3 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.564 1.545 . . . . 0.0 113.589 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.9 mm -135.76 -37.19 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 126.369 1.867 . . . . 0.0 109.83 -170.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.11 -41.99 0.52 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.313 2.645 . . . . 0.0 115.523 170.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.511 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -127.85 148.56 50.47 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.334 1.854 . . . . 0.0 108.644 -177.05 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -149.19 155.97 41.44 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -174.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -83.76 142.72 30.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.38 -9.06 2.05 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.549 1.54 . . . . 0.0 112.913 170.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -115.47 -6.29 12.27 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.527 1.131 . . . . 0.0 112.394 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.8 m -80.13 -0.09 34.45 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 168.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.29 -8.8 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 126.852 2.061 . . . . 0.0 111.638 171.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.17 36.46 63.91 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.547 1.07 . . . . 0.0 113.06 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 32.0 mt . . . . . 0 CA--C 1.538 0.508 0 CA-C-N 118.287 1.043 . . . . 0.0 110.613 171.139 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.4 t90 . . . . . 0 CA--C 1.538 0.493 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -139.83 141.85 36.66 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.064 0.945 . . . . 0.0 109.409 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.1 p -66.08 163.62 36.21 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.876 0.87 . . . . 0.0 111.724 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.53 32.92 0.32 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 123.986 3.124 . . . . 0.0 113.087 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -135.64 -39.11 0.72 Allowed 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.45 1.5 . . . . 0.0 109.67 170.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.442 -0.864 0 C-N-CA 126.919 2.088 . . . . 0.0 112.222 170.869 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -156.06 -38.19 0.08 Allowed 'General case' 0 C--N 1.35 0.626 0 CA-C-O 115.956 -1.973 . . . . 0.0 115.563 -168.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.5 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.9 OUTLIER -52.99 174.15 0.04 OUTLIER 'General case' 0 C--N 1.359 0.991 0 CA-C-N 122.069 2.213 . . . . 0.0 112.027 172.06 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.0 mt -62.98 -5.07 2.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.641 1.577 . . . . 0.0 111.339 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 69.6 m -100.0 -12.28 19.88 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 126.069 1.748 . . . . 0.0 112.675 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.8 p80 45.36 50.1 10.09 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.775 2.03 . . . . 0.0 112.008 -174.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -164.62 148.57 9.21 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 125.219 1.408 . . . . 0.0 107.67 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 205' ' ' SER . 0.6 OUTLIER -132.69 174.01 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 127.131 2.172 . . . . 0.0 110.871 177.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.529 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.1 t 63.26 63.04 0.93 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.688 1.995 . . . . 0.0 112.904 -174.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.36 108.32 1.07 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.574 1.95 . . . . 0.0 108.332 -174.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 62.04 -164.38 23.22 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 123.278 1.488 . . . . 0.0 112.798 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.524 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.8 pm0 -65.25 150.17 48.69 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.314 2.246 . . . . 0.0 111.577 169.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 76.8 mtm -149.55 159.71 44.08 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.903 1.681 . . . . 0.0 110.684 -167.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 6.8 tp -138.34 -133.8 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.117 0.967 . . . . 0.0 109.302 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 145.62 132.73 2.47 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 126.447 1.975 . . . . 0.0 113.242 -169.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.534 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 8.8 t -65.11 124.12 21.29 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.63 4.18 0.62 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.129 1.372 . . . . 0.0 113.104 173.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.65 112.04 5.01 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 128.51 2.724 . . . . 0.0 107.797 167.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -78.55 11.9 2.31 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.372 2.715 . . . . 0.0 112.955 -176.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -129.24 8.46 5.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.114 1.766 . . . . 0.0 109.807 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 12.2 t -57.3 116.7 3.46 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-O 121.767 0.794 . . . . 0.0 111.62 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 68.7 m -79.59 6.58 10.18 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.181 1.792 . . . . 0.0 112.48 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.5 mm -123.08 -36.99 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 126.547 1.939 . . . . 0.0 108.92 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . 0.254 0.1 OUTLIER 67.26 -23.98 0.11 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 129.093 2.957 . . . . 0.0 116.494 169.226 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.501 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.6 OUTLIER -147.59 149.85 33.33 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.662 1.585 . . . . 0.0 109.152 -179.129 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -147.44 157.2 43.48 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.293 1.037 . . . . 0.0 108.299 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -83.19 143.13 30.68 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.33 0.585 . . . . 0.0 110.142 -174.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.51 -4.45 0.4 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.924 2.09 . . . . 0.0 114.039 170.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.47 -9.15 8.01 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.317 1.447 . . . . 0.0 112.276 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 10.3 m -77.45 -1.65 31.38 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.029 0.831 . . . . 0.0 112.769 168.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 12.7 p -132.04 -1.42 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 126.923 2.089 . . . . 0.0 110.92 171.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 63.6 32.56 84.58 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.25 1.405 . . . . 0.0 113.297 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.1 mt . . . . . 0 C--N 1.344 0.368 0 CA-C-N 117.999 0.9 . . . . 0.0 112.276 -172.955 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 237' ' ' TRP . . . . . 0.404 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 90.3 t90 . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.534 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 97.5 m-85 -139.4 141.35 37.54 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.726 0.81 . . . . 0.0 110.698 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' CYS . . . . . 0.404 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 29.1 p -65.75 160.27 62.72 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.519 0.727 . . . . 0.0 111.685 174.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.33 28.4 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.275 3.317 . . . . 0.0 113.327 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -133.58 -35.66 0.99 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.344 1.858 . . . . 0.0 109.637 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.447 -0.611 0 C-N-CA 126.099 1.76 . . . . 0.0 110.969 168.972 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -157.47 -43.42 0.07 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -168.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.49 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 2.1 p -39.62 170.2 0.0 OUTLIER 'General case' 0 C--N 1.349 0.57 0 C-N-CA 126.364 1.866 . . . . 0.0 114.379 169.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.3 mt -70.96 -6.63 40.16 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 113.31 -1.768 . . . . 0.0 110.131 168.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.49 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 97.4 m -96.29 -13.67 23.18 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 123.472 0.709 . . . . 0.0 111.755 174.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.7 p80 46.34 52.4 10.64 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.773 2.029 . . . . 0.0 112.607 -173.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -171.56 140.36 1.36 Allowed 'General case' 0 C--N 1.346 0.455 0 C-N-CA 126.004 1.721 . . . . 0.0 108.083 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.513 HG12 ' H ' ' A' ' 205' ' ' SER . 1.5 t -122.33 171.17 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.506 1.522 . . . . 0.0 111.179 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.513 ' H ' HG12 ' A' ' 204' ' ' VAL . 52.8 m 67.17 64.31 0.44 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.983 2.113 . . . . 0.0 113.405 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -160.14 112.48 2.04 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.661 1.984 . . . . 0.0 108.024 -176.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 68.19 -123.19 17.12 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -170.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.35 167.59 12.6 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.003 2.121 . . . . 0.0 110.982 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -138.26 156.17 47.93 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.178 0.991 . . . . 0.0 111.23 -169.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.453 HG12 ' H ' ' A' ' 211' ' ' GLY . 8.1 tt -134.53 -139.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 173.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 148.04 132.97 2.26 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 125.35 1.453 . . . . 0.0 112.648 -169.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.9 t -66.13 122.94 18.55 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.83 -2.19 3.58 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.504 1.522 . . . . 0.0 113.553 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -67.15 117.12 43.09 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 124.3 1.04 . . . . 0.0 108.33 168.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.65 5.42 4.81 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.229 2.619 . . . . 0.0 113.147 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -118.09 6.88 12.1 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.934 1.694 . . . . 0.0 110.428 174.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 45.9 t -58.88 127.54 32.73 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 121.234 0.54 . . . . 0.0 109.875 170.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 67.9 m -78.64 6.82 7.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.56 1.544 . . . . 0.0 113.336 -176.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.7 mt -133.76 -33.58 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.124 1.77 . . . . 0.0 110.261 -176.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.98 -39.42 0.45 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.869 2.468 . . . . 0.0 115.168 170.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.459 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -131.27 148.68 52.72 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.524 1.93 . . . . 0.0 108.719 -175.609 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -147.17 150.16 34.39 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -72.34 148.55 45.22 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.41 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -60.54 -5.87 1.4 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.342 1.457 . . . . 0.0 112.336 167.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -119.78 -2.01 10.45 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.925 1.29 . . . . 0.0 112.478 171.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.3 m -73.48 -5.24 38.81 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.907 0.776 . . . . 0.0 111.078 166.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 14.2 p -134.6 -10.17 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.766 2.026 . . . . 0.0 112.211 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.58 36.59 62.32 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.619 1.104 . . . . 0.0 113.354 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 11.0 mt . . . . . 0 CA--C 1.537 0.45 0 CA-C-N 118.514 1.157 . . . . 0.0 111.603 173.729 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 91.2 t90 . . . . . 0 CA--C 1.539 0.526 0 CA-C-O 121.427 0.632 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -140.5 141.96 35.32 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.129 1.372 . . . . 0.0 108.897 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 16.9 p -68.82 164.06 49.95 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.896 -0.573 . . . . 0.0 112.005 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.45 34.1 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 124.148 3.232 . . . . 0.0 113.203 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -135.84 -36.97 0.75 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 125.793 1.637 . . . . 0.0 109.757 171.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.5 m . . . . . 0 N--CA 1.442 -0.865 0 C-N-CA 126.797 2.039 . . . . 0.0 112.091 171.755 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -156.29 -44.31 0.07 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -169.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.486 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 2.3 p -40.58 169.92 0.0 OUTLIER 'General case' 0 C--N 1.349 0.555 0 C-N-CA 126.139 1.775 . . . . 0.0 114.158 169.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.9 mt -71.48 -6.32 39.61 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 113.233 -1.803 . . . . 0.0 110.07 168.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.486 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 95.1 m -96.02 -13.54 23.66 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 123.455 0.702 . . . . 0.0 111.808 174.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.1 p80 46.28 53.75 9.16 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.804 2.042 . . . . 0.0 112.609 -173.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -171.78 141.38 1.41 Allowed 'General case' 0 C--N 1.346 0.441 0 C-N-CA 125.707 1.603 . . . . 0.0 108.221 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 205' ' ' SER . 0.9 OUTLIER -123.99 170.5 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.36 1.464 . . . . 0.0 110.906 177.231 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.484 ' H ' HG12 ' A' ' 204' ' ' VAL . 7.9 t 67.8 65.91 0.37 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.026 2.13 . . . . 0.0 113.165 -174.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.89 111.88 1.16 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.732 2.013 . . . . 0.0 107.733 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.16 -134.97 36.85 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -169.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.52 169.33 8.88 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.91 2.084 . . . . 0.0 111.252 177.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -137.8 159.86 40.83 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.478 1.111 . . . . 0.0 111.596 -168.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.457 HG13 ' H ' ' A' ' 211' ' ' GLY . 5.6 tp -134.76 -138.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 170.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 149.47 131.87 2.0 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 126.024 1.773 . . . . 0.0 112.132 -169.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 43.7 t -63.42 125.43 24.15 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.217 1.007 . . . . 0.0 108.675 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.97 -3.43 3.48 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.824 1.25 . . . . 0.0 113.709 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -70.48 117.18 52.63 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 124.242 1.017 . . . . 0.0 108.659 169.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -76.82 4.22 5.86 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.261 2.641 . . . . 0.0 113.16 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -115.99 6.3 14.1 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.85 1.66 . . . . 0.0 110.463 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 49.9 t -58.72 128.3 36.5 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.019 0.528 . . . . 0.0 109.975 170.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.2 m -74.38 2.83 8.5 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.727 1.611 . . . . 0.0 113.689 -176.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.8 mt -133.18 -33.66 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.186 1.794 . . . . 0.0 110.175 -173.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.89 -38.1 0.41 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.796 2.438 . . . . 0.0 115.226 170.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.471 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -132.06 148.51 52.5 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.618 1.967 . . . . 0.0 108.751 -174.091 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -148.35 149.47 31.85 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -73.94 150.7 40.66 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.244 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -59.66 -4.25 0.63 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.84 1.656 . . . . 0.0 113.252 167.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.79 -2.84 8.26 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.326 1.45 . . . . 0.0 112.609 171.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.1 m -71.9 -7.88 51.1 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.112 0.869 . . . . 0.0 111.612 167.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.0 p -133.94 -4.45 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 125.958 1.703 . . . . 0.0 111.765 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.18 33.55 78.67 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.605 1.098 . . . . 0.0 113.012 -174.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.5 mt . . . . . 0 C--N 1.343 0.311 0 C-N-CA 124.437 1.095 . . . . 0.0 112.096 -174.368 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 81.1 t90 . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -138.64 138.26 37.67 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.187 0.995 . . . . 0.0 108.728 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.7 p -64.82 166.78 10.95 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.965 0.906 . . . . 0.0 112.171 176.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.4 36.01 0.37 Allowed 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 123.861 3.041 . . . . 0.0 113.095 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -138.68 -39.51 0.51 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 125.473 1.509 . . . . 0.0 109.329 169.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.442 -0.837 0 C-N-CA 126.979 2.112 . . . . 0.0 112.393 172.184 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.8 p . . . . . 0 C--O 1.235 0.305 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -155.89 -44.91 0.08 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.502 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.7 p -39.83 170.32 0.0 OUTLIER 'General case' 0 C--N 1.348 0.522 0 C-N-CA 126.408 1.883 . . . . 0.0 114.001 168.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.68 -6.97 41.1 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.527 -1.67 . . . . 0.0 110.127 168.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.502 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 89.2 m -97.13 -14.16 21.68 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 123.859 0.864 . . . . 0.0 111.763 175.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.5 p80 45.57 52.48 9.23 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.082 2.153 . . . . 0.0 112.883 -173.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.15 139.79 2.3 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 126.043 1.737 . . . . 0.0 108.439 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -122.6 -174.82 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.878 1.671 . . . . 0.0 109.752 176.711 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.493 ' H ' HG12 ' A' ' 204' ' ' VAL 0.277 59.7 p 59.87 53.98 4.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.124 2.17 . . . . 0.0 114.571 -174.812 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.75 121.05 5.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.7 2.0 . . . . 0.0 109.1 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 57.54 -113.46 4.6 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.616 1.579 . . . . 0.0 111.188 -174.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.76 168.56 18.82 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.346 2.259 . . . . 0.0 111.41 -174.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -138.57 159.76 41.3 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.802 0.841 . . . . 0.0 113.036 -167.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.415 HG13 ' H ' ' A' ' 211' ' ' GLY . 5.7 tp -134.8 -137.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 168.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 147.71 131.53 2.13 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 125.555 1.55 . . . . 0.0 112.03 -170.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 53.3 t -64.75 119.49 10.69 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -67.38 1.28 2.31 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.432 1.493 . . . . 0.0 113.747 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -67.0 118.0 51.15 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.22 6.23 4.05 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.28 2.654 . . . . 0.0 113.191 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -119.66 7.64 11.1 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.821 1.648 . . . . 0.0 110.575 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 47.5 t -59.34 130.26 46.04 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 123.286 0.634 . . . . 0.0 110.3 172.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.0 m -76.2 1.48 15.77 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.56 1.544 . . . . 0.0 113.671 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 26.2 mt -134.94 -34.34 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.029 1.731 . . . . 0.0 110.285 -171.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.7 -39.77 0.44 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.71 2.404 . . . . 0.0 115.011 170.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.45 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -131.27 147.73 52.62 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.523 1.929 . . . . 0.0 108.42 -174.612 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -147.76 147.79 30.26 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -71.45 150.97 44.42 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.204 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.96 -1.33 0.64 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.589 1.556 . . . . 0.0 113.41 168.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -126.95 1.3 6.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.756 1.222 . . . . 0.0 112.28 169.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.1 m -72.28 -9.42 58.45 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.793 0.724 . . . . 0.0 111.608 167.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.1 p -135.07 -10.83 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 124.696 1.198 . . . . 0.0 113.046 170.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.49 38.37 8.98 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.615 1.102 . . . . 0.0 113.888 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.344 0.366 0 CA-C-N 118.69 1.245 . . . . 0.0 110.764 173.154 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 237' ' ' TRP . . . . . 0.417 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 87.5 t90 . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 121.075 0.464 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -139.25 141.25 37.83 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 124.854 1.262 . . . . 0.0 109.471 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' CYS . . . . . 0.417 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 15.9 p -67.87 163.68 47.61 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.49 0.716 . . . . 0.0 112.288 176.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.54 34.14 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 124.056 3.171 . . . . 0.0 113.458 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -137.32 -35.92 0.67 Allowed 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.45 1.5 . . . . 0.0 110.076 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.442 -0.86 0 C-N-CA 126.556 1.942 . . . . 0.0 111.808 169.972 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 81.1 p . . . . . 0 CA--C 1.534 0.329 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -156.58 -48.59 0.07 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -174.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.484 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -38.62 171.28 0.0 OUTLIER 'General case' 0 C--N 1.351 0.663 0 C-N-CA 126.803 2.041 . . . . 0.0 114.633 169.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.9 mt -70.38 -7.24 41.39 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 113.458 -1.701 . . . . 0.0 110.021 168.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.484 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 94.6 m -96.43 -13.71 22.96 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 123.546 0.738 . . . . 0.0 111.852 174.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.3 p80 46.01 51.04 11.16 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.306 2.242 . . . . 0.0 113.101 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -169.66 142.05 2.45 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 125.854 1.662 . . . . 0.0 107.897 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 205' ' ' SER . 1.1 t -123.65 174.09 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.666 1.587 . . . . 0.0 110.733 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.528 ' H ' HG12 ' A' ' 204' ' ' VAL . 50.0 m 67.48 57.84 0.55 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.719 2.007 . . . . 0.0 113.114 -177.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -158.66 109.4 2.09 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.298 2.239 . . . . 0.0 106.945 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.77 -159.74 45.55 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-O 122.814 1.23 . . . . 0.0 110.757 -168.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -83.43 170.58 14.34 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.375 1.87 . . . . 0.0 112.075 171.402 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -140.23 159.73 41.53 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.921 1.289 . . . . 0.0 112.137 -169.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . 0.258 9.1 tp -132.19 -138.42 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 146.94 136.45 2.85 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 126.454 1.978 . . . . 0.0 112.308 -169.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.507 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 7.5 t -65.75 127.68 32.92 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.755 -0.723 . . . . 0.0 109.748 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.72 -8.27 1.98 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.343 1.457 . . . . 0.0 113.75 171.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -57.55 110.16 2.29 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 128.163 2.585 . . . . 0.0 108.288 169.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -78.61 10.91 2.64 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.42 2.747 . . . . 0.0 112.758 -175.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -129.22 9.9 5.73 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.279 1.832 . . . . 0.0 109.603 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 21.9 t -55.38 117.46 3.57 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-O 121.781 0.801 . . . . 0.0 111.66 175.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 85.7 p -74.49 1.94 10.73 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.94 2.096 . . . . 0.0 113.265 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.8 mm -123.67 -36.54 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.37 1.868 . . . . 0.0 108.957 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.03 -30.15 0.21 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 128.207 2.603 . . . . 0.0 115.195 169.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.468 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -144.24 149.81 36.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.689 1.596 . . . . 0.0 109.435 -175.266 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -148.21 149.67 32.36 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -72.88 149.86 43.13 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.192 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -59.36 -4.76 0.63 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.57 1.548 . . . . 0.0 113.473 167.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.65 -4.23 8.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.215 1.406 . . . . 0.0 112.638 171.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 14.6 m -72.8 -5.34 37.35 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.002 0.819 . . . . 0.0 111.359 167.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.5 p -136.56 -5.22 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 126.479 1.911 . . . . 0.0 111.931 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.8 35.86 91.46 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.802 1.191 . . . . 0.0 113.023 -175.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.5 mt . . . . . 0 C--N 1.344 0.334 0 C-N-CA 123.968 0.907 . . . . 0.0 111.281 -176.642 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.8 t90 . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.507 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 91.3 m-85 -138.44 138.42 38.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.716 0.807 . . . . 0.0 110.249 -176.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 31.5 p -64.03 162.48 30.36 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 123.675 0.79 . . . . 0.0 111.622 172.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.82 28.95 0.24 Allowed 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 124.028 3.152 . . . . 0.0 113.59 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -133.61 -36.85 0.95 Allowed 'General case' 0 C--N 1.343 0.326 0 C-N-CA 125.794 1.638 . . . . 0.0 109.702 173.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.447 -0.615 0 C-N-CA 126.325 1.85 . . . . 0.0 111.863 169.341 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.98 -49.48 0.09 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -168.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.494 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.9 p -41.65 170.33 0.0 OUTLIER 'General case' 0 C--N 1.349 0.58 0 C-N-CA 125.892 1.677 . . . . 0.0 114.165 169.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.7 mt -71.1 -6.86 42.48 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.925 168.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.494 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 93.7 m -95.62 -13.6 24.2 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.513 0.725 . . . . 0.0 111.797 174.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.0 p80 46.83 52.94 10.92 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.031 2.132 . . . . 0.0 112.85 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -173.16 139.73 0.82 Allowed 'General case' 0 C--N 1.345 0.391 0 C-N-CA 125.878 1.671 . . . . 0.0 108.498 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 205' ' ' SER . 0.5 OUTLIER -114.29 -173.18 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 125.605 1.562 . . . . 0.0 110.665 175.449 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.521 ' H ' HG12 ' A' ' 204' ' ' VAL 0.254 97.5 p 53.12 64.29 1.91 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.812 2.445 . . . . 0.0 114.771 -174.675 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.08 112.07 1.54 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.894 2.078 . . . . 0.0 108.011 -177.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 63.65 -133.72 41.25 Favored Glycine 0 C--N 1.339 0.75 0 C-N-CA 124.497 1.046 . . . . 0.0 110.546 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.08 169.05 9.21 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 127.248 2.219 . . . . 0.0 111.42 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -138.66 159.51 41.92 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.251 1.02 . . . . 0.0 112.209 -168.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.448 HG13 ' H ' ' A' ' 211' ' ' GLY . 5.8 tp -133.44 -138.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 169.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 148.32 131.25 2.04 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 125.597 1.57 . . . . 0.0 112.507 -170.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 45.9 t -63.94 121.39 13.99 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.24 2.11 1.79 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.436 1.494 . . . . 0.0 113.699 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -70.94 118.01 61.43 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.378 1.071 . . . . 0.0 108.146 168.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -76.33 4.58 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.185 2.59 . . . . 0.0 113.273 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -116.21 6.41 13.87 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.717 1.607 . . . . 0.0 110.508 174.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 46.5 t -59.14 129.13 40.64 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 123.118 0.567 . . . . 0.0 109.924 171.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 11.0 t -73.27 -1.44 17.87 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.922 1.689 . . . . 0.0 113.455 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.6 mt -132.76 -33.84 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.968 1.707 . . . . 0.0 110.449 -170.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.68 -38.9 0.43 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 127.47 2.308 . . . . 0.0 114.985 171.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.479 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -132.49 148.29 52.39 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.497 1.919 . . . . 0.0 109.03 -173.268 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -148.85 149.95 32.17 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -74.17 151.08 40.09 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.369 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -59.28 -5.12 0.66 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.766 1.626 . . . . 0.0 113.259 167.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.04 -3.58 8.56 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.294 1.438 . . . . 0.0 112.581 171.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 15.5 m -72.8 -6.9 47.92 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.04 0.836 . . . . 0.0 111.739 167.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.35 -5.6 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.864 1.666 . . . . 0.0 111.817 172.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.51 34.82 80.03 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.726 1.155 . . . . 0.0 112.8 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--N 1.343 0.324 0 C-N-CA 124.327 1.051 . . . . 0.0 111.771 -174.599 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 88.8 t90 . . . . . 0 CA--C 1.539 0.538 0 CA-C-O 120.975 0.417 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -138.63 140.46 38.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.201 1.0 . . . . 0.0 109.584 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.2 p -66.73 165.24 26.69 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.73 0.812 . . . . 0.0 112.06 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.47 33.03 0.29 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 124.024 3.149 . . . . 0.0 113.482 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -136.02 -40.31 0.68 Allowed 'General case' 0 C--N 1.345 0.404 0 C-N-CA 125.068 1.347 . . . . 0.0 109.674 169.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.442 -0.856 0 C-N-CA 126.736 2.014 . . . . 0.0 111.705 171.803 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 63.6 p . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -155.26 -42.26 0.08 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 115.705 -2.093 . . . . 0.0 115.099 -173.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.487 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.7 OUTLIER -52.01 173.64 0.03 OUTLIER 'General case' 0 C--N 1.359 0.985 0 CA-C-N 122.223 2.283 . . . . 0.0 112.572 172.852 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.6 mt -62.83 -6.13 3.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.559 1.543 . . . . 0.0 111.243 172.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 92.4 m -99.29 -11.87 20.86 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 126.298 1.839 . . . . 0.0 112.762 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.7 p80 45.36 48.61 10.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.406 2.283 . . . . 0.0 112.342 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -162.91 147.99 11.78 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.367 1.467 . . . . 0.0 107.539 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 205' ' ' SER . 1.1 t -135.19 171.72 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 127.388 2.275 . . . . 0.0 110.323 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.492 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.3 t 61.36 64.52 1.07 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.61 1.964 . . . . 0.0 112.987 -173.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.86 108.11 1.14 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.48 1.912 . . . . 0.0 108.374 -174.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 59.69 -160.22 19.8 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-O 123.271 1.484 . . . . 0.0 112.631 -174.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.9 pm0 -64.17 148.94 48.85 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.959 2.104 . . . . 0.0 111.621 169.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.8 mtm -150.94 156.17 40.62 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.653 1.981 . . . . 0.0 109.492 -168.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.411 HG13 ' H ' ' A' ' 211' ' ' GLY . 7.2 tp -140.53 -135.56 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -175.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 148.78 133.89 2.32 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 126.054 1.788 . . . . 0.0 112.444 -171.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 50.4 t -64.63 126.58 28.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.168 -1.016 . . . . 0.0 109.013 175.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.91 -7.33 2.33 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -69.61 114.73 26.57 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 119.496 1.044 . . . . 0.0 108.593 171.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -78.45 6.04 5.08 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.418 2.745 . . . . 0.0 112.948 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -118.95 5.58 11.38 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.952 1.701 . . . . 0.0 109.987 174.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.2 t -59.39 131.07 49.87 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 118.487 0.585 . . . . 0.0 109.844 170.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.0 m -74.11 6.31 3.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.725 1.61 . . . . 0.0 113.417 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.0 mm -135.75 -38.15 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 126.54 1.936 . . . . 0.0 109.62 -170.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.86 -43.2 0.53 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.525 2.73 . . . . 0.0 115.511 171.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.487 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -126.02 148.51 49.28 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.566 1.946 . . . . 0.0 108.625 -177.373 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.412 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 74.0 m-85 -149.11 155.31 40.52 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -173.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -83.97 145.1 28.72 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.559 0.695 . . . . 0.0 110.628 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.34 -3.94 1.08 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.005 1.722 . . . . 0.0 113.979 171.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.86 -4.22 7.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.546 1.138 . . . . 0.0 112.185 172.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.3 m -77.44 -3.03 38.3 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.036 0.835 . . . . 0.0 113.02 168.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.2 p -135.02 -6.11 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.789 1.235 . . . . 0.0 112.259 169.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.77 40.88 20.71 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.59 1.091 . . . . 0.0 113.723 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.7 mt . . . . . 0 N--CA 1.468 0.432 0 CA-C-N 118.517 1.158 . . . . 0.0 110.221 172.064 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 89.1 t90 . . . . . 0 CA--C 1.537 0.444 0 CA-C-O 120.956 0.408 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -140.98 141.99 34.35 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.297 1.039 . . . . 0.0 109.646 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.0 p -70.02 166.02 37.21 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.485 0.714 . . . . 0.0 111.896 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -73.1 32.48 0.31 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.028 3.152 . . . . 0.0 113.383 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -136.29 -36.74 0.72 Allowed 'General case' 0 C--N 1.344 0.34 0 C-N-CA 125.161 1.385 . . . . 0.0 109.845 171.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 37.5 m . . . . . 0 N--CA 1.44 -0.947 0 C-N-CA 126.779 2.032 . . . . 0.0 111.961 172.3 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.9 p . . . . . 0 N--CA 1.465 0.275 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -154.69 -40.47 0.09 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 115.884 -2.007 . . . . 0.0 115.319 -171.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.519 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.8 OUTLIER -53.43 173.64 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 122.312 2.324 . . . . 0.0 112.213 170.59 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.6 mt -62.44 -7.66 4.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.671 1.588 . . . . 0.0 111.232 171.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 67.6 m -95.75 -12.9 24.67 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 126.062 1.745 . . . . 0.0 112.753 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.5 p80 45.2 49.03 10.02 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.339 2.256 . . . . 0.0 112.232 -173.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -164.27 147.94 9.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.217 1.407 . . . . 0.0 108.147 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -127.45 -169.93 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 127.202 2.201 . . . . 0.0 109.285 174.479 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.444 ' H ' HG12 ' A' ' 204' ' ' VAL . 89.8 p 49.24 58.04 5.83 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.893 2.077 . . . . 0.0 114.324 -174.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.15 100.77 2.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.845 2.058 . . . . 0.0 109.295 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 68.95 -96.78 0.47 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.615 1.578 . . . . 0.0 111.5 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.17 169.47 17.8 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.148 1.779 . . . . 0.0 111.977 -169.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -146.0 161.23 40.57 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.42 1.088 . . . . 0.0 112.073 -169.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.4 HG13 ' H ' ' A' ' 211' ' ' GLY . 4.6 tp -133.31 -134.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 168.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 146.25 133.15 2.46 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 125.493 1.52 . . . . 0.0 111.923 -170.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.51 121.17 14.29 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.374 -0.913 . . . . 0.0 109.082 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -71.78 7.2 1.61 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.51 1.524 . . . . 0.0 113.602 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -71.73 120.2 78.6 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.469 1.107 . . . . 0.0 108.402 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -75.7 6.61 3.58 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.333 2.689 . . . . 0.0 113.361 177.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -119.68 7.67 11.09 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.785 1.634 . . . . 0.0 110.648 174.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.76 129.23 40.44 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 123.438 0.695 . . . . 0.0 110.226 173.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.1 m -81.17 3.45 23.58 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.281 1.432 . . . . 0.0 113.363 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 78.7 mt -134.71 -33.72 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.614 1.565 . . . . 0.0 110.364 -169.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER 73.06 -46.05 0.64 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 128.78 2.832 . . . . 0.0 115.235 170.341 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.519 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.3 OUTLIER -125.44 149.12 48.5 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.588 1.555 . . . . 0.0 109.24 -175.767 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.4 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 82.6 m-85 -149.69 157.88 43.65 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.945 1.298 . . . . 0.0 108.832 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -89.11 144.6 26.01 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.378 0.609 . . . . 0.0 111.174 -172.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -56.57 -8.24 0.53 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.421 2.288 . . . . 0.0 114.245 169.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.86 -7.69 8.43 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.827 1.251 . . . . 0.0 112.297 174.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 10.6 m -77.28 -3.15 38.4 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.044 0.838 . . . . 0.0 112.938 168.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 12.7 p -131.11 -0.44 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 126.091 1.757 . . . . 0.0 110.857 169.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.46 29.33 74.97 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.208 1.385 . . . . 0.0 113.174 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 C--N 1.342 0.272 0 C-N-CA 124.307 1.043 . . . . 0.0 112.362 -171.509 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.1 t90 . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -139.82 142.43 36.64 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.012 0.925 . . . . 0.0 110.096 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.0 p -70.83 164.96 51.36 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.574 0.75 . . . . 0.0 111.347 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -73.76 31.5 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.047 3.165 . . . . 0.0 113.096 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -136.18 -36.85 0.73 Allowed 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.386 1.474 . . . . 0.0 109.937 176.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.443 -0.815 0 C-N-CA 127.354 2.262 . . . . 0.0 112.011 173.675 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 78.5 p . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -156.83 -39.0 0.07 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 115.901 -2.0 . . . . 0.0 115.194 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.502 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.7 OUTLIER -52.86 173.79 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 122.218 2.281 . . . . 0.0 112.438 171.688 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.6 mt -62.88 -6.71 4.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.691 1.596 . . . . 0.0 111.216 171.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.8 m -98.53 -11.31 22.35 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 126.14 1.776 . . . . 0.0 112.712 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.2 p80 45.75 48.92 11.63 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.401 2.28 . . . . 0.0 112.424 -174.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -163.76 148.97 10.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.457 1.503 . . . . 0.0 107.548 176.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 205' ' ' SER . 1.1 t -133.83 172.03 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 127.225 2.21 . . . . 0.0 110.635 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.511 ' H ' HG12 ' A' ' 204' ' ' VAL . 13.2 t 64.66 61.53 0.82 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.869 2.068 . . . . 0.0 113.3 -174.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.82 111.07 1.52 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.396 1.878 . . . . 0.0 108.558 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.5 -163.18 23.44 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-O 123.171 1.428 . . . . 0.0 112.575 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.9 pm0 -65.61 147.27 53.68 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 112.233 -1.983 . . . . 0.0 111.1 169.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.8 mtm -148.98 153.71 38.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.208 1.803 . . . . 0.0 109.743 -168.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.9 tp -137.96 -134.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.346 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -173.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 149.35 132.06 2.03 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 126.232 1.872 . . . . 0.0 112.788 -169.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 47.6 t -64.35 125.35 24.31 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.29 -0.955 . . . . 0.0 108.678 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.8 -0.32 2.14 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.484 1.514 . . . . 0.0 113.245 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -72.97 116.83 54.39 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 124.501 1.121 . . . . 0.0 108.466 168.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.02 4.21 5.97 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.288 2.658 . . . . 0.0 113.217 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -114.78 5.01 15.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.766 1.626 . . . . 0.0 110.526 174.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.98 130.13 45.52 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 122.987 0.515 . . . . 0.0 110.4 171.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.0 m -74.03 1.62 10.59 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.785 1.634 . . . . 0.0 113.868 -176.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 19.1 mt -134.07 -32.82 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 126.091 1.756 . . . . 0.0 110.359 -172.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.77 -37.51 0.38 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 128.366 2.666 . . . . 0.0 115.78 172.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.504 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.5 OUTLIER -130.14 148.77 52.02 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.371 1.868 . . . . 0.0 108.985 -176.774 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.411 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 82.5 m-85 -147.27 155.12 41.77 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.849 0.86 . . . . 0.0 108.868 -175.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -82.05 143.19 31.71 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.922 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -58.97 -7.27 1.0 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.789 1.636 . . . . 0.0 113.827 170.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -118.83 -5.26 10.63 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.412 1.085 . . . . 0.0 112.417 172.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.0 m -78.55 -0.77 30.95 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.903 0.774 . . . . 0.0 112.855 168.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.0 -9.67 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.845 2.058 . . . . 0.0 111.943 173.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 73.14 36.98 55.93 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.575 1.084 . . . . 0.0 112.993 -177.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 CA--C 1.533 0.319 0 CA-C-N 117.854 0.827 . . . . 0.0 109.919 175.344 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 89.6 t90 . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -139.76 141.66 36.82 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.313 1.045 . . . . 0.0 109.491 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.1 p -67.2 165.58 26.92 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 123.586 0.755 . . . . 0.0 112.109 174.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -72.97 34.84 0.33 Allowed 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.978 3.119 . . . . 0.0 113.274 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -139.11 -37.45 0.51 Allowed 'General case' 0 C--N 1.343 0.324 0 C-N-CA 125.02 1.328 . . . . 0.0 110.275 169.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.442 -0.868 0 C-N-CA 126.934 2.094 . . . . 0.0 112.025 172.999 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.4 p . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -156.49 -37.98 0.08 Allowed 'General case' 0 C--N 1.35 0.625 0 CA-C-O 115.728 -2.082 . . . . 0.0 115.958 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.52 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 1.1 t -53.65 174.11 0.05 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 122.49 2.405 . . . . 0.0 111.851 170.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.1 mt -62.33 -7.29 4.12 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.953 1.701 . . . . 0.0 111.283 170.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 69.7 m -97.11 -12.4 23.19 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.989 1.716 . . . . 0.0 112.711 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.4 p80 45.32 49.33 10.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.173 2.189 . . . . 0.0 112.437 -173.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -164.02 148.06 9.97 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.417 1.487 . . . . 0.0 107.864 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -133.86 176.1 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 127.179 2.192 . . . . 0.0 110.81 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.552 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.0 t 63.69 61.85 0.96 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.692 1.997 . . . . 0.0 112.803 -175.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.96 110.08 1.22 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.334 1.853 . . . . 0.0 109.001 -173.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 60.06 -158.78 24.9 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-O 123.21 1.45 . . . . 0.0 113.247 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.8 pm0 -65.49 145.17 56.45 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.098 2.159 . . . . 0.0 111.317 169.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.3 mtm -151.52 156.68 41.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.294 1.838 . . . . 0.0 109.863 -168.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 7.5 tp -138.03 -133.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 124.258 1.023 . . . . 0.0 109.204 -175.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 146.37 136.08 2.85 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 126.466 1.984 . . . . 0.0 113.285 -169.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.532 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 7.0 t -65.14 125.62 25.55 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 114.622 -0.789 . . . . 0.0 109.324 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.2 0.29 0.65 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.589 1.156 . . . . 0.0 112.758 170.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -63.49 111.4 5.07 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 127.783 2.433 . . . . 0.0 107.844 167.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -78.58 11.5 2.44 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.374 2.716 . . . . 0.0 113.031 -176.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -129.23 9.04 5.61 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.161 1.784 . . . . 0.0 109.787 174.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 25.8 t -55.58 124.11 16.25 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.636 0.732 . . . . 0.0 112.403 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 15.8 m -74.34 1.14 12.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.703 2.001 . . . . 0.0 113.271 -177.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 12.5 mt -131.48 -34.55 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 126.382 1.873 . . . . 0.0 109.574 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.13 -25.3 0.16 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 128.017 2.527 . . . . 0.0 115.78 169.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.521 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.6 OUTLIER -143.6 148.06 35.31 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.855 1.662 . . . . 0.0 109.178 -178.433 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -145.96 155.87 43.13 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.168 0.987 . . . . 0.0 108.825 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -80.91 143.16 32.86 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.901 -175.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.99 -2.4 0.41 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.297 1.839 . . . . 0.0 114.12 171.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.61 -7.59 7.42 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.26 1.424 . . . . 0.0 112.166 172.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.6 m -77.27 -2.16 33.35 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.154 0.888 . . . . 0.0 112.678 168.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.77 -5.59 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 127.444 2.298 . . . . 0.0 111.266 172.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.34 36.58 91.85 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.894 1.235 . . . . 0.0 112.885 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 N--CA 1.465 0.307 0 C-N-CA 123.727 0.811 . . . . 0.0 111.452 -178.166 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 85.0 t90 . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.532 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 71.8 m-85 -134.77 135.97 42.25 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.831 0.852 . . . . 0.0 110.655 -176.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 31.2 p -65.96 164.42 28.55 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.311 1.044 . . . . 0.0 112.237 172.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.88 30.84 0.25 Allowed 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.244 3.296 . . . . 0.0 113.664 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -133.67 -36.4 0.96 Allowed 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.545 1.538 . . . . 0.0 110.041 170.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.444 -0.74 0 C-N-CA 126.158 1.783 . . . . 0.0 112.156 169.853 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 82.0 p . . . . . 0 C--O 1.233 0.235 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -156.55 -46.56 0.07 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 117.861 -1.066 . . . . 0.0 113.804 -175.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.506 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -39.38 170.05 0.0 OUTLIER 'General case' 0 C--N 1.349 0.578 0 C-N-CA 126.375 1.87 . . . . 0.0 114.064 168.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -71.08 -6.74 41.44 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.118 168.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.506 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 95.7 m -95.89 -14.31 23.26 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 123.633 0.773 . . . . 0.0 111.792 174.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.1 p80 46.25 52.34 10.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.304 2.242 . . . . 0.0 112.899 -173.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -170.36 141.62 2.03 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 126.091 1.756 . . . . 0.0 107.95 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 205' ' ' SER . 1.6 t -126.47 171.11 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 125.488 1.515 . . . . 0.0 111.18 -176.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.505 ' H ' HG12 ' A' ' 204' ' ' VAL . 43.2 m 68.72 62.81 0.33 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.267 2.227 . . . . 0.0 113.387 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.65 113.45 1.29 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.595 1.958 . . . . 0.0 108.531 -174.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 63.26 -168.68 20.12 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-O 122.708 1.171 . . . . 0.0 112.06 -173.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -69.02 150.53 47.55 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 113.273 -1.463 . . . . 0.0 110.651 168.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.9 mtm -143.63 152.57 41.53 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.929 1.692 . . . . 0.0 109.824 -166.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.6 tp -135.5 -138.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.304 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 151.86 132.4 1.85 Allowed Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 125.906 1.717 . . . . 0.0 112.151 -169.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 40.7 t -63.61 125.55 24.63 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 114.074 -1.063 . . . . 0.0 108.249 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -68.9 6.16 0.96 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.54 1.136 . . . . 0.0 113.559 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -74.42 114.11 30.47 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 166.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -77.65 9.11 3.06 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.328 2.685 . . . . 0.0 113.059 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -124.21 8.74 8.55 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.888 1.675 . . . . 0.0 110.248 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.6 129.97 44.23 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 118.306 0.503 . . . . 0.0 109.924 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -73.59 4.36 5.05 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.755 1.622 . . . . 0.0 113.404 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.2 mt -132.54 -35.17 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 126.268 1.827 . . . . 0.0 109.938 -175.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.7 -38.72 0.43 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.762 2.425 . . . . 0.0 115.27 170.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.47 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -131.43 148.67 52.67 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.899 2.08 . . . . 0.0 108.646 -174.215 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -148.62 146.72 28.35 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -73.22 149.61 42.7 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.793 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -60.29 -6.28 1.43 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.74 1.216 . . . . 0.0 113.641 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -120.36 -0.56 10.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.33 1.052 . . . . 0.0 112.611 170.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.5 m -72.61 -5.99 41.11 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.901 0.773 . . . . 0.0 111.301 166.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.1 p -137.48 -12.48 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.765 2.026 . . . . 0.0 112.388 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.97 38.84 55.62 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.348 0.975 . . . . 0.0 112.86 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 15.8 mt . . . . . 0 N--CA 1.467 0.415 0 CA-C-N 117.82 0.81 . . . . 0.0 109.796 175.142 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 88.9 t90 . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -140.12 143.21 36.11 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.2 1.0 . . . . 0.0 108.755 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 17.1 p -68.12 163.37 51.99 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-O 118.808 -0.615 . . . . 0.0 111.633 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.25 33.81 0.32 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.965 3.11 . . . . 0.0 112.891 178.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -138.26 -35.7 0.61 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 125.988 1.715 . . . . 0.0 109.964 173.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.443 -0.818 0 C-N-CA 126.774 2.03 . . . . 0.0 111.591 170.324 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.6 p . . . . . 0 CA--C 1.532 0.282 0 CA-C-O 118.616 -0.707 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -156.28 -38.91 0.08 Allowed 'General case' 0 C--N 1.35 0.623 0 CA-C-O 115.764 -2.065 . . . . 0.0 115.725 -174.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.516 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.8 OUTLIER -53.1 174.2 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 122.449 2.386 . . . . 0.0 112.145 172.035 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.0 mt -62.65 -6.3 3.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.734 1.614 . . . . 0.0 111.275 170.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 82.6 m -99.32 -12.1 20.63 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 126.193 1.797 . . . . 0.0 112.699 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.0 p80 45.19 49.03 10.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.189 2.196 . . . . 0.0 112.357 -174.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -164.15 148.16 9.8 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 125.572 1.549 . . . . 0.0 108.045 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -132.26 175.51 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 127.244 2.218 . . . . 0.0 110.253 178.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.504 ' H ' HG12 ' A' ' 204' ' ' VAL . 16.8 t 61.93 63.1 1.15 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.377 1.871 . . . . 0.0 113.292 -175.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -161.12 112.58 1.81 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.333 1.853 . . . . 0.0 109.165 -173.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.48 -110.02 3.24 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 125.232 1.396 . . . . 0.0 109.872 -172.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.14 165.9 24.64 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.84 2.056 . . . . 0.0 111.332 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -138.72 157.16 46.62 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.742 1.217 . . . . 0.0 111.063 -168.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.421 HG12 ' H ' ' A' ' 211' ' ' GLY . 9.5 tt -134.48 -136.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 174.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 147.59 132.08 2.2 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 125.167 1.365 . . . . 0.0 113.113 -170.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.5 t -65.86 123.44 19.81 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.9 0.88 . . . . 0.0 108.777 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.34 -1.8 3.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.71 1.604 . . . . 0.0 113.574 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -66.93 116.29 33.97 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 168.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.93 5.15 5.15 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.409 2.739 . . . . 0.0 113.009 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -117.69 6.16 12.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.902 1.681 . . . . 0.0 110.424 174.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 41.8 t -59.01 130.23 46.03 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 122.973 0.509 . . . . 0.0 110.378 172.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.3 t -76.07 3.21 10.92 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.732 1.613 . . . . 0.0 113.617 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 19.6 mt -134.42 -35.02 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.995 1.718 . . . . 0.0 110.279 -172.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.22 -40.95 0.49 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.992 2.517 . . . . 0.0 115.38 172.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.516 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.5 OUTLIER -126.56 147.67 49.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.135 1.774 . . . . 0.0 108.837 -177.683 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -146.89 157.48 43.66 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.39 1.076 . . . . 0.0 108.794 -175.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -84.16 141.82 30.78 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.793 -175.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.73 -8.55 1.35 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.574 1.949 . . . . 0.0 113.096 169.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -118.01 -7.06 10.91 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.823 1.249 . . . . 0.0 112.189 174.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 4.6 m -77.9 -2.1 35.09 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.94 0.791 . . . . 0.0 112.306 168.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 14.3 p -130.86 -6.31 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 126.955 2.102 . . . . 0.0 111.481 173.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.67 35.32 89.65 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.735 1.16 . . . . 0.0 113.176 -176.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.7 mt . . . . . 0 CA--C 1.536 0.419 0 CA-C-N 118.366 1.083 . . . . 0.0 111.315 175.999 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 237' ' ' TRP . . . . . 0.4 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 91.4 t90 . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 121.245 0.545 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -139.02 141.13 38.29 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.864 1.266 . . . . 0.0 109.125 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' CYS . . . . . 0.4 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 17.6 p -66.88 162.87 48.85 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.302 0.641 . . . . 0.0 112.071 173.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -73.63 35.99 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 124.006 3.137 . . . . 0.0 112.888 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -138.46 -35.68 0.59 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.868 1.667 . . . . 0.0 109.935 170.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.444 -0.763 0 C-N-CA 126.424 1.89 . . . . 0.0 111.832 169.98 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.8 p . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -155.42 -47.14 0.08 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -173.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.495 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -38.6 170.11 0.0 OUTLIER 'General case' 0 C--N 1.351 0.635 0 C-N-CA 126.557 1.943 . . . . 0.0 114.607 169.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.3 mt -70.57 -6.7 38.44 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 113.32 -1.764 . . . . 0.0 110.044 168.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.495 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 84.9 m -96.77 -14.18 22.13 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 123.646 0.778 . . . . 0.0 111.784 174.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.8 p80 45.46 52.27 9.16 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.224 2.21 . . . . 0.0 112.915 -173.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -169.9 140.7 2.1 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.934 1.694 . . . . 0.0 108.269 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.499 HG12 ' H ' ' A' ' 205' ' ' SER . 0.9 OUTLIER -125.0 174.1 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.675 1.59 . . . . 0.0 110.634 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.499 ' H ' HG12 ' A' ' 204' ' ' VAL . 13.7 t 66.36 62.05 0.57 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.721 2.009 . . . . 0.0 113.413 -174.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.75 110.87 1.98 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.174 1.79 . . . . 0.0 108.977 -175.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 66.81 -109.51 2.95 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 125.283 1.421 . . . . 0.0 110.438 -172.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.61 168.64 19.35 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.123 2.169 . . . . 0.0 111.139 -174.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -140.35 158.89 43.33 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.719 0.808 . . . . 0.0 112.748 -168.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.451 HG13 ' H ' ' A' ' 211' ' ' GLY . 7.2 tp -133.18 -138.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.401 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.451 ' H ' HG13 ' A' ' 210' ' ' ILE . . . 145.43 134.6 2.73 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 126.165 1.84 . . . . 0.0 111.714 -169.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.419 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 41.4 t -63.18 126.38 27.21 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.75 -4.29 3.0 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.376 1.47 . . . . 0.0 113.545 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -71.72 118.85 70.32 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.458 1.103 . . . . 0.0 109.071 169.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.36 3.76 6.02 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.362 2.708 . . . . 0.0 113.283 176.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -115.04 6.11 15.14 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.912 1.685 . . . . 0.0 110.495 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 50.8 t -58.18 128.37 36.78 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 123.174 0.59 . . . . 0.0 109.905 171.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.9 t -74.14 1.74 10.52 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.7 1.6 . . . . 0.0 113.442 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.5 mm -134.33 -35.08 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.848 1.659 . . . . 0.0 110.126 -170.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.92 -38.34 0.4 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.117 2.567 . . . . 0.0 115.201 169.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.451 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.0 OUTLIER -135.8 148.91 48.92 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.936 1.694 . . . . 0.0 109.168 -174.605 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -149.15 148.13 29.28 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -72.15 150.89 43.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.264 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -59.03 -4.6 0.51 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.884 1.674 . . . . 0.0 113.027 166.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.86 -3.69 8.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.237 1.415 . . . . 0.0 112.647 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 18.8 m -72.92 -6.2 43.59 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.107 0.867 . . . . 0.0 111.645 167.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.22 -4.76 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 126.179 1.792 . . . . 0.0 111.709 172.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.69 32.57 74.56 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.753 1.168 . . . . 0.0 113.117 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 C--N 1.344 0.342 0 C-N-CA 124.375 1.07 . . . . 0.0 112.048 -175.011 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.1 t90 . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.419 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 93.3 m-85 -140.49 140.89 35.39 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.826 0.851 . . . . 0.0 109.506 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 242' ' ' CYS . 6.0 p -70.16 167.36 25.91 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.118 0.967 . . . . 0.0 112.174 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -69.59 9.32 0.58 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 123.463 2.776 . . . . 0.0 114.42 -176.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -133.41 27.03 4.11 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.188 1.795 . . . . 0.0 111.504 176.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 239' ' ' CYS . 3.7 t . . . . . 0 CA--C 1.536 0.425 0 C-N-CA 126.11 1.764 . . . . 0.0 110.768 -173.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.7 p . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -156.41 -37.92 0.08 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 115.935 -1.983 . . . . 0.0 115.759 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.512 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.9 OUTLIER -53.82 174.11 0.05 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 122.352 2.342 . . . . 0.0 111.97 169.948 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.3 mt -62.52 -7.46 4.66 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.869 1.668 . . . . 0.0 111.278 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 67.0 m -96.62 -12.54 23.8 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.943 1.697 . . . . 0.0 112.68 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.8 p80 45.16 49.27 9.83 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.262 2.225 . . . . 0.0 112.371 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -163.92 148.29 10.24 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.352 1.461 . . . . 0.0 107.825 175.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -134.66 174.48 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 127.274 2.23 . . . . 0.0 110.796 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.547 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.0 t 63.64 62.04 0.96 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.653 1.981 . . . . 0.0 112.727 -174.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.88 108.74 1.16 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.546 1.938 . . . . 0.0 108.716 -173.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 60.48 -160.14 24.17 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-O 123.296 1.498 . . . . 0.0 113.172 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.8 pm0 -65.6 147.24 53.72 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.337 2.255 . . . . 0.0 111.63 170.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.6 mtm -150.57 158.83 44.6 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.186 1.794 . . . . 0.0 110.218 -168.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 9.2 tp -139.35 -133.87 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.247 1.019 . . . . 0.0 109.219 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 147.29 136.01 2.75 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 126.456 1.979 . . . . 0.0 113.14 -169.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.516 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 7.1 t -64.59 124.98 23.27 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 114.642 -0.779 . . . . 0.0 109.124 177.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.45 1.59 0.52 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.631 1.173 . . . . 0.0 113.105 170.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -63.73 111.65 5.69 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 127.622 2.369 . . . . 0.0 107.951 167.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -78.7 11.46 2.49 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.455 2.77 . . . . 0.0 112.916 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -128.95 9.08 5.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.087 1.755 . . . . 0.0 109.798 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 20.8 t -56.65 123.21 14.1 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-O 121.542 0.687 . . . . 0.0 112.131 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 39.7 m -74.5 0.35 15.03 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.537 1.935 . . . . 0.0 113.321 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 14.5 mt -129.14 -34.76 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.436 1.894 . . . . 0.0 109.425 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.75 -25.63 0.15 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.144 2.578 . . . . 0.0 115.77 169.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.52 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.6 OUTLIER -142.45 148.59 38.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.957 1.703 . . . . 0.0 109.041 -177.503 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -147.03 156.61 43.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.095 0.958 . . . . 0.0 108.511 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -82.74 143.58 30.78 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.43 0.633 . . . . 0.0 110.203 -175.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.17 -4.36 0.51 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.675 1.99 . . . . 0.0 114.056 170.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.1 -8.92 7.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.364 1.466 . . . . 0.0 112.215 173.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.5 m -76.68 -2.57 33.53 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.102 0.865 . . . . 0.0 112.81 168.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.2 p -131.43 -1.62 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 126.675 1.99 . . . . 0.0 110.931 170.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 62.45 34.12 88.43 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.112 1.339 . . . . 0.0 113.003 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.5 mt . . . . . 0 C--N 1.343 0.309 0 CA-C-N 117.859 0.829 . . . . 0.0 111.524 -174.018 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 86.7 t90 . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.516 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 88.7 m-85 -135.92 136.65 40.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.942 0.897 . . . . 0.0 110.592 -176.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 30.6 p -69.8 164.53 50.35 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 124.259 1.023 . . . . 0.0 112.163 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.28 28.85 0.26 Allowed 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 124.352 3.368 . . . . 0.0 113.817 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -132.15 -30.22 1.56 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.722 2.009 . . . . 0.0 110.079 174.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.443 -0.794 0 C-N-CA 127.301 2.24 . . . . 0.0 112.312 169.88 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.8 p . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -155.34 -44.47 0.08 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.504 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -38.86 169.84 0.0 OUTLIER 'General case' 0 C--N 1.349 0.578 0 C-N-CA 126.299 1.839 . . . . 0.0 114.257 168.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.6 mt -71.05 -6.34 38.28 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 113.417 -1.72 . . . . 0.0 110.129 168.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.504 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 86.9 m -96.69 -14.2 22.24 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 123.617 0.767 . . . . 0.0 111.819 174.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.9 p80 45.87 52.7 9.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.21 2.204 . . . . 0.0 112.779 -173.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.42 140.39 2.27 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 125.818 1.647 . . . . 0.0 107.958 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 205' ' ' SER . 1.4 t -129.34 171.02 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.368 1.467 . . . . 0.0 111.069 -176.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.511 ' H ' HG12 ' A' ' 204' ' ' VAL . 7.8 t 67.04 64.75 0.44 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.033 2.133 . . . . 0.0 113.048 -174.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.15 113.63 1.21 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.468 1.907 . . . . 0.0 108.48 -175.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.36 -162.68 23.8 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 123.181 1.434 . . . . 0.0 112.769 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.456 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.7 pm0 -67.61 145.05 55.23 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 112.223 -1.988 . . . . 0.0 110.829 169.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.4 mtm -146.45 152.89 39.75 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.166 1.787 . . . . 0.0 109.858 -168.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 9.7 tp -138.98 -137.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.36 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 -174.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 152.92 133.01 1.83 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 125.938 1.732 . . . . 0.0 112.375 -169.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 43.9 t -63.08 124.39 21.03 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.081 -1.059 . . . . 0.0 108.395 175.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.63 4.87 1.22 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.353 1.461 . . . . 0.0 113.426 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -74.95 114.59 36.35 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 167.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.31 9.07 2.97 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.384 2.722 . . . . 0.0 113.009 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -123.89 8.76 8.74 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.798 1.639 . . . . 0.0 110.34 175.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.79 130.88 48.69 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 118.293 0.497 . . . . 0.0 109.951 172.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.5 t -73.48 3.86 5.55 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.794 1.638 . . . . 0.0 113.578 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 30.7 mt -132.96 -34.61 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 126.274 1.829 . . . . 0.0 110.035 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.79 -39.54 0.45 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.624 2.369 . . . . 0.0 115.415 170.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.473 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -130.7 148.6 52.5 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.923 2.089 . . . . 0.0 108.371 -174.283 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -148.63 145.9 27.97 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -175.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -71.64 149.78 45.25 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.634 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.38 -6.04 1.39 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.742 1.217 . . . . 0.0 113.389 168.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -121.66 0.1 9.79 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.454 1.102 . . . . 0.0 112.588 170.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.1 m -72.1 -6.77 44.87 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.946 0.794 . . . . 0.0 111.252 166.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.12 -12.67 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 126.376 1.87 . . . . 0.0 112.627 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.22 36.61 34.44 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.422 1.011 . . . . 0.0 113.113 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 17.0 mt . . . . . 0 CA--C 1.535 0.376 0 C-N-CA 124.309 1.044 . . . . 0.0 109.838 174.003 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 87.4 t90 . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 121.196 0.522 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -140.08 140.01 36.01 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.204 1.001 . . . . 0.0 109.093 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 16.6 p -68.94 164.69 44.84 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 123.614 0.765 . . . . 0.0 112.187 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.47 35.3 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.291 3.327 . . . . 0.0 113.071 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -139.55 -28.65 0.76 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.622 1.569 . . . . 0.0 111.032 169.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.441 -0.885 0 C-N-CA 127.521 2.328 . . . . 0.0 112.18 178.149 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -155.55 -41.53 0.08 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -166.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.514 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.7 p -38.56 170.15 0.0 OUTLIER 'General case' 0 C--N 1.347 0.49 0 C-N-CA 126.392 1.877 . . . . 0.0 113.973 168.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.1 mt -70.68 -6.17 35.17 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.149 168.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.514 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 93.4 m -96.38 -14.14 22.7 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 123.659 0.784 . . . . 0.0 111.705 174.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.2 p80 46.38 50.92 12.06 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.903 2.081 . . . . 0.0 112.388 -174.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -168.26 141.63 3.16 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 125.068 1.347 . . . . 0.0 108.035 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -124.84 -177.39 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.618 1.567 . . . . 0.0 110.293 177.124 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.475 ' H ' HG12 ' A' ' 204' ' ' VAL . 10.6 t 62.16 57.59 1.99 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.294 2.238 . . . . 0.0 114.449 -169.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' TYR . . . . . 0.433 ' H ' ' CE ' ' A' ' 209' ' ' MET . 0.1 OUTLIER -164.04 113.85 1.24 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.574 1.95 . . . . 0.0 109.834 -177.008 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 66.09 -174.23 21.72 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 122.888 1.271 . . . . 0.0 114.099 176.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -62.05 151.3 35.78 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.474 1.91 . . . . 0.0 111.846 169.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.433 ' CE ' ' H ' ' A' ' 206' ' ' TYR . 26.0 mtt -145.14 160.6 41.18 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.625 1.17 . . . . 0.0 112.724 -166.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . 0.265 9.6 tp -138.33 -139.21 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 145.73 135.22 2.78 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 126.486 1.993 . . . . 0.0 111.787 -168.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 6.6 t -65.1 123.18 18.83 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 124.447 0.734 . . . . 0.0 109.208 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.68 1.99 0.52 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.851 1.26 . . . . 0.0 113.11 171.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -62.59 112.43 6.57 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.903 2.481 . . . . 0.0 107.658 166.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -78.28 12.17 2.15 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.363 2.709 . . . . 0.0 112.953 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -129.8 9.49 5.42 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.081 1.752 . . . . 0.0 109.811 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 15.4 t -57.88 117.89 4.76 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-O 121.647 0.737 . . . . 0.0 111.669 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.7 t -74.49 -2.37 25.34 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.571 1.948 . . . . 0.0 112.571 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.0 mm -117.6 -37.03 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.041 1.736 . . . . 0.0 109.05 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.51 -30.26 0.21 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.25 2.62 . . . . 0.0 115.462 168.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.474 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.0 OUTLIER -144.46 150.15 37.16 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.19 1.796 . . . . 0.0 109.03 -174.576 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -148.12 148.17 30.32 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -71.57 150.41 44.75 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.413 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -60.16 -4.61 0.84 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.904 1.281 . . . . 0.0 113.595 168.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -120.87 -2.5 9.77 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.765 1.226 . . . . 0.0 112.485 170.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 21.2 m -73.36 -5.05 37.2 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.863 0.756 . . . . 0.0 111.606 167.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.5 p -138.91 -9.4 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 126.986 2.114 . . . . 0.0 112.187 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.0 37.13 60.49 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.409 1.004 . . . . 0.0 112.941 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 24.6 mt . . . . . 0 N--CA 1.467 0.396 0 CA-C-N 117.819 0.81 . . . . 0.0 109.909 175.287 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 78.9 t90 . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 238' ' ' PHE . . . . . 0.522 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 75.1 m-85 -133.03 135.81 45.62 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.926 0.89 . . . . 0.0 110.298 -176.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 30.8 p -65.6 163.08 37.23 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 123.821 0.848 . . . . 0.0 111.599 170.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.28 28.85 0.26 Allowed 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 124.31 3.34 . . . . 0.0 113.529 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -134.17 -34.85 0.95 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.694 1.998 . . . . 0.0 109.377 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.447 -0.616 0 C-N-CA 126.602 1.961 . . . . 0.0 112.104 169.349 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 55.3 p . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -155.45 -38.5 0.09 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 115.739 -2.077 . . . . 0.0 115.92 -168.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.523 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.8 OUTLIER -53.48 174.29 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 122.551 2.432 . . . . 0.0 112.169 170.554 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.0 mt -62.47 -6.74 3.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.607 1.563 . . . . 0.0 111.212 171.421 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 89.1 m -98.22 -12.53 21.56 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 126.186 1.794 . . . . 0.0 112.71 179.29 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.8 p80 44.97 48.29 9.39 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.219 2.208 . . . . 0.0 112.368 -173.795 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -162.94 147.16 11.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.461 1.504 . . . . 0.0 108.047 176.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.497 HG12 ' H ' ' A' ' 205' ' ' SER . 0.6 OUTLIER -132.62 175.44 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 127.157 2.183 . . . . 0.0 110.109 178.682 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.497 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.6 t 59.82 65.91 1.06 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.347 1.859 . . . . 0.0 112.824 -174.886 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.62 102.89 1.36 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.344 1.858 . . . . 0.0 109.163 -173.561 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 68.45 -98.4 0.52 Allowed Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.386 1.47 . . . . 0.0 110.392 -172.276 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.26 170.67 15.55 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.401 1.88 . . . . 0.0 111.731 -174.036 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -143.97 160.19 41.26 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.903 1.281 . . . . 0.0 111.364 -169.383 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.421 HG13 ' H ' ' A' ' 211' ' ' GLY . 4.6 tp -133.42 -135.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.372 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 169.439 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 148.19 133.7 2.35 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 125.434 1.493 . . . . 0.0 112.478 -172.297 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 53.6 t -64.89 119.32 10.46 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.366 -0.917 . . . . 0.0 109.055 174.667 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -70.01 5.28 1.66 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.695 1.598 . . . . 0.0 113.874 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -68.8 119.78 71.58 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 168.518 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.95 5.88 4.16 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.317 2.678 . . . . 0.0 113.312 178.445 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.86 6.06 12.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.657 1.583 . . . . 0.0 110.608 174.216 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 42.5 t -60.53 129.06 39.7 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 123.584 0.753 . . . . 0.0 110.442 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.2 m -79.91 4.47 16.66 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.496 1.518 . . . . 0.0 113.333 -176.746 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.6 mm -135.1 -36.27 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.787 1.635 . . . . 0.0 110.348 -169.598 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.45 -41.65 0.51 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.84 2.856 . . . . 0.0 115.201 170.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.523 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -129.08 148.09 50.99 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.738 1.615 . . . . 0.0 109.276 -176.057 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -149.38 157.54 43.4 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 124.94 1.296 . . . . 0.0 108.84 -175.193 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -88.24 144.11 26.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.304 0.573 . . . . 0.0 111.098 -171.243 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -57.43 -7.2 0.56 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.292 2.237 . . . . 0.0 114.265 170.078 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.22 -8.29 8.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.029 1.332 . . . . 0.0 112.207 174.228 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 10.0 m -77.11 -2.51 34.63 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.07 0.85 . . . . 0.0 112.87 168.476 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 12.9 p -131.72 -2.03 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 126.435 1.894 . . . . 0.0 111.116 170.073 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.2 34.38 89.77 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.938 1.256 . . . . 0.0 112.894 -177.678 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.2 mt . . . . . 0 C--N 1.342 0.266 0 C-N-CA 124.183 0.993 . . . . 0.0 111.919 -174.299 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.5 t90 . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -140.67 141.78 34.99 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.275 1.03 . . . . 0.0 110.348 178.863 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.7 p -70.37 165.61 42.9 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.082 0.953 . . . . 0.0 111.731 174.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.47 29.32 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.994 3.13 . . . . 0.0 113.569 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -135.58 -33.8 0.86 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.664 1.586 . . . . 0.0 110.091 174.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.44 -0.959 0 C-N-CA 126.554 1.941 . . . . 0.0 111.99 170.381 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 57.6 p . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -156.33 -39.95 0.08 Allowed 'General case' 0 C--N 1.353 0.735 0 CA-C-O 115.621 -2.133 . . . . 0.0 115.207 -169.765 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.5 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.7 OUTLIER -51.53 175.47 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 122.01 2.186 . . . . 0.0 112.953 176.538 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.9 -5.11 3.92 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.082 -1.417 . . . . 0.0 111.21 170.742 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 88.6 m -99.32 -15.95 18.63 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 125.976 1.711 . . . . 0.0 112.548 176.549 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 51.12 46.82 25.9 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.723 2.009 . . . . 0.0 111.628 -177.142 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -164.51 147.27 8.85 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.764 1.626 . . . . 0.0 107.621 179.112 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.472 HG12 ' H ' ' A' ' 205' ' ' SER . 0.5 OUTLIER -132.35 -178.14 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 127.355 2.262 . . . . 0.0 109.553 175.654 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.472 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.2 t 60.16 58.32 2.69 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.93 1.692 . . . . 0.0 113.08 -172.833 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.89 114.48 2.58 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.944 2.098 . . . . 0.0 109.122 -175.202 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.86 -109.34 2.48 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 125.571 1.558 . . . . 0.0 110.827 -175.661 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.78 169.11 18.36 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.627 1.971 . . . . 0.0 111.546 -173.618 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -141.69 161.26 38.38 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.146 0.978 . . . . 0.0 112.627 -167.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.428 HG13 ' H ' ' A' ' 211' ' ' GLY . 7.5 tp -135.78 -135.32 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 168.341 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 145.61 130.47 2.2 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 125.559 1.552 . . . . 0.0 112.096 -170.866 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 41.0 t -63.82 122.66 16.97 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.239 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.78 -2.12 2.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.692 1.597 . . . . 0.0 113.506 -179.216 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -69.25 116.25 40.39 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.277 1.031 . . . . 0.0 108.518 168.785 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -78.08 8.58 3.44 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.036 2.491 . . . . 0.0 112.916 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -121.37 6.4 10.15 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.727 1.611 . . . . 0.0 110.145 174.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.9 t -60.98 129.95 43.96 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 118.683 0.674 . . . . 0.0 109.589 171.124 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.3 t -74.94 6.31 4.22 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.708 1.603 . . . . 0.0 113.188 -176.275 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.3 mm -134.45 -36.81 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 126.134 1.774 . . . . 0.0 109.776 -171.639 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . 0.251 0.0 OUTLIER 71.06 -43.88 0.57 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.355 2.662 . . . . 0.0 115.497 169.737 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.5 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -125.33 148.77 48.6 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.469 1.908 . . . . 0.0 108.511 -178.383 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.43 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 72.9 m-85 -147.89 154.51 40.48 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.147 0.979 . . . . 0.0 108.804 -175.474 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -84.58 144.08 28.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.447 0.641 . . . . 0.0 110.499 -175.118 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -57.0 -7.12 0.43 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.363 2.265 . . . . 0.0 114.413 169.688 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.58 -8.02 8.55 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.877 1.271 . . . . 0.0 112.184 173.807 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 14.4 m -77.61 -2.26 34.95 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.088 0.858 . . . . 0.0 113.051 168.716 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.5 p -129.53 -4.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 126.447 1.899 . . . . 0.0 111.039 169.369 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.29 35.4 91.48 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.938 1.256 . . . . 0.0 112.82 -175.5 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.4 mt . . . . . 0 C--N 1.343 0.287 0 C-N-CA 123.863 0.865 . . . . 0.0 111.326 -176.385 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 87.2 t90 . . . . . 0 CA--C 1.54 0.565 0 CA-C-O 121.319 0.581 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -139.29 139.1 37.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.312 1.445 . . . . 0.0 108.375 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 13.4 p -68.2 165.87 29.7 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 123.143 0.577 . . . . 0.0 111.9 172.573 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.26 31.6 0.31 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.327 3.351 . . . . 0.0 113.389 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -136.36 -37.81 0.69 Allowed 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.494 1.517 . . . . 0.0 109.816 169.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.441 -0.91 0 C-N-CA 126.565 1.946 . . . . 0.0 112.721 173.761 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -156.17 -45.61 0.08 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -168.459 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.482 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 2.0 p -40.25 170.28 0.0 OUTLIER 'General case' 0 C--N 1.349 0.586 0 C-N-CA 126.091 1.757 . . . . 0.0 114.252 169.136 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -71.3 -6.14 37.63 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.137 168.327 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.482 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 95.1 m -97.03 -13.36 22.32 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 123.499 0.72 . . . . 0.0 111.776 175.021 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.9 p80 46.37 53.38 9.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.862 2.065 . . . . 0.0 112.755 -174.006 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -171.0 142.12 1.79 Allowed 'General case' 0 C--N 1.347 0.474 0 C-N-CA 125.652 1.581 . . . . 0.0 108.114 177.434 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 205' ' ' SER . 1.1 t -123.79 168.92 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 125.606 1.562 . . . . 0.0 110.933 177.724 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.446 ' H ' HG12 ' A' ' 204' ' ' VAL . 10.5 t 70.81 61.06 0.19 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.144 2.178 . . . . 0.0 113.389 -176.248 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -162.72 108.95 1.2 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.986 2.115 . . . . 0.0 107.403 -176.513 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.44 -168.94 29.89 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 122.643 1.135 . . . . 0.0 110.761 -168.785 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -72.79 164.3 26.78 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.06 1.344 . . . . 0.0 111.978 169.61 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -138.54 155.46 48.36 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.693 1.597 . . . . 0.0 110.652 -169.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.0 tp -131.6 -139.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.362 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 149.11 130.76 1.91 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 125.812 1.673 . . . . 0.0 112.428 -169.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 40.6 t -62.73 123.19 17.78 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.468 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.1 0.18 1.4 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.027 1.331 . . . . 0.0 113.529 -179.332 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -70.4 115.05 30.93 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 167.87 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.56 9.14 3.02 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.304 2.669 . . . . 0.0 113.017 -179.412 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -124.02 8.29 8.65 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.988 1.715 . . . . 0.0 110.206 175.178 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.7 t -60.45 129.23 40.56 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 118.605 0.639 . . . . 0.0 109.558 170.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -73.4 3.41 6.01 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.999 1.72 . . . . 0.0 113.368 -175.472 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 26.6 mt -132.01 -34.22 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 126.37 1.868 . . . . 0.0 109.965 -175.414 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.99 -37.35 0.39 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.357 2.263 . . . . 0.0 115.76 170.341 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.478 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -132.58 148.57 52.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.864 2.065 . . . . 0.0 108.785 -174.945 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -148.02 148.52 30.79 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -177.439 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -73.02 150.15 42.65 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.895 178.448 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -60.96 -4.27 0.98 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.369 1.467 . . . . 0.0 113.417 167.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.2 -1.63 9.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.771 1.228 . . . . 0.0 112.558 170.431 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.4 m -72.43 -7.48 50.04 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.96 0.8 . . . . 0.0 111.296 167.031 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 2.8 p -134.38 -13.98 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 127.283 2.233 . . . . 0.0 112.016 179.197 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.86 37.46 44.36 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.592 1.091 . . . . 0.0 112.934 -176.154 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 20.6 mt . . . . . 0 N--CA 1.467 0.413 0 C-N-CA 123.732 0.813 . . . . 0.0 110.235 176.172 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 88.3 t90 . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.282 0.563 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.01 142.13 34.28 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.337 1.055 . . . . 0.0 109.199 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 2.4 p -63.03 165.37 10.45 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 123.72 0.808 . . . . 0.0 112.026 175.582 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.95 23.96 0.34 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.543 2.828 . . . . 0.0 113.643 -173.568 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -134.54 -33.07 0.99 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 125.687 1.595 . . . . 0.0 110.472 174.376 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.443 -0.782 0 C-N-CA 126.72 2.008 . . . . 0.0 111.533 169.315 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -154.72 -47.43 0.09 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -173.613 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.505 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -38.29 169.62 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 0 C-N-CA 126.401 1.881 . . . . 0.0 114.444 168.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.72 -6.69 39.23 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.198 168.366 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.505 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 89.7 m -96.08 -14.51 22.84 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 123.602 0.761 . . . . 0.0 111.71 174.456 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.2 p80 45.73 52.85 9.24 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.211 2.204 . . . . 0.0 112.759 -173.382 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.17 140.88 2.47 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 125.866 1.666 . . . . 0.0 107.889 179.178 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.519 HG12 ' H ' ' A' ' 205' ' ' SER . 1.4 t -129.2 172.72 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.336 1.454 . . . . 0.0 111.051 -176.827 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.519 ' H ' HG12 ' A' ' 204' ' ' VAL . 13.0 t 66.16 60.73 0.63 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.769 2.027 . . . . 0.0 113.208 -174.906 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.02 112.52 1.83 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.566 1.946 . . . . 0.0 108.318 -175.218 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.85 -163.45 24.42 Favored Glycine 0 C--N 1.34 0.759 0 CA-C-O 123.314 1.508 . . . . 0.0 112.931 -176.503 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.515 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.6 pm0 -67.88 146.13 53.94 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.028 2.131 . . . . 0.0 111.074 169.704 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.0 mtm -146.85 155.58 42.44 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.198 1.799 . . . . 0.0 110.461 -167.078 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 211' ' ' GLY . 8.2 tp -138.89 -138.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.41 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -175.764 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 152.22 133.93 2.02 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 126.239 1.876 . . . . 0.0 112.46 -169.61 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.25 123.59 20.36 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 114.179 -1.011 . . . . 0.0 109.398 177.909 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.19 0.14 2.18 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.314 1.846 . . . . 0.0 114.86 178.716 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -68.44 118.91 64.35 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.57 1.148 . . . . 0.0 108.592 169.627 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.26 7.27 3.43 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.413 2.742 . . . . 0.0 113.242 178.185 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -123.04 9.84 9.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.044 1.738 . . . . 0.0 110.358 174.445 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 42.6 t -58.65 128.87 39.34 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 123.494 0.718 . . . . 0.0 110.607 173.921 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.6 t -78.19 1.44 21.41 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.668 1.587 . . . . 0.0 113.072 -177.369 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.4 mm -132.7 -36.2 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 125.484 1.513 . . . . 0.0 110.375 -169.432 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.9 -39.16 0.42 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.415 2.686 . . . . 0.0 115.63 170.526 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.475 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.0 OUTLIER -134.16 149.07 51.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.176 1.791 . . . . 0.0 108.803 -174.569 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -149.34 147.01 27.82 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -176.199 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -73.11 150.49 42.2 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.771 0.796 . . . . 0.0 111.189 178.711 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -60.52 -4.02 0.81 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.374 1.47 . . . . 0.0 113.304 168.014 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.12 -2.03 8.18 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.074 1.35 . . . . 0.0 112.556 171.201 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.2 m -71.34 -8.11 51.57 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.043 0.838 . . . . 0.0 111.394 167.021 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.7 p -136.02 -4.1 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.084 1.753 . . . . 0.0 111.863 174.597 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 69.3 30.24 71.61 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.848 1.213 . . . . 0.0 112.909 -175.758 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 C--N 1.343 0.291 0 C-N-CA 124.662 1.185 . . . . 0.0 112.043 -172.264 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 82.2 t90 . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -139.59 136.4 34.35 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.638 0.775 . . . . 0.0 110.03 -177.225 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 10.8 p -66.95 164.07 38.31 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.125 0.97 . . . . 0.0 111.871 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -72.49 22.69 0.28 Allowed 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 123.94 3.094 . . . . 0.0 114.054 -177.492 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 -134.21 6.19 3.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.441 1.497 . . . . 0.0 112.027 172.097 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.438 -1.029 0 C-N-CA 128.128 2.571 . . . . 0.0 110.01 -175.487 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 73.8 p . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -155.12 -44.7 0.08 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -175.457 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.505 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -39.23 170.2 0.0 OUTLIER 'General case' 0 C--N 1.35 0.615 0 C-N-CA 126.273 1.829 . . . . 0.0 114.216 168.667 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.89 -6.62 39.7 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 113.425 -1.716 . . . . 0.0 110.115 168.172 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.505 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 85.3 m -96.79 -14.22 22.09 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 123.7 0.8 . . . . 0.0 111.725 174.818 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.9 p80 45.73 53.18 8.95 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.138 2.175 . . . . 0.0 112.811 -173.417 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.74 140.77 2.18 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 125.858 1.663 . . . . 0.0 107.911 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 205' ' ' SER . 1.5 t -128.93 170.04 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.364 1.465 . . . . 0.0 111.105 -175.964 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.508 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.1 t 65.89 66.1 0.51 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.083 2.153 . . . . 0.0 113.09 -174.609 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.24 111.3 1.08 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.566 1.946 . . . . 0.0 108.336 -175.496 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.47 -163.45 22.6 Favored Glycine 0 C--N 1.34 0.778 0 CA-C-O 123.254 1.474 . . . . 0.0 112.592 -174.916 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.7 pm0 -65.71 149.06 50.74 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 112.237 -1.981 . . . . 0.0 111.193 169.436 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.0 mtm -147.41 156.9 43.31 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.138 1.775 . . . . 0.0 110.067 -167.941 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.446 HG13 ' H ' ' A' ' 211' ' ' GLY . 4.9 tp -141.01 -138.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.369 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.447 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 151.49 132.88 1.94 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 126.11 1.814 . . . . 0.0 112.629 -169.783 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 46.6 t -64.35 125.64 25.26 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.064 0.946 . . . . 0.0 108.814 177.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.08 -2.74 2.16 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.533 1.533 . . . . 0.0 114.068 178.699 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -70.44 116.08 41.47 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 124.136 0.975 . . . . 0.0 108.387 169.216 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -76.99 4.4 5.79 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.315 2.677 . . . . 0.0 113.103 179.315 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -117.49 7.09 12.63 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.896 1.678 . . . . 0.0 110.36 174.544 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.7 t -58.42 127.82 34.04 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 123.113 0.565 . . . . 0.0 110.005 170.459 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.8 t -74.5 2.48 9.52 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.796 1.639 . . . . 0.0 113.207 -176.113 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 30.2 mt -132.19 -33.78 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.069 1.748 . . . . 0.0 110.247 -173.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.69 -37.64 0.4 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.006 2.522 . . . . 0.0 115.305 170.313 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 221' ' ' TRP . . . . . 0.478 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -133.06 148.96 52.2 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 126.777 2.031 . . . . 0.0 108.677 -174.032 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -148.44 146.62 28.5 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -176.272 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -70.63 150.61 45.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.942 0.877 . . . . 0.0 110.884 178.183 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -60.63 -5.06 1.09 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.073 1.349 . . . . 0.0 113.727 168.3 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.47 -0.84 9.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.656 1.182 . . . . 0.0 112.372 170.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.8 m -71.69 -7.19 46.46 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.892 0.769 . . . . 0.0 111.531 167.294 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 p -137.39 -11.51 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.809 1.244 . . . . 0.0 113.269 173.037 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 80.39 41.28 11.74 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.514 1.054 . . . . 0.0 113.54 -175.635 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 24.0 mt . . . . . 0 N--CA 1.472 0.637 0 CA-C-N 118.295 1.047 . . . . 0.0 111.439 171.476 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 88.9 t90 . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 121.211 0.529 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -141.06 139.78 34.13 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.184 0.994 . . . . 0.0 109.2 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.5 p -66.69 165.11 27.38 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.674 0.789 . . . . 0.0 111.957 177.721 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.5 31.93 0.28 Allowed 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.908 3.072 . . . . 0.0 113.413 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -135.97 -38.09 0.72 Allowed 'General case' 0 C--N 1.345 0.373 0 C-N-CA 125.584 1.554 . . . . 0.0 109.689 171.897 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 26.6 m . . . . . 0 N--CA 1.441 -0.899 0 C-N-CA 126.585 1.954 . . . . 0.0 111.888 171.811 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -154.8 -43.62 0.09 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.71 1.204 . . . . 0.0 110.536 -174.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 64.8 mtt 33.4 62.38 1.62 Allowed Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 128.155 2.582 . . . . 0.0 114.413 169.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -67.49 160.59 47.21 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.369 2.712 . . . . 0.0 112.159 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.9 p -138.2 0.68 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.268 1.427 . . . . 0.0 111.539 -175.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -51.73 -44.56 90.8 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.987 1.715 . . . . 0.0 113.303 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.46 111.48 3.32 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 121.89 1.727 . . . . 0.0 109.302 169.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -73.29 -7.21 50.57 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.03 0.932 . . . . 0.0 112.601 173.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -145.6 72.51 14.04 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.571 1.548 . . . . 0.0 108.366 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.21 159.12 37.21 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.609 2.872 . . . . 0.0 111.107 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 64.14 147.0 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.327 2.251 . . . . 0.0 112.272 -171.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -154.74 -43.95 0.09 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -166.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.499 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -38.05 169.66 0.0 OUTLIER 'General case' 0 C--N 1.348 0.54 0 C-N-CA 126.385 1.874 . . . . 0.0 114.414 169.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.0 mt -70.69 -6.16 35.14 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 113.399 -1.728 . . . . 0.0 110.12 168.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.499 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 93.8 m -96.15 -14.22 22.96 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 123.423 0.689 . . . . 0.0 111.738 173.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.6 p80 46.08 52.16 10.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.912 2.085 . . . . 0.0 112.406 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -169.01 141.47 2.66 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.482 1.513 . . . . 0.0 108.018 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -124.44 174.87 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.475 1.51 . . . . 0.0 110.51 176.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.503 ' H ' HG12 ' A' ' 204' ' ' VAL . 7.1 t 66.69 60.89 0.55 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.701 2.0 . . . . 0.0 113.429 -173.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.51 120.11 1.77 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.98 2.112 . . . . 0.0 107.881 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.44 -151.2 43.5 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 122.613 1.118 . . . . 0.0 111.49 -172.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.58 169.26 10.47 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.388 1.875 . . . . 0.0 111.255 170.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -136.89 162.26 33.73 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.913 1.285 . . . . 0.0 111.677 -169.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 11.2 tt -138.0 -139.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 169.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 147.47 132.22 2.23 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 125.79 1.662 . . . . 0.0 111.57 -169.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 41.4 t -64.25 123.9 20.32 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.81 -0.48 3.03 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.365 1.466 . . . . 0.0 113.686 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -70.25 117.31 53.35 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.67 4.16 5.84 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.301 2.667 . . . . 0.0 113.168 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -117.37 7.63 12.87 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.85 1.66 . . . . 0.0 110.456 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.1 t -58.33 127.23 31.08 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 123.192 0.597 . . . . 0.0 109.736 170.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 70.5 m -77.01 5.95 7.17 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.538 1.535 . . . . 0.0 113.304 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.9 mm -132.58 -35.53 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 126.082 1.753 . . . . 0.0 109.95 -173.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.44 -42.9 0.55 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.512 2.725 . . . . 0.0 115.333 169.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.443 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -129.42 149.71 51.09 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.4 1.88 . . . . 0.0 108.431 -175.564 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -149.42 149.31 30.62 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -73.4 149.63 42.35 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.62 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.95 -3.59 0.81 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.985 1.714 . . . . 0.0 112.394 168.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.45 -3.74 8.35 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.674 1.59 . . . . 0.0 112.462 172.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.9 m -71.62 -7.47 48.0 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.06 0.845 . . . . 0.0 111.281 166.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -134.71 -4.63 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 126.853 2.061 . . . . 0.0 111.591 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.97 31.11 74.7 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.904 1.24 . . . . 0.0 113.272 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 4.6 mt -62.48 -52.95 61.48 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.338 1.055 . . . . 0.0 112.584 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.5 m 63.87 -17.42 0.07 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.699 2.0 . . . . 0.0 114.411 -173.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 82.8 p -143.64 164.74 29.56 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.268 1.827 . . . . 0.0 110.327 -175.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -70.18 123.13 88.26 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.029 173.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.62 -55.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.567 2.178 . . . . 0.0 111.594 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 4.3 ttp85 -175.31 -176.6 0.93 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.654 1.981 . . . . 0.0 109.403 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -78.32 17.73 6.08 Favored Glycine 0 CA--C 1.539 1.567 0 CA-C-O 118.821 -0.988 . . . . 0.0 113.639 169.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -159.3 120.52 3.27 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 125.401 1.48 . . . . 0.0 108.063 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 79.2 t90 -138.74 163.66 31.6 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.358 1.863 . . . . 0.0 110.777 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -141.68 140.45 33.2 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.076 1.35 . . . . 0.0 109.283 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.0 p -66.67 165.32 25.84 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 123.467 0.707 . . . . 0.0 112.198 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.06 35.23 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.97 3.113 . . . . 0.0 113.08 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -137.95 -38.37 0.57 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.445 1.498 . . . . 0.0 109.764 169.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 28.7 m -70.81 -35.57 72.58 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.756 2.022 . . . . 0.0 111.805 171.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 t -77.35 -27.43 52.66 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.175 1.39 . . . . 0.0 112.082 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -66.33 -24.77 66.58 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.015 0.926 . . . . 0.0 112.431 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.26 -19.55 64.73 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.831 1.252 . . . . 0.0 113.1 176.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.63 72.3 1.39 Allowed 'General case' 0 C--N 1.347 0.476 0 C-N-CA 125.401 1.48 . . . . 0.0 109.655 177.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -82.67 91.7 7.03 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.986 1.314 . . . . 0.0 108.611 170.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.69 27.33 3.66 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.109 1.764 . . . . 0.0 112.18 -175.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? . . . . . 0 C--O 1.25 1.097 0 C-N-CA 130.901 3.68 . . . . 0.0 109.502 -175.898 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 55.4 40.3 31.34 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.377 1.471 . . . . 0.0 113.355 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 94.4 mtp -132.23 81.33 61.49 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.407 1.483 . . . . 0.0 109.351 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -74.55 86.49 1.34 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.034 3.156 . . . . 0.0 110.016 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 10.8 p -136.08 55.85 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.991 1.316 . . . . 0.0 110.067 -173.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -49.72 -45.27 79.18 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 116.932 -1.509 . . . . 0.0 113.878 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.16 91.26 1.04 Allowed 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.811 2.341 . . . . 0.0 110.611 172.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -150.49 57.93 0.94 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.891 1.276 . . . . 0.0 109.6 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -133.02 70.15 78.61 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.858 1.263 . . . . 0.0 109.739 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.96 105.35 1.34 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.898 3.065 . . . . 0.0 110.329 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 47.2 p -146.06 139.46 26.07 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.423 1.889 . . . . 0.0 108.121 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -155.04 -45.39 0.08 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -168.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.505 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.7 p -38.01 169.66 0.0 OUTLIER 'General case' 0 C--N 1.348 0.54 0 C-N-CA 126.429 1.892 . . . . 0.0 114.269 168.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.49 -6.3 35.07 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 113.452 -1.703 . . . . 0.0 110.199 168.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.505 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 89.5 m -97.34 -14.17 21.44 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 123.812 0.845 . . . . 0.0 111.805 174.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.5 p80 45.06 51.85 8.67 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.109 2.164 . . . . 0.0 112.842 -173.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -167.34 139.24 3.23 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 125.762 1.625 . . . . 0.0 107.94 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 205' ' ' SER . 1.3 t -129.95 172.32 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.307 1.443 . . . . 0.0 111.058 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.524 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.0 t 65.44 63.47 0.63 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.833 2.053 . . . . 0.0 112.792 -173.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.07 112.55 1.34 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.555 1.942 . . . . 0.0 108.45 -175.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.01 -161.65 24.18 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-O 123.283 1.49 . . . . 0.0 113.124 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.526 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.6 pm0 -68.26 143.79 55.12 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.155 2.182 . . . . 0.0 111.128 169.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.4 mtm -147.09 155.11 41.91 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.38 1.872 . . . . 0.0 110.289 -167.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.426 HG13 ' H ' ' A' ' 211' ' ' GLY . 9.2 tp -139.02 -138.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.409 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -175.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 150.91 131.23 1.8 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 126.152 1.834 . . . . 0.0 112.301 -169.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 42.2 t -63.05 121.71 14.27 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.259 1.023 . . . . 0.0 108.559 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.85 1.4 1.89 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.384 1.474 . . . . 0.0 113.868 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -69.94 117.89 58.2 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.474 1.11 . . . . 0.0 108.072 168.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.35 6.21 4.13 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.305 2.67 . . . . 0.0 113.234 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -120.89 9.22 10.6 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.817 1.647 . . . . 0.0 110.482 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 45.1 t -59.23 128.63 38.08 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.316 0.646 . . . . 0.0 110.116 171.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 44.0 m -76.14 2.99 11.5 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.59 1.556 . . . . 0.0 113.542 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.8 mm -133.78 -35.33 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.925 1.69 . . . . 0.0 109.966 -170.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.91 -39.53 0.45 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 128.422 2.689 . . . . 0.0 115.454 169.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.478 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.0 OUTLIER -133.87 148.95 51.32 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.305 1.842 . . . . 0.0 108.74 -174.158 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -150.06 146.02 26.71 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.4 -1.334 . . . . 0.0 107.4 -175.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -72.23 151.43 42.87 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.721 0.772 . . . . 0.0 111.043 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.33 -4.31 0.82 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.352 1.461 . . . . 0.0 113.06 167.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.33 -3.6 8.93 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.305 1.442 . . . . 0.0 112.544 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 20.6 m -72.43 -6.0 40.51 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.114 0.87 . . . . 0.0 111.715 167.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 10.9 p -135.4 -4.95 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 126.29 1.836 . . . . 0.0 111.797 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.34 35.77 90.71 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.667 1.127 . . . . 0.0 112.924 -173.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.7 mt -64.82 -51.3 62.87 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 124.358 1.063 . . . . 0.0 111.493 -175.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 18.0 m 62.16 -10.42 0.08 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.132 2.173 . . . . 0.0 114.738 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 11.1 t -149.59 170.0 19.67 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.049 1.739 . . . . 0.0 110.191 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -62.9 127.15 90.24 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.838 1.255 . . . . 0.0 109.943 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.1 168.46 20.49 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.381 2.72 . . . . 0.0 112.114 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -71.03 170.73 12.21 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.159 0.983 . . . . 0.0 110.218 168.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -57.24 152.39 25.17 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.186 0.898 . . . . 0.0 113.368 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 46.6 tttp 40.3 74.84 0.09 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.375 2.27 . . . . 0.0 113.395 -172.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 84.5 t90 -76.33 159.03 30.92 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.811 0.845 . . . . 0.0 110.113 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -138.82 139.87 38.35 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.153 0.981 . . . . 0.0 109.587 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 13.9 p -65.7 163.43 35.03 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.436 0.695 . . . . 0.0 111.658 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.41 28.66 0.27 Allowed 'Trans proline' 0 CA--C 1.548 1.198 0 C-N-CA 124.013 3.142 . . . . 0.0 113.694 -178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -136.02 -32.95 0.86 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.555 1.542 . . . . 0.0 110.422 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 15.8 m -74.83 -35.29 62.42 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 126.556 1.942 . . . . 0.0 111.727 169.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 10.1 t -76.17 -12.24 60.07 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.215 1.406 . . . . 0.0 112.863 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -61.99 -25.5 67.67 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.206 1.402 . . . . 0.0 112.312 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -51.88 -29.93 21.87 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.197 1.799 . . . . 0.0 114.4 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 39.16 54.59 2.18 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.175 2.19 . . . . 0.0 113.662 170.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -76.6 71.15 3.19 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.878 1.671 . . . . 0.0 111.104 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -146.96 35.18 0.91 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.336 1.455 . . . . 0.0 110.817 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt . . . . . 0 C--O 1.251 1.167 0 CA-C-O 117.533 -1.222 . . . . 0.0 110.112 175.007 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 60.4 ttm . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -144.35 157.95 43.99 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.262 1.025 . . . . 0.0 110.695 -168.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 27.2 ttt -148.25 83.45 7.17 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.506 1.122 . . . . 0.0 108.828 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -79.9 24.04 0.65 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.614 3.543 . . . . 0.0 112.865 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 14.9 p -130.05 51.8 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.483 1.513 . . . . 0.0 110.492 -169.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.598 ' H ' ' HD2' ' A' ' 193' ' ' PRO . 27.4 m-20 -131.83 -46.5 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 116.595 -1.669 . . . . 0.0 112.764 174.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.598 ' HD2' ' H ' ' A' ' 192' ' ' ASP . 89.3 Cg_endo -77.56 93.66 1.08 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.433 2.089 . . . . 0.0 110.419 177.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -142.23 -15.82 0.76 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -172.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -77.61 121.28 84.08 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 119.61 1.095 . . . . 0.0 109.933 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -82.41 165.0 16.6 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.308 2.672 . . . . 0.0 111.614 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.3 p -143.13 144.55 32.26 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.647 1.579 . . . . 0.0 108.865 -174.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -155.15 -46.53 0.08 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.506 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -37.46 169.54 0.0 OUTLIER 'General case' 0 C--N 1.351 0.637 0 C-N-CA 126.665 1.986 . . . . 0.0 114.593 169.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.4 -6.23 34.06 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 113.311 -1.768 . . . . 0.0 110.08 168.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.506 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 86.6 m -97.46 -14.41 21.17 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 123.841 0.856 . . . . 0.0 111.776 174.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.2 p80 45.67 52.16 9.62 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.236 2.214 . . . . 0.0 112.807 -173.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -169.5 140.53 2.26 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.678 1.591 . . . . 0.0 107.906 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 205' ' ' SER . 1.5 t -127.07 173.37 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.219 1.407 . . . . 0.0 111.168 -175.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.537 ' H ' HG12 ' A' ' 204' ' ' VAL . 13.2 t 66.33 61.68 0.58 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.983 2.113 . . . . 0.0 113.537 -175.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -161.98 114.1 1.72 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.39 1.876 . . . . 0.0 108.548 -175.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 62.12 -164.03 24.4 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-O 123.084 1.38 . . . . 0.0 112.702 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.9 pm0 -66.14 147.18 53.72 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 112.405 -1.898 . . . . 0.0 110.92 169.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 75.7 mtm -146.33 154.26 41.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.939 1.696 . . . . 0.0 110.045 -168.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.6 tp -138.56 -139.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.357 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 149.8 131.0 1.87 Allowed Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 126.203 1.859 . . . . 0.0 112.289 -169.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.83 123.53 18.7 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.295 1.038 . . . . 0.0 108.557 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.05 -2.16 2.58 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.153 1.381 . . . . 0.0 113.467 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -69.64 117.38 52.63 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 168.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.5 4.93 5.09 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.131 2.554 . . . . 0.0 113.166 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -118.58 8.24 11.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.954 1.702 . . . . 0.0 110.416 174.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 50.0 t -58.25 127.6 32.95 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.181 0.593 . . . . 0.0 109.897 170.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.7 t -74.69 2.87 8.93 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.576 1.55 . . . . 0.0 113.444 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.6 mm -132.96 -34.96 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 126.072 1.749 . . . . 0.0 109.931 -171.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.34 -39.31 0.44 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.186 2.595 . . . . 0.0 115.52 169.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.472 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.0 OUTLIER -134.82 149.81 50.41 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.403 1.881 . . . . 0.0 108.929 -174.771 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -149.5 146.37 27.36 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 -176.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -70.36 149.81 46.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.548 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -60.75 -4.9 1.07 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.977 1.311 . . . . 0.0 113.237 168.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -120.62 -2.05 9.97 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.732 1.213 . . . . 0.0 112.543 170.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 16.9 m -73.11 -5.65 40.46 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.933 0.788 . . . . 0.0 111.507 167.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 p -135.7 -13.41 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 126.853 2.061 . . . . 0.0 112.323 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 75.77 37.98 37.96 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.562 1.077 . . . . 0.0 112.922 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 18.3 mt -69.42 106.05 2.81 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.92 0.888 . . . . 0.0 110.159 174.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 37.5 m -69.82 -25.38 63.74 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.661 1.184 . . . . 0.0 111.631 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 13.7 t -151.34 178.01 9.7 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.568 1.547 . . . . 0.0 110.09 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -59.91 129.01 87.68 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.995 1.318 . . . . 0.0 110.091 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.65 169.63 21.44 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.174 2.583 . . . . 0.0 111.717 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -74.96 169.82 17.21 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.948 169.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -59.93 155.16 30.91 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 123.339 0.495 . . . . 0.0 112.375 176.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.6 tptp 51.54 60.97 3.48 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.393 1.477 . . . . 0.0 112.096 -173.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 83.3 t90 -73.8 157.83 35.69 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.346 0.658 . . . . 0.0 109.995 174.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -139.54 139.73 36.95 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.351 1.06 . . . . 0.0 109.377 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.2 p -66.36 166.69 15.84 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.96 0.904 . . . . 0.0 112.401 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.67 36.79 0.4 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.914 3.076 . . . . 0.0 112.985 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -139.96 -39.62 0.45 Allowed 'General case' 0 C--N 1.344 0.366 0 C-N-CA 125.336 1.455 . . . . 0.0 109.582 168.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.1 m -71.28 -34.28 70.53 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.722 2.009 . . . . 0.0 112.038 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.0 t -77.93 -33.17 51.83 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.529 1.131 . . . . 0.0 111.376 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -62.63 -25.64 68.21 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 124.808 1.243 . . . . 0.0 112.497 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -49.95 -46.25 52.05 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.875 2.07 . . . . 0.0 112.56 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -157.89 78.08 0.83 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.707 0.803 . . . . 0.0 109.989 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -69.99 93.25 0.77 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.442 1.097 . . . . 0.0 109.288 171.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -132.43 47.95 2.46 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.059 1.744 . . . . 0.0 109.365 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt . . . . . 0 C--O 1.249 1.079 0 C-N-CA 126.5 1.92 . . . . 0.0 111.424 179.611 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -144.41 141.15 29.45 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.94 0.896 . . . . 0.0 110.171 -168.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 25.9 mmt -143.31 69.28 17.71 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.3 1.44 . . . . 0.0 109.258 -178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.38 111.25 2.24 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.33 2.686 . . . . 0.0 110.042 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 5.8 p -148.17 3.76 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 124.465 1.106 . . . . 0.0 112.266 -170.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -137.61 91.97 13.52 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.225 1.41 . . . . 0.0 108.654 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.53 132.8 16.52 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.034 2.49 . . . . 0.0 110.556 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -135.37 29.76 3.29 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.133 1.373 . . . . 0.0 110.709 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -31.93 99.22 0.13 Allowed Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 129.896 3.278 . . . . 0.0 113.701 -172.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -87.48 164.58 8.03 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.2 3.267 . . . . 0.0 112.219 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.7 p 66.17 142.78 0.03 OUTLIER 'General case' 0 C--N 1.347 0.475 0 C-N-CA 127.693 2.397 . . . . 0.0 112.62 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -154.93 -37.89 0.09 Allowed 'General case' 0 C--N 1.349 0.56 0 CA-C-O 116.027 -1.939 . . . . 0.0 115.042 -168.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.7 OUTLIER -52.88 172.61 0.05 OUTLIER 'General case' 0 C--N 1.358 0.938 0 CA-C-N 122.002 2.183 . . . . 0.0 112.245 170.541 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.5 mt -63.24 -5.09 2.96 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.749 1.619 . . . . 0.0 111.24 172.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.2 m -99.21 -12.12 20.71 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 126.105 1.762 . . . . 0.0 112.585 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.0 p80 46.04 50.02 11.86 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 126.678 1.991 . . . . 0.0 111.894 -174.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -165.2 148.12 8.13 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.931 1.293 . . . . 0.0 107.901 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 205' ' ' SER . 0.5 OUTLIER -132.0 173.66 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 126.958 2.103 . . . . 0.0 110.78 176.534 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.508 ' H ' HG12 ' A' ' 204' ' ' VAL . 7.9 t 65.19 63.93 0.64 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.85 2.06 . . . . 0.0 113.067 -174.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.59 112.23 0.92 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.324 1.85 . . . . 0.0 109.034 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 60.1 -160.65 21.05 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 123.09 1.383 . . . . 0.0 112.982 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -66.11 143.29 57.4 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 112.253 -1.973 . . . . 0.0 111.097 169.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.0 mtm -149.04 154.05 38.75 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.752 2.021 . . . . 0.0 109.095 -168.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 211' ' ' GLY . 6.2 tt -142.04 -136.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -171.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 149.42 132.05 2.03 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 125.482 1.515 . . . . 0.0 112.867 -170.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.47 120.91 12.0 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.473 1.109 . . . . 0.0 108.548 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.3 -1.52 2.42 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.522 1.529 . . . . 0.0 113.561 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -69.54 116.4 42.62 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 169.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -77.17 9.43 2.79 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.28 2.653 . . . . 0.0 113.066 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -123.29 7.46 9.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.978 1.711 . . . . 0.0 110.172 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.7 t -61.21 130.98 48.92 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 118.402 0.546 . . . . 0.0 109.768 171.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 38.0 m -74.92 6.22 4.3 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.564 1.545 . . . . 0.0 113.589 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.9 mm -135.76 -37.19 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 126.369 1.867 . . . . 0.0 109.83 -170.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.11 -41.99 0.52 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.313 2.645 . . . . 0.0 115.523 170.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.511 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -127.85 148.56 50.47 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.334 1.854 . . . . 0.0 108.644 -177.05 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -149.19 155.97 41.44 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -174.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -83.76 142.72 30.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.38 -9.06 2.05 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.549 1.54 . . . . 0.0 112.913 170.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -115.47 -6.29 12.27 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.527 1.131 . . . . 0.0 112.394 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.8 m -80.13 -0.09 34.45 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 168.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.29 -8.8 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 126.852 2.061 . . . . 0.0 111.638 171.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.17 36.46 63.91 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.547 1.07 . . . . 0.0 113.06 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 32.0 mt -67.59 157.82 33.52 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.287 1.043 . . . . 0.0 110.613 171.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 27.8 m -136.73 -19.12 1.37 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.382 1.473 . . . . 0.0 110.752 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 13.8 t -149.2 170.54 18.21 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.198 1.799 . . . . 0.0 108.944 169.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -63.05 119.92 56.55 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 124.165 0.986 . . . . 0.0 109.649 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.27 174.26 12.37 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.105 2.537 . . . . 0.0 111.532 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -65.99 162.94 18.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.682 0.793 . . . . 0.0 110.118 169.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -61.8 164.67 21.36 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.944 0.783 . . . . 0.0 113.185 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 15.8 tptp 52.91 57.5 6.29 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.298 1.439 . . . . 0.0 112.149 -172.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -73.41 158.36 35.14 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.746 0.819 . . . . 0.0 109.8 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -139.83 141.85 36.66 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.064 0.945 . . . . 0.0 109.409 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.1 p -66.08 163.62 36.21 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.876 0.87 . . . . 0.0 111.724 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.53 32.92 0.32 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 123.986 3.124 . . . . 0.0 113.087 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -135.64 -39.11 0.72 Allowed 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.45 1.5 . . . . 0.0 109.67 170.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 28.2 m -70.98 -31.68 68.29 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.919 2.088 . . . . 0.0 112.222 170.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 8.1 t -83.51 -34.85 25.23 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.093 1.357 . . . . 0.0 110.858 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -63.8 -21.26 66.34 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.502 1.121 . . . . 0.0 112.979 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.33 -14.87 13.08 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.071 1.748 . . . . 0.0 113.158 172.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.91 26.13 4.63 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.602 1.561 . . . . 0.0 111.065 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt 51.24 64.74 1.72 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.454 1.902 . . . . 0.0 112.305 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -140.89 114.29 8.71 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 126.003 1.721 . . . . 0.0 106.417 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 27.0 tptp . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.408 1.483 . . . . 0.0 110.582 -170.851 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 89.5 mtp . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 57.25 -167.64 0.12 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.746 1.618 . . . . 0.0 112.802 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 13.8 ptm -89.13 110.16 36.21 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.601 1.16 . . . . 0.0 109.441 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -75.97 -35.77 2.33 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.501 2.134 . . . . 0.0 112.043 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 6.3 p -156.55 10.5 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 126.213 1.805 . . . . 0.0 110.996 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 34.3 t70 50.86 64.39 8.29 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 125.576 1.55 . . . . 0.0 111.325 -167.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.33 105.68 1.78 Allowed 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.397 2.731 . . . . 0.0 110.491 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -79.56 -6.11 56.34 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.494 1.117 . . . . 0.0 113.046 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -144.24 69.47 15.92 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.486 1.115 . . . . 0.0 109.999 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.88 162.39 41.2 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.377 2.718 . . . . 0.0 111.291 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.7 p 64.88 142.31 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.578 2.351 . . . . 0.0 112.871 -174.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -156.06 -38.19 0.08 Allowed 'General case' 0 C--N 1.35 0.626 0 CA-C-O 115.956 -1.973 . . . . 0.0 115.563 -168.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.5 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.9 OUTLIER -52.99 174.15 0.04 OUTLIER 'General case' 0 C--N 1.359 0.991 0 CA-C-N 122.069 2.213 . . . . 0.0 112.027 172.06 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.0 mt -62.98 -5.07 2.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.641 1.577 . . . . 0.0 111.339 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 69.6 m -100.0 -12.28 19.88 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 126.069 1.748 . . . . 0.0 112.675 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.8 p80 45.36 50.1 10.09 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.775 2.03 . . . . 0.0 112.008 -174.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -164.62 148.57 9.21 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 125.219 1.408 . . . . 0.0 107.67 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 205' ' ' SER . 0.6 OUTLIER -132.69 174.01 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 127.131 2.172 . . . . 0.0 110.871 177.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.529 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.1 t 63.26 63.04 0.93 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.688 1.995 . . . . 0.0 112.904 -174.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.36 108.32 1.07 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.574 1.95 . . . . 0.0 108.332 -174.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 62.04 -164.38 23.22 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 123.278 1.488 . . . . 0.0 112.798 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.524 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.8 pm0 -65.25 150.17 48.69 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.314 2.246 . . . . 0.0 111.577 169.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 76.8 mtm -149.55 159.71 44.08 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.903 1.681 . . . . 0.0 110.684 -167.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 6.8 tp -138.34 -133.8 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.117 0.967 . . . . 0.0 109.302 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 145.62 132.73 2.47 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 126.447 1.975 . . . . 0.0 113.242 -169.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.534 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 8.8 t -65.11 124.12 21.29 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.63 4.18 0.62 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.129 1.372 . . . . 0.0 113.104 173.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.65 112.04 5.01 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 128.51 2.724 . . . . 0.0 107.797 167.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -78.55 11.9 2.31 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.372 2.715 . . . . 0.0 112.955 -176.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -129.24 8.46 5.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.114 1.766 . . . . 0.0 109.807 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 12.2 t -57.3 116.7 3.46 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-O 121.767 0.794 . . . . 0.0 111.62 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 68.7 m -79.59 6.58 10.18 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.181 1.792 . . . . 0.0 112.48 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.5 mm -123.08 -36.99 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 126.547 1.939 . . . . 0.0 108.92 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . 0.254 0.1 OUTLIER 67.26 -23.98 0.11 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 129.093 2.957 . . . . 0.0 116.494 169.226 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.501 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.6 OUTLIER -147.59 149.85 33.33 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.662 1.585 . . . . 0.0 109.152 -179.129 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -147.44 157.2 43.48 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.293 1.037 . . . . 0.0 108.299 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -83.19 143.13 30.68 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.33 0.585 . . . . 0.0 110.142 -174.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.51 -4.45 0.4 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.924 2.09 . . . . 0.0 114.039 170.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.47 -9.15 8.01 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.317 1.447 . . . . 0.0 112.276 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 10.3 m -77.45 -1.65 31.38 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.029 0.831 . . . . 0.0 112.769 168.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 12.7 p -132.04 -1.42 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 126.923 2.089 . . . . 0.0 110.92 171.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 63.6 32.56 84.58 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.25 1.405 . . . . 0.0 113.297 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.1 mt -66.93 -53.71 29.22 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 117.999 0.9 . . . . 0.0 112.276 -172.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . 0.272 2.4 t 45.39 12.66 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 127.964 2.505 . . . . 0.0 115.637 -169.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 60.5 p -152.24 158.48 42.89 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.096 2.158 . . . . 0.0 109.422 -175.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -69.29 125.01 91.66 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 170.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.01 -66.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.722 2.281 . . . . 0.0 111.352 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 37.2 ttt-85 -174.88 -173.77 0.73 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.889 2.476 . . . . 0.0 107.554 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -77.08 16.06 5.98 Favored Glycine 0 CA--C 1.54 1.641 0 CA-C-O 119.036 -0.869 . . . . 0.0 112.944 168.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -159.68 120.48 3.12 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 126.008 1.723 . . . . 0.0 107.948 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' TRP . . . . . 0.404 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 90.3 t90 -136.43 162.56 32.72 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.733 2.013 . . . . 0.0 109.989 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.534 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 97.5 m-85 -139.4 141.35 37.54 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.726 0.81 . . . . 0.0 110.698 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' CYS . . . . . 0.404 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 29.1 p -65.75 160.27 62.72 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.519 0.727 . . . . 0.0 111.685 174.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.33 28.4 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.275 3.317 . . . . 0.0 113.327 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -133.58 -35.66 0.99 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.344 1.858 . . . . 0.0 109.637 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 1.4 m -72.53 -38.89 67.9 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.099 1.76 . . . . 0.0 110.969 168.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.3 t -76.32 -27.33 56.49 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.971 1.308 . . . . 0.0 111.564 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -64.41 -29.55 70.61 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.125 0.97 . . . . 0.0 112.273 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.91 -16.27 28.21 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.405 1.882 . . . . 0.0 113.165 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 37.8 ttt85 -127.85 21.88 6.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.867 1.667 . . . . 0.0 111.144 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 10.4 mtpm? -133.81 57.99 1.79 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.997 1.719 . . . . 0.0 109.603 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 59.3 mtmt -75.28 76.95 2.39 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.268 1.427 . . . . 0.0 107.849 169.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt . . . . . 0 C--O 1.252 1.194 0 C-N-CA 127.008 2.123 . . . . 0.0 109.749 -167.695 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 11.4 tmm? . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -144.24 -42.88 0.26 Allowed 'General case' 0 CA--C 1.534 0.337 0 O-C-N 124.017 0.823 . . . . 0.0 111.105 -169.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 43.5 tpp -155.08 67.19 5.12 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.826 1.25 . . . . 0.0 108.994 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.91 1.97 8.05 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 124.214 3.276 . . . . 0.0 114.777 -169.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.58 98.08 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.465 1.506 . . . . 0.0 111.041 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -73.65 129.29 85.59 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.842 1.257 . . . . 0.0 110.503 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.16 148.58 27.45 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.443 2.762 . . . . 0.0 111.531 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -89.19 22.43 2.83 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.881 1.272 . . . . 0.0 112.158 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -138.83 75.36 36.51 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.017 1.327 . . . . 0.0 109.642 -172.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.53 143.27 51.37 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.701 2.267 . . . . 0.0 110.801 176.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.3 p 61.58 149.41 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.06 2.544 . . . . 0.0 113.826 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -157.47 -43.42 0.07 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -168.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.49 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 2.1 p -39.62 170.2 0.0 OUTLIER 'General case' 0 C--N 1.349 0.57 0 C-N-CA 126.364 1.866 . . . . 0.0 114.379 169.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.3 mt -70.96 -6.63 40.16 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 113.31 -1.768 . . . . 0.0 110.131 168.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.49 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 97.4 m -96.29 -13.67 23.18 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 123.472 0.709 . . . . 0.0 111.755 174.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.7 p80 46.34 52.4 10.64 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.773 2.029 . . . . 0.0 112.607 -173.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -171.56 140.36 1.36 Allowed 'General case' 0 C--N 1.346 0.455 0 C-N-CA 126.004 1.721 . . . . 0.0 108.083 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.513 HG12 ' H ' ' A' ' 205' ' ' SER . 1.5 t -122.33 171.17 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.506 1.522 . . . . 0.0 111.179 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.513 ' H ' HG12 ' A' ' 204' ' ' VAL . 52.8 m 67.17 64.31 0.44 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.983 2.113 . . . . 0.0 113.405 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -160.14 112.48 2.04 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.661 1.984 . . . . 0.0 108.024 -176.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 68.19 -123.19 17.12 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -170.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.35 167.59 12.6 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.003 2.121 . . . . 0.0 110.982 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -138.26 156.17 47.93 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.178 0.991 . . . . 0.0 111.23 -169.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.453 HG12 ' H ' ' A' ' 211' ' ' GLY . 8.1 tt -134.53 -139.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 173.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 148.04 132.97 2.26 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 125.35 1.453 . . . . 0.0 112.648 -169.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.9 t -66.13 122.94 18.55 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.83 -2.19 3.58 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.504 1.522 . . . . 0.0 113.553 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -67.15 117.12 43.09 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 124.3 1.04 . . . . 0.0 108.33 168.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.65 5.42 4.81 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.229 2.619 . . . . 0.0 113.147 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -118.09 6.88 12.1 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.934 1.694 . . . . 0.0 110.428 174.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 45.9 t -58.88 127.54 32.73 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 121.234 0.54 . . . . 0.0 109.875 170.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 67.9 m -78.64 6.82 7.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.56 1.544 . . . . 0.0 113.336 -176.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.7 mt -133.76 -33.58 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.124 1.77 . . . . 0.0 110.261 -176.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.98 -39.42 0.45 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.869 2.468 . . . . 0.0 115.168 170.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.459 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -131.27 148.68 52.72 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.524 1.93 . . . . 0.0 108.719 -175.609 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -147.17 150.16 34.39 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -72.34 148.55 45.22 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.41 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -60.54 -5.87 1.4 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.342 1.457 . . . . 0.0 112.336 167.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -119.78 -2.01 10.45 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.925 1.29 . . . . 0.0 112.478 171.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.3 m -73.48 -5.24 38.81 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.907 0.776 . . . . 0.0 111.078 166.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 14.2 p -134.6 -10.17 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.766 2.026 . . . . 0.0 112.211 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.58 36.59 62.32 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.619 1.104 . . . . 0.0 113.354 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 11.0 mt -65.85 158.63 27.36 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.514 1.157 . . . . 0.0 111.603 173.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.3 t -139.84 -3.57 1.44 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.738 1.615 . . . . 0.0 111.808 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 9.9 t -151.12 166.23 31.43 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 126.017 1.727 . . . . 0.0 109.484 175.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -82.33 116.21 62.35 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.093 0.957 . . . . 0.0 109.106 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.12 166.36 27.97 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.166 2.578 . . . . 0.0 111.093 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 32.8 mtp-105 -140.25 164.48 29.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.559 1.143 . . . . 0.0 110.56 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 89.59 -76.05 1.78 Allowed Glycine 0 C--N 1.34 0.768 0 N-CA-C 109.181 -1.567 . . . . 0.0 109.181 -172.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -170.46 153.17 4.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 127.298 2.239 . . . . 0.0 107.334 169.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -119.34 163.14 17.61 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.916 2.086 . . . . 0.0 110.306 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -140.5 141.96 35.32 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.129 1.372 . . . . 0.0 108.897 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 16.9 p -68.82 164.06 49.95 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.896 -0.573 . . . . 0.0 112.005 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.45 34.1 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 124.148 3.232 . . . . 0.0 113.203 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -135.84 -36.97 0.75 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 125.793 1.637 . . . . 0.0 109.757 171.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.5 m -73.89 -33.83 64.19 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.797 2.039 . . . . 0.0 112.091 171.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 13.7 t -87.49 -16.47 34.64 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.628 1.171 . . . . 0.0 112.172 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -64.66 -21.75 66.81 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.976 1.311 . . . . 0.0 112.674 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -46.84 -36.87 7.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.05 1.74 . . . . 0.0 113.127 170.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 11.4 ttt85 -133.05 16.54 4.17 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.832 1.253 . . . . 0.0 112.117 -173.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -134.45 79.51 1.81 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 126.192 1.797 . . . . 0.0 107.045 172.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -142.32 36.98 1.52 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.649 1.98 . . . . 0.0 110.669 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--O 1.251 1.172 0 C-N-CA 126.532 1.933 . . . . 0.0 111.676 -179.6 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -63.48 123.29 18.39 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.413 1.085 . . . . 0.0 110.425 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.617 ' H ' ' HD2' ' A' ' 190' ' ' PRO . 63.5 mtt -145.44 -48.71 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 116.574 -1.679 . . . . 0.0 112.48 -175.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.617 ' HD2' ' H ' ' A' ' 189' ' ' MET . 61.7 Cg_endo -73.21 -38.93 2.4 Favored 'Trans proline' 0 C--N 1.357 1.0 0 CA-C-N 122.35 1.875 . . . . 0.0 111.956 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . 0.28 2.1 p 46.82 13.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 129.945 3.298 . . . . 0.0 117.782 169.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.601 ' H ' ' HD2' ' A' ' 193' ' ' PRO . 23.9 m-20 -143.44 -49.33 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.703 0 CA-C-O 116.697 -1.621 . . . . 0.0 113.58 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.601 ' HD2' ' H ' ' A' ' 192' ' ' ASP . 60.5 Cg_endo -72.11 138.87 31.58 Favored 'Trans proline' 0 C--N 1.355 0.908 0 CA-C-N 122.47 1.918 . . . . 0.0 110.933 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -153.13 35.92 0.47 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.645 1.178 . . . . 0.0 110.724 -173.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -136.65 77.18 46.23 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.81 1.244 . . . . 0.0 109.597 -172.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.47 151.99 59.79 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.337 2.692 . . . . 0.0 111.464 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.2 p 62.43 147.73 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.946 2.498 . . . . 0.0 113.151 -173.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -156.29 -44.31 0.07 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -169.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.486 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 2.3 p -40.58 169.92 0.0 OUTLIER 'General case' 0 C--N 1.349 0.555 0 C-N-CA 126.139 1.775 . . . . 0.0 114.158 169.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.9 mt -71.48 -6.32 39.61 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 113.233 -1.803 . . . . 0.0 110.07 168.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.486 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 95.1 m -96.02 -13.54 23.66 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 123.455 0.702 . . . . 0.0 111.808 174.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.1 p80 46.28 53.75 9.16 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.804 2.042 . . . . 0.0 112.609 -173.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -171.78 141.38 1.41 Allowed 'General case' 0 C--N 1.346 0.441 0 C-N-CA 125.707 1.603 . . . . 0.0 108.221 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 205' ' ' SER . 0.9 OUTLIER -123.99 170.5 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.36 1.464 . . . . 0.0 110.906 177.231 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.484 ' H ' HG12 ' A' ' 204' ' ' VAL . 7.9 t 67.8 65.91 0.37 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.026 2.13 . . . . 0.0 113.165 -174.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.89 111.88 1.16 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.732 2.013 . . . . 0.0 107.733 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.16 -134.97 36.85 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -169.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.52 169.33 8.88 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.91 2.084 . . . . 0.0 111.252 177.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -137.8 159.86 40.83 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.478 1.111 . . . . 0.0 111.596 -168.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.457 HG13 ' H ' ' A' ' 211' ' ' GLY . 5.6 tp -134.76 -138.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 170.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 149.47 131.87 2.0 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 126.024 1.773 . . . . 0.0 112.132 -169.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 43.7 t -63.42 125.43 24.15 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.217 1.007 . . . . 0.0 108.675 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.97 -3.43 3.48 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.824 1.25 . . . . 0.0 113.709 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -70.48 117.18 52.63 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 124.242 1.017 . . . . 0.0 108.659 169.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -76.82 4.22 5.86 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.261 2.641 . . . . 0.0 113.16 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -115.99 6.3 14.1 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.85 1.66 . . . . 0.0 110.463 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 49.9 t -58.72 128.3 36.5 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.019 0.528 . . . . 0.0 109.975 170.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.2 m -74.38 2.83 8.5 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.727 1.611 . . . . 0.0 113.689 -176.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.8 mt -133.18 -33.66 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.186 1.794 . . . . 0.0 110.175 -173.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.89 -38.1 0.41 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.796 2.438 . . . . 0.0 115.226 170.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.471 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -132.06 148.51 52.5 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.618 1.967 . . . . 0.0 108.751 -174.091 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -148.35 149.47 31.85 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -73.94 150.7 40.66 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.244 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -59.66 -4.25 0.63 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.84 1.656 . . . . 0.0 113.252 167.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.79 -2.84 8.26 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.326 1.45 . . . . 0.0 112.609 171.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.1 m -71.9 -7.88 51.1 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.112 0.869 . . . . 0.0 111.612 167.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.0 p -133.94 -4.45 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 125.958 1.703 . . . . 0.0 111.765 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.18 33.55 78.67 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.605 1.098 . . . . 0.0 113.012 -174.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.5 mt -65.18 -50.51 65.65 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.437 1.095 . . . . 0.0 112.096 -174.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . 0.277 1.7 t 47.45 6.09 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 128.678 2.791 . . . . 0.0 116.585 -171.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 76.3 p -148.14 165.96 29.31 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.703 2.001 . . . . 0.0 109.818 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -65.4 127.83 93.27 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.644 -0.693 . . . . 0.0 109.305 171.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -80.68 173.31 12.32 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.336 2.691 . . . . 0.0 112.578 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 54.4 mmm-85 -67.22 160.96 25.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.478 1.111 . . . . 0.0 109.418 167.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -61.09 152.86 39.65 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 173.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt 50.99 62.96 2.44 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.07 1.348 . . . . 0.0 111.279 -171.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 81.1 t90 -75.36 153.21 37.91 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 113.641 -1.618 . . . . 0.0 109.287 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -138.64 138.26 37.67 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.187 0.995 . . . . 0.0 108.728 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.7 p -64.82 166.78 10.95 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.965 0.906 . . . . 0.0 112.171 176.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.4 36.01 0.37 Allowed 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 123.861 3.041 . . . . 0.0 113.095 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -138.68 -39.51 0.51 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 125.473 1.509 . . . . 0.0 109.329 169.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 33.9 m -72.13 -29.04 63.67 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.979 2.112 . . . . 0.0 112.393 172.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 69.2 m -73.73 -36.6 65.19 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.833 1.253 . . . . 0.0 110.962 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -70.07 -12.18 61.42 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.231 1.012 . . . . 0.0 112.893 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -54.07 -66.93 0.31 Allowed 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 127.158 2.183 . . . . 0.0 111.448 172.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.93 21.52 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.59 1.556 . . . . 0.0 111.001 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -130.63 75.54 1.66 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.424 1.49 . . . . 0.0 109.992 -167.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp 70.97 105.76 0.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.496 2.318 . . . . 0.0 111.204 -174.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt . . . . . 0 C--O 1.25 1.086 0 C-N-CA 125.963 1.705 . . . . 0.0 108.772 178.715 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.6 153.57 15.21 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.697 1.199 . . . . 0.0 110.046 -170.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 27.7 ttt -156.88 82.85 3.19 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.596 1.159 . . . . 0.0 108.398 175.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -71.83 125.36 10.97 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.811 2.34 . . . . 0.0 110.353 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.23 25.54 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 125.342 1.457 . . . . 0.0 109.182 176.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -55.69 -46.32 99.75 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 117.256 -1.354 . . . . 0.0 112.061 174.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.75 111.7 3.35 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.19 1.927 . . . . 0.0 109.192 168.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -149.78 31.13 0.72 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.45 1.1 . . . . 0.0 110.907 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -135.99 72.22 61.36 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 125.056 1.342 . . . . 0.0 109.107 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.14 111.24 2.83 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.728 2.952 . . . . 0.0 110.416 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.8 p -146.68 138.29 24.48 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.821 1.648 . . . . 0.0 108.846 -174.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -155.89 -44.91 0.08 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.502 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.7 p -39.83 170.32 0.0 OUTLIER 'General case' 0 C--N 1.348 0.522 0 C-N-CA 126.408 1.883 . . . . 0.0 114.001 168.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.68 -6.97 41.1 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.527 -1.67 . . . . 0.0 110.127 168.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.502 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 89.2 m -97.13 -14.16 21.68 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 123.859 0.864 . . . . 0.0 111.763 175.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.5 p80 45.57 52.48 9.23 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.082 2.153 . . . . 0.0 112.883 -173.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.15 139.79 2.3 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 126.043 1.737 . . . . 0.0 108.439 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -122.6 -174.82 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.878 1.671 . . . . 0.0 109.752 176.711 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.493 ' H ' HG12 ' A' ' 204' ' ' VAL 0.277 59.7 p 59.87 53.98 4.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.124 2.17 . . . . 0.0 114.571 -174.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.75 121.05 5.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.7 2.0 . . . . 0.0 109.1 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 57.54 -113.46 4.6 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.616 1.579 . . . . 0.0 111.188 -174.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.76 168.56 18.82 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.346 2.259 . . . . 0.0 111.41 -174.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -138.57 159.76 41.3 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.802 0.841 . . . . 0.0 113.036 -167.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.415 HG13 ' H ' ' A' ' 211' ' ' GLY . 5.7 tp -134.8 -137.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 168.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 147.71 131.53 2.13 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 125.555 1.55 . . . . 0.0 112.03 -170.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 53.3 t -64.75 119.49 10.69 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -67.38 1.28 2.31 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.432 1.493 . . . . 0.0 113.747 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -67.0 118.0 51.15 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.22 6.23 4.05 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.28 2.654 . . . . 0.0 113.191 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -119.66 7.64 11.1 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.821 1.648 . . . . 0.0 110.575 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 47.5 t -59.34 130.26 46.04 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 123.286 0.634 . . . . 0.0 110.3 172.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.0 m -76.2 1.48 15.77 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.56 1.544 . . . . 0.0 113.671 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 26.2 mt -134.94 -34.34 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.029 1.731 . . . . 0.0 110.285 -171.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.7 -39.77 0.44 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.71 2.404 . . . . 0.0 115.011 170.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.45 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -131.27 147.73 52.62 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.523 1.929 . . . . 0.0 108.42 -174.612 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -147.76 147.79 30.26 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -71.45 150.97 44.42 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.204 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.96 -1.33 0.64 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.589 1.556 . . . . 0.0 113.41 168.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -126.95 1.3 6.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.756 1.222 . . . . 0.0 112.28 169.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.1 m -72.28 -9.42 58.45 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.793 0.724 . . . . 0.0 111.608 167.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.1 p -135.07 -10.83 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 124.696 1.198 . . . . 0.0 113.046 170.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.49 38.37 8.98 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.615 1.102 . . . . 0.0 113.888 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 68.3 mt -65.8 112.64 3.83 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.69 1.245 . . . . 0.0 110.764 173.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.3 t -78.5 -20.96 49.65 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.967 0.907 . . . . 0.0 111.567 169.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 8.9 t -156.87 176.04 13.28 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.605 1.562 . . . . 0.0 110.193 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -65.31 120.27 66.26 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.402 1.081 . . . . 0.0 109.192 175.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.74 -50.74 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.741 2.294 . . . . 0.0 111.543 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -173.76 -178.83 1.65 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.114 2.165 . . . . 0.0 108.452 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -82.44 18.19 15.72 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.43 1.014 . . . . 0.0 112.278 167.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -154.71 112.81 3.49 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 125.93 1.692 . . . . 0.0 108.186 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' TRP . . . . . 0.417 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 87.5 t90 -139.32 164.15 30.59 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.568 1.947 . . . . 0.0 110.429 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -139.25 141.25 37.83 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 124.854 1.262 . . . . 0.0 109.471 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' CYS . . . . . 0.417 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 15.9 p -67.87 163.68 47.61 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.49 0.716 . . . . 0.0 112.288 176.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.54 34.14 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 124.056 3.171 . . . . 0.0 113.458 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -137.32 -35.92 0.67 Allowed 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.45 1.5 . . . . 0.0 110.076 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 24.3 m -72.8 -32.48 65.58 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.556 1.942 . . . . 0.0 111.808 169.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.4 t -82.19 -16.36 49.96 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.777 1.631 . . . . 0.0 112.586 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -68.26 -32.17 72.16 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.81 0.844 . . . . 0.0 111.34 173.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.75 167.13 7.82 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.788 1.635 . . . . 0.0 111.212 169.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 56.6 ttt-85 58.99 41.27 21.25 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.358 1.463 . . . . 0.0 112.12 175.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -66.45 94.27 0.27 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 125.9 1.68 . . . . 0.0 108.989 171.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 49.3 tptt 57.66 109.33 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.182 2.593 . . . . 0.0 112.742 -170.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm . . . . . 0 C--O 1.251 1.136 0 C-N-CA 125.18 1.392 . . . . 0.0 107.412 169.57 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 52.12 65.15 1.59 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.385 1.474 . . . . 0.0 112.046 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 66.6 mtt -126.99 79.2 73.25 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.39 1.476 . . . . 0.0 110.138 -170.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.48 155.57 66.48 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.127 2.552 . . . . 0.0 111.031 173.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 86.7 t -143.36 133.43 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.204 1.402 . . . . 0.0 107.417 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -143.55 153.18 58.25 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.812 1.245 . . . . 0.0 110.699 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -80.45 35.76 0.59 Allowed 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 125.024 3.816 . . . . 0.0 111.951 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -135.14 37.14 3.0 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.605 1.562 . . . . 0.0 110.961 -169.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.48 130.19 89.81 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.489 1.116 . . . . 0.0 110.734 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.22 116.89 4.89 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.241 2.627 . . . . 0.0 110.762 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 81.1 p -147.66 136.0 21.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.815 1.646 . . . . 0.0 108.661 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -156.58 -48.59 0.07 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -174.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.484 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -38.62 171.28 0.0 OUTLIER 'General case' 0 C--N 1.351 0.663 0 C-N-CA 126.803 2.041 . . . . 0.0 114.633 169.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.9 mt -70.38 -7.24 41.39 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 113.458 -1.701 . . . . 0.0 110.021 168.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.484 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 94.6 m -96.43 -13.71 22.96 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 123.546 0.738 . . . . 0.0 111.852 174.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.3 p80 46.01 51.04 11.16 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.306 2.242 . . . . 0.0 113.101 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -169.66 142.05 2.45 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 125.854 1.662 . . . . 0.0 107.897 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 205' ' ' SER . 1.1 t -123.65 174.09 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.666 1.587 . . . . 0.0 110.733 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.528 ' H ' HG12 ' A' ' 204' ' ' VAL . 50.0 m 67.48 57.84 0.55 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.719 2.007 . . . . 0.0 113.114 -177.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -158.66 109.4 2.09 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.298 2.239 . . . . 0.0 106.945 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.77 -159.74 45.55 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-O 122.814 1.23 . . . . 0.0 110.757 -168.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -83.43 170.58 14.34 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.375 1.87 . . . . 0.0 112.075 171.402 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -140.23 159.73 41.53 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.921 1.289 . . . . 0.0 112.137 -169.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . 0.258 9.1 tp -132.19 -138.42 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 146.94 136.45 2.85 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 126.454 1.978 . . . . 0.0 112.308 -169.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.507 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 7.5 t -65.75 127.68 32.92 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.755 -0.723 . . . . 0.0 109.748 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.72 -8.27 1.98 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.343 1.457 . . . . 0.0 113.75 171.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -57.55 110.16 2.29 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 128.163 2.585 . . . . 0.0 108.288 169.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -78.61 10.91 2.64 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.42 2.747 . . . . 0.0 112.758 -175.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -129.22 9.9 5.73 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.279 1.832 . . . . 0.0 109.603 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 21.9 t -55.38 117.46 3.57 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-O 121.781 0.801 . . . . 0.0 111.66 175.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 85.7 p -74.49 1.94 10.73 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.94 2.096 . . . . 0.0 113.265 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.8 mm -123.67 -36.54 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.37 1.868 . . . . 0.0 108.957 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.03 -30.15 0.21 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 128.207 2.603 . . . . 0.0 115.195 169.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.468 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -144.24 149.81 36.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.689 1.596 . . . . 0.0 109.435 -175.266 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -148.21 149.67 32.36 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -72.88 149.86 43.13 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.192 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -59.36 -4.76 0.63 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.57 1.548 . . . . 0.0 113.473 167.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.65 -4.23 8.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.215 1.406 . . . . 0.0 112.638 171.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 14.6 m -72.8 -5.34 37.35 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.002 0.819 . . . . 0.0 111.359 167.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.5 p -136.56 -5.22 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 126.479 1.911 . . . . 0.0 111.931 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.8 35.86 91.46 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.802 1.191 . . . . 0.0 113.023 -175.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.5 mt -67.14 -53.51 29.96 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 123.968 0.907 . . . . 0.0 111.281 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 22.9 m 61.31 -12.21 0.05 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.286 2.234 . . . . 0.0 114.587 -173.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.6 p -143.56 165.39 27.71 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.851 1.66 . . . . 0.0 110.598 -174.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -66.08 126.7 92.38 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 123.968 0.907 . . . . 0.0 109.91 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.51 177.17 9.06 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.529 2.819 . . . . 0.0 111.879 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -65.3 174.89 1.89 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.423 1.089 . . . . 0.0 111.115 169.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.5 7.57 1.94 Allowed Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.08 1.324 . . . . 0.0 115.321 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -148.33 115.07 6.02 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 126.969 2.108 . . . . 0.0 106.762 173.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -126.8 155.9 42.12 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.276 1.83 . . . . 0.0 109.429 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.507 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 91.3 m-85 -138.44 138.42 38.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.716 0.807 . . . . 0.0 110.249 -176.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 31.5 p -64.03 162.48 30.36 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 123.675 0.79 . . . . 0.0 111.622 172.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.82 28.95 0.24 Allowed 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 124.028 3.152 . . . . 0.0 113.59 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -133.61 -36.85 0.95 Allowed 'General case' 0 C--N 1.343 0.326 0 C-N-CA 125.794 1.638 . . . . 0.0 109.702 173.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 2.5 m -71.87 -35.99 69.96 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.325 1.85 . . . . 0.0 111.863 169.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 27.4 t -75.5 -31.07 60.05 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.835 1.254 . . . . 0.0 110.977 174.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -28.73 68.66 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.841 1.256 . . . . 0.0 111.489 175.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.86 -22.5 59.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.578 1.551 . . . . 0.0 112.911 173.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 53.2 ttt85 26.56 71.61 0.04 OUTLIER 'General case' 0 C--N 1.35 0.597 0 C-N-CA 129.412 3.085 . . . . 0.0 114.166 169.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -80.89 -171.5 3.21 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.342 1.457 . . . . 0.0 110.558 -171.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -81.77 76.29 8.68 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.531 1.932 . . . . 0.0 109.469 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 23.4 tptm . . . . . 0 C--O 1.25 1.109 0 C-N-CA 126.962 2.105 . . . . 0.0 111.324 -172.131 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 97.9 mtp . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 63.15 120.79 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.692 2.397 . . . . 0.0 113.699 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 27.5 ttt -150.29 76.72 8.43 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.147 0.979 . . . . 0.0 109.946 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.71 149.72 61.27 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.952 2.435 . . . . 0.0 110.832 173.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.58 9.94 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 125.073 1.349 . . . . 0.0 110.256 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -54.92 -44.46 99.52 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.796 1.639 . . . . 0.0 113.55 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -81.41 73.35 5.94 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 123.232 2.622 . . . . 0.0 109.101 169.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -66.33 -15.9 63.62 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.873 1.269 . . . . 0.0 114.401 -170.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.3 125.68 91.42 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.32 1.048 . . . . 0.0 110.428 178.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.72 153.38 43.24 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.302 2.668 . . . . 0.0 111.703 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.7 p 58.64 144.27 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.866 2.866 . . . . 0.0 113.477 -172.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.98 -49.48 0.09 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -168.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.494 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.9 p -41.65 170.33 0.0 OUTLIER 'General case' 0 C--N 1.349 0.58 0 C-N-CA 125.892 1.677 . . . . 0.0 114.165 169.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.7 mt -71.1 -6.86 42.48 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.925 168.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.494 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 93.7 m -95.62 -13.6 24.2 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.513 0.725 . . . . 0.0 111.797 174.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.0 p80 46.83 52.94 10.92 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.031 2.132 . . . . 0.0 112.85 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -173.16 139.73 0.82 Allowed 'General case' 0 C--N 1.345 0.391 0 C-N-CA 125.878 1.671 . . . . 0.0 108.498 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 205' ' ' SER . 0.5 OUTLIER -114.29 -173.18 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 125.605 1.562 . . . . 0.0 110.665 175.449 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.521 ' H ' HG12 ' A' ' 204' ' ' VAL 0.254 97.5 p 53.12 64.29 1.91 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.812 2.445 . . . . 0.0 114.771 -174.675 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.08 112.07 1.54 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.894 2.078 . . . . 0.0 108.011 -177.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 63.65 -133.72 41.25 Favored Glycine 0 C--N 1.339 0.75 0 C-N-CA 124.497 1.046 . . . . 0.0 110.546 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.08 169.05 9.21 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 127.248 2.219 . . . . 0.0 111.42 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -138.66 159.51 41.92 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.251 1.02 . . . . 0.0 112.209 -168.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.448 HG13 ' H ' ' A' ' 211' ' ' GLY . 5.8 tp -133.44 -138.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 169.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 148.32 131.25 2.04 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 125.597 1.57 . . . . 0.0 112.507 -170.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 45.9 t -63.94 121.39 13.99 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.24 2.11 1.79 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.436 1.494 . . . . 0.0 113.699 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -70.94 118.01 61.43 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.378 1.071 . . . . 0.0 108.146 168.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -76.33 4.58 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.185 2.59 . . . . 0.0 113.273 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -116.21 6.41 13.87 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.717 1.607 . . . . 0.0 110.508 174.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 46.5 t -59.14 129.13 40.64 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 123.118 0.567 . . . . 0.0 109.924 171.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 11.0 t -73.27 -1.44 17.87 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.922 1.689 . . . . 0.0 113.455 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.6 mt -132.76 -33.84 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.968 1.707 . . . . 0.0 110.449 -170.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.68 -38.9 0.43 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 127.47 2.308 . . . . 0.0 114.985 171.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.479 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -132.49 148.29 52.39 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.497 1.919 . . . . 0.0 109.03 -173.268 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -148.85 149.95 32.17 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -74.17 151.08 40.09 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.369 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -59.28 -5.12 0.66 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.766 1.626 . . . . 0.0 113.259 167.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.04 -3.58 8.56 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.294 1.438 . . . . 0.0 112.581 171.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 15.5 m -72.8 -6.9 47.92 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.04 0.836 . . . . 0.0 111.739 167.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.35 -5.6 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.864 1.666 . . . . 0.0 111.817 172.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.51 34.82 80.03 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.726 1.155 . . . . 0.0 112.8 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.3 mt -66.18 -50.46 63.81 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 124.327 1.051 . . . . 0.0 111.771 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 16.9 m 61.81 -8.87 0.09 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.072 2.149 . . . . 0.0 114.612 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 12.1 t -150.1 176.78 10.51 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.839 1.656 . . . . 0.0 110.39 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -71.83 129.22 88.49 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.316 1.046 . . . . 0.0 109.728 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.22 176.55 9.6 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.468 2.779 . . . . 0.0 111.95 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -69.21 171.26 8.68 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.016 0.927 . . . . 0.0 109.992 167.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -58.58 153.66 28.13 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 123.565 0.602 . . . . 0.0 112.348 172.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 45.4 tttp 42.86 71.72 0.21 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.825 2.05 . . . . 0.0 113.498 -172.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -76.86 160.3 29.35 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.95 0.9 . . . . 0.0 109.99 174.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -138.63 140.46 38.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.201 1.0 . . . . 0.0 109.584 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.2 p -66.73 165.24 26.69 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.73 0.812 . . . . 0.0 112.06 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.47 33.03 0.29 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 124.024 3.149 . . . . 0.0 113.482 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -136.02 -40.31 0.68 Allowed 'General case' 0 C--N 1.345 0.404 0 C-N-CA 125.068 1.347 . . . . 0.0 109.674 169.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.3 m -68.38 -36.94 79.9 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.736 2.014 . . . . 0.0 111.705 171.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.8 t -80.52 -31.77 37.02 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.325 1.45 . . . . 0.0 111.384 175.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -36.56 84.07 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.528 1.131 . . . . 0.0 111.182 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.82 -16.96 54.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.704 1.602 . . . . 0.0 113.388 176.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 41.0 ttt-85 -137.0 35.37 2.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.019 1.328 . . . . 0.0 110.586 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.19 95.86 0.43 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.325 1.85 . . . . 0.0 109.736 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 85.3 tttt 58.08 93.47 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.861 2.464 . . . . 0.0 112.328 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt . . . . . 0 C--O 1.249 1.043 0 C-N-CA 125.942 1.697 . . . . 0.0 109.702 176.835 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -80.27 143.52 33.61 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.658 0.783 . . . . 0.0 111.147 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -130.24 68.82 81.61 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.541 1.536 . . . . 0.0 109.064 -177.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.84 -23.32 6.9 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.505 2.803 . . . . 0.0 113.889 -171.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 11.7 t -142.82 56.7 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.45 1.5 . . . . 0.0 107.32 -175.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -144.53 157.11 56.33 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.161 1.385 . . . . 0.0 110.253 -169.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -70.2 157.45 59.49 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.056 2.504 . . . . 0.0 112.108 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -100.8 34.27 2.52 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.289 1.436 . . . . 0.0 110.385 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -135.07 75.54 60.23 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.275 1.43 . . . . 0.0 109.161 -171.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.26 116.1 4.46 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.614 2.876 . . . . 0.0 110.635 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 63.6 p -147.68 137.62 22.82 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.104 1.762 . . . . 0.0 108.474 -174.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -155.26 -42.26 0.08 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 115.705 -2.093 . . . . 0.0 115.099 -173.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.487 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.7 OUTLIER -52.01 173.64 0.03 OUTLIER 'General case' 0 C--N 1.359 0.985 0 CA-C-N 122.223 2.283 . . . . 0.0 112.572 172.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.6 mt -62.83 -6.13 3.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.559 1.543 . . . . 0.0 111.243 172.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 92.4 m -99.29 -11.87 20.86 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 126.298 1.839 . . . . 0.0 112.762 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.7 p80 45.36 48.61 10.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.406 2.283 . . . . 0.0 112.342 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -162.91 147.99 11.78 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.367 1.467 . . . . 0.0 107.539 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 205' ' ' SER . 1.1 t -135.19 171.72 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 127.388 2.275 . . . . 0.0 110.323 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.492 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.3 t 61.36 64.52 1.07 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.61 1.964 . . . . 0.0 112.987 -173.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.86 108.11 1.14 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.48 1.912 . . . . 0.0 108.374 -174.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 59.69 -160.22 19.8 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-O 123.271 1.484 . . . . 0.0 112.631 -174.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.9 pm0 -64.17 148.94 48.85 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.959 2.104 . . . . 0.0 111.621 169.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.8 mtm -150.94 156.17 40.62 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.653 1.981 . . . . 0.0 109.492 -168.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.411 HG13 ' H ' ' A' ' 211' ' ' GLY . 7.2 tp -140.53 -135.56 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -175.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 148.78 133.89 2.32 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 126.054 1.788 . . . . 0.0 112.444 -171.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 50.4 t -64.63 126.58 28.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.168 -1.016 . . . . 0.0 109.013 175.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.91 -7.33 2.33 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -69.61 114.73 26.57 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 119.496 1.044 . . . . 0.0 108.593 171.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -78.45 6.04 5.08 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.418 2.745 . . . . 0.0 112.948 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -118.95 5.58 11.38 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.952 1.701 . . . . 0.0 109.987 174.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.2 t -59.39 131.07 49.87 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 118.487 0.585 . . . . 0.0 109.844 170.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.0 m -74.11 6.31 3.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.725 1.61 . . . . 0.0 113.417 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.0 mm -135.75 -38.15 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 126.54 1.936 . . . . 0.0 109.62 -170.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.86 -43.2 0.53 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.525 2.73 . . . . 0.0 115.511 171.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.487 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -126.02 148.51 49.28 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.566 1.946 . . . . 0.0 108.625 -177.373 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.412 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 74.0 m-85 -149.11 155.31 40.52 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -173.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -83.97 145.1 28.72 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.559 0.695 . . . . 0.0 110.628 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.34 -3.94 1.08 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.005 1.722 . . . . 0.0 113.979 171.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.86 -4.22 7.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.546 1.138 . . . . 0.0 112.185 172.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.3 m -77.44 -3.03 38.3 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.036 0.835 . . . . 0.0 113.02 168.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.2 p -135.02 -6.11 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.789 1.235 . . . . 0.0 112.259 169.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.77 40.88 20.71 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.59 1.091 . . . . 0.0 113.723 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.7 mt -67.76 103.07 1.33 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.517 1.158 . . . . 0.0 110.221 172.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.7 t -71.19 -21.07 62.2 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.813 0.845 . . . . 0.0 111.76 169.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 14.3 t -155.99 172.75 17.86 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.933 1.693 . . . . 0.0 110.1 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -63.45 120.96 66.99 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.47 1.108 . . . . 0.0 108.776 174.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.45 -58.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.615 2.21 . . . . 0.0 111.478 -169.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -172.39 -176.17 1.52 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.771 2.028 . . . . 0.0 108.571 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -78.27 23.05 2.88 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.419 1.009 . . . . 0.0 112.702 168.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -157.3 114.33 3.03 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 125.781 1.633 . . . . 0.0 108.697 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -141.52 160.4 40.23 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.148 1.779 . . . . 0.0 110.347 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -140.98 141.99 34.35 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.297 1.039 . . . . 0.0 109.646 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.0 p -70.02 166.02 37.21 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.485 0.714 . . . . 0.0 111.896 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -73.1 32.48 0.31 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.028 3.152 . . . . 0.0 113.383 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -136.29 -36.74 0.72 Allowed 'General case' 0 C--N 1.344 0.34 0 C-N-CA 125.161 1.385 . . . . 0.0 109.845 171.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 37.5 m -75.4 -33.45 60.98 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 126.779 2.032 . . . . 0.0 111.961 172.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 10.1 t -80.96 -20.77 41.23 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.466 1.506 . . . . 0.0 111.993 175.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -62.16 -38.28 88.45 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.182 1.393 . . . . 0.0 112.312 -174.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.07 -46.11 89.08 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.748 1.619 . . . . 0.0 111.993 176.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 51.46 21.18 1.16 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.19 2.196 . . . . 0.0 115.211 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm 47.63 55.37 8.49 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.586 1.555 . . . . 0.0 111.382 -169.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -142.44 42.57 1.62 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.141 1.376 . . . . 0.0 110.555 -170.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt . . . . . 0 C--O 1.253 1.25 0 C-N-CA 124.837 1.255 . . . . 0.0 111.415 175.796 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.2 ptp . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -145.14 146.03 31.62 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.379 1.072 . . . . 0.0 109.997 -171.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 8.9 tmm? -153.99 98.8 2.58 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.95 152.99 37.06 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.036 2.491 . . . . 0.0 111.806 -176.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.3 t -89.92 84.2 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 174.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.55 153.07 79.0 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.749 1.22 . . . . 0.0 111.32 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.6 128.68 19.55 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.05 2.5 . . . . 0.0 111.151 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -73.88 -8.65 56.89 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.532 1.133 . . . . 0.0 112.988 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -145.23 74.94 14.05 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.298 1.439 . . . . 0.0 108.779 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.74 112.44 3.49 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.865 3.043 . . . . 0.0 110.261 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.9 p -147.46 136.49 22.25 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.53 1.532 . . . . 0.0 109.155 -172.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -154.69 -40.47 0.09 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 115.884 -2.007 . . . . 0.0 115.319 -171.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.519 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.8 OUTLIER -53.43 173.64 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 122.312 2.324 . . . . 0.0 112.213 170.59 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.6 mt -62.44 -7.66 4.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.671 1.588 . . . . 0.0 111.232 171.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 67.6 m -95.75 -12.9 24.67 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 126.062 1.745 . . . . 0.0 112.753 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.5 p80 45.2 49.03 10.02 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.339 2.256 . . . . 0.0 112.232 -173.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -164.27 147.94 9.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.217 1.407 . . . . 0.0 108.147 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -127.45 -169.93 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 127.202 2.201 . . . . 0.0 109.285 174.479 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.444 ' H ' HG12 ' A' ' 204' ' ' VAL . 89.8 p 49.24 58.04 5.83 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.893 2.077 . . . . 0.0 114.324 -174.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.15 100.77 2.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.845 2.058 . . . . 0.0 109.295 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 68.95 -96.78 0.47 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.615 1.578 . . . . 0.0 111.5 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.17 169.47 17.8 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.148 1.779 . . . . 0.0 111.977 -169.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -146.0 161.23 40.57 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.42 1.088 . . . . 0.0 112.073 -169.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.4 HG13 ' H ' ' A' ' 211' ' ' GLY . 4.6 tp -133.31 -134.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 168.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 146.25 133.15 2.46 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 125.493 1.52 . . . . 0.0 111.923 -170.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.51 121.17 14.29 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.374 -0.913 . . . . 0.0 109.082 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -71.78 7.2 1.61 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.51 1.524 . . . . 0.0 113.602 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -71.73 120.2 78.6 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.469 1.107 . . . . 0.0 108.402 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -75.7 6.61 3.58 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.333 2.689 . . . . 0.0 113.361 177.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -119.68 7.67 11.09 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.785 1.634 . . . . 0.0 110.648 174.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.76 129.23 40.44 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 123.438 0.695 . . . . 0.0 110.226 173.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.1 m -81.17 3.45 23.58 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.281 1.432 . . . . 0.0 113.363 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 78.7 mt -134.71 -33.72 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.614 1.565 . . . . 0.0 110.364 -169.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER 73.06 -46.05 0.64 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 128.78 2.832 . . . . 0.0 115.235 170.341 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.519 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.3 OUTLIER -125.44 149.12 48.5 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.588 1.555 . . . . 0.0 109.24 -175.767 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.4 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 82.6 m-85 -149.69 157.88 43.65 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.945 1.298 . . . . 0.0 108.832 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -89.11 144.6 26.01 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.378 0.609 . . . . 0.0 111.174 -172.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -56.57 -8.24 0.53 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.421 2.288 . . . . 0.0 114.245 169.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.86 -7.69 8.43 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.827 1.251 . . . . 0.0 112.297 174.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 10.6 m -77.28 -3.15 38.4 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.044 0.838 . . . . 0.0 112.938 168.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 12.7 p -131.11 -0.44 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 126.091 1.757 . . . . 0.0 110.857 169.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.46 29.33 74.97 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.208 1.385 . . . . 0.0 113.174 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.6 mt -64.59 -48.53 74.61 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.307 1.043 . . . . 0.0 112.362 -171.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.4 m 63.65 -13.63 0.08 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.878 2.071 . . . . 0.0 114.118 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.8 p -144.73 168.99 18.88 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.18 1.792 . . . . 0.0 110.361 -173.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -67.25 128.82 93.83 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-O 118.373 -0.822 . . . . 0.0 108.804 170.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -73.53 -67.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.599 2.199 . . . . 0.0 111.749 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 24.9 ttp85 -173.1 -173.99 1.0 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.63 1.972 . . . . 0.0 108.666 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -75.62 6.53 31.26 Favored Glycine 0 CA--C 1.539 1.567 0 CA-C-O 118.731 -1.039 . . . . 0.0 113.875 169.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -158.04 119.85 3.63 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 125.175 1.39 . . . . 0.0 108.593 175.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.1 t90 -136.2 160.0 40.03 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.08 2.152 . . . . 0.0 109.852 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -139.82 142.43 36.64 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.012 0.925 . . . . 0.0 110.096 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.0 p -70.83 164.96 51.36 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.574 0.75 . . . . 0.0 111.347 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -73.76 31.5 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.047 3.165 . . . . 0.0 113.096 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -136.18 -36.85 0.73 Allowed 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.386 1.474 . . . . 0.0 109.937 176.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 18.8 m -79.21 -30.83 43.5 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 127.354 2.262 . . . . 0.0 112.011 173.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 17.9 t -74.62 -19.24 60.37 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.653 1.181 . . . . 0.0 112.303 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 21.9 tm0? -55.85 -35.9 66.96 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.59 1.556 . . . . 0.0 112.754 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.58 -31.54 62.28 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.543 1.537 . . . . 0.0 113.118 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -116.74 33.42 5.6 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.486 1.514 . . . . 0.0 111.524 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -121.18 32.11 6.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.45 1.5 . . . . 0.0 111.045 178.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -80.49 38.53 0.43 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.112 1.765 . . . . 0.0 111.294 169.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt . . . . . 0 C--O 1.25 1.117 0 C-N-CA 127.097 2.159 . . . . 0.0 111.135 -169.169 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 99.0 mmm . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -144.3 30.71 1.25 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.433 1.093 . . . . 0.0 111.366 -167.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 23.9 ptm -133.67 54.68 13.31 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.416 1.087 . . . . 0.0 113.585 -169.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -68.86 138.47 40.86 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.387 2.058 . . . . 0.0 110.348 170.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 91.0 t -144.64 119.47 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -147.39 147.57 28.67 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.491 1.116 . . . . 0.0 110.404 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -81.74 46.18 2.16 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 125.133 3.889 . . . . 0.0 110.954 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -129.51 -0.87 4.97 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.968 1.307 . . . . 0.0 113.312 -168.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -70.91 125.8 92.05 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 118.857 0.753 . . . . 0.0 110.129 175.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.09 128.77 11.68 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.052 2.501 . . . . 0.0 110.362 174.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 78.5 p -149.27 135.31 18.98 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.615 1.566 . . . . 0.0 108.735 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -156.83 -39.0 0.07 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 115.901 -2.0 . . . . 0.0 115.194 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.502 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.7 OUTLIER -52.86 173.79 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 122.218 2.281 . . . . 0.0 112.438 171.688 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.6 mt -62.88 -6.71 4.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.691 1.596 . . . . 0.0 111.216 171.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.8 m -98.53 -11.31 22.35 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 126.14 1.776 . . . . 0.0 112.712 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.2 p80 45.75 48.92 11.63 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.401 2.28 . . . . 0.0 112.424 -174.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -163.76 148.97 10.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.457 1.503 . . . . 0.0 107.548 176.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 205' ' ' SER . 1.1 t -133.83 172.03 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 127.225 2.21 . . . . 0.0 110.635 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.511 ' H ' HG12 ' A' ' 204' ' ' VAL . 13.2 t 64.66 61.53 0.82 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.869 2.068 . . . . 0.0 113.3 -174.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.82 111.07 1.52 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.396 1.878 . . . . 0.0 108.558 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.5 -163.18 23.44 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-O 123.171 1.428 . . . . 0.0 112.575 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.9 pm0 -65.61 147.27 53.68 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 112.233 -1.983 . . . . 0.0 111.1 169.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.8 mtm -148.98 153.71 38.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.208 1.803 . . . . 0.0 109.743 -168.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.9 tp -137.96 -134.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.346 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -173.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 149.35 132.06 2.03 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 126.232 1.872 . . . . 0.0 112.788 -169.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 47.6 t -64.35 125.35 24.31 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.29 -0.955 . . . . 0.0 108.678 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.8 -0.32 2.14 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.484 1.514 . . . . 0.0 113.245 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -72.97 116.83 54.39 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 124.501 1.121 . . . . 0.0 108.466 168.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.02 4.21 5.97 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.288 2.658 . . . . 0.0 113.217 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -114.78 5.01 15.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.766 1.626 . . . . 0.0 110.526 174.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.98 130.13 45.52 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 122.987 0.515 . . . . 0.0 110.4 171.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.0 m -74.03 1.62 10.59 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.785 1.634 . . . . 0.0 113.868 -176.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 19.1 mt -134.07 -32.82 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 126.091 1.756 . . . . 0.0 110.359 -172.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.77 -37.51 0.38 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 128.366 2.666 . . . . 0.0 115.78 172.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.504 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.5 OUTLIER -130.14 148.77 52.02 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.371 1.868 . . . . 0.0 108.985 -176.774 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.411 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 82.5 m-85 -147.27 155.12 41.77 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.849 0.86 . . . . 0.0 108.868 -175.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -82.05 143.19 31.71 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.922 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -58.97 -7.27 1.0 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.789 1.636 . . . . 0.0 113.827 170.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -118.83 -5.26 10.63 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.412 1.085 . . . . 0.0 112.417 172.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.0 m -78.55 -0.77 30.95 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.903 0.774 . . . . 0.0 112.855 168.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.0 -9.67 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.845 2.058 . . . . 0.0 111.943 173.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 73.14 36.98 55.93 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.575 1.084 . . . . 0.0 112.993 -177.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 21.9 mt -70.3 104.37 2.65 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.854 0.827 . . . . 0.0 109.919 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 71.0 p -73.81 -18.7 60.92 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.224 1.01 . . . . 0.0 112.446 172.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 55.5 p -147.56 167.38 24.68 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.546 1.938 . . . . 0.0 109.616 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -59.95 129.07 87.81 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.781 0.833 . . . . 0.0 110.081 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.51 166.24 30.41 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.043 2.496 . . . . 0.0 112.042 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -73.84 166.35 23.49 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.45 1.1 . . . . 0.0 109.605 169.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -60.8 158.06 29.5 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 123.3 0.476 . . . . 0.0 112.5 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? 52.74 63.84 2.08 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.135 1.374 . . . . 0.0 111.568 -173.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -84.79 159.57 20.42 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.018 1.327 . . . . 0.0 109.468 172.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -139.76 141.66 36.82 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.313 1.045 . . . . 0.0 109.491 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.1 p -67.2 165.58 26.92 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 123.586 0.755 . . . . 0.0 112.109 174.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -72.97 34.84 0.33 Allowed 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.978 3.119 . . . . 0.0 113.274 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -139.11 -37.45 0.51 Allowed 'General case' 0 C--N 1.343 0.324 0 C-N-CA 125.02 1.328 . . . . 0.0 110.275 169.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 19.7 m -72.47 -35.15 68.14 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.934 2.094 . . . . 0.0 112.025 172.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 t -73.11 -34.0 65.89 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.585 1.154 . . . . 0.0 111.201 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -64.96 -30.14 71.11 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.216 1.407 . . . . 0.0 111.68 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.62 -9.82 39.44 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.213 1.805 . . . . 0.0 113.622 175.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 33.9 ttt85 -143.36 30.71 1.38 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.248 1.019 . . . . 0.0 112.018 -170.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 10.8 mtpm? -68.18 96.52 0.64 Allowed 'General case' 0 C--N 1.344 0.336 0 C-N-CA 125.339 1.456 . . . . 0.0 110.229 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -132.31 36.65 3.59 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.222 1.809 . . . . 0.0 110.114 175.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? . . . . . 0 C--O 1.25 1.123 0 C-N-CA 125.791 1.636 . . . . 0.0 109.524 174.654 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 1.2 tmt? . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -157.86 153.0 25.65 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.803 1.241 . . . . 0.0 109.445 176.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 21.0 ptt? -155.99 62.58 3.14 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.324 1.45 . . . . 0.0 110.126 -176.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.3 -40.75 1.5 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.27 2.647 . . . . 0.0 113.565 -169.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . 0.264 9.9 p 44.93 135.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 130.857 3.663 . . . . 0.0 116.576 -175.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -142.65 150.63 54.69 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.841 1.257 . . . . 0.0 110.514 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.76 -40.51 3.7 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.178 2.585 . . . . 0.0 112.327 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 59.5 t30 47.74 27.72 1.14 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.662 1.985 . . . . 0.0 114.228 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -127.47 83.69 65.38 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.657 1.183 . . . . 0.0 110.41 -171.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.84 131.72 17.45 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.413 2.742 . . . . 0.0 111.026 175.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.4 p -149.54 138.42 21.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.964 1.706 . . . . 0.0 108.786 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -156.49 -37.98 0.08 Allowed 'General case' 0 C--N 1.35 0.625 0 CA-C-O 115.728 -2.082 . . . . 0.0 115.958 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.52 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 1.1 t -53.65 174.11 0.05 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 122.49 2.405 . . . . 0.0 111.851 170.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.1 mt -62.33 -7.29 4.12 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.953 1.701 . . . . 0.0 111.283 170.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 69.7 m -97.11 -12.4 23.19 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.989 1.716 . . . . 0.0 112.711 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.4 p80 45.32 49.33 10.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.173 2.189 . . . . 0.0 112.437 -173.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -164.02 148.06 9.97 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.417 1.487 . . . . 0.0 107.864 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -133.86 176.1 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 127.179 2.192 . . . . 0.0 110.81 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.552 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.0 t 63.69 61.85 0.96 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.692 1.997 . . . . 0.0 112.803 -175.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.96 110.08 1.22 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.334 1.853 . . . . 0.0 109.001 -173.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 60.06 -158.78 24.9 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-O 123.21 1.45 . . . . 0.0 113.247 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.8 pm0 -65.49 145.17 56.45 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.098 2.159 . . . . 0.0 111.317 169.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.3 mtm -151.52 156.68 41.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.294 1.838 . . . . 0.0 109.863 -168.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 7.5 tp -138.03 -133.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 124.258 1.023 . . . . 0.0 109.204 -175.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 146.37 136.08 2.85 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 126.466 1.984 . . . . 0.0 113.285 -169.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.532 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 7.0 t -65.14 125.62 25.55 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 114.622 -0.789 . . . . 0.0 109.324 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.2 0.29 0.65 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.589 1.156 . . . . 0.0 112.758 170.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -63.49 111.4 5.07 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 127.783 2.433 . . . . 0.0 107.844 167.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -78.58 11.5 2.44 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.374 2.716 . . . . 0.0 113.031 -176.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -129.23 9.04 5.61 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.161 1.784 . . . . 0.0 109.787 174.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 25.8 t -55.58 124.11 16.25 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.636 0.732 . . . . 0.0 112.403 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 15.8 m -74.34 1.14 12.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.703 2.001 . . . . 0.0 113.271 -177.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 12.5 mt -131.48 -34.55 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 126.382 1.873 . . . . 0.0 109.574 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.13 -25.3 0.16 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 128.017 2.527 . . . . 0.0 115.78 169.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.521 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.6 OUTLIER -143.6 148.06 35.31 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.855 1.662 . . . . 0.0 109.178 -178.433 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -145.96 155.87 43.13 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.168 0.987 . . . . 0.0 108.825 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -80.91 143.16 32.86 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.901 -175.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.99 -2.4 0.41 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.297 1.839 . . . . 0.0 114.12 171.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.61 -7.59 7.42 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.26 1.424 . . . . 0.0 112.166 172.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.6 m -77.27 -2.16 33.35 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.154 0.888 . . . . 0.0 112.678 168.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.77 -5.59 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 127.444 2.298 . . . . 0.0 111.266 172.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.34 36.58 91.85 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.894 1.235 . . . . 0.0 112.885 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.9 -58.64 5.62 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.727 0.811 . . . . 0.0 111.452 -178.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 25.7 m 62.26 -22.22 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.229 2.211 . . . . 0.0 114.58 -172.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 71.1 p -142.01 157.79 44.52 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.687 1.995 . . . . 0.0 109.528 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -65.18 127.19 92.63 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 123.557 0.743 . . . . 0.0 110.986 -173.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.81 174.44 12.58 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.449 2.766 . . . . 0.0 112.091 176.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -69.05 168.71 13.28 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.949 0.9 . . . . 0.0 109.593 167.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -61.03 161.12 25.26 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 123.224 0.44 . . . . 0.0 112.354 173.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.6 tptp 54.7 56.09 7.15 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.102 1.361 . . . . 0.0 112.645 -173.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -74.46 156.11 37.3 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.44 0.696 . . . . 0.0 109.22 172.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.532 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 71.8 m-85 -134.77 135.97 42.25 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.831 0.852 . . . . 0.0 110.655 -176.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 31.2 p -65.96 164.42 28.55 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.311 1.044 . . . . 0.0 112.237 172.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.88 30.84 0.25 Allowed 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.244 3.296 . . . . 0.0 113.664 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -133.67 -36.4 0.96 Allowed 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.545 1.538 . . . . 0.0 110.041 170.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 3.6 m -71.78 -38.19 70.36 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.158 1.783 . . . . 0.0 112.156 169.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 17.6 t -81.39 -27.99 34.55 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.826 1.251 . . . . 0.0 111.155 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -65.21 -31.62 72.89 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.451 1.5 . . . . 0.0 111.46 173.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.74 -27.48 68.76 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.9 1.68 . . . . 0.0 112.584 175.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 64.2 ttt-85 33.79 70.47 0.12 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 128.407 2.683 . . . . 0.0 114.049 172.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -70.66 -175.43 1.07 Allowed 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.458 1.903 . . . . 0.0 111.066 -176.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -79.22 34.58 0.25 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.645 2.378 . . . . 0.0 111.531 169.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 83.8 tttt . . . . . 0 C--O 1.252 1.21 0 C-N-CA 127.493 2.317 . . . . 0.0 110.806 -168.479 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 66.7 ttp . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -73.5 -48.66 31.57 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.739 0.816 . . . . 0.0 111.403 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 14.0 tpt 19.79 68.79 0.25 Allowed Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 129.233 3.013 . . . . 0.0 114.305 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.06 -41.9 2.39 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.681 2.254 . . . . 0.0 112.809 -170.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . 0.259 1.3 p 49.19 145.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 130.656 3.582 . . . . 0.0 115.727 -174.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 29.3 t70 43.12 76.81 0.49 Allowed Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 126.518 1.927 . . . . 0.0 112.599 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -65.48 136.08 45.13 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.951 2.434 . . . . 0.0 111.626 -172.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -132.75 19.13 4.21 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.385 1.474 . . . . 0.0 111.078 -176.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -57.3 129.72 80.02 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.278 1.431 . . . . 0.0 111.766 -171.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.07 118.07 5.44 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.147 2.565 . . . . 0.0 110.261 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 82.0 p -149.24 132.13 16.11 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.751 1.62 . . . . 0.0 108.409 176.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -156.55 -46.56 0.07 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 117.861 -1.066 . . . . 0.0 113.804 -175.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.506 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -39.38 170.05 0.0 OUTLIER 'General case' 0 C--N 1.349 0.578 0 C-N-CA 126.375 1.87 . . . . 0.0 114.064 168.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -71.08 -6.74 41.44 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.118 168.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.506 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 95.7 m -95.89 -14.31 23.26 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 123.633 0.773 . . . . 0.0 111.792 174.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.1 p80 46.25 52.34 10.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.304 2.242 . . . . 0.0 112.899 -173.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -170.36 141.62 2.03 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 126.091 1.756 . . . . 0.0 107.95 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 205' ' ' SER . 1.6 t -126.47 171.11 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 125.488 1.515 . . . . 0.0 111.18 -176.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.505 ' H ' HG12 ' A' ' 204' ' ' VAL . 43.2 m 68.72 62.81 0.33 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.267 2.227 . . . . 0.0 113.387 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.65 113.45 1.29 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.595 1.958 . . . . 0.0 108.531 -174.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 63.26 -168.68 20.12 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-O 122.708 1.171 . . . . 0.0 112.06 -173.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -69.02 150.53 47.55 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 113.273 -1.463 . . . . 0.0 110.651 168.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.9 mtm -143.63 152.57 41.53 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.929 1.692 . . . . 0.0 109.824 -166.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.6 tp -135.5 -138.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.304 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 151.86 132.4 1.85 Allowed Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 125.906 1.717 . . . . 0.0 112.151 -169.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 40.7 t -63.61 125.55 24.63 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 114.074 -1.063 . . . . 0.0 108.249 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -68.9 6.16 0.96 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.54 1.136 . . . . 0.0 113.559 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -74.42 114.11 30.47 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 166.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -77.65 9.11 3.06 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.328 2.685 . . . . 0.0 113.059 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -124.21 8.74 8.55 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.888 1.675 . . . . 0.0 110.248 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.6 129.97 44.23 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 118.306 0.503 . . . . 0.0 109.924 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -73.59 4.36 5.05 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.755 1.622 . . . . 0.0 113.404 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.2 mt -132.54 -35.17 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 126.268 1.827 . . . . 0.0 109.938 -175.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.7 -38.72 0.43 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.762 2.425 . . . . 0.0 115.27 170.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.47 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -131.43 148.67 52.67 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.899 2.08 . . . . 0.0 108.646 -174.215 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -148.62 146.72 28.35 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -73.22 149.61 42.7 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.793 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -60.29 -6.28 1.43 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.74 1.216 . . . . 0.0 113.641 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -120.36 -0.56 10.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.33 1.052 . . . . 0.0 112.611 170.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.5 m -72.61 -5.99 41.11 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.901 0.773 . . . . 0.0 111.301 166.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.1 p -137.48 -12.48 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.765 2.026 . . . . 0.0 112.388 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.97 38.84 55.62 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.348 0.975 . . . . 0.0 112.86 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.7 111.12 3.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 117.82 0.81 . . . . 0.0 109.796 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 73.6 p -78.04 -15.69 58.7 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.44 1.096 . . . . 0.0 112.565 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 15.1 t -155.59 172.29 18.53 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.759 1.623 . . . . 0.0 109.822 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -66.74 127.04 93.27 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 124.599 1.16 . . . . 0.0 109.948 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.04 170.65 19.66 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.149 2.566 . . . . 0.0 112.121 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 50.6 ttp85 -63.71 168.87 4.47 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.208 1.403 . . . . 0.0 111.15 172.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -60.92 -1.5 2.02 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.92 1.724 . . . . 0.0 116.169 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -139.3 116.95 11.45 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.744 1.618 . . . . 0.0 107.361 169.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -130.57 156.17 45.28 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.54 2.336 . . . . 0.0 109.245 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -140.12 143.21 36.11 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.2 1.0 . . . . 0.0 108.755 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 17.1 p -68.12 163.37 51.99 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-O 118.808 -0.615 . . . . 0.0 111.633 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.25 33.81 0.32 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.965 3.11 . . . . 0.0 112.891 178.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -138.26 -35.7 0.61 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 125.988 1.715 . . . . 0.0 109.964 173.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 15.7 m -75.36 -35.8 61.07 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.774 2.03 . . . . 0.0 111.591 170.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 8.2 t -81.36 -5.97 58.42 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.272 1.429 . . . . 0.0 112.781 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -73.49 -40.18 64.3 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.962 0.905 . . . . 0.0 111.497 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -58.3 -47.74 82.7 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.868 1.667 . . . . 0.0 111.85 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 50.09 32.91 6.29 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.553 1.941 . . . . 0.0 114.822 170.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 56.3 tttm 50.45 56.46 7.92 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.081 1.753 . . . . 0.0 111.593 -174.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -138.7 30.76 2.3 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.119 1.368 . . . . 0.0 111.695 -172.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 83.4 tttt . . . . . 0 C--O 1.252 1.205 0 C-N-CA 127.65 2.38 . . . . 0.0 112.647 178.439 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 58.0 tpp . . . . . 0 N--CA 1.475 0.805 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -81.68 17.28 1.5 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.51 1.524 . . . . 0.0 113.024 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 25.5 ttt -57.73 -46.92 99.71 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-O 116.856 -1.545 . . . . 0.0 113.816 -177.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -75.63 142.5 26.07 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.042 1.828 . . . . 0.0 110.032 169.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 88.8 t -66.86 -52.96 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.621 0.769 . . . . 0.0 110.185 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -166.62 -55.39 0.01 OUTLIER Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.942 1.697 . . . . 0.0 110.145 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -72.97 131.58 17.07 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.045 1.83 . . . . 0.0 110.638 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -156.85 23.67 0.32 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.765 1.226 . . . . 0.0 111.178 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.85 118.22 27.4 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.445 1.498 . . . . 0.0 111.535 -172.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -88.54 26.23 0.59 Allowed 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 124.119 3.212 . . . . 0.0 113.557 -173.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.6 p -141.75 140.07 32.99 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.954 1.702 . . . . 0.0 109.361 -173.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -156.28 -38.91 0.08 Allowed 'General case' 0 C--N 1.35 0.623 0 CA-C-O 115.764 -2.065 . . . . 0.0 115.725 -174.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.516 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.8 OUTLIER -53.1 174.2 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 122.449 2.386 . . . . 0.0 112.145 172.035 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.0 mt -62.65 -6.3 3.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.734 1.614 . . . . 0.0 111.275 170.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 82.6 m -99.32 -12.1 20.63 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 126.193 1.797 . . . . 0.0 112.699 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.0 p80 45.19 49.03 10.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.189 2.196 . . . . 0.0 112.357 -174.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -164.15 148.16 9.8 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 125.572 1.549 . . . . 0.0 108.045 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -132.26 175.51 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 127.244 2.218 . . . . 0.0 110.253 178.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.504 ' H ' HG12 ' A' ' 204' ' ' VAL . 16.8 t 61.93 63.1 1.15 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.377 1.871 . . . . 0.0 113.292 -175.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -161.12 112.58 1.81 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.333 1.853 . . . . 0.0 109.165 -173.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.48 -110.02 3.24 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 125.232 1.396 . . . . 0.0 109.872 -172.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.14 165.9 24.64 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.84 2.056 . . . . 0.0 111.332 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -138.72 157.16 46.62 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.742 1.217 . . . . 0.0 111.063 -168.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.421 HG12 ' H ' ' A' ' 211' ' ' GLY . 9.5 tt -134.48 -136.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 174.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 147.59 132.08 2.2 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 125.167 1.365 . . . . 0.0 113.113 -170.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.5 t -65.86 123.44 19.81 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.9 0.88 . . . . 0.0 108.777 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.34 -1.8 3.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.71 1.604 . . . . 0.0 113.574 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -66.93 116.29 33.97 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 168.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.93 5.15 5.15 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.409 2.739 . . . . 0.0 113.009 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -117.69 6.16 12.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.902 1.681 . . . . 0.0 110.424 174.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 41.8 t -59.01 130.23 46.03 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 122.973 0.509 . . . . 0.0 110.378 172.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.3 t -76.07 3.21 10.92 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.732 1.613 . . . . 0.0 113.617 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 19.6 mt -134.42 -35.02 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.995 1.718 . . . . 0.0 110.279 -172.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.22 -40.95 0.49 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.992 2.517 . . . . 0.0 115.38 172.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.516 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.5 OUTLIER -126.56 147.67 49.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.135 1.774 . . . . 0.0 108.837 -177.683 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -146.89 157.48 43.66 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.39 1.076 . . . . 0.0 108.794 -175.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -84.16 141.82 30.78 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.793 -175.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.73 -8.55 1.35 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.574 1.949 . . . . 0.0 113.096 169.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -118.01 -7.06 10.91 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.823 1.249 . . . . 0.0 112.189 174.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 4.6 m -77.9 -2.1 35.09 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.94 0.791 . . . . 0.0 112.306 168.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 14.3 p -130.86 -6.31 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 126.955 2.102 . . . . 0.0 111.481 173.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.67 35.32 89.65 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.735 1.16 . . . . 0.0 113.176 -176.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.7 mt -66.29 155.54 36.91 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.366 1.083 . . . . 0.0 111.315 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 90.6 m -134.46 -12.58 2.37 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.758 1.623 . . . . 0.0 110.924 -176.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 9.9 t -148.49 165.09 32.22 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 125.649 1.579 . . . . 0.0 109.859 174.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -79.63 119.51 77.1 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.33 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.06 172.14 16.67 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.434 2.756 . . . . 0.0 111.46 176.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -146.11 153.54 40.8 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.066 0.946 . . . . 0.0 109.897 174.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 109.56 -82.55 0.3 Allowed Glycine 0 C--N 1.338 0.686 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -175.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -168.92 139.56 2.38 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.732 2.013 . . . . 0.0 107.491 168.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' TRP . . . . . 0.4 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 91.4 t90 -106.35 162.65 13.5 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.277 1.831 . . . . 0.0 110.256 177.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -139.02 141.13 38.29 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.864 1.266 . . . . 0.0 109.125 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' CYS . . . . . 0.4 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 17.6 p -66.88 162.87 48.85 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.302 0.641 . . . . 0.0 112.071 173.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -73.63 35.99 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 124.006 3.137 . . . . 0.0 112.888 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -138.46 -35.68 0.59 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.868 1.667 . . . . 0.0 109.935 170.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 17.6 m -72.34 -34.87 68.36 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.424 1.89 . . . . 0.0 111.832 169.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 10.5 t -80.33 -14.92 57.97 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.086 1.354 . . . . 0.0 112.873 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -67.11 -19.51 65.64 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.81 0.844 . . . . 0.0 113.006 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -58.76 -27.26 64.8 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.504 1.922 . . . . 0.0 113.82 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 40.2 mtp180 -136.01 43.44 2.54 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.388 1.075 . . . . 0.0 111.345 -170.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -68.45 86.94 0.3 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.319 1.848 . . . . 0.0 110.917 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -135.5 28.08 3.36 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.901 1.68 . . . . 0.0 111.21 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? . . . . . 0 C--O 1.251 1.171 0 C-N-CA 127.481 2.313 . . . . 0.0 111.502 -169.803 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 68.4 mtt . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -66.48 143.75 56.9 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.493 1.117 . . . . 0.0 110.843 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 73.3 mtm -142.7 73.56 19.5 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 124.883 1.273 . . . . 0.0 108.975 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -78.94 21.93 0.7 Allowed 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 124.678 3.586 . . . . 0.0 113.418 -175.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.7 t -128.53 40.26 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.378 1.471 . . . . 0.0 109.319 -171.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -142.52 151.5 57.71 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.502 1.521 . . . . 0.0 110.132 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.45 126.45 13.53 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.315 2.677 . . . . 0.0 110.81 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -153.77 35.74 0.45 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.577 1.151 . . . . 0.0 110.809 -174.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -135.24 80.29 47.22 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.885 1.274 . . . . 0.0 109.391 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.02 126.96 11.66 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.504 2.803 . . . . 0.0 111.115 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.8 p -147.43 141.66 26.19 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.078 1.751 . . . . 0.0 108.841 -174.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -155.42 -47.14 0.08 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -173.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.495 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -38.6 170.11 0.0 OUTLIER 'General case' 0 C--N 1.351 0.635 0 C-N-CA 126.557 1.943 . . . . 0.0 114.607 169.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.3 mt -70.57 -6.7 38.44 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 113.32 -1.764 . . . . 0.0 110.044 168.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.495 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 84.9 m -96.77 -14.18 22.13 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 123.646 0.778 . . . . 0.0 111.784 174.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.8 p80 45.46 52.27 9.16 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.224 2.21 . . . . 0.0 112.915 -173.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -169.9 140.7 2.1 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.934 1.694 . . . . 0.0 108.269 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.499 HG12 ' H ' ' A' ' 205' ' ' SER . 0.9 OUTLIER -125.0 174.1 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.675 1.59 . . . . 0.0 110.634 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.499 ' H ' HG12 ' A' ' 204' ' ' VAL . 13.7 t 66.36 62.05 0.57 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.721 2.009 . . . . 0.0 113.413 -174.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.75 110.87 1.98 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.174 1.79 . . . . 0.0 108.977 -175.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 66.81 -109.51 2.95 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 125.283 1.421 . . . . 0.0 110.438 -172.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.61 168.64 19.35 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.123 2.169 . . . . 0.0 111.139 -174.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -140.35 158.89 43.33 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.719 0.808 . . . . 0.0 112.748 -168.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.451 HG13 ' H ' ' A' ' 211' ' ' GLY . 7.2 tp -133.18 -138.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.401 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.451 ' H ' HG13 ' A' ' 210' ' ' ILE . . . 145.43 134.6 2.73 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 126.165 1.84 . . . . 0.0 111.714 -169.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.419 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 41.4 t -63.18 126.38 27.21 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.75 -4.29 3.0 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.376 1.47 . . . . 0.0 113.545 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -71.72 118.85 70.32 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.458 1.103 . . . . 0.0 109.071 169.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.36 3.76 6.02 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.362 2.708 . . . . 0.0 113.283 176.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -115.04 6.11 15.14 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.912 1.685 . . . . 0.0 110.495 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 50.8 t -58.18 128.37 36.78 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 123.174 0.59 . . . . 0.0 109.905 171.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.9 t -74.14 1.74 10.52 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.7 1.6 . . . . 0.0 113.442 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.5 mm -134.33 -35.08 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.848 1.659 . . . . 0.0 110.126 -170.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.92 -38.34 0.4 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.117 2.567 . . . . 0.0 115.201 169.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.451 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.0 OUTLIER -135.8 148.91 48.92 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.936 1.694 . . . . 0.0 109.168 -174.605 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -149.15 148.13 29.28 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -72.15 150.89 43.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.264 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -59.03 -4.6 0.51 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.884 1.674 . . . . 0.0 113.027 166.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.86 -3.69 8.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.237 1.415 . . . . 0.0 112.647 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 18.8 m -72.92 -6.2 43.59 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.107 0.867 . . . . 0.0 111.645 167.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.22 -4.76 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 126.179 1.792 . . . . 0.0 111.709 172.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.69 32.57 74.56 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.753 1.168 . . . . 0.0 113.117 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.6 mt -66.53 -51.07 60.6 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.375 1.07 . . . . 0.0 112.048 -175.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . 0.278 2.6 t 46.69 8.98 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 128.549 2.74 . . . . 0.0 116.263 -169.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 75.1 p -147.4 162.97 37.92 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.319 1.848 . . . . 0.0 110.228 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -68.13 121.61 80.78 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 124.103 0.961 . . . . 0.0 109.259 172.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.64 164.38 20.9 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.229 2.619 . . . . 0.0 112.042 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -67.09 159.4 28.89 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.76 0.824 . . . . 0.0 109.77 169.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -57.9 155.14 21.52 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.836 0.731 . . . . 0.0 112.883 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt 53.06 64.77 1.73 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.341 1.456 . . . . 0.0 111.56 -170.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.1 t90 -81.83 152.7 26.78 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 113.168 -1.833 . . . . 0.0 109.044 169.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.419 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 93.3 m-85 -140.49 140.89 35.39 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.826 0.851 . . . . 0.0 109.506 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 242' ' ' CYS . 6.0 p -70.16 167.36 25.91 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.118 0.967 . . . . 0.0 112.174 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -69.59 9.32 0.58 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 123.463 2.776 . . . . 0.0 114.42 -176.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -133.41 27.03 4.11 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.188 1.795 . . . . 0.0 111.504 176.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 239' ' ' CYS . 3.7 t -152.16 -32.26 0.14 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.11 1.764 . . . . 0.0 110.768 -173.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 76.0 p -70.32 -29.98 66.84 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.395 1.478 . . . . 0.0 112.2 170.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -67.61 -34.23 76.58 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.385 1.474 . . . . 0.0 112.294 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -57.02 -50.9 71.31 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.867 1.667 . . . . 0.0 111.888 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 52.22 27.95 5.14 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.648 1.979 . . . . 0.0 114.823 172.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt 47.72 43.76 17.06 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.069 1.748 . . . . 0.0 111.691 -171.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.1 tptm 59.84 118.62 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.326 2.65 . . . . 0.0 112.042 -167.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? . . . . . 0 C--O 1.251 1.161 0 CA-C-O 116.427 -1.749 . . . . 0.0 107.313 170.387 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -68.68 156.63 37.85 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.937 0.895 . . . . 0.0 111.465 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 64.6 mtt -139.17 74.47 35.99 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.675 1.59 . . . . 0.0 108.191 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.56 164.18 36.56 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.639 2.893 . . . . 0.0 112.35 -174.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.479 HG12 ' H ' ' A' ' 192' ' ' ASP . 0.6 OUTLIER -141.07 -173.25 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 125.953 1.701 . . . . 0.0 107.961 -176.127 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.479 ' H ' HG12 ' A' ' 191' ' ' VAL . 26.1 m-20 68.33 154.71 0.14 Allowed Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 128.183 2.593 . . . . 0.0 112.916 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.43 144.88 63.11 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.635 2.224 . . . . 0.0 111.403 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -65.8 -19.57 65.94 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.623 1.169 . . . . 0.0 112.824 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -144.94 83.1 9.6 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.949 1.3 . . . . 0.0 108.452 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.09 121.16 7.99 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.275 2.65 . . . . 0.0 110.48 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.7 p -148.81 135.55 19.73 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.909 1.684 . . . . 0.0 108.615 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -156.41 -37.92 0.08 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 115.935 -1.983 . . . . 0.0 115.759 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.512 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.9 OUTLIER -53.82 174.11 0.05 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 122.352 2.342 . . . . 0.0 111.97 169.948 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.3 mt -62.52 -7.46 4.66 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.869 1.668 . . . . 0.0 111.278 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 67.0 m -96.62 -12.54 23.8 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.943 1.697 . . . . 0.0 112.68 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.8 p80 45.16 49.27 9.83 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.262 2.225 . . . . 0.0 112.371 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -163.92 148.29 10.24 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.352 1.461 . . . . 0.0 107.825 175.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -134.66 174.48 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 127.274 2.23 . . . . 0.0 110.796 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.547 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.0 t 63.64 62.04 0.96 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.653 1.981 . . . . 0.0 112.727 -174.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.88 108.74 1.16 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.546 1.938 . . . . 0.0 108.716 -173.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 60.48 -160.14 24.17 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-O 123.296 1.498 . . . . 0.0 113.172 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.8 pm0 -65.6 147.24 53.72 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.337 2.255 . . . . 0.0 111.63 170.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.6 mtm -150.57 158.83 44.6 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.186 1.794 . . . . 0.0 110.218 -168.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 9.2 tp -139.35 -133.87 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.247 1.019 . . . . 0.0 109.219 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 147.29 136.01 2.75 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 126.456 1.979 . . . . 0.0 113.14 -169.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.516 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 7.1 t -64.59 124.98 23.27 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 114.642 -0.779 . . . . 0.0 109.124 177.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.45 1.59 0.52 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.631 1.173 . . . . 0.0 113.105 170.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -63.73 111.65 5.69 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 127.622 2.369 . . . . 0.0 107.951 167.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -78.7 11.46 2.49 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.455 2.77 . . . . 0.0 112.916 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -128.95 9.08 5.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.087 1.755 . . . . 0.0 109.798 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 20.8 t -56.65 123.21 14.1 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-O 121.542 0.687 . . . . 0.0 112.131 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 39.7 m -74.5 0.35 15.03 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.537 1.935 . . . . 0.0 113.321 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 14.5 mt -129.14 -34.76 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.436 1.894 . . . . 0.0 109.425 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.75 -25.63 0.15 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.144 2.578 . . . . 0.0 115.77 169.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.52 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.6 OUTLIER -142.45 148.59 38.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.957 1.703 . . . . 0.0 109.041 -177.503 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -147.03 156.61 43.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.095 0.958 . . . . 0.0 108.511 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -82.74 143.58 30.78 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.43 0.633 . . . . 0.0 110.203 -175.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.17 -4.36 0.51 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.675 1.99 . . . . 0.0 114.056 170.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.1 -8.92 7.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.364 1.466 . . . . 0.0 112.215 173.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.5 m -76.68 -2.57 33.53 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.102 0.865 . . . . 0.0 112.81 168.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.2 p -131.43 -1.62 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 126.675 1.99 . . . . 0.0 110.931 170.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 62.45 34.12 88.43 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.112 1.339 . . . . 0.0 113.003 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.76 -53.76 41.97 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 117.859 0.829 . . . . 0.0 111.524 -174.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 36.1 p 48.67 10.32 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.976 2.51 . . . . 0.0 116.118 -173.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 11.0 t -156.84 165.05 37.32 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 125.829 1.652 . . . . 0.0 110.328 174.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -61.27 118.54 37.62 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.84 1.656 . . . . 0.0 108.756 177.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.58 169.76 21.58 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.393 2.729 . . . . 0.0 113.194 -174.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.53 172.31 4.24 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.267 1.027 . . . . 0.0 110.239 168.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -60.42 148.29 44.34 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.374 0.512 . . . . 0.0 111.974 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 46.1 tttp 43.93 82.13 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.284 2.234 . . . . 0.0 113.845 -175.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 86.7 t90 -81.55 157.53 24.75 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.039 0.935 . . . . 0.0 109.66 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.516 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 88.7 m-85 -135.92 136.65 40.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.942 0.897 . . . . 0.0 110.592 -176.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 30.6 p -69.8 164.53 50.35 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 124.259 1.023 . . . . 0.0 112.163 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.28 28.85 0.26 Allowed 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 124.352 3.368 . . . . 0.0 113.817 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -132.15 -30.22 1.56 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.722 2.009 . . . . 0.0 110.079 174.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 2.0 m -81.49 -31.0 33.1 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.301 2.24 . . . . 0.0 112.312 169.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.5 t -70.09 -19.54 63.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.216 1.406 . . . . 0.0 112.393 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.52 -38.48 91.15 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.945 1.298 . . . . 0.0 111.1 170.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 246' ' ' ARG . 0.9 OUTLIER -71.83 179.77 3.02 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.919 1.688 . . . . 0.0 112.114 173.327 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.415 ' H ' ' CD ' ' A' ' 245' ' ' GLU . 32.4 ttm105 55.12 64.29 1.84 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.228 1.811 . . . . 0.0 111.258 -176.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -80.94 -156.3 0.13 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.556 1.942 . . . . 0.0 109.721 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.24 126.09 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 128.488 2.715 . . . . 0.0 111.565 -173.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.481 ' HA ' ' HE2' ' A' ' 249' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.062 0 C-N-CA 127.917 2.487 . . . . 0.0 112.902 -174.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 33.3 t70 62.64 159.49 0.07 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.044 2.137 . . . . 0.0 113.425 -170.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.0 ttt -152.08 89.56 3.96 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.254 1.422 . . . . 0.0 107.997 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.0 156.74 59.57 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.977 2.452 . . . . 0.0 111.486 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.0 -34.79 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.405 1.082 . . . . 0.0 111.616 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 28.4 t70 40.75 73.57 0.85 Allowed Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 126.368 1.867 . . . . 0.0 112.469 -171.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -67.23 88.6 0.32 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 124.304 3.336 . . . . 0.0 109.54 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -152.9 48.69 0.72 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.847 1.659 . . . . 0.0 109.054 -167.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -118.61 91.47 42.01 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.098 1.359 . . . . 0.0 109.159 -171.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.33 141.61 29.02 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.092 2.528 . . . . 0.0 110.856 177.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.8 p -148.47 141.17 24.54 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.996 1.718 . . . . 0.0 108.789 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -155.34 -44.47 0.08 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.504 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -38.86 169.84 0.0 OUTLIER 'General case' 0 C--N 1.349 0.578 0 C-N-CA 126.299 1.839 . . . . 0.0 114.257 168.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.6 mt -71.05 -6.34 38.28 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 113.417 -1.72 . . . . 0.0 110.129 168.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.504 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 86.9 m -96.69 -14.2 22.24 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 123.617 0.767 . . . . 0.0 111.819 174.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.9 p80 45.87 52.7 9.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.21 2.204 . . . . 0.0 112.779 -173.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.42 140.39 2.27 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 125.818 1.647 . . . . 0.0 107.958 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 205' ' ' SER . 1.4 t -129.34 171.02 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.368 1.467 . . . . 0.0 111.069 -176.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.511 ' H ' HG12 ' A' ' 204' ' ' VAL . 7.8 t 67.04 64.75 0.44 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.033 2.133 . . . . 0.0 113.048 -174.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.15 113.63 1.21 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.468 1.907 . . . . 0.0 108.48 -175.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.36 -162.68 23.8 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 123.181 1.434 . . . . 0.0 112.769 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.456 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.7 pm0 -67.61 145.05 55.23 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 112.223 -1.988 . . . . 0.0 110.829 169.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.4 mtm -146.45 152.89 39.75 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.166 1.787 . . . . 0.0 109.858 -168.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 9.7 tp -138.98 -137.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.36 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 -174.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 152.92 133.01 1.83 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 125.938 1.732 . . . . 0.0 112.375 -169.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 43.9 t -63.08 124.39 21.03 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.081 -1.059 . . . . 0.0 108.395 175.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.63 4.87 1.22 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.353 1.461 . . . . 0.0 113.426 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -74.95 114.59 36.35 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 167.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.31 9.07 2.97 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.384 2.722 . . . . 0.0 113.009 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -123.89 8.76 8.74 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.798 1.639 . . . . 0.0 110.34 175.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.79 130.88 48.69 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 118.293 0.497 . . . . 0.0 109.951 172.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.5 t -73.48 3.86 5.55 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.794 1.638 . . . . 0.0 113.578 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 30.7 mt -132.96 -34.61 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 126.274 1.829 . . . . 0.0 110.035 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.79 -39.54 0.45 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.624 2.369 . . . . 0.0 115.415 170.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.473 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -130.7 148.6 52.5 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.923 2.089 . . . . 0.0 108.371 -174.283 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -148.63 145.9 27.97 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -175.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -71.64 149.78 45.25 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.634 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.38 -6.04 1.39 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.742 1.217 . . . . 0.0 113.389 168.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -121.66 0.1 9.79 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.454 1.102 . . . . 0.0 112.588 170.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.1 m -72.1 -6.77 44.87 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.946 0.794 . . . . 0.0 111.252 166.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.12 -12.67 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 126.376 1.87 . . . . 0.0 112.627 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.22 36.61 34.44 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.422 1.011 . . . . 0.0 113.113 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 17.0 mt -68.62 104.3 1.93 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.309 1.044 . . . . 0.0 109.838 174.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.7 t -71.89 -17.82 62.09 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.46 1.104 . . . . 0.0 112.575 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 14.1 t -152.66 174.56 13.83 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.679 1.592 . . . . 0.0 110.017 176.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -65.98 131.03 94.48 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.457 1.103 . . . . 0.0 110.085 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.26 176.94 9.42 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.38 2.72 . . . . 0.0 112.011 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -61.66 170.94 1.72 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.924 1.29 . . . . 0.0 111.677 171.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -68.21 8.77 1.86 Allowed Glycine 0 CA--C 1.539 1.546 0 C-N-CA 125.281 1.42 . . . . 0.0 115.063 177.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -150.46 112.33 4.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.165 1.386 . . . . 0.0 107.443 170.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 87.4 t90 -128.07 157.82 39.66 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.226 1.81 . . . . 0.0 109.745 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -140.08 140.01 36.01 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.204 1.001 . . . . 0.0 109.093 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 16.6 p -68.94 164.69 44.84 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 123.614 0.765 . . . . 0.0 112.187 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.47 35.3 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.291 3.327 . . . . 0.0 113.071 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -139.55 -28.65 0.76 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.622 1.569 . . . . 0.0 111.032 169.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 7.5 m -88.27 -29.63 20.26 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 127.521 2.328 . . . . 0.0 112.18 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 16.1 t -73.41 -20.11 60.82 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.133 0.973 . . . . 0.0 112.159 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 17.0 mp0 -69.9 -25.67 63.8 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.453 1.501 . . . . 0.0 112.078 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -11.81 31.64 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.739 1.616 . . . . 0.0 113.253 172.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -130.84 31.77 4.45 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.691 1.597 . . . . 0.0 110.967 -175.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -63.77 93.93 0.09 Allowed 'General case' 0 C--N 1.345 0.38 0 C-N-CA 125.731 1.612 . . . . 0.0 109.819 169.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -137.81 68.19 1.41 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.288 2.235 . . . . 0.0 106.827 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt . . . . . 0 C--O 1.251 1.17 0 C-N-CA 126.882 2.073 . . . . 0.0 110.15 -168.347 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 119.255 -0.402 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -148.17 158.38 44.04 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.861 1.265 . . . . 0.0 110.463 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -156.39 99.19 2.11 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 124.271 1.028 . . . . 0.0 108.619 175.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.68 132.9 16.41 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.722 2.281 . . . . 0.0 109.269 169.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.9 t -83.64 -89.5 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.457 ' H ' ' HD2' ' A' ' 193' ' ' PRO . 12.8 m-20 -154.87 -54.3 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 125.487 1.515 . . . . 0.0 111.399 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.457 ' HD2' ' H ' ' A' ' 192' ' ' ASP . 73.3 Cg_endo -77.89 -40.96 0.34 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 CA-C-N 122.037 1.763 . . . . 0.0 113.18 -175.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 47.13 32.88 2.17 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.519 1.528 . . . . 0.0 112.871 -169.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -128.04 84.58 62.87 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.172 1.389 . . . . 0.0 109.907 -169.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -81.81 164.7 18.03 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 124.377 3.385 . . . . 0.0 111.889 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.1 p 64.54 144.44 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.869 2.467 . . . . 0.0 112.472 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -155.55 -41.53 0.08 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -166.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.514 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.7 p -38.56 170.15 0.0 OUTLIER 'General case' 0 C--N 1.347 0.49 0 C-N-CA 126.392 1.877 . . . . 0.0 113.973 168.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.1 mt -70.68 -6.17 35.17 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.149 168.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.514 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 93.4 m -96.38 -14.14 22.7 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 123.659 0.784 . . . . 0.0 111.705 174.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.2 p80 46.38 50.92 12.06 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.903 2.081 . . . . 0.0 112.388 -174.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -168.26 141.63 3.16 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 125.068 1.347 . . . . 0.0 108.035 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -124.84 -177.39 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.618 1.567 . . . . 0.0 110.293 177.124 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.475 ' H ' HG12 ' A' ' 204' ' ' VAL . 10.6 t 62.16 57.59 1.99 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.294 2.238 . . . . 0.0 114.449 -169.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' TYR . . . . . 0.433 ' H ' ' CE ' ' A' ' 209' ' ' MET . 0.1 OUTLIER -164.04 113.85 1.24 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.574 1.95 . . . . 0.0 109.834 -177.008 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 66.09 -174.23 21.72 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 122.888 1.271 . . . . 0.0 114.099 176.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -62.05 151.3 35.78 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.474 1.91 . . . . 0.0 111.846 169.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.433 ' CE ' ' H ' ' A' ' 206' ' ' TYR . 26.0 mtt -145.14 160.6 41.18 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.625 1.17 . . . . 0.0 112.724 -166.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . 0.265 9.6 tp -138.33 -139.21 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 145.73 135.22 2.78 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 126.486 1.993 . . . . 0.0 111.787 -168.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 6.6 t -65.1 123.18 18.83 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 124.447 0.734 . . . . 0.0 109.208 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.68 1.99 0.52 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.851 1.26 . . . . 0.0 113.11 171.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -62.59 112.43 6.57 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.903 2.481 . . . . 0.0 107.658 166.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -78.28 12.17 2.15 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.363 2.709 . . . . 0.0 112.953 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -129.8 9.49 5.42 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.081 1.752 . . . . 0.0 109.811 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 15.4 t -57.88 117.89 4.76 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-O 121.647 0.737 . . . . 0.0 111.669 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.7 t -74.49 -2.37 25.34 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.571 1.948 . . . . 0.0 112.571 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.0 mm -117.6 -37.03 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.041 1.736 . . . . 0.0 109.05 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.51 -30.26 0.21 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.25 2.62 . . . . 0.0 115.462 168.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.474 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.0 OUTLIER -144.46 150.15 37.16 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.19 1.796 . . . . 0.0 109.03 -174.576 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -148.12 148.17 30.32 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -71.57 150.41 44.75 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.413 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -60.16 -4.61 0.84 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.904 1.281 . . . . 0.0 113.595 168.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -120.87 -2.5 9.77 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.765 1.226 . . . . 0.0 112.485 170.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 21.2 m -73.36 -5.05 37.2 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.863 0.756 . . . . 0.0 111.606 167.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.5 p -138.91 -9.4 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 126.986 2.114 . . . . 0.0 112.187 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.0 37.13 60.49 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.409 1.004 . . . . 0.0 112.941 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 24.6 mt -68.05 111.27 4.35 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 117.819 0.81 . . . . 0.0 109.909 175.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 66.9 p -79.85 -13.6 59.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.268 1.027 . . . . 0.0 112.525 173.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 14.3 t -158.27 172.83 17.66 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.337 1.455 . . . . 0.0 110.493 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.92 115.7 30.89 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.739 1.616 . . . . 0.0 109.065 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.3 170.42 20.04 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.366 2.711 . . . . 0.0 112.822 -173.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -63.87 165.87 8.1 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.874 0.87 . . . . 0.0 110.898 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -58.87 160.08 16.05 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.117 0.865 . . . . 0.0 113.159 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 43.5 tttp 45.88 69.42 0.46 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.474 1.91 . . . . 0.0 113.164 -170.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -75.7 156.7 34.47 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.97 0.908 . . . . 0.0 109.255 173.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' PHE . . . . . 0.522 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 75.1 m-85 -133.03 135.81 45.62 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.926 0.89 . . . . 0.0 110.298 -176.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 30.8 p -65.6 163.08 37.23 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 123.821 0.848 . . . . 0.0 111.599 170.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.28 28.85 0.26 Allowed 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 124.31 3.34 . . . . 0.0 113.529 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -134.17 -34.85 0.95 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.694 1.998 . . . . 0.0 109.377 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 1.5 m -74.87 -33.42 62.08 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.602 1.961 . . . . 0.0 112.104 169.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.5 t -67.02 -33.38 75.43 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.964 0.906 . . . . 0.0 111.148 173.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 16.9 tm0? -68.93 -37.52 78.95 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.346 1.059 . . . . 0.0 111.247 173.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.11 -30.0 65.94 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.633 1.573 . . . . 0.0 112.968 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 35.71 61.56 0.7 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.516 2.727 . . . . 0.0 114.491 168.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -79.37 64.03 4.15 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.406 1.082 . . . . 0.0 111.668 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt 46.53 53.91 9.32 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.771 2.028 . . . . 0.0 112.703 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.089 0 C-N-CA 126.485 1.914 . . . . 0.0 110.651 -174.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 73.5 mtm . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -128.34 103.01 6.92 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 124.25 1.02 . . . . 0.0 109.427 -170.369 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.2 ttt -150.13 81.58 6.77 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.939 1.295 . . . . 0.0 108.433 179.315 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.47 78.81 2.93 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 124.348 3.365 . . . . 0.0 110.663 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 97.1 t -137.56 -40.48 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.667 1.587 . . . . 0.0 109.332 -175.586 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -71.16 151.65 94.65 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.475 1.11 . . . . 0.0 110.745 172.195 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.64 135.43 33.22 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.096 2.531 . . . . 0.0 110.724 177.697 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -152.23 34.62 0.52 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.476 1.111 . . . . 0.0 110.825 -173.489 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -135.63 73.91 60.51 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 124.75 1.22 . . . . 0.0 109.747 -175.036 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.11 102.23 1.32 Allowed 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.861 3.041 . . . . 0.0 110.465 177.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 55.3 p -144.45 137.58 27.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.939 1.696 . . . . 0.0 108.603 -174.231 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -155.45 -38.5 0.09 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 115.739 -2.077 . . . . 0.0 115.92 -168.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.523 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.8 OUTLIER -53.48 174.29 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 122.551 2.432 . . . . 0.0 112.169 170.554 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.0 mt -62.47 -6.74 3.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.607 1.563 . . . . 0.0 111.212 171.421 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 89.1 m -98.22 -12.53 21.56 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 126.186 1.794 . . . . 0.0 112.71 179.29 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.8 p80 44.97 48.29 9.39 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.219 2.208 . . . . 0.0 112.368 -173.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -162.94 147.16 11.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.461 1.504 . . . . 0.0 108.047 176.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.497 HG12 ' H ' ' A' ' 205' ' ' SER . 0.6 OUTLIER -132.62 175.44 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 127.157 2.183 . . . . 0.0 110.109 178.682 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.497 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.6 t 59.82 65.91 1.06 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.347 1.859 . . . . 0.0 112.824 -174.886 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.62 102.89 1.36 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.344 1.858 . . . . 0.0 109.163 -173.561 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 68.45 -98.4 0.52 Allowed Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.386 1.47 . . . . 0.0 110.392 -172.276 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.26 170.67 15.55 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.401 1.88 . . . . 0.0 111.731 -174.036 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -143.97 160.19 41.26 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.903 1.281 . . . . 0.0 111.364 -169.383 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.421 HG13 ' H ' ' A' ' 211' ' ' GLY . 4.6 tp -133.42 -135.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.372 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 169.439 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 148.19 133.7 2.35 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 125.434 1.493 . . . . 0.0 112.478 -172.297 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 53.6 t -64.89 119.32 10.46 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.366 -0.917 . . . . 0.0 109.055 174.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -70.01 5.28 1.66 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.695 1.598 . . . . 0.0 113.874 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -68.8 119.78 71.58 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 168.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.95 5.88 4.16 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.317 2.678 . . . . 0.0 113.312 178.445 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.86 6.06 12.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.657 1.583 . . . . 0.0 110.608 174.216 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 42.5 t -60.53 129.06 39.7 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 123.584 0.753 . . . . 0.0 110.442 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.2 m -79.91 4.47 16.66 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.496 1.518 . . . . 0.0 113.333 -176.746 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.6 mm -135.1 -36.27 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.787 1.635 . . . . 0.0 110.348 -169.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.45 -41.65 0.51 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.84 2.856 . . . . 0.0 115.201 170.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.523 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -129.08 148.09 50.99 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.738 1.615 . . . . 0.0 109.276 -176.057 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -149.38 157.54 43.4 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 124.94 1.296 . . . . 0.0 108.84 -175.193 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -88.24 144.11 26.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.304 0.573 . . . . 0.0 111.098 -171.243 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -57.43 -7.2 0.56 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.292 2.237 . . . . 0.0 114.265 170.078 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.22 -8.29 8.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.029 1.332 . . . . 0.0 112.207 174.228 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 10.0 m -77.11 -2.51 34.63 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.07 0.85 . . . . 0.0 112.87 168.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 12.9 p -131.72 -2.03 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 126.435 1.894 . . . . 0.0 111.116 170.073 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.2 34.38 89.77 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.938 1.256 . . . . 0.0 112.894 -177.678 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.2 mt -66.34 -52.33 48.17 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.183 0.993 . . . . 0.0 111.919 -174.299 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 17.5 m 61.92 -9.83 0.08 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.82 2.048 . . . . 0.0 114.47 -175.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 13.0 t -150.0 173.27 14.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.85 1.66 . . . . 0.0 110.659 178.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -68.3 125.39 91.54 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.773 1.229 . . . . 0.0 109.487 177.741 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.7 -69.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.539 2.159 . . . . 0.0 110.755 177.188 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 -175.96 176.14 1.84 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.897 2.879 . . . . 0.0 107.074 -176.256 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -72.67 15.28 2.24 Favored Glycine 0 CA--C 1.541 1.709 0 CA-C-O 118.935 -0.925 . . . . 0.0 113.374 168.182 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt -152.67 112.73 3.99 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 125.806 1.642 . . . . 0.0 108.99 176.204 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.5 t90 -140.83 162.47 35.35 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.581 2.352 . . . . 0.0 109.832 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -140.67 141.78 34.99 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.275 1.03 . . . . 0.0 110.348 178.863 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.7 p -70.37 165.61 42.9 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.082 0.953 . . . . 0.0 111.731 174.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.47 29.32 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.994 3.13 . . . . 0.0 113.569 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -135.58 -33.8 0.86 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.664 1.586 . . . . 0.0 110.091 174.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.9 m -78.28 -31.78 49.14 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 126.554 1.941 . . . . 0.0 111.99 170.381 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.8 t -71.67 -24.94 61.92 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.2 1.4 . . . . 0.0 112.085 175.161 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 17.8 tm0? -62.62 -35.27 79.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.483 1.113 . . . . 0.0 111.913 176.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -52.06 -42.49 63.19 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.242 1.817 . . . . 0.0 112.966 -178.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.8 111.23 3.7 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.994 1.318 . . . . 0.0 107.516 174.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -128.06 -153.94 0.6 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.358 1.863 . . . . 0.0 108.742 -170.486 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -108.35 33.0 4.39 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.683 1.593 . . . . 0.0 110.849 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 65.2 tttm . . . . . 0 C--O 1.25 1.099 0 C-N-CA 126.224 1.81 . . . . 0.0 109.245 178.376 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 18.3 ptp . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -145.55 135.99 24.12 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.094 0.958 . . . . 0.0 109.725 -168.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 48.8 ttm 35.11 62.86 2.2 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 127.082 2.153 . . . . 0.0 113.541 -176.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.17 112.3 2.72 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.185 2.59 . . . . 0.0 110.162 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 95.4 t -140.68 92.83 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.2 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 -178.585 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -137.6 63.82 41.83 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.919 1.288 . . . . 0.0 109.332 -170.534 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.71 145.99 71.4 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.319 2.679 . . . . 0.0 111.754 -175.449 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -148.3 45.21 1.06 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.939 1.296 . . . . 0.0 109.734 -179.108 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -129.87 70.09 81.91 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.474 1.509 . . . . 0.0 108.854 -179.489 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.3 165.96 25.05 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.55 2.833 . . . . 0.0 111.507 176.504 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 57.6 p -137.07 142.52 42.38 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.283 1.433 . . . . 0.0 110.709 -167.539 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -156.33 -39.95 0.08 Allowed 'General case' 0 C--N 1.353 0.735 0 CA-C-O 115.621 -2.133 . . . . 0.0 115.207 -169.765 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.5 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.7 OUTLIER -51.53 175.47 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 122.01 2.186 . . . . 0.0 112.953 176.538 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.9 -5.11 3.92 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.082 -1.417 . . . . 0.0 111.21 170.742 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 88.6 m -99.32 -15.95 18.63 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 125.976 1.711 . . . . 0.0 112.548 176.549 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 51.12 46.82 25.9 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.723 2.009 . . . . 0.0 111.628 -177.142 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -164.51 147.27 8.85 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.764 1.626 . . . . 0.0 107.621 179.112 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.472 HG12 ' H ' ' A' ' 205' ' ' SER . 0.5 OUTLIER -132.35 -178.14 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 127.355 2.262 . . . . 0.0 109.553 175.654 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.472 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.2 t 60.16 58.32 2.69 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.93 1.692 . . . . 0.0 113.08 -172.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.89 114.48 2.58 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.944 2.098 . . . . 0.0 109.122 -175.202 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.86 -109.34 2.48 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 125.571 1.558 . . . . 0.0 110.827 -175.661 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.78 169.11 18.36 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.627 1.971 . . . . 0.0 111.546 -173.618 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -141.69 161.26 38.38 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.146 0.978 . . . . 0.0 112.627 -167.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.428 HG13 ' H ' ' A' ' 211' ' ' GLY . 7.5 tp -135.78 -135.32 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 168.341 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 145.61 130.47 2.2 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 125.559 1.552 . . . . 0.0 112.096 -170.866 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 41.0 t -63.82 122.66 16.97 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.239 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.78 -2.12 2.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.692 1.597 . . . . 0.0 113.506 -179.216 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -69.25 116.25 40.39 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.277 1.031 . . . . 0.0 108.518 168.785 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -78.08 8.58 3.44 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.036 2.491 . . . . 0.0 112.916 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -121.37 6.4 10.15 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.727 1.611 . . . . 0.0 110.145 174.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.9 t -60.98 129.95 43.96 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 118.683 0.674 . . . . 0.0 109.589 171.124 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.3 t -74.94 6.31 4.22 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.708 1.603 . . . . 0.0 113.188 -176.275 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.3 mm -134.45 -36.81 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 126.134 1.774 . . . . 0.0 109.776 -171.639 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . 0.251 0.0 OUTLIER 71.06 -43.88 0.57 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.355 2.662 . . . . 0.0 115.497 169.737 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.5 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -125.33 148.77 48.6 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.469 1.908 . . . . 0.0 108.511 -178.383 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.43 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 72.9 m-85 -147.89 154.51 40.48 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.147 0.979 . . . . 0.0 108.804 -175.474 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -84.58 144.08 28.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.447 0.641 . . . . 0.0 110.499 -175.118 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -57.0 -7.12 0.43 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.363 2.265 . . . . 0.0 114.413 169.688 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.58 -8.02 8.55 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.877 1.271 . . . . 0.0 112.184 173.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 14.4 m -77.61 -2.26 34.95 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.088 0.858 . . . . 0.0 113.051 168.716 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.5 p -129.53 -4.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 126.447 1.899 . . . . 0.0 111.039 169.369 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.29 35.4 91.48 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.938 1.256 . . . . 0.0 112.82 -175.5 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.4 mt -66.84 -54.21 24.77 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.863 0.865 . . . . 0.0 111.326 -176.385 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 21.8 m 61.2 -11.22 0.06 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.929 2.091 . . . . 0.0 114.338 -174.138 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.7 p -143.97 167.04 23.29 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.33 1.852 . . . . 0.0 110.027 -175.088 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -64.7 126.45 90.9 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 123.789 0.836 . . . . 0.0 109.995 177.342 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.3 169.95 19.33 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.371 2.714 . . . . 0.0 112.138 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 31.1 ttt85 -67.84 158.06 33.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.87 0.868 . . . . 0.0 109.477 168.58 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -58.5 152.82 29.55 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 123.504 0.574 . . . . 0.0 113.171 -178.735 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? 50.68 68.86 0.71 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.176 1.79 . . . . 0.0 111.533 -174.016 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -76.42 162.98 27.4 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.799 1.239 . . . . 0.0 110.241 177.546 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -139.29 139.1 37.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.312 1.445 . . . . 0.0 108.375 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 13.4 p -68.2 165.87 29.7 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 123.143 0.577 . . . . 0.0 111.9 172.573 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.26 31.6 0.31 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.327 3.351 . . . . 0.0 113.389 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -136.36 -37.81 0.69 Allowed 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.494 1.517 . . . . 0.0 109.816 169.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 18.3 m -72.03 -26.48 62.23 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 126.565 1.946 . . . . 0.0 112.721 173.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.454 ' HA ' ' HE ' ' A' ' 246' ' ' ARG . 3.2 t -96.25 -17.45 20.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.511 1.125 . . . . 0.0 112.388 172.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -65.33 -36.7 84.85 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.113 0.965 . . . . 0.0 111.666 -175.895 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.36 -12.53 59.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.449 1.099 . . . . 0.0 113.569 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.454 ' HE ' ' HA ' ' A' ' 243' ' ' SER . 35.1 mtm180 -87.13 54.93 3.34 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.883 1.273 . . . . 0.0 110.768 -173.737 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -85.28 -142.68 0.09 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.478 1.911 . . . . 0.0 110.001 -175.689 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 248' ' ' LYS . 6.0 mmpt? -126.79 87.08 2.6 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.21 1.804 . . . . 0.0 108.068 -179.526 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.251 1.162 0 C-N-CA 126.116 1.766 . . . . 0.0 109.012 -176.808 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 66.4 ttp . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -145.47 -43.51 0.22 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.491 0.717 . . . . 0.0 111.795 -169.057 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.52 157.58 16.82 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.74 1.216 . . . . 0.0 111.005 -176.405 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.18 50.72 3.15 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 124.892 3.728 . . . . 0.0 112.088 -179.433 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.8 t -121.34 90.99 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.671 1.189 . . . . 0.0 108.376 -175.604 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.481 ' H ' ' HD2' ' A' ' 193' ' ' PRO . 18.6 t70 -153.64 -52.03 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.655 1.582 . . . . 0.0 110.652 176.208 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.481 ' HD2' ' H ' ' A' ' 192' ' ' ASP . 95.5 Cg_endo -77.04 161.28 32.89 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.28 1.986 . . . . 0.0 111.716 174.041 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -76.78 5.57 7.5 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.166 1.386 . . . . 0.0 113.51 178.607 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -138.57 75.02 38.78 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.801 1.24 . . . . 0.0 110.035 -173.166 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.78 160.13 46.88 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.528 2.819 . . . . 0.0 111.424 174.652 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.7 p 62.48 143.78 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.247 2.619 . . . . 0.0 113.285 -173.687 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -156.17 -45.61 0.08 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -168.459 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.482 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 2.0 p -40.25 170.28 0.0 OUTLIER 'General case' 0 C--N 1.349 0.586 0 C-N-CA 126.091 1.757 . . . . 0.0 114.252 169.136 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -71.3 -6.14 37.63 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.137 168.327 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.482 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 95.1 m -97.03 -13.36 22.32 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 123.499 0.72 . . . . 0.0 111.776 175.021 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.9 p80 46.37 53.38 9.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.862 2.065 . . . . 0.0 112.755 -174.006 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -171.0 142.12 1.79 Allowed 'General case' 0 C--N 1.347 0.474 0 C-N-CA 125.652 1.581 . . . . 0.0 108.114 177.434 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 205' ' ' SER . 1.1 t -123.79 168.92 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 125.606 1.562 . . . . 0.0 110.933 177.724 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.446 ' H ' HG12 ' A' ' 204' ' ' VAL . 10.5 t 70.81 61.06 0.19 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.144 2.178 . . . . 0.0 113.389 -176.248 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -162.72 108.95 1.2 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.986 2.115 . . . . 0.0 107.403 -176.513 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.44 -168.94 29.89 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 122.643 1.135 . . . . 0.0 110.761 -168.785 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -72.79 164.3 26.78 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.06 1.344 . . . . 0.0 111.978 169.61 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -138.54 155.46 48.36 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.693 1.597 . . . . 0.0 110.652 -169.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.0 tp -131.6 -139.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.362 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 149.11 130.76 1.91 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 125.812 1.673 . . . . 0.0 112.428 -169.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 40.6 t -62.73 123.19 17.78 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.468 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.1 0.18 1.4 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.027 1.331 . . . . 0.0 113.529 -179.332 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -70.4 115.05 30.93 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 167.87 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.56 9.14 3.02 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.304 2.669 . . . . 0.0 113.017 -179.412 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -124.02 8.29 8.65 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.988 1.715 . . . . 0.0 110.206 175.178 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.7 t -60.45 129.23 40.56 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 118.605 0.639 . . . . 0.0 109.558 170.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -73.4 3.41 6.01 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.999 1.72 . . . . 0.0 113.368 -175.472 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 26.6 mt -132.01 -34.22 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 126.37 1.868 . . . . 0.0 109.965 -175.414 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.99 -37.35 0.39 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.357 2.263 . . . . 0.0 115.76 170.341 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.478 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -132.58 148.57 52.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.864 2.065 . . . . 0.0 108.785 -174.945 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -148.02 148.52 30.79 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -177.439 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -73.02 150.15 42.65 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.895 178.448 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -60.96 -4.27 0.98 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.369 1.467 . . . . 0.0 113.417 167.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.2 -1.63 9.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.771 1.228 . . . . 0.0 112.558 170.431 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.4 m -72.43 -7.48 50.04 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.96 0.8 . . . . 0.0 111.296 167.031 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 2.8 p -134.38 -13.98 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 127.283 2.233 . . . . 0.0 112.016 179.197 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.86 37.46 44.36 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.592 1.091 . . . . 0.0 112.934 -176.154 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 20.6 mt -66.76 111.05 3.51 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.732 0.813 . . . . 0.0 110.235 176.172 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 26.3 m -72.12 -27.32 62.55 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.511 1.125 . . . . 0.0 111.464 174.355 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 14.5 t -153.25 175.4 13.11 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.704 1.602 . . . . 0.0 110.065 177.693 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -61.62 126.39 86.7 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 124.814 1.246 . . . . 0.0 110.256 -177.666 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.73 170.2 20.57 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.111 2.541 . . . . 0.0 111.967 179.185 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 68.0 mtm180 -69.98 169.79 12.61 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.936 0.894 . . . . 0.0 110.181 169.058 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -60.41 159.2 25.73 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.276 0.465 . . . . 0.0 112.308 172.519 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 15.0 tptp 51.99 57.38 6.56 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.192 1.397 . . . . 0.0 112.363 -172.264 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -74.97 159.64 31.54 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.611 0.764 . . . . 0.0 109.702 171.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.01 142.13 34.28 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.337 1.055 . . . . 0.0 109.199 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 2.4 p -63.03 165.37 10.45 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 123.72 0.808 . . . . 0.0 112.026 175.582 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.95 23.96 0.34 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.543 2.828 . . . . 0.0 113.643 -173.568 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -134.54 -33.07 0.99 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 125.687 1.595 . . . . 0.0 110.472 174.376 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.6 m -71.9 -36.5 70.03 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.72 2.008 . . . . 0.0 111.533 169.315 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 21.2 t -73.13 -19.4 61.14 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.758 1.623 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -60.59 -24.84 65.78 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -178.718 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -50.58 -46.47 57.8 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.209 1.804 . . . . 0.0 112.438 177.085 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -144.92 81.57 1.65 Allowed 'General case' 0 C--N 1.343 0.295 0 C-N-CA 125.688 1.595 . . . . 0.0 107.344 171.391 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -75.59 24.5 0.11 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.749 1.62 . . . . 0.0 114.408 -169.695 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -80.14 61.27 3.92 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.845 1.658 . . . . 0.0 109.682 169.815 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.131 0 C-N-CA 126.619 1.968 . . . . 0.0 110.227 -176.71 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 97.8 mtp . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 62.93 147.63 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.515 2.326 . . . . 0.0 113.806 -173.807 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 78.0 mtm -151.59 154.92 33.86 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.029 1.332 . . . . 0.0 110.344 -177.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -71.59 168.78 22.68 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.617 2.878 . . . . 0.0 111.835 170.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.8 p -108.32 -4.1 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.275 1.43 . . . . 0.0 111.87 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -57.23 -43.97 99.45 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-O 117.119 -1.42 . . . . 0.0 113.214 170.214 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.74 165.64 29.83 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.358 2.039 . . . . 0.0 111.499 170.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 52.66 56.08 8.14 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.42 1.488 . . . . 0.0 112.016 -177.458 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -126.12 84.32 61.75 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.479 1.511 . . . . 0.0 108.619 -176.816 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.09 120.41 6.31 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.831 3.021 . . . . 0.0 111.178 -175.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.1 p -147.24 140.51 25.33 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.903 1.681 . . . . 0.0 108.722 -176.471 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -154.72 -47.43 0.09 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -173.613 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.505 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -38.29 169.62 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 0 C-N-CA 126.401 1.881 . . . . 0.0 114.444 168.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.72 -6.69 39.23 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.198 168.366 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.505 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 89.7 m -96.08 -14.51 22.84 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 123.602 0.761 . . . . 0.0 111.71 174.456 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.2 p80 45.73 52.85 9.24 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.211 2.204 . . . . 0.0 112.759 -173.382 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.17 140.88 2.47 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 125.866 1.666 . . . . 0.0 107.889 179.178 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.519 HG12 ' H ' ' A' ' 205' ' ' SER . 1.4 t -129.2 172.72 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.336 1.454 . . . . 0.0 111.051 -176.827 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.519 ' H ' HG12 ' A' ' 204' ' ' VAL . 13.0 t 66.16 60.73 0.63 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.769 2.027 . . . . 0.0 113.208 -174.906 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.02 112.52 1.83 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.566 1.946 . . . . 0.0 108.318 -175.218 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.85 -163.45 24.42 Favored Glycine 0 C--N 1.34 0.759 0 CA-C-O 123.314 1.508 . . . . 0.0 112.931 -176.503 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.515 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.6 pm0 -67.88 146.13 53.94 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.028 2.131 . . . . 0.0 111.074 169.704 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.0 mtm -146.85 155.58 42.44 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.198 1.799 . . . . 0.0 110.461 -167.078 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 211' ' ' GLY . 8.2 tp -138.89 -138.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.41 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -175.764 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 152.22 133.93 2.02 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 126.239 1.876 . . . . 0.0 112.46 -169.61 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.25 123.59 20.36 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 114.179 -1.011 . . . . 0.0 109.398 177.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.19 0.14 2.18 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.314 1.846 . . . . 0.0 114.86 178.716 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -68.44 118.91 64.35 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.57 1.148 . . . . 0.0 108.592 169.627 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.26 7.27 3.43 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.413 2.742 . . . . 0.0 113.242 178.185 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -123.04 9.84 9.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.044 1.738 . . . . 0.0 110.358 174.445 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 42.6 t -58.65 128.87 39.34 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 123.494 0.718 . . . . 0.0 110.607 173.921 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.6 t -78.19 1.44 21.41 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.668 1.587 . . . . 0.0 113.072 -177.369 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.4 mm -132.7 -36.2 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 125.484 1.513 . . . . 0.0 110.375 -169.432 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.9 -39.16 0.42 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.415 2.686 . . . . 0.0 115.63 170.526 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.475 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.0 OUTLIER -134.16 149.07 51.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.176 1.791 . . . . 0.0 108.803 -174.569 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -149.34 147.01 27.82 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -176.199 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -73.11 150.49 42.2 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.771 0.796 . . . . 0.0 111.189 178.711 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -60.52 -4.02 0.81 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.374 1.47 . . . . 0.0 113.304 168.014 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.12 -2.03 8.18 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.074 1.35 . . . . 0.0 112.556 171.201 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.2 m -71.34 -8.11 51.57 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.043 0.838 . . . . 0.0 111.394 167.021 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.7 p -136.02 -4.1 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.084 1.753 . . . . 0.0 111.863 174.597 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 69.3 30.24 71.61 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.848 1.213 . . . . 0.0 112.909 -175.758 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.89 -47.93 83.78 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.662 1.185 . . . . 0.0 112.043 -172.264 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 m 64.4 -18.83 0.07 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.379 2.272 . . . . 0.0 114.755 -179.662 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 74.8 p -143.84 163.64 32.79 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.926 1.69 . . . . 0.0 110.605 -173.607 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -64.23 119.94 60.32 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 124.939 1.295 . . . . 0.0 108.925 177.769 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.31 166.86 28.52 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.213 2.609 . . . . 0.0 113.019 -175.795 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -67.39 170.98 6.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.216 1.006 . . . . 0.0 111.242 171.209 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -49.64 114.34 2.28 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.483 1.516 . . . . 0.0 112.416 -179.564 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 49.0 mttm 58.54 124.17 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 128.33 2.652 . . . . 0.0 114.1 -169.558 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -116.88 153.88 31.76 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.394 1.877 . . . . 0.0 109.652 175.054 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -139.59 136.4 34.35 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.638 0.775 . . . . 0.0 110.03 -177.225 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 10.8 p -66.95 164.07 38.31 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.125 0.97 . . . . 0.0 111.871 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -72.49 22.69 0.28 Allowed 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 123.94 3.094 . . . . 0.0 114.054 -177.492 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 -134.21 6.19 3.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.441 1.497 . . . . 0.0 112.027 172.097 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 5.2 m -128.96 -28.78 2.37 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 128.128 2.571 . . . . 0.0 110.01 -175.487 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 88.8 p -79.25 -29.77 42.81 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 124.688 1.195 . . . . 0.0 111.549 172.766 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -72.99 -38.34 66.69 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 125.017 1.327 . . . . 0.0 111.028 179.469 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -58.43 -40.96 83.94 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 126.439 1.896 . . . . 0.0 111.856 173.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 54.52 23.6 4.71 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.35 1.86 . . . . 0.0 114.31 172.423 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 51.1 tttm 46.59 55.01 8.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.227 1.811 . . . . 0.0 111.915 -172.05 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -130.7 35.69 3.98 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.027 1.331 . . . . 0.0 111.617 -169.455 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 83.7 tttt . . . . . 0 C--O 1.252 1.19 0 C-N-CA 127.157 2.183 . . . . 0.0 112.653 176.442 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -59.56 157.03 12.24 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.46 1.504 . . . . 0.0 112.02 170.442 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 94.4 mtp -140.4 72.4 31.61 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 124.705 1.202 . . . . 0.0 109.727 -173.181 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.38 152.83 71.31 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.329 2.686 . . . . 0.0 111.491 177.638 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.82 64.62 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.065 1.346 . . . . 0.0 107.987 -175.554 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.44 -48.97 85.72 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-O 117.286 -1.34 . . . . 0.0 112.778 173.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.85 -179.14 5.1 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.782 2.322 . . . . 0.0 111.3 171.391 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 61.2 t30 57.85 61.66 2.32 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.266 1.427 . . . . 0.0 112.273 178.135 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -114.82 98.38 49.74 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.943 1.297 . . . . 0.0 108.324 177.234 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.73 132.1 16.77 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.225 2.617 . . . . 0.0 111.24 -178.816 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 73.8 p -149.22 140.16 22.87 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.112 1.765 . . . . 0.0 108.914 -174.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -155.12 -44.7 0.08 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -175.457 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.505 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -39.23 170.2 0.0 OUTLIER 'General case' 0 C--N 1.35 0.615 0 C-N-CA 126.273 1.829 . . . . 0.0 114.216 168.667 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.89 -6.62 39.7 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 113.425 -1.716 . . . . 0.0 110.115 168.172 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.505 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 85.3 m -96.79 -14.22 22.09 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 123.7 0.8 . . . . 0.0 111.725 174.818 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.9 p80 45.73 53.18 8.95 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.138 2.175 . . . . 0.0 112.811 -173.417 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.74 140.77 2.18 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 125.858 1.663 . . . . 0.0 107.911 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 205' ' ' SER . 1.5 t -128.93 170.04 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.364 1.465 . . . . 0.0 111.105 -175.964 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.508 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.1 t 65.89 66.1 0.51 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.083 2.153 . . . . 0.0 113.09 -174.609 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.24 111.3 1.08 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.566 1.946 . . . . 0.0 108.336 -175.496 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.47 -163.45 22.6 Favored Glycine 0 C--N 1.34 0.778 0 CA-C-O 123.254 1.474 . . . . 0.0 112.592 -174.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.7 pm0 -65.71 149.06 50.74 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 112.237 -1.981 . . . . 0.0 111.193 169.436 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.0 mtm -147.41 156.9 43.31 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.138 1.775 . . . . 0.0 110.067 -167.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.446 HG13 ' H ' ' A' ' 211' ' ' GLY . 4.9 tp -141.01 -138.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.369 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.447 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 151.49 132.88 1.94 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 126.11 1.814 . . . . 0.0 112.629 -169.783 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 46.6 t -64.35 125.64 25.26 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.064 0.946 . . . . 0.0 108.814 177.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.08 -2.74 2.16 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.533 1.533 . . . . 0.0 114.068 178.699 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -70.44 116.08 41.47 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 124.136 0.975 . . . . 0.0 108.387 169.216 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -76.99 4.4 5.79 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.315 2.677 . . . . 0.0 113.103 179.315 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -117.49 7.09 12.63 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.896 1.678 . . . . 0.0 110.36 174.544 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.7 t -58.42 127.82 34.04 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 123.113 0.565 . . . . 0.0 110.005 170.459 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.8 t -74.5 2.48 9.52 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.796 1.639 . . . . 0.0 113.207 -176.113 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 30.2 mt -132.19 -33.78 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.069 1.748 . . . . 0.0 110.247 -173.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.69 -37.64 0.4 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.006 2.522 . . . . 0.0 115.305 170.313 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.478 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -133.06 148.96 52.2 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 126.777 2.031 . . . . 0.0 108.677 -174.032 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -148.44 146.62 28.5 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -176.272 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -70.63 150.61 45.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.942 0.877 . . . . 0.0 110.884 178.183 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -60.63 -5.06 1.09 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.073 1.349 . . . . 0.0 113.727 168.3 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.47 -0.84 9.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.656 1.182 . . . . 0.0 112.372 170.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.8 m -71.69 -7.19 46.46 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.892 0.769 . . . . 0.0 111.531 167.294 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 p -137.39 -11.51 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.809 1.244 . . . . 0.0 113.269 173.037 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 80.39 41.28 11.74 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.514 1.054 . . . . 0.0 113.54 -175.635 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 24.0 mt -65.98 160.88 22.64 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.295 1.047 . . . . 0.0 111.439 171.476 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 87.8 m -136.39 -16.81 1.57 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.986 1.714 . . . . 0.0 111.001 178.816 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 10.0 t -148.42 169.53 20.01 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.129 1.771 . . . . 0.0 109.368 174.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -65.84 122.86 82.98 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 174.277 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -73.43 164.3 35.46 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.823 2.349 . . . . 0.0 111.293 177.695 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 24.8 mtp-105 -142.33 161.76 37.19 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.117 1.367 . . . . 0.0 109.763 -178.175 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 73.09 22.24 79.17 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-O 118.929 -0.928 . . . . 0.0 113.444 -177.071 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? 72.2 126.54 0.03 OUTLIER 'General case' 0 C--N 1.346 0.42 0 C-N-CA 128.441 2.696 . . . . 0.0 111.821 -173.756 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -99.77 158.34 15.86 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.333 1.453 . . . . 0.0 110.305 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -141.06 139.78 34.13 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.184 0.994 . . . . 0.0 109.2 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.5 p -66.69 165.11 27.38 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.674 0.789 . . . . 0.0 111.957 177.721 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.5 31.93 0.28 Allowed 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.908 3.072 . . . . 0.0 113.413 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -135.97 -38.09 0.72 Allowed 'General case' 0 C--N 1.345 0.373 0 C-N-CA 125.584 1.554 . . . . 0.0 109.689 171.897 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 26.6 m -71.96 -34.61 69.11 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.585 1.954 . . . . 0.0 111.888 171.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 15.9 t -85.27 -21.39 29.05 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.061 1.344 . . . . 0.0 112.117 175.904 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.86 -33.72 76.23 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.896 1.278 . . . . 0.0 111.287 -179.299 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.81 -33.14 55.16 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.069 1.747 . . . . 0.0 113.343 178.16 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 33.35 63.48 0.35 Allowed 'General case' 0 C--N 1.345 0.412 0 C-N-CA 128.971 2.908 . . . . 0.0 113.917 169.542 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -81.44 56.27 2.88 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.365 1.066 . . . . 0.0 110.77 176.609 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -155.66 126.94 7.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 127.423 2.289 . . . . 0.0 106.852 177.669 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt . . . . . 0 C--O 1.25 1.117 0 CA-C-O 116.736 -1.602 . . . . 0.0 109.493 -172.712 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -154.74 -43.95 0.09 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -166.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.499 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -38.05 169.66 0.0 OUTLIER 'General case' 0 C--N 1.348 0.54 0 C-N-CA 126.385 1.874 . . . . 0.0 114.414 169.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.0 mt -70.69 -6.16 35.14 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 113.399 -1.728 . . . . 0.0 110.12 168.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.499 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 93.8 m -96.15 -14.22 22.96 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 123.423 0.689 . . . . 0.0 111.738 173.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.6 p80 46.08 52.16 10.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.912 2.085 . . . . 0.0 112.406 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -169.01 141.47 2.66 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.482 1.513 . . . . 0.0 108.018 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -124.44 174.87 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.475 1.51 . . . . 0.0 110.51 176.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.503 ' H ' HG12 ' A' ' 204' ' ' VAL . 7.1 t 66.69 60.89 0.55 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.701 2.0 . . . . 0.0 113.429 -173.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.51 120.11 1.77 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.98 2.112 . . . . 0.0 107.881 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.44 -151.2 43.5 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 122.613 1.118 . . . . 0.0 111.49 -172.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.58 169.26 10.47 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.388 1.875 . . . . 0.0 111.255 170.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -136.89 162.26 33.73 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.913 1.285 . . . . 0.0 111.677 -169.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 11.2 tt -138.0 -139.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 169.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 147.47 132.22 2.23 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 125.79 1.662 . . . . 0.0 111.57 -169.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 41.4 t -64.25 123.9 20.32 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.81 -0.48 3.03 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.365 1.466 . . . . 0.0 113.686 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -70.25 117.31 53.35 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.67 4.16 5.84 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.301 2.667 . . . . 0.0 113.168 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -117.37 7.63 12.87 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.85 1.66 . . . . 0.0 110.456 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.1 t -58.33 127.23 31.08 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 123.192 0.597 . . . . 0.0 109.736 170.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 70.5 m -77.01 5.95 7.17 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.538 1.535 . . . . 0.0 113.304 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.9 mm -132.58 -35.53 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 126.082 1.753 . . . . 0.0 109.95 -173.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.44 -42.9 0.55 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.512 2.725 . . . . 0.0 115.333 169.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.443 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -129.42 149.71 51.09 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.4 1.88 . . . . 0.0 108.431 -175.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -149.42 149.31 30.62 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -73.4 149.63 42.35 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.62 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.95 -3.59 0.81 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.985 1.714 . . . . 0.0 112.394 168.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.45 -3.74 8.35 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.674 1.59 . . . . 0.0 112.462 172.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.9 m -71.62 -7.47 48.0 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.06 0.845 . . . . 0.0 111.281 166.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -134.71 -4.63 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 126.853 2.061 . . . . 0.0 111.591 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.97 31.11 74.7 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.904 1.24 . . . . 0.0 113.272 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 4.6 mt . . . . . 0 C--N 1.343 0.291 0 C-N-CA 124.338 1.055 . . . . 0.0 112.584 -174.27 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 79.2 t90 . . . . . 0 CA--C 1.538 0.499 0 CA-C-O 121.203 0.525 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -141.68 140.45 33.2 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.076 1.35 . . . . 0.0 109.283 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.0 p -66.67 165.32 25.84 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 123.467 0.707 . . . . 0.0 112.198 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.06 35.23 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.97 3.113 . . . . 0.0 113.08 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -137.95 -38.37 0.57 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.445 1.498 . . . . 0.0 109.764 169.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.443 -0.82 0 C-N-CA 126.756 2.022 . . . . 0.0 111.805 171.702 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 47.2 p . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -155.04 -45.39 0.08 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -168.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.505 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.7 p -38.01 169.66 0.0 OUTLIER 'General case' 0 C--N 1.348 0.54 0 C-N-CA 126.429 1.892 . . . . 0.0 114.269 168.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.49 -6.3 35.07 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 113.452 -1.703 . . . . 0.0 110.199 168.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.505 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 89.5 m -97.34 -14.17 21.44 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 123.812 0.845 . . . . 0.0 111.805 174.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.5 p80 45.06 51.85 8.67 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.109 2.164 . . . . 0.0 112.842 -173.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -167.34 139.24 3.23 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 125.762 1.625 . . . . 0.0 107.94 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 205' ' ' SER . 1.3 t -129.95 172.32 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.307 1.443 . . . . 0.0 111.058 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.524 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.0 t 65.44 63.47 0.63 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.833 2.053 . . . . 0.0 112.792 -173.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.07 112.55 1.34 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.555 1.942 . . . . 0.0 108.45 -175.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.01 -161.65 24.18 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-O 123.283 1.49 . . . . 0.0 113.124 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.526 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.6 pm0 -68.26 143.79 55.12 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.155 2.182 . . . . 0.0 111.128 169.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.4 mtm -147.09 155.11 41.91 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.38 1.872 . . . . 0.0 110.289 -167.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.426 HG13 ' H ' ' A' ' 211' ' ' GLY . 9.2 tp -139.02 -138.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.409 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -175.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 150.91 131.23 1.8 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 126.152 1.834 . . . . 0.0 112.301 -169.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 42.2 t -63.05 121.71 14.27 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.259 1.023 . . . . 0.0 108.559 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.85 1.4 1.89 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.384 1.474 . . . . 0.0 113.868 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -69.94 117.89 58.2 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.474 1.11 . . . . 0.0 108.072 168.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.35 6.21 4.13 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.305 2.67 . . . . 0.0 113.234 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -120.89 9.22 10.6 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.817 1.647 . . . . 0.0 110.482 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 45.1 t -59.23 128.63 38.08 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.316 0.646 . . . . 0.0 110.116 171.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 44.0 m -76.14 2.99 11.5 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.59 1.556 . . . . 0.0 113.542 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.8 mm -133.78 -35.33 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.925 1.69 . . . . 0.0 109.966 -170.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.91 -39.53 0.45 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 128.422 2.689 . . . . 0.0 115.454 169.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.478 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.0 OUTLIER -133.87 148.95 51.32 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.305 1.842 . . . . 0.0 108.74 -174.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -150.06 146.02 26.71 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.4 -1.334 . . . . 0.0 107.4 -175.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -72.23 151.43 42.87 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.721 0.772 . . . . 0.0 111.043 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.33 -4.31 0.82 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.352 1.461 . . . . 0.0 113.06 167.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.33 -3.6 8.93 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.305 1.442 . . . . 0.0 112.544 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 20.6 m -72.43 -6.0 40.51 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.114 0.87 . . . . 0.0 111.715 167.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 10.9 p -135.4 -4.95 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 126.29 1.836 . . . . 0.0 111.797 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.34 35.77 90.71 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.667 1.127 . . . . 0.0 112.924 -173.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--N 1.343 0.304 0 C-N-CA 124.358 1.063 . . . . 0.0 111.493 -175.846 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 84.5 t90 . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 120.971 0.415 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -138.82 139.87 38.35 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.153 0.981 . . . . 0.0 109.587 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 13.9 p -65.7 163.43 35.03 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.436 0.695 . . . . 0.0 111.658 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.41 28.66 0.27 Allowed 'Trans proline' 0 CA--C 1.548 1.198 0 C-N-CA 124.013 3.142 . . . . 0.0 113.694 -178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -136.02 -32.95 0.86 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.555 1.542 . . . . 0.0 110.422 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.443 -0.795 0 C-N-CA 126.556 1.942 . . . . 0.0 111.727 169.693 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.3 p . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -155.15 -46.53 0.08 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.506 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -37.46 169.54 0.0 OUTLIER 'General case' 0 C--N 1.351 0.637 0 C-N-CA 126.665 1.986 . . . . 0.0 114.593 169.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.4 -6.23 34.06 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 113.311 -1.768 . . . . 0.0 110.08 168.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.506 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 86.6 m -97.46 -14.41 21.17 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 123.841 0.856 . . . . 0.0 111.776 174.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.2 p80 45.67 52.16 9.62 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.236 2.214 . . . . 0.0 112.807 -173.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -169.5 140.53 2.26 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.678 1.591 . . . . 0.0 107.906 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 205' ' ' SER . 1.5 t -127.07 173.37 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.219 1.407 . . . . 0.0 111.168 -175.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.537 ' H ' HG12 ' A' ' 204' ' ' VAL . 13.2 t 66.33 61.68 0.58 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.983 2.113 . . . . 0.0 113.537 -175.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -161.98 114.1 1.72 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.39 1.876 . . . . 0.0 108.548 -175.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 62.12 -164.03 24.4 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-O 123.084 1.38 . . . . 0.0 112.702 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.9 pm0 -66.14 147.18 53.72 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 112.405 -1.898 . . . . 0.0 110.92 169.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 75.7 mtm -146.33 154.26 41.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.939 1.696 . . . . 0.0 110.045 -168.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.6 tp -138.56 -139.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.357 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 149.8 131.0 1.87 Allowed Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 126.203 1.859 . . . . 0.0 112.289 -169.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.83 123.53 18.7 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.295 1.038 . . . . 0.0 108.557 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.05 -2.16 2.58 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.153 1.381 . . . . 0.0 113.467 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -69.64 117.38 52.63 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 168.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.5 4.93 5.09 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.131 2.554 . . . . 0.0 113.166 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -118.58 8.24 11.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.954 1.702 . . . . 0.0 110.416 174.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 50.0 t -58.25 127.6 32.95 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.181 0.593 . . . . 0.0 109.897 170.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.7 t -74.69 2.87 8.93 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.576 1.55 . . . . 0.0 113.444 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.6 mm -132.96 -34.96 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 126.072 1.749 . . . . 0.0 109.931 -171.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.34 -39.31 0.44 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.186 2.595 . . . . 0.0 115.52 169.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.472 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.0 OUTLIER -134.82 149.81 50.41 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.403 1.881 . . . . 0.0 108.929 -174.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -149.5 146.37 27.36 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 -176.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -70.36 149.81 46.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.548 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -60.75 -4.9 1.07 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.977 1.311 . . . . 0.0 113.237 168.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -120.62 -2.05 9.97 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.732 1.213 . . . . 0.0 112.543 170.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 16.9 m -73.11 -5.65 40.46 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.933 0.788 . . . . 0.0 111.507 167.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 p -135.7 -13.41 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 126.853 2.061 . . . . 0.0 112.323 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 75.77 37.98 37.96 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.562 1.077 . . . . 0.0 112.922 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 18.3 mt . . . . . 0 N--CA 1.466 0.343 0 C-N-CA 123.92 0.888 . . . . 0.0 110.159 174.905 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 83.3 t90 . . . . . 0 CA--C 1.537 0.45 0 CA-C-O 121.185 0.517 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -139.54 139.73 36.95 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.351 1.06 . . . . 0.0 109.377 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.2 p -66.36 166.69 15.84 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.96 0.904 . . . . 0.0 112.401 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.67 36.79 0.4 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.914 3.076 . . . . 0.0 112.985 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -139.96 -39.62 0.45 Allowed 'General case' 0 C--N 1.344 0.366 0 C-N-CA 125.336 1.455 . . . . 0.0 109.582 168.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.441 -0.899 0 C-N-CA 126.722 2.009 . . . . 0.0 112.038 173.017 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -154.93 -37.89 0.09 Allowed 'General case' 0 C--N 1.349 0.56 0 CA-C-O 116.027 -1.939 . . . . 0.0 115.042 -168.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.7 OUTLIER -52.88 172.61 0.05 OUTLIER 'General case' 0 C--N 1.358 0.938 0 CA-C-N 122.002 2.183 . . . . 0.0 112.245 170.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.5 mt -63.24 -5.09 2.96 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.749 1.619 . . . . 0.0 111.24 172.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.2 m -99.21 -12.12 20.71 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 126.105 1.762 . . . . 0.0 112.585 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.0 p80 46.04 50.02 11.86 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 126.678 1.991 . . . . 0.0 111.894 -174.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -165.2 148.12 8.13 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.931 1.293 . . . . 0.0 107.901 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 205' ' ' SER . 0.5 OUTLIER -132.0 173.66 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 126.958 2.103 . . . . 0.0 110.78 176.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.508 ' H ' HG12 ' A' ' 204' ' ' VAL . 7.9 t 65.19 63.93 0.64 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.85 2.06 . . . . 0.0 113.067 -174.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.59 112.23 0.92 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.324 1.85 . . . . 0.0 109.034 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 60.1 -160.65 21.05 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 123.09 1.383 . . . . 0.0 112.982 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -66.11 143.29 57.4 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 112.253 -1.973 . . . . 0.0 111.097 169.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.0 mtm -149.04 154.05 38.75 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.752 2.021 . . . . 0.0 109.095 -168.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 211' ' ' GLY . 6.2 tt -142.04 -136.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -171.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 149.42 132.05 2.03 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 125.482 1.515 . . . . 0.0 112.867 -170.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.47 120.91 12.0 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.473 1.109 . . . . 0.0 108.548 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.3 -1.52 2.42 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.522 1.529 . . . . 0.0 113.561 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -69.54 116.4 42.62 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 169.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -77.17 9.43 2.79 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.28 2.653 . . . . 0.0 113.066 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -123.29 7.46 9.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.978 1.711 . . . . 0.0 110.172 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.7 t -61.21 130.98 48.92 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 118.402 0.546 . . . . 0.0 109.768 171.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 38.0 m -74.92 6.22 4.3 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.564 1.545 . . . . 0.0 113.589 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.9 mm -135.76 -37.19 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 126.369 1.867 . . . . 0.0 109.83 -170.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.11 -41.99 0.52 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.313 2.645 . . . . 0.0 115.523 170.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.511 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -127.85 148.56 50.47 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.334 1.854 . . . . 0.0 108.644 -177.05 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -149.19 155.97 41.44 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -174.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -83.76 142.72 30.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.38 -9.06 2.05 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.549 1.54 . . . . 0.0 112.913 170.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -115.47 -6.29 12.27 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.527 1.131 . . . . 0.0 112.394 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.8 m -80.13 -0.09 34.45 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 168.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.29 -8.8 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 126.852 2.061 . . . . 0.0 111.638 171.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.17 36.46 63.91 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.547 1.07 . . . . 0.0 113.06 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 32.0 mt . . . . . 0 CA--C 1.538 0.508 0 CA-C-N 118.287 1.043 . . . . 0.0 110.613 171.139 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.4 t90 . . . . . 0 CA--C 1.538 0.493 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -139.83 141.85 36.66 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.064 0.945 . . . . 0.0 109.409 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.1 p -66.08 163.62 36.21 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.876 0.87 . . . . 0.0 111.724 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.53 32.92 0.32 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 123.986 3.124 . . . . 0.0 113.087 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -135.64 -39.11 0.72 Allowed 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.45 1.5 . . . . 0.0 109.67 170.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.442 -0.864 0 C-N-CA 126.919 2.088 . . . . 0.0 112.222 170.869 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -156.06 -38.19 0.08 Allowed 'General case' 0 C--N 1.35 0.626 0 CA-C-O 115.956 -1.973 . . . . 0.0 115.563 -168.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.5 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.9 OUTLIER -52.99 174.15 0.04 OUTLIER 'General case' 0 C--N 1.359 0.991 0 CA-C-N 122.069 2.213 . . . . 0.0 112.027 172.06 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.0 mt -62.98 -5.07 2.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.641 1.577 . . . . 0.0 111.339 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 69.6 m -100.0 -12.28 19.88 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 126.069 1.748 . . . . 0.0 112.675 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.8 p80 45.36 50.1 10.09 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.775 2.03 . . . . 0.0 112.008 -174.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -164.62 148.57 9.21 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 125.219 1.408 . . . . 0.0 107.67 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 205' ' ' SER . 0.6 OUTLIER -132.69 174.01 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 127.131 2.172 . . . . 0.0 110.871 177.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.529 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.1 t 63.26 63.04 0.93 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.688 1.995 . . . . 0.0 112.904 -174.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.36 108.32 1.07 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.574 1.95 . . . . 0.0 108.332 -174.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 62.04 -164.38 23.22 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 123.278 1.488 . . . . 0.0 112.798 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.524 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.8 pm0 -65.25 150.17 48.69 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.314 2.246 . . . . 0.0 111.577 169.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 76.8 mtm -149.55 159.71 44.08 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.903 1.681 . . . . 0.0 110.684 -167.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 6.8 tp -138.34 -133.8 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.117 0.967 . . . . 0.0 109.302 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 145.62 132.73 2.47 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 126.447 1.975 . . . . 0.0 113.242 -169.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.534 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 8.8 t -65.11 124.12 21.29 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.63 4.18 0.62 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.129 1.372 . . . . 0.0 113.104 173.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.65 112.04 5.01 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 128.51 2.724 . . . . 0.0 107.797 167.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -78.55 11.9 2.31 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.372 2.715 . . . . 0.0 112.955 -176.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -129.24 8.46 5.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.114 1.766 . . . . 0.0 109.807 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 12.2 t -57.3 116.7 3.46 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-O 121.767 0.794 . . . . 0.0 111.62 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 68.7 m -79.59 6.58 10.18 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.181 1.792 . . . . 0.0 112.48 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.5 mm -123.08 -36.99 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 126.547 1.939 . . . . 0.0 108.92 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . 0.254 0.1 OUTLIER 67.26 -23.98 0.11 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 129.093 2.957 . . . . 0.0 116.494 169.226 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.501 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.6 OUTLIER -147.59 149.85 33.33 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.662 1.585 . . . . 0.0 109.152 -179.129 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -147.44 157.2 43.48 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.293 1.037 . . . . 0.0 108.299 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -83.19 143.13 30.68 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.33 0.585 . . . . 0.0 110.142 -174.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.51 -4.45 0.4 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.924 2.09 . . . . 0.0 114.039 170.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.47 -9.15 8.01 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.317 1.447 . . . . 0.0 112.276 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 10.3 m -77.45 -1.65 31.38 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.029 0.831 . . . . 0.0 112.769 168.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 12.7 p -132.04 -1.42 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 126.923 2.089 . . . . 0.0 110.92 171.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 63.6 32.56 84.58 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.25 1.405 . . . . 0.0 113.297 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.1 mt . . . . . 0 C--N 1.344 0.368 0 CA-C-N 117.999 0.9 . . . . 0.0 112.276 -172.955 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . 0.404 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 90.3 t90 . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.534 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 97.5 m-85 -139.4 141.35 37.54 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.726 0.81 . . . . 0.0 110.698 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . 0.404 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 29.1 p -65.75 160.27 62.72 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.519 0.727 . . . . 0.0 111.685 174.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.33 28.4 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.275 3.317 . . . . 0.0 113.327 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -133.58 -35.66 0.99 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.344 1.858 . . . . 0.0 109.637 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.447 -0.611 0 C-N-CA 126.099 1.76 . . . . 0.0 110.969 168.972 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -157.47 -43.42 0.07 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -168.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.49 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 2.1 p -39.62 170.2 0.0 OUTLIER 'General case' 0 C--N 1.349 0.57 0 C-N-CA 126.364 1.866 . . . . 0.0 114.379 169.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.3 mt -70.96 -6.63 40.16 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 113.31 -1.768 . . . . 0.0 110.131 168.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.49 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 97.4 m -96.29 -13.67 23.18 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 123.472 0.709 . . . . 0.0 111.755 174.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.7 p80 46.34 52.4 10.64 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.773 2.029 . . . . 0.0 112.607 -173.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -171.56 140.36 1.36 Allowed 'General case' 0 C--N 1.346 0.455 0 C-N-CA 126.004 1.721 . . . . 0.0 108.083 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.513 HG12 ' H ' ' A' ' 205' ' ' SER . 1.5 t -122.33 171.17 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.506 1.522 . . . . 0.0 111.179 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.513 ' H ' HG12 ' A' ' 204' ' ' VAL . 52.8 m 67.17 64.31 0.44 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.983 2.113 . . . . 0.0 113.405 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -160.14 112.48 2.04 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.661 1.984 . . . . 0.0 108.024 -176.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 68.19 -123.19 17.12 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -170.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.35 167.59 12.6 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.003 2.121 . . . . 0.0 110.982 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -138.26 156.17 47.93 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.178 0.991 . . . . 0.0 111.23 -169.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.453 HG12 ' H ' ' A' ' 211' ' ' GLY . 8.1 tt -134.53 -139.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 173.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 148.04 132.97 2.26 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 125.35 1.453 . . . . 0.0 112.648 -169.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.9 t -66.13 122.94 18.55 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.83 -2.19 3.58 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.504 1.522 . . . . 0.0 113.553 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -67.15 117.12 43.09 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 124.3 1.04 . . . . 0.0 108.33 168.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.65 5.42 4.81 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.229 2.619 . . . . 0.0 113.147 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -118.09 6.88 12.1 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.934 1.694 . . . . 0.0 110.428 174.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 45.9 t -58.88 127.54 32.73 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 121.234 0.54 . . . . 0.0 109.875 170.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 67.9 m -78.64 6.82 7.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.56 1.544 . . . . 0.0 113.336 -176.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.7 mt -133.76 -33.58 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.124 1.77 . . . . 0.0 110.261 -176.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.98 -39.42 0.45 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.869 2.468 . . . . 0.0 115.168 170.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.459 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -131.27 148.68 52.72 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.524 1.93 . . . . 0.0 108.719 -175.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -147.17 150.16 34.39 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -72.34 148.55 45.22 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.41 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -60.54 -5.87 1.4 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.342 1.457 . . . . 0.0 112.336 167.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -119.78 -2.01 10.45 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.925 1.29 . . . . 0.0 112.478 171.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.3 m -73.48 -5.24 38.81 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.907 0.776 . . . . 0.0 111.078 166.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 14.2 p -134.6 -10.17 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.766 2.026 . . . . 0.0 112.211 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.58 36.59 62.32 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.619 1.104 . . . . 0.0 113.354 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 11.0 mt . . . . . 0 CA--C 1.537 0.45 0 CA-C-N 118.514 1.157 . . . . 0.0 111.603 173.729 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 91.2 t90 . . . . . 0 CA--C 1.539 0.526 0 CA-C-O 121.427 0.632 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -140.5 141.96 35.32 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.129 1.372 . . . . 0.0 108.897 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 16.9 p -68.82 164.06 49.95 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.896 -0.573 . . . . 0.0 112.005 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.45 34.1 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 124.148 3.232 . . . . 0.0 113.203 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -135.84 -36.97 0.75 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 125.793 1.637 . . . . 0.0 109.757 171.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.5 m . . . . . 0 N--CA 1.442 -0.865 0 C-N-CA 126.797 2.039 . . . . 0.0 112.091 171.755 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -156.29 -44.31 0.07 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -169.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.486 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 2.3 p -40.58 169.92 0.0 OUTLIER 'General case' 0 C--N 1.349 0.555 0 C-N-CA 126.139 1.775 . . . . 0.0 114.158 169.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.9 mt -71.48 -6.32 39.61 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 113.233 -1.803 . . . . 0.0 110.07 168.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.486 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 95.1 m -96.02 -13.54 23.66 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 123.455 0.702 . . . . 0.0 111.808 174.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.1 p80 46.28 53.75 9.16 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.804 2.042 . . . . 0.0 112.609 -173.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -171.78 141.38 1.41 Allowed 'General case' 0 C--N 1.346 0.441 0 C-N-CA 125.707 1.603 . . . . 0.0 108.221 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 205' ' ' SER . 0.9 OUTLIER -123.99 170.5 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.36 1.464 . . . . 0.0 110.906 177.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.484 ' H ' HG12 ' A' ' 204' ' ' VAL . 7.9 t 67.8 65.91 0.37 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.026 2.13 . . . . 0.0 113.165 -174.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.89 111.88 1.16 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.732 2.013 . . . . 0.0 107.733 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.16 -134.97 36.85 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -169.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.52 169.33 8.88 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.91 2.084 . . . . 0.0 111.252 177.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -137.8 159.86 40.83 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.478 1.111 . . . . 0.0 111.596 -168.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.457 HG13 ' H ' ' A' ' 211' ' ' GLY . 5.6 tp -134.76 -138.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 170.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 149.47 131.87 2.0 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 126.024 1.773 . . . . 0.0 112.132 -169.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 43.7 t -63.42 125.43 24.15 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.217 1.007 . . . . 0.0 108.675 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.97 -3.43 3.48 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.824 1.25 . . . . 0.0 113.709 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -70.48 117.18 52.63 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 124.242 1.017 . . . . 0.0 108.659 169.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -76.82 4.22 5.86 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.261 2.641 . . . . 0.0 113.16 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -115.99 6.3 14.1 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.85 1.66 . . . . 0.0 110.463 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 49.9 t -58.72 128.3 36.5 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.019 0.528 . . . . 0.0 109.975 170.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.2 m -74.38 2.83 8.5 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.727 1.611 . . . . 0.0 113.689 -176.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.8 mt -133.18 -33.66 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.186 1.794 . . . . 0.0 110.175 -173.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.89 -38.1 0.41 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.796 2.438 . . . . 0.0 115.226 170.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.471 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -132.06 148.51 52.5 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.618 1.967 . . . . 0.0 108.751 -174.091 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -148.35 149.47 31.85 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -73.94 150.7 40.66 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.244 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -59.66 -4.25 0.63 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.84 1.656 . . . . 0.0 113.252 167.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.79 -2.84 8.26 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.326 1.45 . . . . 0.0 112.609 171.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.1 m -71.9 -7.88 51.1 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.112 0.869 . . . . 0.0 111.612 167.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.0 p -133.94 -4.45 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 125.958 1.703 . . . . 0.0 111.765 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.18 33.55 78.67 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.605 1.098 . . . . 0.0 113.012 -174.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.5 mt . . . . . 0 C--N 1.343 0.311 0 C-N-CA 124.437 1.095 . . . . 0.0 112.096 -174.368 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 81.1 t90 . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -138.64 138.26 37.67 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.187 0.995 . . . . 0.0 108.728 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.7 p -64.82 166.78 10.95 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.965 0.906 . . . . 0.0 112.171 176.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.4 36.01 0.37 Allowed 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 123.861 3.041 . . . . 0.0 113.095 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -138.68 -39.51 0.51 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 125.473 1.509 . . . . 0.0 109.329 169.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.442 -0.837 0 C-N-CA 126.979 2.112 . . . . 0.0 112.393 172.184 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.8 p . . . . . 0 C--O 1.235 0.305 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -155.89 -44.91 0.08 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.502 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.7 p -39.83 170.32 0.0 OUTLIER 'General case' 0 C--N 1.348 0.522 0 C-N-CA 126.408 1.883 . . . . 0.0 114.001 168.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.68 -6.97 41.1 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.527 -1.67 . . . . 0.0 110.127 168.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.502 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 89.2 m -97.13 -14.16 21.68 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 123.859 0.864 . . . . 0.0 111.763 175.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.5 p80 45.57 52.48 9.23 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.082 2.153 . . . . 0.0 112.883 -173.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.15 139.79 2.3 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 126.043 1.737 . . . . 0.0 108.439 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -122.6 -174.82 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.878 1.671 . . . . 0.0 109.752 176.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.493 ' H ' HG12 ' A' ' 204' ' ' VAL 0.277 59.7 p 59.87 53.98 4.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.124 2.17 . . . . 0.0 114.571 -174.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.75 121.05 5.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.7 2.0 . . . . 0.0 109.1 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 57.54 -113.46 4.6 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.616 1.579 . . . . 0.0 111.188 -174.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.76 168.56 18.82 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.346 2.259 . . . . 0.0 111.41 -174.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -138.57 159.76 41.3 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.802 0.841 . . . . 0.0 113.036 -167.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.415 HG13 ' H ' ' A' ' 211' ' ' GLY . 5.7 tp -134.8 -137.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 168.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 147.71 131.53 2.13 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 125.555 1.55 . . . . 0.0 112.03 -170.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 53.3 t -64.75 119.49 10.69 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -67.38 1.28 2.31 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.432 1.493 . . . . 0.0 113.747 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -67.0 118.0 51.15 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.22 6.23 4.05 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.28 2.654 . . . . 0.0 113.191 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -119.66 7.64 11.1 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.821 1.648 . . . . 0.0 110.575 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 47.5 t -59.34 130.26 46.04 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 123.286 0.634 . . . . 0.0 110.3 172.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.0 m -76.2 1.48 15.77 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.56 1.544 . . . . 0.0 113.671 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 26.2 mt -134.94 -34.34 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.029 1.731 . . . . 0.0 110.285 -171.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.7 -39.77 0.44 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.71 2.404 . . . . 0.0 115.011 170.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.45 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -131.27 147.73 52.62 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.523 1.929 . . . . 0.0 108.42 -174.612 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -147.76 147.79 30.26 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -71.45 150.97 44.42 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.204 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.96 -1.33 0.64 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.589 1.556 . . . . 0.0 113.41 168.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -126.95 1.3 6.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.756 1.222 . . . . 0.0 112.28 169.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.1 m -72.28 -9.42 58.45 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.793 0.724 . . . . 0.0 111.608 167.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.1 p -135.07 -10.83 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 124.696 1.198 . . . . 0.0 113.046 170.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.49 38.37 8.98 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.615 1.102 . . . . 0.0 113.888 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.344 0.366 0 CA-C-N 118.69 1.245 . . . . 0.0 110.764 173.154 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . 0.417 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 87.5 t90 . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 121.075 0.464 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -139.25 141.25 37.83 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 124.854 1.262 . . . . 0.0 109.471 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . 0.417 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 15.9 p -67.87 163.68 47.61 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.49 0.716 . . . . 0.0 112.288 176.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.54 34.14 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 124.056 3.171 . . . . 0.0 113.458 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -137.32 -35.92 0.67 Allowed 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.45 1.5 . . . . 0.0 110.076 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.442 -0.86 0 C-N-CA 126.556 1.942 . . . . 0.0 111.808 169.972 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 81.1 p . . . . . 0 CA--C 1.534 0.329 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -156.58 -48.59 0.07 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -174.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.484 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -38.62 171.28 0.0 OUTLIER 'General case' 0 C--N 1.351 0.663 0 C-N-CA 126.803 2.041 . . . . 0.0 114.633 169.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.9 mt -70.38 -7.24 41.39 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 113.458 -1.701 . . . . 0.0 110.021 168.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.484 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 94.6 m -96.43 -13.71 22.96 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 123.546 0.738 . . . . 0.0 111.852 174.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.3 p80 46.01 51.04 11.16 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.306 2.242 . . . . 0.0 113.101 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -169.66 142.05 2.45 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 125.854 1.662 . . . . 0.0 107.897 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 205' ' ' SER . 1.1 t -123.65 174.09 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.666 1.587 . . . . 0.0 110.733 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.528 ' H ' HG12 ' A' ' 204' ' ' VAL . 50.0 m 67.48 57.84 0.55 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.719 2.007 . . . . 0.0 113.114 -177.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -158.66 109.4 2.09 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.298 2.239 . . . . 0.0 106.945 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.77 -159.74 45.55 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-O 122.814 1.23 . . . . 0.0 110.757 -168.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -83.43 170.58 14.34 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.375 1.87 . . . . 0.0 112.075 171.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -140.23 159.73 41.53 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.921 1.289 . . . . 0.0 112.137 -169.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . 0.258 9.1 tp -132.19 -138.42 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 146.94 136.45 2.85 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 126.454 1.978 . . . . 0.0 112.308 -169.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.507 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 7.5 t -65.75 127.68 32.92 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.755 -0.723 . . . . 0.0 109.748 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.72 -8.27 1.98 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.343 1.457 . . . . 0.0 113.75 171.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -57.55 110.16 2.29 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 128.163 2.585 . . . . 0.0 108.288 169.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -78.61 10.91 2.64 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.42 2.747 . . . . 0.0 112.758 -175.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -129.22 9.9 5.73 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.279 1.832 . . . . 0.0 109.603 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 21.9 t -55.38 117.46 3.57 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-O 121.781 0.801 . . . . 0.0 111.66 175.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 85.7 p -74.49 1.94 10.73 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.94 2.096 . . . . 0.0 113.265 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.8 mm -123.67 -36.54 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.37 1.868 . . . . 0.0 108.957 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.03 -30.15 0.21 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 128.207 2.603 . . . . 0.0 115.195 169.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.468 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -144.24 149.81 36.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.689 1.596 . . . . 0.0 109.435 -175.266 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -148.21 149.67 32.36 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -72.88 149.86 43.13 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.192 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -59.36 -4.76 0.63 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.57 1.548 . . . . 0.0 113.473 167.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.65 -4.23 8.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.215 1.406 . . . . 0.0 112.638 171.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 14.6 m -72.8 -5.34 37.35 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.002 0.819 . . . . 0.0 111.359 167.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.5 p -136.56 -5.22 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 126.479 1.911 . . . . 0.0 111.931 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.8 35.86 91.46 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.802 1.191 . . . . 0.0 113.023 -175.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.5 mt . . . . . 0 C--N 1.344 0.334 0 C-N-CA 123.968 0.907 . . . . 0.0 111.281 -176.642 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.8 t90 . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.507 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 91.3 m-85 -138.44 138.42 38.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.716 0.807 . . . . 0.0 110.249 -176.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 31.5 p -64.03 162.48 30.36 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 123.675 0.79 . . . . 0.0 111.622 172.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.82 28.95 0.24 Allowed 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 124.028 3.152 . . . . 0.0 113.59 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -133.61 -36.85 0.95 Allowed 'General case' 0 C--N 1.343 0.326 0 C-N-CA 125.794 1.638 . . . . 0.0 109.702 173.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.447 -0.615 0 C-N-CA 126.325 1.85 . . . . 0.0 111.863 169.341 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.98 -49.48 0.09 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -168.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.494 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.9 p -41.65 170.33 0.0 OUTLIER 'General case' 0 C--N 1.349 0.58 0 C-N-CA 125.892 1.677 . . . . 0.0 114.165 169.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.7 mt -71.1 -6.86 42.48 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.925 168.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.494 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 93.7 m -95.62 -13.6 24.2 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.513 0.725 . . . . 0.0 111.797 174.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.0 p80 46.83 52.94 10.92 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.031 2.132 . . . . 0.0 112.85 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -173.16 139.73 0.82 Allowed 'General case' 0 C--N 1.345 0.391 0 C-N-CA 125.878 1.671 . . . . 0.0 108.498 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 205' ' ' SER . 0.5 OUTLIER -114.29 -173.18 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 125.605 1.562 . . . . 0.0 110.665 175.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.521 ' H ' HG12 ' A' ' 204' ' ' VAL 0.254 97.5 p 53.12 64.29 1.91 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.812 2.445 . . . . 0.0 114.771 -174.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.08 112.07 1.54 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.894 2.078 . . . . 0.0 108.011 -177.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 63.65 -133.72 41.25 Favored Glycine 0 C--N 1.339 0.75 0 C-N-CA 124.497 1.046 . . . . 0.0 110.546 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.08 169.05 9.21 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 127.248 2.219 . . . . 0.0 111.42 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -138.66 159.51 41.92 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.251 1.02 . . . . 0.0 112.209 -168.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.448 HG13 ' H ' ' A' ' 211' ' ' GLY . 5.8 tp -133.44 -138.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 169.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 148.32 131.25 2.04 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 125.597 1.57 . . . . 0.0 112.507 -170.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 45.9 t -63.94 121.39 13.99 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.24 2.11 1.79 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.436 1.494 . . . . 0.0 113.699 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -70.94 118.01 61.43 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.378 1.071 . . . . 0.0 108.146 168.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -76.33 4.58 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.185 2.59 . . . . 0.0 113.273 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -116.21 6.41 13.87 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.717 1.607 . . . . 0.0 110.508 174.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 46.5 t -59.14 129.13 40.64 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 123.118 0.567 . . . . 0.0 109.924 171.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 11.0 t -73.27 -1.44 17.87 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.922 1.689 . . . . 0.0 113.455 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.6 mt -132.76 -33.84 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.968 1.707 . . . . 0.0 110.449 -170.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.68 -38.9 0.43 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 127.47 2.308 . . . . 0.0 114.985 171.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.479 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -132.49 148.29 52.39 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.497 1.919 . . . . 0.0 109.03 -173.268 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -148.85 149.95 32.17 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -74.17 151.08 40.09 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.369 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -59.28 -5.12 0.66 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.766 1.626 . . . . 0.0 113.259 167.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.04 -3.58 8.56 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.294 1.438 . . . . 0.0 112.581 171.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 15.5 m -72.8 -6.9 47.92 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.04 0.836 . . . . 0.0 111.739 167.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.35 -5.6 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.864 1.666 . . . . 0.0 111.817 172.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.51 34.82 80.03 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.726 1.155 . . . . 0.0 112.8 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--N 1.343 0.324 0 C-N-CA 124.327 1.051 . . . . 0.0 111.771 -174.599 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 88.8 t90 . . . . . 0 CA--C 1.539 0.538 0 CA-C-O 120.975 0.417 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -138.63 140.46 38.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.201 1.0 . . . . 0.0 109.584 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.2 p -66.73 165.24 26.69 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.73 0.812 . . . . 0.0 112.06 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.47 33.03 0.29 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 124.024 3.149 . . . . 0.0 113.482 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -136.02 -40.31 0.68 Allowed 'General case' 0 C--N 1.345 0.404 0 C-N-CA 125.068 1.347 . . . . 0.0 109.674 169.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.442 -0.856 0 C-N-CA 126.736 2.014 . . . . 0.0 111.705 171.803 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 63.6 p . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -155.26 -42.26 0.08 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 115.705 -2.093 . . . . 0.0 115.099 -173.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.487 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.7 OUTLIER -52.01 173.64 0.03 OUTLIER 'General case' 0 C--N 1.359 0.985 0 CA-C-N 122.223 2.283 . . . . 0.0 112.572 172.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.6 mt -62.83 -6.13 3.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.559 1.543 . . . . 0.0 111.243 172.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 92.4 m -99.29 -11.87 20.86 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 126.298 1.839 . . . . 0.0 112.762 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.7 p80 45.36 48.61 10.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.406 2.283 . . . . 0.0 112.342 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -162.91 147.99 11.78 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.367 1.467 . . . . 0.0 107.539 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 205' ' ' SER . 1.1 t -135.19 171.72 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 127.388 2.275 . . . . 0.0 110.323 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.492 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.3 t 61.36 64.52 1.07 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.61 1.964 . . . . 0.0 112.987 -173.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.86 108.11 1.14 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.48 1.912 . . . . 0.0 108.374 -174.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 59.69 -160.22 19.8 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-O 123.271 1.484 . . . . 0.0 112.631 -174.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.9 pm0 -64.17 148.94 48.85 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.959 2.104 . . . . 0.0 111.621 169.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.8 mtm -150.94 156.17 40.62 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.653 1.981 . . . . 0.0 109.492 -168.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.411 HG13 ' H ' ' A' ' 211' ' ' GLY . 7.2 tp -140.53 -135.56 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -175.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 148.78 133.89 2.32 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 126.054 1.788 . . . . 0.0 112.444 -171.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 50.4 t -64.63 126.58 28.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.168 -1.016 . . . . 0.0 109.013 175.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.91 -7.33 2.33 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -69.61 114.73 26.57 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 119.496 1.044 . . . . 0.0 108.593 171.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -78.45 6.04 5.08 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.418 2.745 . . . . 0.0 112.948 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -118.95 5.58 11.38 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.952 1.701 . . . . 0.0 109.987 174.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.2 t -59.39 131.07 49.87 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 118.487 0.585 . . . . 0.0 109.844 170.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.0 m -74.11 6.31 3.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.725 1.61 . . . . 0.0 113.417 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.0 mm -135.75 -38.15 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 126.54 1.936 . . . . 0.0 109.62 -170.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.86 -43.2 0.53 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.525 2.73 . . . . 0.0 115.511 171.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.487 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -126.02 148.51 49.28 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.566 1.946 . . . . 0.0 108.625 -177.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.412 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 74.0 m-85 -149.11 155.31 40.52 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -173.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -83.97 145.1 28.72 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.559 0.695 . . . . 0.0 110.628 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.34 -3.94 1.08 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.005 1.722 . . . . 0.0 113.979 171.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.86 -4.22 7.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.546 1.138 . . . . 0.0 112.185 172.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.3 m -77.44 -3.03 38.3 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.036 0.835 . . . . 0.0 113.02 168.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.2 p -135.02 -6.11 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.789 1.235 . . . . 0.0 112.259 169.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.77 40.88 20.71 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.59 1.091 . . . . 0.0 113.723 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.7 mt . . . . . 0 N--CA 1.468 0.432 0 CA-C-N 118.517 1.158 . . . . 0.0 110.221 172.064 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 89.1 t90 . . . . . 0 CA--C 1.537 0.444 0 CA-C-O 120.956 0.408 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -140.98 141.99 34.35 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.297 1.039 . . . . 0.0 109.646 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.0 p -70.02 166.02 37.21 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.485 0.714 . . . . 0.0 111.896 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -73.1 32.48 0.31 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.028 3.152 . . . . 0.0 113.383 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -136.29 -36.74 0.72 Allowed 'General case' 0 C--N 1.344 0.34 0 C-N-CA 125.161 1.385 . . . . 0.0 109.845 171.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 37.5 m . . . . . 0 N--CA 1.44 -0.947 0 C-N-CA 126.779 2.032 . . . . 0.0 111.961 172.3 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.9 p . . . . . 0 N--CA 1.465 0.275 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -154.69 -40.47 0.09 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 115.884 -2.007 . . . . 0.0 115.319 -171.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.519 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.8 OUTLIER -53.43 173.64 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 122.312 2.324 . . . . 0.0 112.213 170.59 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.6 mt -62.44 -7.66 4.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.671 1.588 . . . . 0.0 111.232 171.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 67.6 m -95.75 -12.9 24.67 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 126.062 1.745 . . . . 0.0 112.753 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.5 p80 45.2 49.03 10.02 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.339 2.256 . . . . 0.0 112.232 -173.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -164.27 147.94 9.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.217 1.407 . . . . 0.0 108.147 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -127.45 -169.93 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 127.202 2.201 . . . . 0.0 109.285 174.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.444 ' H ' HG12 ' A' ' 204' ' ' VAL . 89.8 p 49.24 58.04 5.83 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.893 2.077 . . . . 0.0 114.324 -174.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.15 100.77 2.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.845 2.058 . . . . 0.0 109.295 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 68.95 -96.78 0.47 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.615 1.578 . . . . 0.0 111.5 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.17 169.47 17.8 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.148 1.779 . . . . 0.0 111.977 -169.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -146.0 161.23 40.57 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.42 1.088 . . . . 0.0 112.073 -169.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.4 HG13 ' H ' ' A' ' 211' ' ' GLY . 4.6 tp -133.31 -134.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 168.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 146.25 133.15 2.46 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 125.493 1.52 . . . . 0.0 111.923 -170.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.51 121.17 14.29 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.374 -0.913 . . . . 0.0 109.082 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -71.78 7.2 1.61 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.51 1.524 . . . . 0.0 113.602 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -71.73 120.2 78.6 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.469 1.107 . . . . 0.0 108.402 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -75.7 6.61 3.58 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.333 2.689 . . . . 0.0 113.361 177.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -119.68 7.67 11.09 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.785 1.634 . . . . 0.0 110.648 174.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.76 129.23 40.44 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 123.438 0.695 . . . . 0.0 110.226 173.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.1 m -81.17 3.45 23.58 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.281 1.432 . . . . 0.0 113.363 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 78.7 mt -134.71 -33.72 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.614 1.565 . . . . 0.0 110.364 -169.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER 73.06 -46.05 0.64 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 128.78 2.832 . . . . 0.0 115.235 170.341 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.519 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.3 OUTLIER -125.44 149.12 48.5 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.588 1.555 . . . . 0.0 109.24 -175.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.4 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 82.6 m-85 -149.69 157.88 43.65 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.945 1.298 . . . . 0.0 108.832 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -89.11 144.6 26.01 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.378 0.609 . . . . 0.0 111.174 -172.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -56.57 -8.24 0.53 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.421 2.288 . . . . 0.0 114.245 169.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.86 -7.69 8.43 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.827 1.251 . . . . 0.0 112.297 174.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 10.6 m -77.28 -3.15 38.4 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.044 0.838 . . . . 0.0 112.938 168.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 12.7 p -131.11 -0.44 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 126.091 1.757 . . . . 0.0 110.857 169.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.46 29.33 74.97 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.208 1.385 . . . . 0.0 113.174 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 C--N 1.342 0.272 0 C-N-CA 124.307 1.043 . . . . 0.0 112.362 -171.509 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.1 t90 . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -139.82 142.43 36.64 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.012 0.925 . . . . 0.0 110.096 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.0 p -70.83 164.96 51.36 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.574 0.75 . . . . 0.0 111.347 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -73.76 31.5 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.047 3.165 . . . . 0.0 113.096 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -136.18 -36.85 0.73 Allowed 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.386 1.474 . . . . 0.0 109.937 176.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.443 -0.815 0 C-N-CA 127.354 2.262 . . . . 0.0 112.011 173.675 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 78.5 p . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -156.83 -39.0 0.07 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 115.901 -2.0 . . . . 0.0 115.194 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.502 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.7 OUTLIER -52.86 173.79 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 122.218 2.281 . . . . 0.0 112.438 171.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.6 mt -62.88 -6.71 4.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.691 1.596 . . . . 0.0 111.216 171.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.8 m -98.53 -11.31 22.35 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 126.14 1.776 . . . . 0.0 112.712 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.2 p80 45.75 48.92 11.63 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.401 2.28 . . . . 0.0 112.424 -174.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -163.76 148.97 10.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.457 1.503 . . . . 0.0 107.548 176.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 205' ' ' SER . 1.1 t -133.83 172.03 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 127.225 2.21 . . . . 0.0 110.635 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.511 ' H ' HG12 ' A' ' 204' ' ' VAL . 13.2 t 64.66 61.53 0.82 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.869 2.068 . . . . 0.0 113.3 -174.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.82 111.07 1.52 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.396 1.878 . . . . 0.0 108.558 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.5 -163.18 23.44 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-O 123.171 1.428 . . . . 0.0 112.575 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.9 pm0 -65.61 147.27 53.68 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 112.233 -1.983 . . . . 0.0 111.1 169.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.8 mtm -148.98 153.71 38.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.208 1.803 . . . . 0.0 109.743 -168.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.9 tp -137.96 -134.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.346 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -173.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 149.35 132.06 2.03 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 126.232 1.872 . . . . 0.0 112.788 -169.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 47.6 t -64.35 125.35 24.31 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.29 -0.955 . . . . 0.0 108.678 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.8 -0.32 2.14 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.484 1.514 . . . . 0.0 113.245 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -72.97 116.83 54.39 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 124.501 1.121 . . . . 0.0 108.466 168.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.02 4.21 5.97 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.288 2.658 . . . . 0.0 113.217 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -114.78 5.01 15.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.766 1.626 . . . . 0.0 110.526 174.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.98 130.13 45.52 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 122.987 0.515 . . . . 0.0 110.4 171.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.0 m -74.03 1.62 10.59 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.785 1.634 . . . . 0.0 113.868 -176.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 19.1 mt -134.07 -32.82 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 126.091 1.756 . . . . 0.0 110.359 -172.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.77 -37.51 0.38 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 128.366 2.666 . . . . 0.0 115.78 172.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.504 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.5 OUTLIER -130.14 148.77 52.02 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.371 1.868 . . . . 0.0 108.985 -176.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.411 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 82.5 m-85 -147.27 155.12 41.77 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.849 0.86 . . . . 0.0 108.868 -175.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -82.05 143.19 31.71 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.922 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -58.97 -7.27 1.0 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.789 1.636 . . . . 0.0 113.827 170.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -118.83 -5.26 10.63 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.412 1.085 . . . . 0.0 112.417 172.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.0 m -78.55 -0.77 30.95 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.903 0.774 . . . . 0.0 112.855 168.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.0 -9.67 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.845 2.058 . . . . 0.0 111.943 173.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 73.14 36.98 55.93 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.575 1.084 . . . . 0.0 112.993 -177.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 CA--C 1.533 0.319 0 CA-C-N 117.854 0.827 . . . . 0.0 109.919 175.344 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 89.6 t90 . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -139.76 141.66 36.82 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.313 1.045 . . . . 0.0 109.491 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.1 p -67.2 165.58 26.92 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 123.586 0.755 . . . . 0.0 112.109 174.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -72.97 34.84 0.33 Allowed 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.978 3.119 . . . . 0.0 113.274 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -139.11 -37.45 0.51 Allowed 'General case' 0 C--N 1.343 0.324 0 C-N-CA 125.02 1.328 . . . . 0.0 110.275 169.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.442 -0.868 0 C-N-CA 126.934 2.094 . . . . 0.0 112.025 172.999 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.4 p . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -156.49 -37.98 0.08 Allowed 'General case' 0 C--N 1.35 0.625 0 CA-C-O 115.728 -2.082 . . . . 0.0 115.958 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.52 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 1.1 t -53.65 174.11 0.05 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 122.49 2.405 . . . . 0.0 111.851 170.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.1 mt -62.33 -7.29 4.12 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.953 1.701 . . . . 0.0 111.283 170.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 69.7 m -97.11 -12.4 23.19 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.989 1.716 . . . . 0.0 112.711 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.4 p80 45.32 49.33 10.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.173 2.189 . . . . 0.0 112.437 -173.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -164.02 148.06 9.97 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.417 1.487 . . . . 0.0 107.864 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -133.86 176.1 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 127.179 2.192 . . . . 0.0 110.81 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.552 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.0 t 63.69 61.85 0.96 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.692 1.997 . . . . 0.0 112.803 -175.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.96 110.08 1.22 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.334 1.853 . . . . 0.0 109.001 -173.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 60.06 -158.78 24.9 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-O 123.21 1.45 . . . . 0.0 113.247 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.8 pm0 -65.49 145.17 56.45 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.098 2.159 . . . . 0.0 111.317 169.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.3 mtm -151.52 156.68 41.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.294 1.838 . . . . 0.0 109.863 -168.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 7.5 tp -138.03 -133.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 124.258 1.023 . . . . 0.0 109.204 -175.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 146.37 136.08 2.85 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 126.466 1.984 . . . . 0.0 113.285 -169.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.532 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 7.0 t -65.14 125.62 25.55 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 114.622 -0.789 . . . . 0.0 109.324 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.2 0.29 0.65 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.589 1.156 . . . . 0.0 112.758 170.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -63.49 111.4 5.07 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 127.783 2.433 . . . . 0.0 107.844 167.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -78.58 11.5 2.44 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.374 2.716 . . . . 0.0 113.031 -176.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -129.23 9.04 5.61 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.161 1.784 . . . . 0.0 109.787 174.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 25.8 t -55.58 124.11 16.25 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.636 0.732 . . . . 0.0 112.403 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 15.8 m -74.34 1.14 12.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.703 2.001 . . . . 0.0 113.271 -177.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 12.5 mt -131.48 -34.55 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 126.382 1.873 . . . . 0.0 109.574 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.13 -25.3 0.16 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 128.017 2.527 . . . . 0.0 115.78 169.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.521 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.6 OUTLIER -143.6 148.06 35.31 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.855 1.662 . . . . 0.0 109.178 -178.433 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -145.96 155.87 43.13 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.168 0.987 . . . . 0.0 108.825 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -80.91 143.16 32.86 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.901 -175.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.99 -2.4 0.41 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.297 1.839 . . . . 0.0 114.12 171.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.61 -7.59 7.42 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.26 1.424 . . . . 0.0 112.166 172.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.6 m -77.27 -2.16 33.35 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.154 0.888 . . . . 0.0 112.678 168.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.77 -5.59 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 127.444 2.298 . . . . 0.0 111.266 172.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.34 36.58 91.85 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.894 1.235 . . . . 0.0 112.885 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 N--CA 1.465 0.307 0 C-N-CA 123.727 0.811 . . . . 0.0 111.452 -178.166 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 85.0 t90 . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.532 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 71.8 m-85 -134.77 135.97 42.25 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.831 0.852 . . . . 0.0 110.655 -176.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 31.2 p -65.96 164.42 28.55 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.311 1.044 . . . . 0.0 112.237 172.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.88 30.84 0.25 Allowed 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.244 3.296 . . . . 0.0 113.664 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -133.67 -36.4 0.96 Allowed 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.545 1.538 . . . . 0.0 110.041 170.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.444 -0.74 0 C-N-CA 126.158 1.783 . . . . 0.0 112.156 169.853 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 82.0 p . . . . . 0 C--O 1.233 0.235 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -156.55 -46.56 0.07 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 117.861 -1.066 . . . . 0.0 113.804 -175.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.506 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -39.38 170.05 0.0 OUTLIER 'General case' 0 C--N 1.349 0.578 0 C-N-CA 126.375 1.87 . . . . 0.0 114.064 168.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -71.08 -6.74 41.44 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.118 168.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.506 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 95.7 m -95.89 -14.31 23.26 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 123.633 0.773 . . . . 0.0 111.792 174.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.1 p80 46.25 52.34 10.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.304 2.242 . . . . 0.0 112.899 -173.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -170.36 141.62 2.03 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 126.091 1.756 . . . . 0.0 107.95 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 205' ' ' SER . 1.6 t -126.47 171.11 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 125.488 1.515 . . . . 0.0 111.18 -176.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.505 ' H ' HG12 ' A' ' 204' ' ' VAL . 43.2 m 68.72 62.81 0.33 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.267 2.227 . . . . 0.0 113.387 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.65 113.45 1.29 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.595 1.958 . . . . 0.0 108.531 -174.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 63.26 -168.68 20.12 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-O 122.708 1.171 . . . . 0.0 112.06 -173.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -69.02 150.53 47.55 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 113.273 -1.463 . . . . 0.0 110.651 168.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.9 mtm -143.63 152.57 41.53 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.929 1.692 . . . . 0.0 109.824 -166.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.6 tp -135.5 -138.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.304 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 151.86 132.4 1.85 Allowed Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 125.906 1.717 . . . . 0.0 112.151 -169.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 40.7 t -63.61 125.55 24.63 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 114.074 -1.063 . . . . 0.0 108.249 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -68.9 6.16 0.96 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.54 1.136 . . . . 0.0 113.559 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -74.42 114.11 30.47 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 166.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -77.65 9.11 3.06 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.328 2.685 . . . . 0.0 113.059 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -124.21 8.74 8.55 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.888 1.675 . . . . 0.0 110.248 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.6 129.97 44.23 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 118.306 0.503 . . . . 0.0 109.924 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -73.59 4.36 5.05 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.755 1.622 . . . . 0.0 113.404 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.2 mt -132.54 -35.17 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 126.268 1.827 . . . . 0.0 109.938 -175.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.7 -38.72 0.43 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.762 2.425 . . . . 0.0 115.27 170.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.47 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -131.43 148.67 52.67 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.899 2.08 . . . . 0.0 108.646 -174.215 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -148.62 146.72 28.35 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -73.22 149.61 42.7 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.793 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -60.29 -6.28 1.43 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.74 1.216 . . . . 0.0 113.641 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -120.36 -0.56 10.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.33 1.052 . . . . 0.0 112.611 170.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.5 m -72.61 -5.99 41.11 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.901 0.773 . . . . 0.0 111.301 166.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.1 p -137.48 -12.48 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.765 2.026 . . . . 0.0 112.388 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.97 38.84 55.62 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.348 0.975 . . . . 0.0 112.86 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 15.8 mt . . . . . 0 N--CA 1.467 0.415 0 CA-C-N 117.82 0.81 . . . . 0.0 109.796 175.142 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 88.9 t90 . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -140.12 143.21 36.11 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.2 1.0 . . . . 0.0 108.755 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 17.1 p -68.12 163.37 51.99 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-O 118.808 -0.615 . . . . 0.0 111.633 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.25 33.81 0.32 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.965 3.11 . . . . 0.0 112.891 178.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -138.26 -35.7 0.61 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 125.988 1.715 . . . . 0.0 109.964 173.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.443 -0.818 0 C-N-CA 126.774 2.03 . . . . 0.0 111.591 170.324 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.6 p . . . . . 0 CA--C 1.532 0.282 0 CA-C-O 118.616 -0.707 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -156.28 -38.91 0.08 Allowed 'General case' 0 C--N 1.35 0.623 0 CA-C-O 115.764 -2.065 . . . . 0.0 115.725 -174.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.516 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.8 OUTLIER -53.1 174.2 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 122.449 2.386 . . . . 0.0 112.145 172.035 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.0 mt -62.65 -6.3 3.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.734 1.614 . . . . 0.0 111.275 170.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 82.6 m -99.32 -12.1 20.63 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 126.193 1.797 . . . . 0.0 112.699 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.0 p80 45.19 49.03 10.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.189 2.196 . . . . 0.0 112.357 -174.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -164.15 148.16 9.8 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 125.572 1.549 . . . . 0.0 108.045 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -132.26 175.51 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 127.244 2.218 . . . . 0.0 110.253 178.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.504 ' H ' HG12 ' A' ' 204' ' ' VAL . 16.8 t 61.93 63.1 1.15 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.377 1.871 . . . . 0.0 113.292 -175.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -161.12 112.58 1.81 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.333 1.853 . . . . 0.0 109.165 -173.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.48 -110.02 3.24 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 125.232 1.396 . . . . 0.0 109.872 -172.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.14 165.9 24.64 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.84 2.056 . . . . 0.0 111.332 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -138.72 157.16 46.62 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.742 1.217 . . . . 0.0 111.063 -168.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.421 HG12 ' H ' ' A' ' 211' ' ' GLY . 9.5 tt -134.48 -136.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 174.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 147.59 132.08 2.2 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 125.167 1.365 . . . . 0.0 113.113 -170.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.5 t -65.86 123.44 19.81 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.9 0.88 . . . . 0.0 108.777 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.34 -1.8 3.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.71 1.604 . . . . 0.0 113.574 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -66.93 116.29 33.97 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 168.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.93 5.15 5.15 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.409 2.739 . . . . 0.0 113.009 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -117.69 6.16 12.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.902 1.681 . . . . 0.0 110.424 174.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 41.8 t -59.01 130.23 46.03 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 122.973 0.509 . . . . 0.0 110.378 172.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.3 t -76.07 3.21 10.92 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.732 1.613 . . . . 0.0 113.617 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 19.6 mt -134.42 -35.02 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.995 1.718 . . . . 0.0 110.279 -172.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.22 -40.95 0.49 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.992 2.517 . . . . 0.0 115.38 172.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.516 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.5 OUTLIER -126.56 147.67 49.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.135 1.774 . . . . 0.0 108.837 -177.683 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -146.89 157.48 43.66 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.39 1.076 . . . . 0.0 108.794 -175.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -84.16 141.82 30.78 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.793 -175.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.73 -8.55 1.35 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.574 1.949 . . . . 0.0 113.096 169.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -118.01 -7.06 10.91 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.823 1.249 . . . . 0.0 112.189 174.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 4.6 m -77.9 -2.1 35.09 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.94 0.791 . . . . 0.0 112.306 168.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 14.3 p -130.86 -6.31 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 126.955 2.102 . . . . 0.0 111.481 173.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.67 35.32 89.65 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.735 1.16 . . . . 0.0 113.176 -176.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.7 mt . . . . . 0 CA--C 1.536 0.419 0 CA-C-N 118.366 1.083 . . . . 0.0 111.315 175.999 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . 0.4 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 91.4 t90 . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 121.245 0.545 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -139.02 141.13 38.29 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.864 1.266 . . . . 0.0 109.125 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . 0.4 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 17.6 p -66.88 162.87 48.85 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.302 0.641 . . . . 0.0 112.071 173.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -73.63 35.99 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 124.006 3.137 . . . . 0.0 112.888 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -138.46 -35.68 0.59 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.868 1.667 . . . . 0.0 109.935 170.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.444 -0.763 0 C-N-CA 126.424 1.89 . . . . 0.0 111.832 169.98 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.8 p . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -155.42 -47.14 0.08 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -173.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.495 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -38.6 170.11 0.0 OUTLIER 'General case' 0 C--N 1.351 0.635 0 C-N-CA 126.557 1.943 . . . . 0.0 114.607 169.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.3 mt -70.57 -6.7 38.44 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 113.32 -1.764 . . . . 0.0 110.044 168.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.495 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 84.9 m -96.77 -14.18 22.13 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 123.646 0.778 . . . . 0.0 111.784 174.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.8 p80 45.46 52.27 9.16 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.224 2.21 . . . . 0.0 112.915 -173.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -169.9 140.7 2.1 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.934 1.694 . . . . 0.0 108.269 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.499 HG12 ' H ' ' A' ' 205' ' ' SER . 0.9 OUTLIER -125.0 174.1 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.675 1.59 . . . . 0.0 110.634 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.499 ' H ' HG12 ' A' ' 204' ' ' VAL . 13.7 t 66.36 62.05 0.57 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.721 2.009 . . . . 0.0 113.413 -174.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.75 110.87 1.98 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.174 1.79 . . . . 0.0 108.977 -175.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 66.81 -109.51 2.95 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 125.283 1.421 . . . . 0.0 110.438 -172.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.61 168.64 19.35 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.123 2.169 . . . . 0.0 111.139 -174.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -140.35 158.89 43.33 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.719 0.808 . . . . 0.0 112.748 -168.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.451 HG13 ' H ' ' A' ' 211' ' ' GLY . 7.2 tp -133.18 -138.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.401 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.451 ' H ' HG13 ' A' ' 210' ' ' ILE . . . 145.43 134.6 2.73 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 126.165 1.84 . . . . 0.0 111.714 -169.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.419 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 41.4 t -63.18 126.38 27.21 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.75 -4.29 3.0 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.376 1.47 . . . . 0.0 113.545 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -71.72 118.85 70.32 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.458 1.103 . . . . 0.0 109.071 169.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.36 3.76 6.02 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.362 2.708 . . . . 0.0 113.283 176.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -115.04 6.11 15.14 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.912 1.685 . . . . 0.0 110.495 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 50.8 t -58.18 128.37 36.78 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 123.174 0.59 . . . . 0.0 109.905 171.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.9 t -74.14 1.74 10.52 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.7 1.6 . . . . 0.0 113.442 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.5 mm -134.33 -35.08 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.848 1.659 . . . . 0.0 110.126 -170.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.92 -38.34 0.4 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.117 2.567 . . . . 0.0 115.201 169.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.451 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.0 OUTLIER -135.8 148.91 48.92 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.936 1.694 . . . . 0.0 109.168 -174.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -149.15 148.13 29.28 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -72.15 150.89 43.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.264 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -59.03 -4.6 0.51 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.884 1.674 . . . . 0.0 113.027 166.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.86 -3.69 8.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.237 1.415 . . . . 0.0 112.647 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 18.8 m -72.92 -6.2 43.59 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.107 0.867 . . . . 0.0 111.645 167.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.22 -4.76 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 126.179 1.792 . . . . 0.0 111.709 172.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.69 32.57 74.56 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.753 1.168 . . . . 0.0 113.117 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 C--N 1.344 0.342 0 C-N-CA 124.375 1.07 . . . . 0.0 112.048 -175.011 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.1 t90 . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.419 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 93.3 m-85 -140.49 140.89 35.39 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.826 0.851 . . . . 0.0 109.506 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 242' ' ' CYS . 6.0 p -70.16 167.36 25.91 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.118 0.967 . . . . 0.0 112.174 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -69.59 9.32 0.58 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 123.463 2.776 . . . . 0.0 114.42 -176.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -133.41 27.03 4.11 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.188 1.795 . . . . 0.0 111.504 176.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 239' ' ' CYS . 3.7 t . . . . . 0 CA--C 1.536 0.425 0 C-N-CA 126.11 1.764 . . . . 0.0 110.768 -173.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.7 p . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -156.41 -37.92 0.08 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 115.935 -1.983 . . . . 0.0 115.759 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.512 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.9 OUTLIER -53.82 174.11 0.05 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 122.352 2.342 . . . . 0.0 111.97 169.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.3 mt -62.52 -7.46 4.66 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.869 1.668 . . . . 0.0 111.278 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 67.0 m -96.62 -12.54 23.8 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.943 1.697 . . . . 0.0 112.68 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.8 p80 45.16 49.27 9.83 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.262 2.225 . . . . 0.0 112.371 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -163.92 148.29 10.24 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.352 1.461 . . . . 0.0 107.825 175.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -134.66 174.48 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 127.274 2.23 . . . . 0.0 110.796 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.547 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.0 t 63.64 62.04 0.96 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.653 1.981 . . . . 0.0 112.727 -174.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.88 108.74 1.16 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.546 1.938 . . . . 0.0 108.716 -173.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 60.48 -160.14 24.17 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-O 123.296 1.498 . . . . 0.0 113.172 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.8 pm0 -65.6 147.24 53.72 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.337 2.255 . . . . 0.0 111.63 170.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.6 mtm -150.57 158.83 44.6 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.186 1.794 . . . . 0.0 110.218 -168.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 9.2 tp -139.35 -133.87 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.247 1.019 . . . . 0.0 109.219 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 147.29 136.01 2.75 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 126.456 1.979 . . . . 0.0 113.14 -169.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.516 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 7.1 t -64.59 124.98 23.27 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 114.642 -0.779 . . . . 0.0 109.124 177.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.45 1.59 0.52 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.631 1.173 . . . . 0.0 113.105 170.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -63.73 111.65 5.69 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 127.622 2.369 . . . . 0.0 107.951 167.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -78.7 11.46 2.49 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.455 2.77 . . . . 0.0 112.916 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -128.95 9.08 5.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.087 1.755 . . . . 0.0 109.798 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 20.8 t -56.65 123.21 14.1 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-O 121.542 0.687 . . . . 0.0 112.131 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 39.7 m -74.5 0.35 15.03 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.537 1.935 . . . . 0.0 113.321 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 14.5 mt -129.14 -34.76 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.436 1.894 . . . . 0.0 109.425 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.75 -25.63 0.15 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.144 2.578 . . . . 0.0 115.77 169.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.52 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.6 OUTLIER -142.45 148.59 38.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.957 1.703 . . . . 0.0 109.041 -177.503 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -147.03 156.61 43.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.095 0.958 . . . . 0.0 108.511 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -82.74 143.58 30.78 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.43 0.633 . . . . 0.0 110.203 -175.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.17 -4.36 0.51 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.675 1.99 . . . . 0.0 114.056 170.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.1 -8.92 7.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.364 1.466 . . . . 0.0 112.215 173.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.5 m -76.68 -2.57 33.53 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.102 0.865 . . . . 0.0 112.81 168.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.2 p -131.43 -1.62 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 126.675 1.99 . . . . 0.0 110.931 170.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 62.45 34.12 88.43 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.112 1.339 . . . . 0.0 113.003 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.5 mt . . . . . 0 C--N 1.343 0.309 0 CA-C-N 117.859 0.829 . . . . 0.0 111.524 -174.018 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 86.7 t90 . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.516 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 88.7 m-85 -135.92 136.65 40.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.942 0.897 . . . . 0.0 110.592 -176.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 30.6 p -69.8 164.53 50.35 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 124.259 1.023 . . . . 0.0 112.163 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.28 28.85 0.26 Allowed 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 124.352 3.368 . . . . 0.0 113.817 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -132.15 -30.22 1.56 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.722 2.009 . . . . 0.0 110.079 174.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.443 -0.794 0 C-N-CA 127.301 2.24 . . . . 0.0 112.312 169.88 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.8 p . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -155.34 -44.47 0.08 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.504 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -38.86 169.84 0.0 OUTLIER 'General case' 0 C--N 1.349 0.578 0 C-N-CA 126.299 1.839 . . . . 0.0 114.257 168.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.6 mt -71.05 -6.34 38.28 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 113.417 -1.72 . . . . 0.0 110.129 168.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.504 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 86.9 m -96.69 -14.2 22.24 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 123.617 0.767 . . . . 0.0 111.819 174.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.9 p80 45.87 52.7 9.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.21 2.204 . . . . 0.0 112.779 -173.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.42 140.39 2.27 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 125.818 1.647 . . . . 0.0 107.958 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 205' ' ' SER . 1.4 t -129.34 171.02 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.368 1.467 . . . . 0.0 111.069 -176.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.511 ' H ' HG12 ' A' ' 204' ' ' VAL . 7.8 t 67.04 64.75 0.44 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.033 2.133 . . . . 0.0 113.048 -174.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.15 113.63 1.21 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.468 1.907 . . . . 0.0 108.48 -175.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.36 -162.68 23.8 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 123.181 1.434 . . . . 0.0 112.769 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.456 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.7 pm0 -67.61 145.05 55.23 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 112.223 -1.988 . . . . 0.0 110.829 169.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.4 mtm -146.45 152.89 39.75 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.166 1.787 . . . . 0.0 109.858 -168.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 9.7 tp -138.98 -137.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.36 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 -174.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 152.92 133.01 1.83 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 125.938 1.732 . . . . 0.0 112.375 -169.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 43.9 t -63.08 124.39 21.03 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.081 -1.059 . . . . 0.0 108.395 175.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.63 4.87 1.22 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.353 1.461 . . . . 0.0 113.426 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -74.95 114.59 36.35 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 167.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.31 9.07 2.97 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.384 2.722 . . . . 0.0 113.009 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -123.89 8.76 8.74 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.798 1.639 . . . . 0.0 110.34 175.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.79 130.88 48.69 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 118.293 0.497 . . . . 0.0 109.951 172.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.5 t -73.48 3.86 5.55 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.794 1.638 . . . . 0.0 113.578 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 30.7 mt -132.96 -34.61 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 126.274 1.829 . . . . 0.0 110.035 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.79 -39.54 0.45 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.624 2.369 . . . . 0.0 115.415 170.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.473 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -130.7 148.6 52.5 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.923 2.089 . . . . 0.0 108.371 -174.283 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -148.63 145.9 27.97 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -175.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -71.64 149.78 45.25 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.634 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.38 -6.04 1.39 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.742 1.217 . . . . 0.0 113.389 168.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -121.66 0.1 9.79 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.454 1.102 . . . . 0.0 112.588 170.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.1 m -72.1 -6.77 44.87 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.946 0.794 . . . . 0.0 111.252 166.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.12 -12.67 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 126.376 1.87 . . . . 0.0 112.627 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.22 36.61 34.44 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.422 1.011 . . . . 0.0 113.113 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 17.0 mt . . . . . 0 CA--C 1.535 0.376 0 C-N-CA 124.309 1.044 . . . . 0.0 109.838 174.003 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 87.4 t90 . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 121.196 0.522 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -140.08 140.01 36.01 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.204 1.001 . . . . 0.0 109.093 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 16.6 p -68.94 164.69 44.84 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 123.614 0.765 . . . . 0.0 112.187 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.47 35.3 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.291 3.327 . . . . 0.0 113.071 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -139.55 -28.65 0.76 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.622 1.569 . . . . 0.0 111.032 169.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.441 -0.885 0 C-N-CA 127.521 2.328 . . . . 0.0 112.18 178.149 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -155.55 -41.53 0.08 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -166.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.514 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.7 p -38.56 170.15 0.0 OUTLIER 'General case' 0 C--N 1.347 0.49 0 C-N-CA 126.392 1.877 . . . . 0.0 113.973 168.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.1 mt -70.68 -6.17 35.17 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.149 168.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.514 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 93.4 m -96.38 -14.14 22.7 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 123.659 0.784 . . . . 0.0 111.705 174.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.2 p80 46.38 50.92 12.06 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.903 2.081 . . . . 0.0 112.388 -174.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -168.26 141.63 3.16 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 125.068 1.347 . . . . 0.0 108.035 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -124.84 -177.39 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.618 1.567 . . . . 0.0 110.293 177.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.475 ' H ' HG12 ' A' ' 204' ' ' VAL . 10.6 t 62.16 57.59 1.99 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.294 2.238 . . . . 0.0 114.449 -169.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . 0.433 ' H ' ' CE ' ' A' ' 209' ' ' MET . 0.1 OUTLIER -164.04 113.85 1.24 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.574 1.95 . . . . 0.0 109.834 -177.008 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 66.09 -174.23 21.72 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 122.888 1.271 . . . . 0.0 114.099 176.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -62.05 151.3 35.78 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.474 1.91 . . . . 0.0 111.846 169.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.433 ' CE ' ' H ' ' A' ' 206' ' ' TYR . 26.0 mtt -145.14 160.6 41.18 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.625 1.17 . . . . 0.0 112.724 -166.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . 0.265 9.6 tp -138.33 -139.21 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 145.73 135.22 2.78 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 126.486 1.993 . . . . 0.0 111.787 -168.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 6.6 t -65.1 123.18 18.83 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 124.447 0.734 . . . . 0.0 109.208 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.68 1.99 0.52 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.851 1.26 . . . . 0.0 113.11 171.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -62.59 112.43 6.57 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.903 2.481 . . . . 0.0 107.658 166.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -78.28 12.17 2.15 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.363 2.709 . . . . 0.0 112.953 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -129.8 9.49 5.42 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.081 1.752 . . . . 0.0 109.811 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 15.4 t -57.88 117.89 4.76 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-O 121.647 0.737 . . . . 0.0 111.669 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.7 t -74.49 -2.37 25.34 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.571 1.948 . . . . 0.0 112.571 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.0 mm -117.6 -37.03 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.041 1.736 . . . . 0.0 109.05 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.51 -30.26 0.21 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.25 2.62 . . . . 0.0 115.462 168.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.474 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.0 OUTLIER -144.46 150.15 37.16 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.19 1.796 . . . . 0.0 109.03 -174.576 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -148.12 148.17 30.32 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -71.57 150.41 44.75 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.413 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -60.16 -4.61 0.84 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.904 1.281 . . . . 0.0 113.595 168.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -120.87 -2.5 9.77 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.765 1.226 . . . . 0.0 112.485 170.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 21.2 m -73.36 -5.05 37.2 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.863 0.756 . . . . 0.0 111.606 167.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.5 p -138.91 -9.4 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 126.986 2.114 . . . . 0.0 112.187 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.0 37.13 60.49 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.409 1.004 . . . . 0.0 112.941 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 24.6 mt . . . . . 0 N--CA 1.467 0.396 0 CA-C-N 117.819 0.81 . . . . 0.0 109.909 175.287 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 78.9 t90 . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . 0.522 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 75.1 m-85 -133.03 135.81 45.62 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.926 0.89 . . . . 0.0 110.298 -176.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 30.8 p -65.6 163.08 37.23 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 123.821 0.848 . . . . 0.0 111.599 170.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.28 28.85 0.26 Allowed 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 124.31 3.34 . . . . 0.0 113.529 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -134.17 -34.85 0.95 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.694 1.998 . . . . 0.0 109.377 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.447 -0.616 0 C-N-CA 126.602 1.961 . . . . 0.0 112.104 169.349 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 55.3 p . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -155.45 -38.5 0.09 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 115.739 -2.077 . . . . 0.0 115.92 -168.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.523 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.8 OUTLIER -53.48 174.29 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 122.551 2.432 . . . . 0.0 112.169 170.554 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.0 mt -62.47 -6.74 3.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.607 1.563 . . . . 0.0 111.212 171.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 89.1 m -98.22 -12.53 21.56 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 126.186 1.794 . . . . 0.0 112.71 179.29 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.8 p80 44.97 48.29 9.39 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.219 2.208 . . . . 0.0 112.368 -173.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -162.94 147.16 11.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.461 1.504 . . . . 0.0 108.047 176.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.497 HG12 ' H ' ' A' ' 205' ' ' SER . 0.6 OUTLIER -132.62 175.44 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 127.157 2.183 . . . . 0.0 110.109 178.682 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.497 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.6 t 59.82 65.91 1.06 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.347 1.859 . . . . 0.0 112.824 -174.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.62 102.89 1.36 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.344 1.858 . . . . 0.0 109.163 -173.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 68.45 -98.4 0.52 Allowed Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.386 1.47 . . . . 0.0 110.392 -172.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.26 170.67 15.55 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.401 1.88 . . . . 0.0 111.731 -174.036 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -143.97 160.19 41.26 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.903 1.281 . . . . 0.0 111.364 -169.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.421 HG13 ' H ' ' A' ' 211' ' ' GLY . 4.6 tp -133.42 -135.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.372 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 169.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 148.19 133.7 2.35 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 125.434 1.493 . . . . 0.0 112.478 -172.297 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 53.6 t -64.89 119.32 10.46 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.366 -0.917 . . . . 0.0 109.055 174.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -70.01 5.28 1.66 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.695 1.598 . . . . 0.0 113.874 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -68.8 119.78 71.58 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 168.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.95 5.88 4.16 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.317 2.678 . . . . 0.0 113.312 178.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.86 6.06 12.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.657 1.583 . . . . 0.0 110.608 174.216 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 42.5 t -60.53 129.06 39.7 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 123.584 0.753 . . . . 0.0 110.442 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.2 m -79.91 4.47 16.66 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.496 1.518 . . . . 0.0 113.333 -176.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.6 mm -135.1 -36.27 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.787 1.635 . . . . 0.0 110.348 -169.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.45 -41.65 0.51 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.84 2.856 . . . . 0.0 115.201 170.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.523 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -129.08 148.09 50.99 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.738 1.615 . . . . 0.0 109.276 -176.057 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -149.38 157.54 43.4 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 124.94 1.296 . . . . 0.0 108.84 -175.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -88.24 144.11 26.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.304 0.573 . . . . 0.0 111.098 -171.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -57.43 -7.2 0.56 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.292 2.237 . . . . 0.0 114.265 170.078 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.22 -8.29 8.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.029 1.332 . . . . 0.0 112.207 174.228 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 10.0 m -77.11 -2.51 34.63 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.07 0.85 . . . . 0.0 112.87 168.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 12.9 p -131.72 -2.03 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 126.435 1.894 . . . . 0.0 111.116 170.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.2 34.38 89.77 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.938 1.256 . . . . 0.0 112.894 -177.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.2 mt . . . . . 0 C--N 1.342 0.266 0 C-N-CA 124.183 0.993 . . . . 0.0 111.919 -174.299 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.5 t90 . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -140.67 141.78 34.99 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.275 1.03 . . . . 0.0 110.348 178.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.7 p -70.37 165.61 42.9 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.082 0.953 . . . . 0.0 111.731 174.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.47 29.32 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.994 3.13 . . . . 0.0 113.569 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -135.58 -33.8 0.86 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.664 1.586 . . . . 0.0 110.091 174.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.44 -0.959 0 C-N-CA 126.554 1.941 . . . . 0.0 111.99 170.381 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 57.6 p . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -156.33 -39.95 0.08 Allowed 'General case' 0 C--N 1.353 0.735 0 CA-C-O 115.621 -2.133 . . . . 0.0 115.207 -169.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.5 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.7 OUTLIER -51.53 175.47 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 122.01 2.186 . . . . 0.0 112.953 176.538 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.9 -5.11 3.92 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.082 -1.417 . . . . 0.0 111.21 170.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 88.6 m -99.32 -15.95 18.63 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 125.976 1.711 . . . . 0.0 112.548 176.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 51.12 46.82 25.9 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.723 2.009 . . . . 0.0 111.628 -177.142 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -164.51 147.27 8.85 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.764 1.626 . . . . 0.0 107.621 179.112 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.472 HG12 ' H ' ' A' ' 205' ' ' SER . 0.5 OUTLIER -132.35 -178.14 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 127.355 2.262 . . . . 0.0 109.553 175.654 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.472 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.2 t 60.16 58.32 2.69 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.93 1.692 . . . . 0.0 113.08 -172.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.89 114.48 2.58 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.944 2.098 . . . . 0.0 109.122 -175.202 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.86 -109.34 2.48 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 125.571 1.558 . . . . 0.0 110.827 -175.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.78 169.11 18.36 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.627 1.971 . . . . 0.0 111.546 -173.618 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -141.69 161.26 38.38 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.146 0.978 . . . . 0.0 112.627 -167.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.428 HG13 ' H ' ' A' ' 211' ' ' GLY . 7.5 tp -135.78 -135.32 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 168.341 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 145.61 130.47 2.2 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 125.559 1.552 . . . . 0.0 112.096 -170.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 41.0 t -63.82 122.66 16.97 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.239 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.78 -2.12 2.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.692 1.597 . . . . 0.0 113.506 -179.216 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -69.25 116.25 40.39 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.277 1.031 . . . . 0.0 108.518 168.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -78.08 8.58 3.44 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.036 2.491 . . . . 0.0 112.916 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -121.37 6.4 10.15 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.727 1.611 . . . . 0.0 110.145 174.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.9 t -60.98 129.95 43.96 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 118.683 0.674 . . . . 0.0 109.589 171.124 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.3 t -74.94 6.31 4.22 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.708 1.603 . . . . 0.0 113.188 -176.275 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.3 mm -134.45 -36.81 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 126.134 1.774 . . . . 0.0 109.776 -171.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . 0.251 0.0 OUTLIER 71.06 -43.88 0.57 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.355 2.662 . . . . 0.0 115.497 169.737 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.5 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -125.33 148.77 48.6 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.469 1.908 . . . . 0.0 108.511 -178.383 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.43 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 72.9 m-85 -147.89 154.51 40.48 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.147 0.979 . . . . 0.0 108.804 -175.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -84.58 144.08 28.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.447 0.641 . . . . 0.0 110.499 -175.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -57.0 -7.12 0.43 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.363 2.265 . . . . 0.0 114.413 169.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.58 -8.02 8.55 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.877 1.271 . . . . 0.0 112.184 173.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 14.4 m -77.61 -2.26 34.95 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.088 0.858 . . . . 0.0 113.051 168.716 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.5 p -129.53 -4.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 126.447 1.899 . . . . 0.0 111.039 169.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.29 35.4 91.48 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.938 1.256 . . . . 0.0 112.82 -175.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.4 mt . . . . . 0 C--N 1.343 0.287 0 C-N-CA 123.863 0.865 . . . . 0.0 111.326 -176.385 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 87.2 t90 . . . . . 0 CA--C 1.54 0.565 0 CA-C-O 121.319 0.581 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -139.29 139.1 37.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.312 1.445 . . . . 0.0 108.375 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 13.4 p -68.2 165.87 29.7 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 123.143 0.577 . . . . 0.0 111.9 172.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.26 31.6 0.31 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.327 3.351 . . . . 0.0 113.389 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -136.36 -37.81 0.69 Allowed 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.494 1.517 . . . . 0.0 109.816 169.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.441 -0.91 0 C-N-CA 126.565 1.946 . . . . 0.0 112.721 173.761 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -156.17 -45.61 0.08 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -168.459 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.482 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 2.0 p -40.25 170.28 0.0 OUTLIER 'General case' 0 C--N 1.349 0.586 0 C-N-CA 126.091 1.757 . . . . 0.0 114.252 169.136 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -71.3 -6.14 37.63 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.137 168.327 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.482 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 95.1 m -97.03 -13.36 22.32 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 123.499 0.72 . . . . 0.0 111.776 175.021 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.9 p80 46.37 53.38 9.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.862 2.065 . . . . 0.0 112.755 -174.006 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -171.0 142.12 1.79 Allowed 'General case' 0 C--N 1.347 0.474 0 C-N-CA 125.652 1.581 . . . . 0.0 108.114 177.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 205' ' ' SER . 1.1 t -123.79 168.92 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 125.606 1.562 . . . . 0.0 110.933 177.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.446 ' H ' HG12 ' A' ' 204' ' ' VAL . 10.5 t 70.81 61.06 0.19 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.144 2.178 . . . . 0.0 113.389 -176.248 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -162.72 108.95 1.2 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.986 2.115 . . . . 0.0 107.403 -176.513 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.44 -168.94 29.89 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 122.643 1.135 . . . . 0.0 110.761 -168.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -72.79 164.3 26.78 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.06 1.344 . . . . 0.0 111.978 169.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -138.54 155.46 48.36 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.693 1.597 . . . . 0.0 110.652 -169.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.0 tp -131.6 -139.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 149.11 130.76 1.91 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 125.812 1.673 . . . . 0.0 112.428 -169.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 40.6 t -62.73 123.19 17.78 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.468 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.1 0.18 1.4 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.027 1.331 . . . . 0.0 113.529 -179.332 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -70.4 115.05 30.93 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 167.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.56 9.14 3.02 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.304 2.669 . . . . 0.0 113.017 -179.412 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -124.02 8.29 8.65 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.988 1.715 . . . . 0.0 110.206 175.178 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.7 t -60.45 129.23 40.56 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 118.605 0.639 . . . . 0.0 109.558 170.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -73.4 3.41 6.01 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.999 1.72 . . . . 0.0 113.368 -175.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 26.6 mt -132.01 -34.22 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 126.37 1.868 . . . . 0.0 109.965 -175.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.99 -37.35 0.39 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.357 2.263 . . . . 0.0 115.76 170.341 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.478 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -132.58 148.57 52.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.864 2.065 . . . . 0.0 108.785 -174.945 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -148.02 148.52 30.79 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -177.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -73.02 150.15 42.65 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.895 178.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -60.96 -4.27 0.98 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.369 1.467 . . . . 0.0 113.417 167.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.2 -1.63 9.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.771 1.228 . . . . 0.0 112.558 170.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.4 m -72.43 -7.48 50.04 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.96 0.8 . . . . 0.0 111.296 167.031 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 2.8 p -134.38 -13.98 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 127.283 2.233 . . . . 0.0 112.016 179.197 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.86 37.46 44.36 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.592 1.091 . . . . 0.0 112.934 -176.154 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 20.6 mt . . . . . 0 N--CA 1.467 0.413 0 C-N-CA 123.732 0.813 . . . . 0.0 110.235 176.172 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 88.3 t90 . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.282 0.563 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.01 142.13 34.28 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.337 1.055 . . . . 0.0 109.199 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 2.4 p -63.03 165.37 10.45 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 123.72 0.808 . . . . 0.0 112.026 175.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.95 23.96 0.34 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.543 2.828 . . . . 0.0 113.643 -173.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -134.54 -33.07 0.99 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 125.687 1.595 . . . . 0.0 110.472 174.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.443 -0.782 0 C-N-CA 126.72 2.008 . . . . 0.0 111.533 169.315 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -154.72 -47.43 0.09 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -173.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.505 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -38.29 169.62 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 0 C-N-CA 126.401 1.881 . . . . 0.0 114.444 168.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.72 -6.69 39.23 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.198 168.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.505 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 89.7 m -96.08 -14.51 22.84 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 123.602 0.761 . . . . 0.0 111.71 174.456 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.2 p80 45.73 52.85 9.24 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.211 2.204 . . . . 0.0 112.759 -173.382 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.17 140.88 2.47 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 125.866 1.666 . . . . 0.0 107.889 179.178 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.519 HG12 ' H ' ' A' ' 205' ' ' SER . 1.4 t -129.2 172.72 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.336 1.454 . . . . 0.0 111.051 -176.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.519 ' H ' HG12 ' A' ' 204' ' ' VAL . 13.0 t 66.16 60.73 0.63 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.769 2.027 . . . . 0.0 113.208 -174.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.02 112.52 1.83 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.566 1.946 . . . . 0.0 108.318 -175.218 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.85 -163.45 24.42 Favored Glycine 0 C--N 1.34 0.759 0 CA-C-O 123.314 1.508 . . . . 0.0 112.931 -176.503 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.515 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.6 pm0 -67.88 146.13 53.94 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.028 2.131 . . . . 0.0 111.074 169.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.0 mtm -146.85 155.58 42.44 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.198 1.799 . . . . 0.0 110.461 -167.078 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 211' ' ' GLY . 8.2 tp -138.89 -138.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.41 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -175.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 152.22 133.93 2.02 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 126.239 1.876 . . . . 0.0 112.46 -169.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.25 123.59 20.36 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 114.179 -1.011 . . . . 0.0 109.398 177.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.19 0.14 2.18 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.314 1.846 . . . . 0.0 114.86 178.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -68.44 118.91 64.35 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.57 1.148 . . . . 0.0 108.592 169.627 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.26 7.27 3.43 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.413 2.742 . . . . 0.0 113.242 178.185 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -123.04 9.84 9.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.044 1.738 . . . . 0.0 110.358 174.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 42.6 t -58.65 128.87 39.34 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 123.494 0.718 . . . . 0.0 110.607 173.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.6 t -78.19 1.44 21.41 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.668 1.587 . . . . 0.0 113.072 -177.369 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.4 mm -132.7 -36.2 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 125.484 1.513 . . . . 0.0 110.375 -169.432 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.9 -39.16 0.42 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.415 2.686 . . . . 0.0 115.63 170.526 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.475 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.0 OUTLIER -134.16 149.07 51.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.176 1.791 . . . . 0.0 108.803 -174.569 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -149.34 147.01 27.82 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -176.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -73.11 150.49 42.2 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.771 0.796 . . . . 0.0 111.189 178.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -60.52 -4.02 0.81 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.374 1.47 . . . . 0.0 113.304 168.014 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.12 -2.03 8.18 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.074 1.35 . . . . 0.0 112.556 171.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.2 m -71.34 -8.11 51.57 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.043 0.838 . . . . 0.0 111.394 167.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.7 p -136.02 -4.1 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.084 1.753 . . . . 0.0 111.863 174.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 69.3 30.24 71.61 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.848 1.213 . . . . 0.0 112.909 -175.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 C--N 1.343 0.291 0 C-N-CA 124.662 1.185 . . . . 0.0 112.043 -172.264 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 82.2 t90 . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -139.59 136.4 34.35 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.638 0.775 . . . . 0.0 110.03 -177.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 10.8 p -66.95 164.07 38.31 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.125 0.97 . . . . 0.0 111.871 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -72.49 22.69 0.28 Allowed 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 123.94 3.094 . . . . 0.0 114.054 -177.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 -134.21 6.19 3.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.441 1.497 . . . . 0.0 112.027 172.097 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.438 -1.029 0 C-N-CA 128.128 2.571 . . . . 0.0 110.01 -175.487 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 73.8 p . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -155.12 -44.7 0.08 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -175.457 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.505 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -39.23 170.2 0.0 OUTLIER 'General case' 0 C--N 1.35 0.615 0 C-N-CA 126.273 1.829 . . . . 0.0 114.216 168.667 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.89 -6.62 39.7 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 113.425 -1.716 . . . . 0.0 110.115 168.172 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.505 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 85.3 m -96.79 -14.22 22.09 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 123.7 0.8 . . . . 0.0 111.725 174.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.9 p80 45.73 53.18 8.95 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.138 2.175 . . . . 0.0 112.811 -173.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.74 140.77 2.18 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 125.858 1.663 . . . . 0.0 107.911 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 205' ' ' SER . 1.5 t -128.93 170.04 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.364 1.465 . . . . 0.0 111.105 -175.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.508 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.1 t 65.89 66.1 0.51 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.083 2.153 . . . . 0.0 113.09 -174.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.24 111.3 1.08 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.566 1.946 . . . . 0.0 108.336 -175.496 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.47 -163.45 22.6 Favored Glycine 0 C--N 1.34 0.778 0 CA-C-O 123.254 1.474 . . . . 0.0 112.592 -174.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.7 pm0 -65.71 149.06 50.74 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 112.237 -1.981 . . . . 0.0 111.193 169.436 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.0 mtm -147.41 156.9 43.31 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.138 1.775 . . . . 0.0 110.067 -167.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.446 HG13 ' H ' ' A' ' 211' ' ' GLY . 4.9 tp -141.01 -138.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.369 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.447 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 151.49 132.88 1.94 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 126.11 1.814 . . . . 0.0 112.629 -169.783 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 46.6 t -64.35 125.64 25.26 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.064 0.946 . . . . 0.0 108.814 177.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.08 -2.74 2.16 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.533 1.533 . . . . 0.0 114.068 178.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -70.44 116.08 41.47 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 124.136 0.975 . . . . 0.0 108.387 169.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -76.99 4.4 5.79 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.315 2.677 . . . . 0.0 113.103 179.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -117.49 7.09 12.63 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.896 1.678 . . . . 0.0 110.36 174.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.7 t -58.42 127.82 34.04 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 123.113 0.565 . . . . 0.0 110.005 170.459 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.8 t -74.5 2.48 9.52 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.796 1.639 . . . . 0.0 113.207 -176.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 30.2 mt -132.19 -33.78 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.069 1.748 . . . . 0.0 110.247 -173.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.69 -37.64 0.4 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.006 2.522 . . . . 0.0 115.305 170.313 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . 0.478 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -133.06 148.96 52.2 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 126.777 2.031 . . . . 0.0 108.677 -174.032 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -148.44 146.62 28.5 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -176.272 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -70.63 150.61 45.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.942 0.877 . . . . 0.0 110.884 178.183 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -60.63 -5.06 1.09 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.073 1.349 . . . . 0.0 113.727 168.3 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.47 -0.84 9.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.656 1.182 . . . . 0.0 112.372 170.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.8 m -71.69 -7.19 46.46 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.892 0.769 . . . . 0.0 111.531 167.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 p -137.39 -11.51 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.809 1.244 . . . . 0.0 113.269 173.037 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 80.39 41.28 11.74 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.514 1.054 . . . . 0.0 113.54 -175.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 24.0 mt . . . . . 0 N--CA 1.472 0.637 0 CA-C-N 118.295 1.047 . . . . 0.0 111.439 171.476 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 88.9 t90 . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 121.211 0.529 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -141.06 139.78 34.13 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.184 0.994 . . . . 0.0 109.2 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.5 p -66.69 165.11 27.38 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.674 0.789 . . . . 0.0 111.957 177.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.5 31.93 0.28 Allowed 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.908 3.072 . . . . 0.0 113.413 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -135.97 -38.09 0.72 Allowed 'General case' 0 C--N 1.345 0.373 0 C-N-CA 125.584 1.554 . . . . 0.0 109.689 171.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 26.6 m . . . . . 0 N--CA 1.441 -0.899 0 C-N-CA 126.585 1.954 . . . . 0.0 111.888 171.811 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -154.8 -43.62 0.09 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.71 1.204 . . . . 0.0 110.536 -174.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 64.8 mtt 33.4 62.38 1.62 Allowed Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 128.155 2.582 . . . . 0.0 114.413 169.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -67.49 160.59 47.21 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.369 2.712 . . . . 0.0 112.159 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.9 p -138.2 0.68 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 125.268 1.427 . . . . 0.0 111.539 -175.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -51.73 -44.56 90.8 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.987 1.715 . . . . 0.0 113.303 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.46 111.48 3.32 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 121.89 1.727 . . . . 0.0 109.302 169.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -73.29 -7.21 50.57 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.03 0.932 . . . . 0.0 112.601 173.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -145.6 72.51 14.04 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.571 1.548 . . . . 0.0 108.366 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.21 159.12 37.21 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.609 2.872 . . . . 0.0 111.107 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 64.14 147.0 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.327 2.251 . . . . 0.0 112.272 -171.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -154.74 -43.95 0.09 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -166.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.499 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -38.05 169.66 0.0 OUTLIER 'General case' 0 C--N 1.348 0.54 0 C-N-CA 126.385 1.874 . . . . 0.0 114.414 169.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.0 mt -70.69 -6.16 35.14 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 113.399 -1.728 . . . . 0.0 110.12 168.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.499 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 93.8 m -96.15 -14.22 22.96 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 123.423 0.689 . . . . 0.0 111.738 173.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.6 p80 46.08 52.16 10.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.912 2.085 . . . . 0.0 112.406 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -169.01 141.47 2.66 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.482 1.513 . . . . 0.0 108.018 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -124.44 174.87 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.475 1.51 . . . . 0.0 110.51 176.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.503 ' H ' HG12 ' A' ' 204' ' ' VAL . 7.1 t 66.69 60.89 0.55 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.701 2.0 . . . . 0.0 113.429 -173.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.51 120.11 1.77 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.98 2.112 . . . . 0.0 107.881 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.44 -151.2 43.5 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 122.613 1.118 . . . . 0.0 111.49 -172.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.58 169.26 10.47 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.388 1.875 . . . . 0.0 111.255 170.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -136.89 162.26 33.73 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.913 1.285 . . . . 0.0 111.677 -169.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 11.2 tt -138.0 -139.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 169.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 147.47 132.22 2.23 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 125.79 1.662 . . . . 0.0 111.57 -169.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 41.4 t -64.25 123.9 20.32 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.81 -0.48 3.03 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.365 1.466 . . . . 0.0 113.686 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -70.25 117.31 53.35 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.67 4.16 5.84 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.301 2.667 . . . . 0.0 113.168 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -117.37 7.63 12.87 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.85 1.66 . . . . 0.0 110.456 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.1 t -58.33 127.23 31.08 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 123.192 0.597 . . . . 0.0 109.736 170.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 70.5 m -77.01 5.95 7.17 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.538 1.535 . . . . 0.0 113.304 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.9 mm -132.58 -35.53 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 126.082 1.753 . . . . 0.0 109.95 -173.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.44 -42.9 0.55 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.512 2.725 . . . . 0.0 115.333 169.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.443 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -129.42 149.71 51.09 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.4 1.88 . . . . 0.0 108.431 -175.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -149.42 149.31 30.62 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -73.4 149.63 42.35 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.62 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.95 -3.59 0.81 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.985 1.714 . . . . 0.0 112.394 168.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.45 -3.74 8.35 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.674 1.59 . . . . 0.0 112.462 172.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.9 m -71.62 -7.47 48.0 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.06 0.845 . . . . 0.0 111.281 166.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -134.71 -4.63 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 126.853 2.061 . . . . 0.0 111.591 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.97 31.11 74.7 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.904 1.24 . . . . 0.0 113.272 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 4.6 mt -62.48 -52.95 61.48 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.338 1.055 . . . . 0.0 112.584 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.5 m 63.87 -17.42 0.07 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.699 2.0 . . . . 0.0 114.411 -173.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 82.8 p -143.64 164.74 29.56 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.268 1.827 . . . . 0.0 110.327 -175.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -70.18 123.13 88.26 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.029 173.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.62 -55.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.567 2.178 . . . . 0.0 111.594 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 4.3 ttp85 -175.31 -176.6 0.93 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.654 1.981 . . . . 0.0 109.403 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -78.32 17.73 6.08 Favored Glycine 0 CA--C 1.539 1.567 0 CA-C-O 118.821 -0.988 . . . . 0.0 113.639 169.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -159.3 120.52 3.27 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 125.401 1.48 . . . . 0.0 108.063 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 79.2 t90 -138.74 163.66 31.6 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.358 1.863 . . . . 0.0 110.777 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -141.68 140.45 33.2 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.076 1.35 . . . . 0.0 109.283 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.0 p -66.67 165.32 25.84 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 123.467 0.707 . . . . 0.0 112.198 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.06 35.23 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.97 3.113 . . . . 0.0 113.08 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -137.95 -38.37 0.57 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.445 1.498 . . . . 0.0 109.764 169.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 28.7 m -70.81 -35.57 72.58 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 126.756 2.022 . . . . 0.0 111.805 171.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 t -77.35 -27.43 52.66 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.175 1.39 . . . . 0.0 112.082 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -66.33 -24.77 66.58 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.015 0.926 . . . . 0.0 112.431 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.26 -19.55 64.73 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.831 1.252 . . . . 0.0 113.1 176.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.63 72.3 1.39 Allowed 'General case' 0 C--N 1.347 0.476 0 C-N-CA 125.401 1.48 . . . . 0.0 109.655 177.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -82.67 91.7 7.03 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.986 1.314 . . . . 0.0 108.611 170.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.69 27.33 3.66 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.109 1.764 . . . . 0.0 112.18 -175.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? . . . . . 0 C--O 1.25 1.097 0 C-N-CA 130.901 3.68 . . . . 0.0 109.502 -175.898 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 55.4 40.3 31.34 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.377 1.471 . . . . 0.0 113.355 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 94.4 mtp -132.23 81.33 61.49 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.407 1.483 . . . . 0.0 109.351 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -74.55 86.49 1.34 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.034 3.156 . . . . 0.0 110.016 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 10.8 p -136.08 55.85 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.991 1.316 . . . . 0.0 110.067 -173.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -49.72 -45.27 79.18 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 116.932 -1.509 . . . . 0.0 113.878 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.16 91.26 1.04 Allowed 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.811 2.341 . . . . 0.0 110.611 172.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -150.49 57.93 0.94 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.891 1.276 . . . . 0.0 109.6 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -133.02 70.15 78.61 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.858 1.263 . . . . 0.0 109.739 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.96 105.35 1.34 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.898 3.065 . . . . 0.0 110.329 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 47.2 p -146.06 139.46 26.07 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.423 1.889 . . . . 0.0 108.121 -173.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -155.04 -45.39 0.08 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -168.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.505 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.7 p -38.01 169.66 0.0 OUTLIER 'General case' 0 C--N 1.348 0.54 0 C-N-CA 126.429 1.892 . . . . 0.0 114.269 168.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.49 -6.3 35.07 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 113.452 -1.703 . . . . 0.0 110.199 168.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.505 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 89.5 m -97.34 -14.17 21.44 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 123.812 0.845 . . . . 0.0 111.805 174.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.5 p80 45.06 51.85 8.67 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.109 2.164 . . . . 0.0 112.842 -173.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -167.34 139.24 3.23 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 125.762 1.625 . . . . 0.0 107.94 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 205' ' ' SER . 1.3 t -129.95 172.32 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.307 1.443 . . . . 0.0 111.058 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.524 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.0 t 65.44 63.47 0.63 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.833 2.053 . . . . 0.0 112.792 -173.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.07 112.55 1.34 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.555 1.942 . . . . 0.0 108.45 -175.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.01 -161.65 24.18 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-O 123.283 1.49 . . . . 0.0 113.124 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.526 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.6 pm0 -68.26 143.79 55.12 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.155 2.182 . . . . 0.0 111.128 169.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.4 mtm -147.09 155.11 41.91 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.38 1.872 . . . . 0.0 110.289 -167.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.426 HG13 ' H ' ' A' ' 211' ' ' GLY . 9.2 tp -139.02 -138.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.409 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -175.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 150.91 131.23 1.8 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 126.152 1.834 . . . . 0.0 112.301 -169.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 42.2 t -63.05 121.71 14.27 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.259 1.023 . . . . 0.0 108.559 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.85 1.4 1.89 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.384 1.474 . . . . 0.0 113.868 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -69.94 117.89 58.2 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.474 1.11 . . . . 0.0 108.072 168.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.35 6.21 4.13 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.305 2.67 . . . . 0.0 113.234 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -120.89 9.22 10.6 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.817 1.647 . . . . 0.0 110.482 174.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 45.1 t -59.23 128.63 38.08 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.316 0.646 . . . . 0.0 110.116 171.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 44.0 m -76.14 2.99 11.5 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.59 1.556 . . . . 0.0 113.542 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.8 mm -133.78 -35.33 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.925 1.69 . . . . 0.0 109.966 -170.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.91 -39.53 0.45 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 128.422 2.689 . . . . 0.0 115.454 169.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.478 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.0 OUTLIER -133.87 148.95 51.32 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.305 1.842 . . . . 0.0 108.74 -174.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -150.06 146.02 26.71 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.4 -1.334 . . . . 0.0 107.4 -175.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -72.23 151.43 42.87 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.721 0.772 . . . . 0.0 111.043 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.33 -4.31 0.82 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.352 1.461 . . . . 0.0 113.06 167.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.33 -3.6 8.93 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.305 1.442 . . . . 0.0 112.544 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 20.6 m -72.43 -6.0 40.51 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.114 0.87 . . . . 0.0 111.715 167.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 10.9 p -135.4 -4.95 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 126.29 1.836 . . . . 0.0 111.797 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.34 35.77 90.71 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.667 1.127 . . . . 0.0 112.924 -173.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.7 mt -64.82 -51.3 62.87 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 124.358 1.063 . . . . 0.0 111.493 -175.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 18.0 m 62.16 -10.42 0.08 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.132 2.173 . . . . 0.0 114.738 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 11.1 t -149.59 170.0 19.67 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.049 1.739 . . . . 0.0 110.191 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -62.9 127.15 90.24 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.838 1.255 . . . . 0.0 109.943 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.1 168.46 20.49 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.381 2.72 . . . . 0.0 112.114 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -71.03 170.73 12.21 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.159 0.983 . . . . 0.0 110.218 168.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -57.24 152.39 25.17 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.186 0.898 . . . . 0.0 113.368 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 46.6 tttp 40.3 74.84 0.09 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.375 2.27 . . . . 0.0 113.395 -172.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 84.5 t90 -76.33 159.03 30.92 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.811 0.845 . . . . 0.0 110.113 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -138.82 139.87 38.35 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.153 0.981 . . . . 0.0 109.587 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 13.9 p -65.7 163.43 35.03 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.436 0.695 . . . . 0.0 111.658 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.41 28.66 0.27 Allowed 'Trans proline' 0 CA--C 1.548 1.198 0 C-N-CA 124.013 3.142 . . . . 0.0 113.694 -178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -136.02 -32.95 0.86 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.555 1.542 . . . . 0.0 110.422 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 15.8 m -74.83 -35.29 62.42 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 126.556 1.942 . . . . 0.0 111.727 169.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 10.1 t -76.17 -12.24 60.07 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.215 1.406 . . . . 0.0 112.863 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -61.99 -25.5 67.67 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.206 1.402 . . . . 0.0 112.312 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -51.88 -29.93 21.87 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.197 1.799 . . . . 0.0 114.4 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 39.16 54.59 2.18 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.175 2.19 . . . . 0.0 113.662 170.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -76.6 71.15 3.19 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.878 1.671 . . . . 0.0 111.104 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -146.96 35.18 0.91 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.336 1.455 . . . . 0.0 110.817 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt . . . . . 0 C--O 1.251 1.167 0 CA-C-O 117.533 -1.222 . . . . 0.0 110.112 175.007 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 60.4 ttm . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -144.35 157.95 43.99 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.262 1.025 . . . . 0.0 110.695 -168.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 27.2 ttt -148.25 83.45 7.17 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.506 1.122 . . . . 0.0 108.828 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -79.9 24.04 0.65 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.614 3.543 . . . . 0.0 112.865 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 14.9 p -130.05 51.8 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.483 1.513 . . . . 0.0 110.492 -169.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.598 ' H ' ' HD2' ' A' ' 193' ' ' PRO . 27.4 m-20 -131.83 -46.5 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 116.595 -1.669 . . . . 0.0 112.764 174.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.598 ' HD2' ' H ' ' A' ' 192' ' ' ASP . 89.3 Cg_endo -77.56 93.66 1.08 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.433 2.089 . . . . 0.0 110.419 177.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -142.23 -15.82 0.76 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -172.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -77.61 121.28 84.08 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 119.61 1.095 . . . . 0.0 109.933 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -82.41 165.0 16.6 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.308 2.672 . . . . 0.0 111.614 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.3 p -143.13 144.55 32.26 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.647 1.579 . . . . 0.0 108.865 -174.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -155.15 -46.53 0.08 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.506 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -37.46 169.54 0.0 OUTLIER 'General case' 0 C--N 1.351 0.637 0 C-N-CA 126.665 1.986 . . . . 0.0 114.593 169.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.4 -6.23 34.06 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 113.311 -1.768 . . . . 0.0 110.08 168.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.506 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 86.6 m -97.46 -14.41 21.17 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 123.841 0.856 . . . . 0.0 111.776 174.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.2 p80 45.67 52.16 9.62 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.236 2.214 . . . . 0.0 112.807 -173.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -169.5 140.53 2.26 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.678 1.591 . . . . 0.0 107.906 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 205' ' ' SER . 1.5 t -127.07 173.37 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.219 1.407 . . . . 0.0 111.168 -175.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.537 ' H ' HG12 ' A' ' 204' ' ' VAL . 13.2 t 66.33 61.68 0.58 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.983 2.113 . . . . 0.0 113.537 -175.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -161.98 114.1 1.72 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.39 1.876 . . . . 0.0 108.548 -175.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 62.12 -164.03 24.4 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-O 123.084 1.38 . . . . 0.0 112.702 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.9 pm0 -66.14 147.18 53.72 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 112.405 -1.898 . . . . 0.0 110.92 169.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 75.7 mtm -146.33 154.26 41.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.939 1.696 . . . . 0.0 110.045 -168.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.6 tp -138.56 -139.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.357 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 149.8 131.0 1.87 Allowed Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 126.203 1.859 . . . . 0.0 112.289 -169.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.83 123.53 18.7 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.295 1.038 . . . . 0.0 108.557 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.05 -2.16 2.58 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.153 1.381 . . . . 0.0 113.467 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -69.64 117.38 52.63 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 168.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.5 4.93 5.09 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.131 2.554 . . . . 0.0 113.166 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -118.58 8.24 11.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.954 1.702 . . . . 0.0 110.416 174.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 50.0 t -58.25 127.6 32.95 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.181 0.593 . . . . 0.0 109.897 170.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.7 t -74.69 2.87 8.93 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.576 1.55 . . . . 0.0 113.444 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.6 mm -132.96 -34.96 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 126.072 1.749 . . . . 0.0 109.931 -171.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.34 -39.31 0.44 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.186 2.595 . . . . 0.0 115.52 169.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.472 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.0 OUTLIER -134.82 149.81 50.41 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.403 1.881 . . . . 0.0 108.929 -174.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -149.5 146.37 27.36 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 -176.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -70.36 149.81 46.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.548 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -60.75 -4.9 1.07 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.977 1.311 . . . . 0.0 113.237 168.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -120.62 -2.05 9.97 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.732 1.213 . . . . 0.0 112.543 170.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 16.9 m -73.11 -5.65 40.46 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.933 0.788 . . . . 0.0 111.507 167.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 p -135.7 -13.41 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 126.853 2.061 . . . . 0.0 112.323 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 75.77 37.98 37.96 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.562 1.077 . . . . 0.0 112.922 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 18.3 mt -69.42 106.05 2.81 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.92 0.888 . . . . 0.0 110.159 174.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 37.5 m -69.82 -25.38 63.74 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.661 1.184 . . . . 0.0 111.631 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 13.7 t -151.34 178.01 9.7 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.568 1.547 . . . . 0.0 110.09 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -59.91 129.01 87.68 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.995 1.318 . . . . 0.0 110.091 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.65 169.63 21.44 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.174 2.583 . . . . 0.0 111.717 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -74.96 169.82 17.21 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.948 169.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -59.93 155.16 30.91 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 123.339 0.495 . . . . 0.0 112.375 176.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.6 tptp 51.54 60.97 3.48 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.393 1.477 . . . . 0.0 112.096 -173.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 83.3 t90 -73.8 157.83 35.69 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.346 0.658 . . . . 0.0 109.995 174.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -139.54 139.73 36.95 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.351 1.06 . . . . 0.0 109.377 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.2 p -66.36 166.69 15.84 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.96 0.904 . . . . 0.0 112.401 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.67 36.79 0.4 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.914 3.076 . . . . 0.0 112.985 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -139.96 -39.62 0.45 Allowed 'General case' 0 C--N 1.344 0.366 0 C-N-CA 125.336 1.455 . . . . 0.0 109.582 168.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.1 m -71.28 -34.28 70.53 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.722 2.009 . . . . 0.0 112.038 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.0 t -77.93 -33.17 51.83 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.529 1.131 . . . . 0.0 111.376 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -62.63 -25.64 68.21 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 124.808 1.243 . . . . 0.0 112.497 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -49.95 -46.25 52.05 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.875 2.07 . . . . 0.0 112.56 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -157.89 78.08 0.83 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.707 0.803 . . . . 0.0 109.989 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -69.99 93.25 0.77 Allowed 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.442 1.097 . . . . 0.0 109.288 171.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -132.43 47.95 2.46 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.059 1.744 . . . . 0.0 109.365 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt . . . . . 0 C--O 1.249 1.079 0 C-N-CA 126.5 1.92 . . . . 0.0 111.424 179.611 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -144.41 141.15 29.45 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.94 0.896 . . . . 0.0 110.171 -168.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 25.9 mmt -143.31 69.28 17.71 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.3 1.44 . . . . 0.0 109.258 -178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.38 111.25 2.24 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.33 2.686 . . . . 0.0 110.042 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 5.8 p -148.17 3.76 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 124.465 1.106 . . . . 0.0 112.266 -170.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -137.61 91.97 13.52 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.225 1.41 . . . . 0.0 108.654 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.53 132.8 16.52 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.034 2.49 . . . . 0.0 110.556 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -135.37 29.76 3.29 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.133 1.373 . . . . 0.0 110.709 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -31.93 99.22 0.13 Allowed Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 129.896 3.278 . . . . 0.0 113.701 -172.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -87.48 164.58 8.03 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.2 3.267 . . . . 0.0 112.219 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.7 p 66.17 142.78 0.03 OUTLIER 'General case' 0 C--N 1.347 0.475 0 C-N-CA 127.693 2.397 . . . . 0.0 112.62 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -154.93 -37.89 0.09 Allowed 'General case' 0 C--N 1.349 0.56 0 CA-C-O 116.027 -1.939 . . . . 0.0 115.042 -168.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.7 OUTLIER -52.88 172.61 0.05 OUTLIER 'General case' 0 C--N 1.358 0.938 0 CA-C-N 122.002 2.183 . . . . 0.0 112.245 170.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.5 mt -63.24 -5.09 2.96 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.749 1.619 . . . . 0.0 111.24 172.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.2 m -99.21 -12.12 20.71 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 126.105 1.762 . . . . 0.0 112.585 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.0 p80 46.04 50.02 11.86 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 126.678 1.991 . . . . 0.0 111.894 -174.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -165.2 148.12 8.13 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.931 1.293 . . . . 0.0 107.901 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 205' ' ' SER . 0.5 OUTLIER -132.0 173.66 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 126.958 2.103 . . . . 0.0 110.78 176.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.508 ' H ' HG12 ' A' ' 204' ' ' VAL . 7.9 t 65.19 63.93 0.64 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.85 2.06 . . . . 0.0 113.067 -174.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.59 112.23 0.92 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.324 1.85 . . . . 0.0 109.034 -173.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 60.1 -160.65 21.05 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 123.09 1.383 . . . . 0.0 112.982 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -66.11 143.29 57.4 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 112.253 -1.973 . . . . 0.0 111.097 169.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.0 mtm -149.04 154.05 38.75 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.752 2.021 . . . . 0.0 109.095 -168.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 211' ' ' GLY . 6.2 tt -142.04 -136.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -171.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 149.42 132.05 2.03 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 125.482 1.515 . . . . 0.0 112.867 -170.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.47 120.91 12.0 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.473 1.109 . . . . 0.0 108.548 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.3 -1.52 2.42 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.522 1.529 . . . . 0.0 113.561 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -69.54 116.4 42.62 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 169.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -77.17 9.43 2.79 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.28 2.653 . . . . 0.0 113.066 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -123.29 7.46 9.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.978 1.711 . . . . 0.0 110.172 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.7 t -61.21 130.98 48.92 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 118.402 0.546 . . . . 0.0 109.768 171.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 38.0 m -74.92 6.22 4.3 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.564 1.545 . . . . 0.0 113.589 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.9 mm -135.76 -37.19 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 126.369 1.867 . . . . 0.0 109.83 -170.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.11 -41.99 0.52 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.313 2.645 . . . . 0.0 115.523 170.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.511 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -127.85 148.56 50.47 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.334 1.854 . . . . 0.0 108.644 -177.05 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -149.19 155.97 41.44 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -174.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -83.76 142.72 30.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.38 -9.06 2.05 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.549 1.54 . . . . 0.0 112.913 170.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -115.47 -6.29 12.27 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.527 1.131 . . . . 0.0 112.394 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.8 m -80.13 -0.09 34.45 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 168.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.29 -8.8 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 126.852 2.061 . . . . 0.0 111.638 171.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.17 36.46 63.91 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.547 1.07 . . . . 0.0 113.06 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 32.0 mt -67.59 157.82 33.52 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.287 1.043 . . . . 0.0 110.613 171.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 27.8 m -136.73 -19.12 1.37 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.382 1.473 . . . . 0.0 110.752 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 13.8 t -149.2 170.54 18.21 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.198 1.799 . . . . 0.0 108.944 169.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -63.05 119.92 56.55 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 124.165 0.986 . . . . 0.0 109.649 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.27 174.26 12.37 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.105 2.537 . . . . 0.0 111.532 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -65.99 162.94 18.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.682 0.793 . . . . 0.0 110.118 169.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -61.8 164.67 21.36 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.944 0.783 . . . . 0.0 113.185 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 15.8 tptp 52.91 57.5 6.29 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.298 1.439 . . . . 0.0 112.149 -172.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -73.41 158.36 35.14 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.746 0.819 . . . . 0.0 109.8 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -139.83 141.85 36.66 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.064 0.945 . . . . 0.0 109.409 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.1 p -66.08 163.62 36.21 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.876 0.87 . . . . 0.0 111.724 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.53 32.92 0.32 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 123.986 3.124 . . . . 0.0 113.087 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -135.64 -39.11 0.72 Allowed 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.45 1.5 . . . . 0.0 109.67 170.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 28.2 m -70.98 -31.68 68.29 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.919 2.088 . . . . 0.0 112.222 170.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 8.1 t -83.51 -34.85 25.23 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.093 1.357 . . . . 0.0 110.858 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -21.26 66.34 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.502 1.121 . . . . 0.0 112.979 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.33 -14.87 13.08 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.071 1.748 . . . . 0.0 113.158 172.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.91 26.13 4.63 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.602 1.561 . . . . 0.0 111.065 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt 51.24 64.74 1.72 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.454 1.902 . . . . 0.0 112.305 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -140.89 114.29 8.71 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 126.003 1.721 . . . . 0.0 106.417 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 27.0 tptp . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.408 1.483 . . . . 0.0 110.582 -170.851 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 89.5 mtp . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 57.25 -167.64 0.12 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.746 1.618 . . . . 0.0 112.802 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 13.8 ptm -89.13 110.16 36.21 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.601 1.16 . . . . 0.0 109.441 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -75.97 -35.77 2.33 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.501 2.134 . . . . 0.0 112.043 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 6.3 p -156.55 10.5 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 126.213 1.805 . . . . 0.0 110.996 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 34.3 t70 50.86 64.39 8.29 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 125.576 1.55 . . . . 0.0 111.325 -167.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.33 105.68 1.78 Allowed 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.397 2.731 . . . . 0.0 110.491 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -79.56 -6.11 56.34 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.494 1.117 . . . . 0.0 113.046 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -144.24 69.47 15.92 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.486 1.115 . . . . 0.0 109.999 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.88 162.39 41.2 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.377 2.718 . . . . 0.0 111.291 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.7 p 64.88 142.31 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.578 2.351 . . . . 0.0 112.871 -174.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -156.06 -38.19 0.08 Allowed 'General case' 0 C--N 1.35 0.626 0 CA-C-O 115.956 -1.973 . . . . 0.0 115.563 -168.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.5 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.9 OUTLIER -52.99 174.15 0.04 OUTLIER 'General case' 0 C--N 1.359 0.991 0 CA-C-N 122.069 2.213 . . . . 0.0 112.027 172.06 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.0 mt -62.98 -5.07 2.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.641 1.577 . . . . 0.0 111.339 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 69.6 m -100.0 -12.28 19.88 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 126.069 1.748 . . . . 0.0 112.675 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.8 p80 45.36 50.1 10.09 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.775 2.03 . . . . 0.0 112.008 -174.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -164.62 148.57 9.21 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 125.219 1.408 . . . . 0.0 107.67 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 205' ' ' SER . 0.6 OUTLIER -132.69 174.01 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 127.131 2.172 . . . . 0.0 110.871 177.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.529 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.1 t 63.26 63.04 0.93 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.688 1.995 . . . . 0.0 112.904 -174.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.36 108.32 1.07 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.574 1.95 . . . . 0.0 108.332 -174.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 62.04 -164.38 23.22 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 123.278 1.488 . . . . 0.0 112.798 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.524 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.8 pm0 -65.25 150.17 48.69 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.314 2.246 . . . . 0.0 111.577 169.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 76.8 mtm -149.55 159.71 44.08 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.903 1.681 . . . . 0.0 110.684 -167.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 6.8 tp -138.34 -133.8 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.117 0.967 . . . . 0.0 109.302 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 145.62 132.73 2.47 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 126.447 1.975 . . . . 0.0 113.242 -169.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.534 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 8.8 t -65.11 124.12 21.29 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.63 4.18 0.62 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.129 1.372 . . . . 0.0 113.104 173.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.65 112.04 5.01 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 128.51 2.724 . . . . 0.0 107.797 167.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -78.55 11.9 2.31 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.372 2.715 . . . . 0.0 112.955 -176.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -129.24 8.46 5.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.114 1.766 . . . . 0.0 109.807 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 12.2 t -57.3 116.7 3.46 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-O 121.767 0.794 . . . . 0.0 111.62 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 68.7 m -79.59 6.58 10.18 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.181 1.792 . . . . 0.0 112.48 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.5 mm -123.08 -36.99 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 126.547 1.939 . . . . 0.0 108.92 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . 0.254 0.1 OUTLIER 67.26 -23.98 0.11 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 129.093 2.957 . . . . 0.0 116.494 169.226 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.501 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.6 OUTLIER -147.59 149.85 33.33 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.662 1.585 . . . . 0.0 109.152 -179.129 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -147.44 157.2 43.48 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.293 1.037 . . . . 0.0 108.299 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -83.19 143.13 30.68 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.33 0.585 . . . . 0.0 110.142 -174.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.51 -4.45 0.4 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.924 2.09 . . . . 0.0 114.039 170.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.47 -9.15 8.01 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.317 1.447 . . . . 0.0 112.276 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 10.3 m -77.45 -1.65 31.38 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.029 0.831 . . . . 0.0 112.769 168.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 12.7 p -132.04 -1.42 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 126.923 2.089 . . . . 0.0 110.92 171.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 63.6 32.56 84.58 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.25 1.405 . . . . 0.0 113.297 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.1 mt -66.93 -53.71 29.22 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 117.999 0.9 . . . . 0.0 112.276 -172.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . 0.272 2.4 t 45.39 12.66 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 127.964 2.505 . . . . 0.0 115.637 -169.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 60.5 p -152.24 158.48 42.89 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.096 2.158 . . . . 0.0 109.422 -175.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -69.29 125.01 91.66 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 170.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.01 -66.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.722 2.281 . . . . 0.0 111.352 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 37.2 ttt-85 -174.88 -173.77 0.73 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.889 2.476 . . . . 0.0 107.554 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -77.08 16.06 5.98 Favored Glycine 0 CA--C 1.54 1.641 0 CA-C-O 119.036 -0.869 . . . . 0.0 112.944 168.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -159.68 120.48 3.12 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 126.008 1.723 . . . . 0.0 107.948 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . 0.404 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 90.3 t90 -136.43 162.56 32.72 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.733 2.013 . . . . 0.0 109.989 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.534 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 97.5 m-85 -139.4 141.35 37.54 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.726 0.81 . . . . 0.0 110.698 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . 0.404 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 29.1 p -65.75 160.27 62.72 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.519 0.727 . . . . 0.0 111.685 174.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.33 28.4 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.275 3.317 . . . . 0.0 113.327 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -133.58 -35.66 0.99 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.344 1.858 . . . . 0.0 109.637 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 1.4 m -72.53 -38.89 67.9 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.099 1.76 . . . . 0.0 110.969 168.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.3 t -76.32 -27.33 56.49 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.971 1.308 . . . . 0.0 111.564 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -64.41 -29.55 70.61 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.125 0.97 . . . . 0.0 112.273 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.91 -16.27 28.21 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.405 1.882 . . . . 0.0 113.165 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 37.8 ttt85 -127.85 21.88 6.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.867 1.667 . . . . 0.0 111.144 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 10.4 mtpm? -133.81 57.99 1.79 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.997 1.719 . . . . 0.0 109.603 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 59.3 mtmt -75.28 76.95 2.39 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.268 1.427 . . . . 0.0 107.849 169.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt . . . . . 0 C--O 1.252 1.194 0 C-N-CA 127.008 2.123 . . . . 0.0 109.749 -167.695 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 11.4 tmm? . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -144.24 -42.88 0.26 Allowed 'General case' 0 CA--C 1.534 0.337 0 O-C-N 124.017 0.823 . . . . 0.0 111.105 -169.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 43.5 tpp -155.08 67.19 5.12 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.826 1.25 . . . . 0.0 108.994 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.91 1.97 8.05 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 124.214 3.276 . . . . 0.0 114.777 -169.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.58 98.08 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.465 1.506 . . . . 0.0 111.041 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -73.65 129.29 85.59 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.842 1.257 . . . . 0.0 110.503 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.16 148.58 27.45 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.443 2.762 . . . . 0.0 111.531 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -89.19 22.43 2.83 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.881 1.272 . . . . 0.0 112.158 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -138.83 75.36 36.51 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.017 1.327 . . . . 0.0 109.642 -172.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.53 143.27 51.37 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.701 2.267 . . . . 0.0 110.801 176.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.3 p 61.58 149.41 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.06 2.544 . . . . 0.0 113.826 -174.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -157.47 -43.42 0.07 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -168.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.49 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 2.1 p -39.62 170.2 0.0 OUTLIER 'General case' 0 C--N 1.349 0.57 0 C-N-CA 126.364 1.866 . . . . 0.0 114.379 169.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.3 mt -70.96 -6.63 40.16 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 113.31 -1.768 . . . . 0.0 110.131 168.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.49 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 97.4 m -96.29 -13.67 23.18 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 123.472 0.709 . . . . 0.0 111.755 174.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.7 p80 46.34 52.4 10.64 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.773 2.029 . . . . 0.0 112.607 -173.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -171.56 140.36 1.36 Allowed 'General case' 0 C--N 1.346 0.455 0 C-N-CA 126.004 1.721 . . . . 0.0 108.083 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.513 HG12 ' H ' ' A' ' 205' ' ' SER . 1.5 t -122.33 171.17 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.506 1.522 . . . . 0.0 111.179 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.513 ' H ' HG12 ' A' ' 204' ' ' VAL . 52.8 m 67.17 64.31 0.44 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.983 2.113 . . . . 0.0 113.405 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -160.14 112.48 2.04 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.661 1.984 . . . . 0.0 108.024 -176.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 68.19 -123.19 17.12 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -170.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.35 167.59 12.6 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.003 2.121 . . . . 0.0 110.982 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -138.26 156.17 47.93 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.178 0.991 . . . . 0.0 111.23 -169.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.453 HG12 ' H ' ' A' ' 211' ' ' GLY . 8.1 tt -134.53 -139.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 173.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 148.04 132.97 2.26 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 125.35 1.453 . . . . 0.0 112.648 -169.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.9 t -66.13 122.94 18.55 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.83 -2.19 3.58 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.504 1.522 . . . . 0.0 113.553 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -67.15 117.12 43.09 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 124.3 1.04 . . . . 0.0 108.33 168.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.65 5.42 4.81 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.229 2.619 . . . . 0.0 113.147 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -118.09 6.88 12.1 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.934 1.694 . . . . 0.0 110.428 174.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 45.9 t -58.88 127.54 32.73 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 121.234 0.54 . . . . 0.0 109.875 170.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 67.9 m -78.64 6.82 7.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.56 1.544 . . . . 0.0 113.336 -176.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.7 mt -133.76 -33.58 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.124 1.77 . . . . 0.0 110.261 -176.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.98 -39.42 0.45 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.869 2.468 . . . . 0.0 115.168 170.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.459 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -131.27 148.68 52.72 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.524 1.93 . . . . 0.0 108.719 -175.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -147.17 150.16 34.39 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -72.34 148.55 45.22 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.41 175.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -60.54 -5.87 1.4 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.342 1.457 . . . . 0.0 112.336 167.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -119.78 -2.01 10.45 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.925 1.29 . . . . 0.0 112.478 171.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.3 m -73.48 -5.24 38.81 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.907 0.776 . . . . 0.0 111.078 166.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 14.2 p -134.6 -10.17 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.766 2.026 . . . . 0.0 112.211 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.58 36.59 62.32 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.619 1.104 . . . . 0.0 113.354 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 11.0 mt -65.85 158.63 27.36 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.514 1.157 . . . . 0.0 111.603 173.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.3 t -139.84 -3.57 1.44 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.738 1.615 . . . . 0.0 111.808 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 9.9 t -151.12 166.23 31.43 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 126.017 1.727 . . . . 0.0 109.484 175.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -82.33 116.21 62.35 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.093 0.957 . . . . 0.0 109.106 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.12 166.36 27.97 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.166 2.578 . . . . 0.0 111.093 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 32.8 mtp-105 -140.25 164.48 29.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.559 1.143 . . . . 0.0 110.56 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 89.59 -76.05 1.78 Allowed Glycine 0 C--N 1.34 0.768 0 N-CA-C 109.181 -1.567 . . . . 0.0 109.181 -172.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -170.46 153.17 4.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 127.298 2.239 . . . . 0.0 107.334 169.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -119.34 163.14 17.61 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.916 2.086 . . . . 0.0 110.306 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -140.5 141.96 35.32 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.129 1.372 . . . . 0.0 108.897 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 16.9 p -68.82 164.06 49.95 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.896 -0.573 . . . . 0.0 112.005 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.45 34.1 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 124.148 3.232 . . . . 0.0 113.203 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -135.84 -36.97 0.75 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 125.793 1.637 . . . . 0.0 109.757 171.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.5 m -73.89 -33.83 64.19 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.797 2.039 . . . . 0.0 112.091 171.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 13.7 t -87.49 -16.47 34.64 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.628 1.171 . . . . 0.0 112.172 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -64.66 -21.75 66.81 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.976 1.311 . . . . 0.0 112.674 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -46.84 -36.87 7.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.05 1.74 . . . . 0.0 113.127 170.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 11.4 ttt85 -133.05 16.54 4.17 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.832 1.253 . . . . 0.0 112.117 -173.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -134.45 79.51 1.81 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 126.192 1.797 . . . . 0.0 107.045 172.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -142.32 36.98 1.52 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.649 1.98 . . . . 0.0 110.669 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--O 1.251 1.172 0 C-N-CA 126.532 1.933 . . . . 0.0 111.676 -179.6 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -63.48 123.29 18.39 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.413 1.085 . . . . 0.0 110.425 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.617 ' H ' ' HD2' ' A' ' 190' ' ' PRO . 63.5 mtt -145.44 -48.71 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 116.574 -1.679 . . . . 0.0 112.48 -175.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.617 ' HD2' ' H ' ' A' ' 189' ' ' MET . 61.7 Cg_endo -73.21 -38.93 2.4 Favored 'Trans proline' 0 C--N 1.357 1.0 0 CA-C-N 122.35 1.875 . . . . 0.0 111.956 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . 0.28 2.1 p 46.82 13.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 129.945 3.298 . . . . 0.0 117.782 169.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.601 ' H ' ' HD2' ' A' ' 193' ' ' PRO . 23.9 m-20 -143.44 -49.33 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.703 0 CA-C-O 116.697 -1.621 . . . . 0.0 113.58 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.601 ' HD2' ' H ' ' A' ' 192' ' ' ASP . 60.5 Cg_endo -72.11 138.87 31.58 Favored 'Trans proline' 0 C--N 1.355 0.908 0 CA-C-N 122.47 1.918 . . . . 0.0 110.933 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -153.13 35.92 0.47 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.645 1.178 . . . . 0.0 110.724 -173.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -136.65 77.18 46.23 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.81 1.244 . . . . 0.0 109.597 -172.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.47 151.99 59.79 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.337 2.692 . . . . 0.0 111.464 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.2 p 62.43 147.73 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.946 2.498 . . . . 0.0 113.151 -173.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -156.29 -44.31 0.07 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -169.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.486 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 2.3 p -40.58 169.92 0.0 OUTLIER 'General case' 0 C--N 1.349 0.555 0 C-N-CA 126.139 1.775 . . . . 0.0 114.158 169.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.9 mt -71.48 -6.32 39.61 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 113.233 -1.803 . . . . 0.0 110.07 168.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.486 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 95.1 m -96.02 -13.54 23.66 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 123.455 0.702 . . . . 0.0 111.808 174.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.1 p80 46.28 53.75 9.16 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.804 2.042 . . . . 0.0 112.609 -173.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -171.78 141.38 1.41 Allowed 'General case' 0 C--N 1.346 0.441 0 C-N-CA 125.707 1.603 . . . . 0.0 108.221 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 205' ' ' SER . 0.9 OUTLIER -123.99 170.5 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.36 1.464 . . . . 0.0 110.906 177.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.484 ' H ' HG12 ' A' ' 204' ' ' VAL . 7.9 t 67.8 65.91 0.37 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.026 2.13 . . . . 0.0 113.165 -174.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.89 111.88 1.16 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.732 2.013 . . . . 0.0 107.733 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.16 -134.97 36.85 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -169.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.52 169.33 8.88 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.91 2.084 . . . . 0.0 111.252 177.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -137.8 159.86 40.83 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.478 1.111 . . . . 0.0 111.596 -168.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.457 HG13 ' H ' ' A' ' 211' ' ' GLY . 5.6 tp -134.76 -138.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 170.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 149.47 131.87 2.0 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 126.024 1.773 . . . . 0.0 112.132 -169.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 43.7 t -63.42 125.43 24.15 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.217 1.007 . . . . 0.0 108.675 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.97 -3.43 3.48 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.824 1.25 . . . . 0.0 113.709 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -70.48 117.18 52.63 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 124.242 1.017 . . . . 0.0 108.659 169.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -76.82 4.22 5.86 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.261 2.641 . . . . 0.0 113.16 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -115.99 6.3 14.1 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.85 1.66 . . . . 0.0 110.463 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 49.9 t -58.72 128.3 36.5 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.019 0.528 . . . . 0.0 109.975 170.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.2 m -74.38 2.83 8.5 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.727 1.611 . . . . 0.0 113.689 -176.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.8 mt -133.18 -33.66 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.186 1.794 . . . . 0.0 110.175 -173.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.89 -38.1 0.41 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.796 2.438 . . . . 0.0 115.226 170.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.471 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -132.06 148.51 52.5 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.618 1.967 . . . . 0.0 108.751 -174.091 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -148.35 149.47 31.85 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -73.94 150.7 40.66 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.244 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -59.66 -4.25 0.63 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.84 1.656 . . . . 0.0 113.252 167.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.79 -2.84 8.26 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.326 1.45 . . . . 0.0 112.609 171.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.1 m -71.9 -7.88 51.1 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.112 0.869 . . . . 0.0 111.612 167.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.0 p -133.94 -4.45 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 125.958 1.703 . . . . 0.0 111.765 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.18 33.55 78.67 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.605 1.098 . . . . 0.0 113.012 -174.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.5 mt -65.18 -50.51 65.65 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.437 1.095 . . . . 0.0 112.096 -174.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . 0.277 1.7 t 47.45 6.09 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 128.678 2.791 . . . . 0.0 116.585 -171.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 76.3 p -148.14 165.96 29.31 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.703 2.001 . . . . 0.0 109.818 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -65.4 127.83 93.27 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.644 -0.693 . . . . 0.0 109.305 171.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -80.68 173.31 12.32 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.336 2.691 . . . . 0.0 112.578 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 54.4 mmm-85 -67.22 160.96 25.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.478 1.111 . . . . 0.0 109.418 167.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -61.09 152.86 39.65 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 173.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt 50.99 62.96 2.44 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.07 1.348 . . . . 0.0 111.279 -171.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 81.1 t90 -75.36 153.21 37.91 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 113.641 -1.618 . . . . 0.0 109.287 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -138.64 138.26 37.67 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.187 0.995 . . . . 0.0 108.728 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.7 p -64.82 166.78 10.95 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.965 0.906 . . . . 0.0 112.171 176.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.4 36.01 0.37 Allowed 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 123.861 3.041 . . . . 0.0 113.095 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -138.68 -39.51 0.51 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 125.473 1.509 . . . . 0.0 109.329 169.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 33.9 m -72.13 -29.04 63.67 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.979 2.112 . . . . 0.0 112.393 172.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 69.2 m -73.73 -36.6 65.19 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.833 1.253 . . . . 0.0 110.962 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -70.07 -12.18 61.42 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.231 1.012 . . . . 0.0 112.893 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -54.07 -66.93 0.31 Allowed 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 127.158 2.183 . . . . 0.0 111.448 172.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.93 21.52 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.59 1.556 . . . . 0.0 111.001 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -130.63 75.54 1.66 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.424 1.49 . . . . 0.0 109.992 -167.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp 70.97 105.76 0.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.496 2.318 . . . . 0.0 111.204 -174.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt . . . . . 0 C--O 1.25 1.086 0 C-N-CA 125.963 1.705 . . . . 0.0 108.772 178.715 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.6 153.57 15.21 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.697 1.199 . . . . 0.0 110.046 -170.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 27.7 ttt -156.88 82.85 3.19 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.596 1.159 . . . . 0.0 108.398 175.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -71.83 125.36 10.97 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.811 2.34 . . . . 0.0 110.353 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.23 25.54 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 125.342 1.457 . . . . 0.0 109.182 176.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -55.69 -46.32 99.75 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 117.256 -1.354 . . . . 0.0 112.061 174.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.75 111.7 3.35 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.19 1.927 . . . . 0.0 109.192 168.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -149.78 31.13 0.72 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.45 1.1 . . . . 0.0 110.907 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -135.99 72.22 61.36 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 125.056 1.342 . . . . 0.0 109.107 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.14 111.24 2.83 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.728 2.952 . . . . 0.0 110.416 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.8 p -146.68 138.29 24.48 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.821 1.648 . . . . 0.0 108.846 -174.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -155.89 -44.91 0.08 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.502 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.7 p -39.83 170.32 0.0 OUTLIER 'General case' 0 C--N 1.348 0.522 0 C-N-CA 126.408 1.883 . . . . 0.0 114.001 168.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.68 -6.97 41.1 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.527 -1.67 . . . . 0.0 110.127 168.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.502 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 89.2 m -97.13 -14.16 21.68 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 123.859 0.864 . . . . 0.0 111.763 175.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.5 p80 45.57 52.48 9.23 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.082 2.153 . . . . 0.0 112.883 -173.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.15 139.79 2.3 Favored 'General case' 0 C--N 1.345 0.4 0 C-N-CA 126.043 1.737 . . . . 0.0 108.439 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -122.6 -174.82 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.878 1.671 . . . . 0.0 109.752 176.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.493 ' H ' HG12 ' A' ' 204' ' ' VAL 0.277 59.7 p 59.87 53.98 4.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.124 2.17 . . . . 0.0 114.571 -174.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.75 121.05 5.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.7 2.0 . . . . 0.0 109.1 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 57.54 -113.46 4.6 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.616 1.579 . . . . 0.0 111.188 -174.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.76 168.56 18.82 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.346 2.259 . . . . 0.0 111.41 -174.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -138.57 159.76 41.3 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.802 0.841 . . . . 0.0 113.036 -167.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.415 HG13 ' H ' ' A' ' 211' ' ' GLY . 5.7 tp -134.8 -137.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 168.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 147.71 131.53 2.13 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 125.555 1.55 . . . . 0.0 112.03 -170.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 53.3 t -64.75 119.49 10.69 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -67.38 1.28 2.31 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.432 1.493 . . . . 0.0 113.747 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -67.0 118.0 51.15 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.22 6.23 4.05 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.28 2.654 . . . . 0.0 113.191 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -119.66 7.64 11.1 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.821 1.648 . . . . 0.0 110.575 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 47.5 t -59.34 130.26 46.04 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 123.286 0.634 . . . . 0.0 110.3 172.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.0 m -76.2 1.48 15.77 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.56 1.544 . . . . 0.0 113.671 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 26.2 mt -134.94 -34.34 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.029 1.731 . . . . 0.0 110.285 -171.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.7 -39.77 0.44 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.71 2.404 . . . . 0.0 115.011 170.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.45 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -131.27 147.73 52.62 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.523 1.929 . . . . 0.0 108.42 -174.612 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -147.76 147.79 30.26 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -71.45 150.97 44.42 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.204 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.96 -1.33 0.64 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.589 1.556 . . . . 0.0 113.41 168.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -126.95 1.3 6.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.756 1.222 . . . . 0.0 112.28 169.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.1 m -72.28 -9.42 58.45 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.793 0.724 . . . . 0.0 111.608 167.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.1 p -135.07 -10.83 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 124.696 1.198 . . . . 0.0 113.046 170.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.49 38.37 8.98 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.615 1.102 . . . . 0.0 113.888 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 68.3 mt -65.8 112.64 3.83 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.69 1.245 . . . . 0.0 110.764 173.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.3 t -78.5 -20.96 49.65 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.967 0.907 . . . . 0.0 111.567 169.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 8.9 t -156.87 176.04 13.28 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.605 1.562 . . . . 0.0 110.193 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -65.31 120.27 66.26 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.402 1.081 . . . . 0.0 109.192 175.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.74 -50.74 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.741 2.294 . . . . 0.0 111.543 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -173.76 -178.83 1.65 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.114 2.165 . . . . 0.0 108.452 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -82.44 18.19 15.72 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.43 1.014 . . . . 0.0 112.278 167.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -154.71 112.81 3.49 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 125.93 1.692 . . . . 0.0 108.186 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . 0.417 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 87.5 t90 -139.32 164.15 30.59 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.568 1.947 . . . . 0.0 110.429 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -139.25 141.25 37.83 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 124.854 1.262 . . . . 0.0 109.471 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . 0.417 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 15.9 p -67.87 163.68 47.61 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.49 0.716 . . . . 0.0 112.288 176.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.54 34.14 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 124.056 3.171 . . . . 0.0 113.458 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -137.32 -35.92 0.67 Allowed 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.45 1.5 . . . . 0.0 110.076 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 24.3 m -72.8 -32.48 65.58 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.556 1.942 . . . . 0.0 111.808 169.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.4 t -82.19 -16.36 49.96 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.777 1.631 . . . . 0.0 112.586 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -68.26 -32.17 72.16 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.81 0.844 . . . . 0.0 111.34 173.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.75 167.13 7.82 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.788 1.635 . . . . 0.0 111.212 169.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 56.6 ttt-85 58.99 41.27 21.25 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.358 1.463 . . . . 0.0 112.12 175.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -66.45 94.27 0.27 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 125.9 1.68 . . . . 0.0 108.989 171.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 49.3 tptt 57.66 109.33 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.182 2.593 . . . . 0.0 112.742 -170.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm . . . . . 0 C--O 1.251 1.136 0 C-N-CA 125.18 1.392 . . . . 0.0 107.412 169.57 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 52.12 65.15 1.59 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.385 1.474 . . . . 0.0 112.046 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 66.6 mtt -126.99 79.2 73.25 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.39 1.476 . . . . 0.0 110.138 -170.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.48 155.57 66.48 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.127 2.552 . . . . 0.0 111.031 173.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 86.7 t -143.36 133.43 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.204 1.402 . . . . 0.0 107.417 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -143.55 153.18 58.25 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.812 1.245 . . . . 0.0 110.699 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -80.45 35.76 0.59 Allowed 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 125.024 3.816 . . . . 0.0 111.951 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -135.14 37.14 3.0 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.605 1.562 . . . . 0.0 110.961 -169.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.48 130.19 89.81 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.489 1.116 . . . . 0.0 110.734 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.22 116.89 4.89 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.241 2.627 . . . . 0.0 110.762 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 81.1 p -147.66 136.0 21.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.815 1.646 . . . . 0.0 108.661 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -156.58 -48.59 0.07 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -174.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.484 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -38.62 171.28 0.0 OUTLIER 'General case' 0 C--N 1.351 0.663 0 C-N-CA 126.803 2.041 . . . . 0.0 114.633 169.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.9 mt -70.38 -7.24 41.39 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 113.458 -1.701 . . . . 0.0 110.021 168.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.484 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 94.6 m -96.43 -13.71 22.96 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 123.546 0.738 . . . . 0.0 111.852 174.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.3 p80 46.01 51.04 11.16 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.306 2.242 . . . . 0.0 113.101 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -169.66 142.05 2.45 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 125.854 1.662 . . . . 0.0 107.897 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 205' ' ' SER . 1.1 t -123.65 174.09 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.666 1.587 . . . . 0.0 110.733 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.528 ' H ' HG12 ' A' ' 204' ' ' VAL . 50.0 m 67.48 57.84 0.55 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.719 2.007 . . . . 0.0 113.114 -177.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -158.66 109.4 2.09 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.298 2.239 . . . . 0.0 106.945 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.77 -159.74 45.55 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-O 122.814 1.23 . . . . 0.0 110.757 -168.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -83.43 170.58 14.34 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.375 1.87 . . . . 0.0 112.075 171.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -140.23 159.73 41.53 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.921 1.289 . . . . 0.0 112.137 -169.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . 0.258 9.1 tp -132.19 -138.42 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 146.94 136.45 2.85 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 126.454 1.978 . . . . 0.0 112.308 -169.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.507 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 7.5 t -65.75 127.68 32.92 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.755 -0.723 . . . . 0.0 109.748 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.72 -8.27 1.98 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.343 1.457 . . . . 0.0 113.75 171.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -57.55 110.16 2.29 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 128.163 2.585 . . . . 0.0 108.288 169.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -78.61 10.91 2.64 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.42 2.747 . . . . 0.0 112.758 -175.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -129.22 9.9 5.73 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.279 1.832 . . . . 0.0 109.603 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 21.9 t -55.38 117.46 3.57 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-O 121.781 0.801 . . . . 0.0 111.66 175.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 85.7 p -74.49 1.94 10.73 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.94 2.096 . . . . 0.0 113.265 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.8 mm -123.67 -36.54 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.37 1.868 . . . . 0.0 108.957 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.03 -30.15 0.21 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 128.207 2.603 . . . . 0.0 115.195 169.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.468 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -144.24 149.81 36.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.689 1.596 . . . . 0.0 109.435 -175.266 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -148.21 149.67 32.36 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -72.88 149.86 43.13 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.192 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -59.36 -4.76 0.63 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.57 1.548 . . . . 0.0 113.473 167.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.65 -4.23 8.73 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.215 1.406 . . . . 0.0 112.638 171.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 14.6 m -72.8 -5.34 37.35 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.002 0.819 . . . . 0.0 111.359 167.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.5 p -136.56 -5.22 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 126.479 1.911 . . . . 0.0 111.931 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.8 35.86 91.46 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.802 1.191 . . . . 0.0 113.023 -175.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.5 mt -67.14 -53.51 29.96 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 123.968 0.907 . . . . 0.0 111.281 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 22.9 m 61.31 -12.21 0.05 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.286 2.234 . . . . 0.0 114.587 -173.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.6 p -143.56 165.39 27.71 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.851 1.66 . . . . 0.0 110.598 -174.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -66.08 126.7 92.38 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 123.968 0.907 . . . . 0.0 109.91 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.51 177.17 9.06 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.529 2.819 . . . . 0.0 111.879 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -65.3 174.89 1.89 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.423 1.089 . . . . 0.0 111.115 169.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.5 7.57 1.94 Allowed Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.08 1.324 . . . . 0.0 115.321 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -148.33 115.07 6.02 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 126.969 2.108 . . . . 0.0 106.762 173.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -126.8 155.9 42.12 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.276 1.83 . . . . 0.0 109.429 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.507 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 91.3 m-85 -138.44 138.42 38.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.716 0.807 . . . . 0.0 110.249 -176.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 31.5 p -64.03 162.48 30.36 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 123.675 0.79 . . . . 0.0 111.622 172.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.82 28.95 0.24 Allowed 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 124.028 3.152 . . . . 0.0 113.59 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -133.61 -36.85 0.95 Allowed 'General case' 0 C--N 1.343 0.326 0 C-N-CA 125.794 1.638 . . . . 0.0 109.702 173.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 2.5 m -71.87 -35.99 69.96 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.325 1.85 . . . . 0.0 111.863 169.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 27.4 t -75.5 -31.07 60.05 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.835 1.254 . . . . 0.0 110.977 174.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -28.73 68.66 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.841 1.256 . . . . 0.0 111.489 175.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.86 -22.5 59.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.578 1.551 . . . . 0.0 112.911 173.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 53.2 ttt85 26.56 71.61 0.04 OUTLIER 'General case' 0 C--N 1.35 0.597 0 C-N-CA 129.412 3.085 . . . . 0.0 114.166 169.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -80.89 -171.5 3.21 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.342 1.457 . . . . 0.0 110.558 -171.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -81.77 76.29 8.68 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.531 1.932 . . . . 0.0 109.469 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 23.4 tptm . . . . . 0 C--O 1.25 1.109 0 C-N-CA 126.962 2.105 . . . . 0.0 111.324 -172.131 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 97.9 mtp . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 63.15 120.79 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.692 2.397 . . . . 0.0 113.699 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 27.5 ttt -150.29 76.72 8.43 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.147 0.979 . . . . 0.0 109.946 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.71 149.72 61.27 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.952 2.435 . . . . 0.0 110.832 173.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.58 9.94 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 125.073 1.349 . . . . 0.0 110.256 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -54.92 -44.46 99.52 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.796 1.639 . . . . 0.0 113.55 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -81.41 73.35 5.94 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 123.232 2.622 . . . . 0.0 109.101 169.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -66.33 -15.9 63.62 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.873 1.269 . . . . 0.0 114.401 -170.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.3 125.68 91.42 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.32 1.048 . . . . 0.0 110.428 178.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.72 153.38 43.24 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.302 2.668 . . . . 0.0 111.703 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.7 p 58.64 144.27 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.866 2.866 . . . . 0.0 113.477 -172.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.98 -49.48 0.09 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -168.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.494 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.9 p -41.65 170.33 0.0 OUTLIER 'General case' 0 C--N 1.349 0.58 0 C-N-CA 125.892 1.677 . . . . 0.0 114.165 169.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.7 mt -71.1 -6.86 42.48 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.925 168.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.494 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 93.7 m -95.62 -13.6 24.2 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.513 0.725 . . . . 0.0 111.797 174.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.0 p80 46.83 52.94 10.92 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.031 2.132 . . . . 0.0 112.85 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -173.16 139.73 0.82 Allowed 'General case' 0 C--N 1.345 0.391 0 C-N-CA 125.878 1.671 . . . . 0.0 108.498 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 205' ' ' SER . 0.5 OUTLIER -114.29 -173.18 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 125.605 1.562 . . . . 0.0 110.665 175.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.521 ' H ' HG12 ' A' ' 204' ' ' VAL 0.254 97.5 p 53.12 64.29 1.91 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.812 2.445 . . . . 0.0 114.771 -174.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.08 112.07 1.54 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.894 2.078 . . . . 0.0 108.011 -177.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 63.65 -133.72 41.25 Favored Glycine 0 C--N 1.339 0.75 0 C-N-CA 124.497 1.046 . . . . 0.0 110.546 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.08 169.05 9.21 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 127.248 2.219 . . . . 0.0 111.42 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -138.66 159.51 41.92 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.251 1.02 . . . . 0.0 112.209 -168.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.448 HG13 ' H ' ' A' ' 211' ' ' GLY . 5.8 tp -133.44 -138.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 169.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 148.32 131.25 2.04 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 125.597 1.57 . . . . 0.0 112.507 -170.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 45.9 t -63.94 121.39 13.99 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.24 2.11 1.79 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.436 1.494 . . . . 0.0 113.699 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -70.94 118.01 61.43 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.378 1.071 . . . . 0.0 108.146 168.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -76.33 4.58 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.185 2.59 . . . . 0.0 113.273 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -116.21 6.41 13.87 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.717 1.607 . . . . 0.0 110.508 174.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 46.5 t -59.14 129.13 40.64 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 123.118 0.567 . . . . 0.0 109.924 171.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 11.0 t -73.27 -1.44 17.87 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.922 1.689 . . . . 0.0 113.455 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.6 mt -132.76 -33.84 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.968 1.707 . . . . 0.0 110.449 -170.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.68 -38.9 0.43 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 127.47 2.308 . . . . 0.0 114.985 171.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.479 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -132.49 148.29 52.39 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.497 1.919 . . . . 0.0 109.03 -173.268 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -148.85 149.95 32.17 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -74.17 151.08 40.09 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.369 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -59.28 -5.12 0.66 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.766 1.626 . . . . 0.0 113.259 167.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.04 -3.58 8.56 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.294 1.438 . . . . 0.0 112.581 171.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 15.5 m -72.8 -6.9 47.92 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.04 0.836 . . . . 0.0 111.739 167.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.35 -5.6 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.864 1.666 . . . . 0.0 111.817 172.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.51 34.82 80.03 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.726 1.155 . . . . 0.0 112.8 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.3 mt -66.18 -50.46 63.81 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 124.327 1.051 . . . . 0.0 111.771 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 16.9 m 61.81 -8.87 0.09 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.072 2.149 . . . . 0.0 114.612 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 12.1 t -150.1 176.78 10.51 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.839 1.656 . . . . 0.0 110.39 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -71.83 129.22 88.49 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.316 1.046 . . . . 0.0 109.728 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.22 176.55 9.6 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.468 2.779 . . . . 0.0 111.95 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -69.21 171.26 8.68 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.016 0.927 . . . . 0.0 109.992 167.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -58.58 153.66 28.13 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 123.565 0.602 . . . . 0.0 112.348 172.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 45.4 tttp 42.86 71.72 0.21 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.825 2.05 . . . . 0.0 113.498 -172.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -76.86 160.3 29.35 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.95 0.9 . . . . 0.0 109.99 174.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -138.63 140.46 38.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.201 1.0 . . . . 0.0 109.584 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.2 p -66.73 165.24 26.69 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.73 0.812 . . . . 0.0 112.06 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.47 33.03 0.29 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 124.024 3.149 . . . . 0.0 113.482 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -136.02 -40.31 0.68 Allowed 'General case' 0 C--N 1.345 0.404 0 C-N-CA 125.068 1.347 . . . . 0.0 109.674 169.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.3 m -68.38 -36.94 79.9 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.736 2.014 . . . . 0.0 111.705 171.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.8 t -80.52 -31.77 37.02 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.325 1.45 . . . . 0.0 111.384 175.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -36.56 84.07 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.528 1.131 . . . . 0.0 111.182 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.82 -16.96 54.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.704 1.602 . . . . 0.0 113.388 176.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 41.0 ttt-85 -137.0 35.37 2.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.019 1.328 . . . . 0.0 110.586 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.19 95.86 0.43 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.325 1.85 . . . . 0.0 109.736 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 85.3 tttt 58.08 93.47 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.861 2.464 . . . . 0.0 112.328 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt . . . . . 0 C--O 1.249 1.043 0 C-N-CA 125.942 1.697 . . . . 0.0 109.702 176.835 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -80.27 143.52 33.61 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.658 0.783 . . . . 0.0 111.147 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -130.24 68.82 81.61 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.541 1.536 . . . . 0.0 109.064 -177.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.84 -23.32 6.9 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.505 2.803 . . . . 0.0 113.889 -171.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 11.7 t -142.82 56.7 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.45 1.5 . . . . 0.0 107.32 -175.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -144.53 157.11 56.33 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.161 1.385 . . . . 0.0 110.253 -169.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -70.2 157.45 59.49 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.056 2.504 . . . . 0.0 112.108 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -100.8 34.27 2.52 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.289 1.436 . . . . 0.0 110.385 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -135.07 75.54 60.23 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.275 1.43 . . . . 0.0 109.161 -171.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.26 116.1 4.46 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.614 2.876 . . . . 0.0 110.635 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 63.6 p -147.68 137.62 22.82 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.104 1.762 . . . . 0.0 108.474 -174.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -155.26 -42.26 0.08 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 115.705 -2.093 . . . . 0.0 115.099 -173.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.487 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.7 OUTLIER -52.01 173.64 0.03 OUTLIER 'General case' 0 C--N 1.359 0.985 0 CA-C-N 122.223 2.283 . . . . 0.0 112.572 172.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.6 mt -62.83 -6.13 3.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.559 1.543 . . . . 0.0 111.243 172.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 92.4 m -99.29 -11.87 20.86 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 126.298 1.839 . . . . 0.0 112.762 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.7 p80 45.36 48.61 10.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.406 2.283 . . . . 0.0 112.342 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -162.91 147.99 11.78 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.367 1.467 . . . . 0.0 107.539 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 205' ' ' SER . 1.1 t -135.19 171.72 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 127.388 2.275 . . . . 0.0 110.323 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.492 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.3 t 61.36 64.52 1.07 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.61 1.964 . . . . 0.0 112.987 -173.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.86 108.11 1.14 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.48 1.912 . . . . 0.0 108.374 -174.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 59.69 -160.22 19.8 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-O 123.271 1.484 . . . . 0.0 112.631 -174.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.9 pm0 -64.17 148.94 48.85 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.959 2.104 . . . . 0.0 111.621 169.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.8 mtm -150.94 156.17 40.62 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.653 1.981 . . . . 0.0 109.492 -168.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.411 HG13 ' H ' ' A' ' 211' ' ' GLY . 7.2 tp -140.53 -135.56 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -175.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 148.78 133.89 2.32 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 126.054 1.788 . . . . 0.0 112.444 -171.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 50.4 t -64.63 126.58 28.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.168 -1.016 . . . . 0.0 109.013 175.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.91 -7.33 2.33 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -69.61 114.73 26.57 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 119.496 1.044 . . . . 0.0 108.593 171.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -78.45 6.04 5.08 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.418 2.745 . . . . 0.0 112.948 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -118.95 5.58 11.38 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.952 1.701 . . . . 0.0 109.987 174.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.2 t -59.39 131.07 49.87 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 118.487 0.585 . . . . 0.0 109.844 170.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.0 m -74.11 6.31 3.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.725 1.61 . . . . 0.0 113.417 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.0 mm -135.75 -38.15 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 126.54 1.936 . . . . 0.0 109.62 -170.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.86 -43.2 0.53 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.525 2.73 . . . . 0.0 115.511 171.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.487 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -126.02 148.51 49.28 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.566 1.946 . . . . 0.0 108.625 -177.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.412 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 74.0 m-85 -149.11 155.31 40.52 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -173.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -83.97 145.1 28.72 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.559 0.695 . . . . 0.0 110.628 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.34 -3.94 1.08 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.005 1.722 . . . . 0.0 113.979 171.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.86 -4.22 7.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.546 1.138 . . . . 0.0 112.185 172.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.3 m -77.44 -3.03 38.3 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.036 0.835 . . . . 0.0 113.02 168.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.2 p -135.02 -6.11 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.789 1.235 . . . . 0.0 112.259 169.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.77 40.88 20.71 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.59 1.091 . . . . 0.0 113.723 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.7 mt -67.76 103.07 1.33 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.517 1.158 . . . . 0.0 110.221 172.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.7 t -71.19 -21.07 62.2 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.813 0.845 . . . . 0.0 111.76 169.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 14.3 t -155.99 172.75 17.86 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.933 1.693 . . . . 0.0 110.1 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -63.45 120.96 66.99 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.47 1.108 . . . . 0.0 108.776 174.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.45 -58.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.615 2.21 . . . . 0.0 111.478 -169.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -172.39 -176.17 1.52 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.771 2.028 . . . . 0.0 108.571 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -78.27 23.05 2.88 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.419 1.009 . . . . 0.0 112.702 168.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -157.3 114.33 3.03 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 125.781 1.633 . . . . 0.0 108.697 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -141.52 160.4 40.23 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.148 1.779 . . . . 0.0 110.347 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -140.98 141.99 34.35 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.297 1.039 . . . . 0.0 109.646 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.0 p -70.02 166.02 37.21 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.485 0.714 . . . . 0.0 111.896 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -73.1 32.48 0.31 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.028 3.152 . . . . 0.0 113.383 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -136.29 -36.74 0.72 Allowed 'General case' 0 C--N 1.344 0.34 0 C-N-CA 125.161 1.385 . . . . 0.0 109.845 171.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 37.5 m -75.4 -33.45 60.98 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 126.779 2.032 . . . . 0.0 111.961 172.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 10.1 t -80.96 -20.77 41.23 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.466 1.506 . . . . 0.0 111.993 175.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -62.16 -38.28 88.45 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.182 1.393 . . . . 0.0 112.312 -174.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.07 -46.11 89.08 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.748 1.619 . . . . 0.0 111.993 176.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 51.46 21.18 1.16 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.19 2.196 . . . . 0.0 115.211 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm 47.63 55.37 8.49 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.586 1.555 . . . . 0.0 111.382 -169.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -142.44 42.57 1.62 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.141 1.376 . . . . 0.0 110.555 -170.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt . . . . . 0 C--O 1.253 1.25 0 C-N-CA 124.837 1.255 . . . . 0.0 111.415 175.796 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.2 ptp . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -145.14 146.03 31.62 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.379 1.072 . . . . 0.0 109.997 -171.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 8.9 tmm? -153.99 98.8 2.58 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.95 152.99 37.06 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.036 2.491 . . . . 0.0 111.806 -176.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.3 t -89.92 84.2 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 174.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.55 153.07 79.0 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.749 1.22 . . . . 0.0 111.32 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.6 128.68 19.55 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.05 2.5 . . . . 0.0 111.151 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -73.88 -8.65 56.89 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.532 1.133 . . . . 0.0 112.988 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -145.23 74.94 14.05 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.298 1.439 . . . . 0.0 108.779 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.74 112.44 3.49 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.865 3.043 . . . . 0.0 110.261 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.9 p -147.46 136.49 22.25 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.53 1.532 . . . . 0.0 109.155 -172.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -154.69 -40.47 0.09 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 115.884 -2.007 . . . . 0.0 115.319 -171.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.519 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.8 OUTLIER -53.43 173.64 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 122.312 2.324 . . . . 0.0 112.213 170.59 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.6 mt -62.44 -7.66 4.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.671 1.588 . . . . 0.0 111.232 171.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 67.6 m -95.75 -12.9 24.67 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 126.062 1.745 . . . . 0.0 112.753 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.5 p80 45.2 49.03 10.02 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.339 2.256 . . . . 0.0 112.232 -173.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -164.27 147.94 9.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.217 1.407 . . . . 0.0 108.147 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -127.45 -169.93 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 127.202 2.201 . . . . 0.0 109.285 174.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.444 ' H ' HG12 ' A' ' 204' ' ' VAL . 89.8 p 49.24 58.04 5.83 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.893 2.077 . . . . 0.0 114.324 -174.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.15 100.77 2.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.845 2.058 . . . . 0.0 109.295 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 68.95 -96.78 0.47 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.615 1.578 . . . . 0.0 111.5 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.17 169.47 17.8 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.148 1.779 . . . . 0.0 111.977 -169.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -146.0 161.23 40.57 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.42 1.088 . . . . 0.0 112.073 -169.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.4 HG13 ' H ' ' A' ' 211' ' ' GLY . 4.6 tp -133.31 -134.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 168.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 146.25 133.15 2.46 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 125.493 1.52 . . . . 0.0 111.923 -170.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.51 121.17 14.29 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.374 -0.913 . . . . 0.0 109.082 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -71.78 7.2 1.61 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.51 1.524 . . . . 0.0 113.602 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -71.73 120.2 78.6 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.469 1.107 . . . . 0.0 108.402 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -75.7 6.61 3.58 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.333 2.689 . . . . 0.0 113.361 177.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -119.68 7.67 11.09 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.785 1.634 . . . . 0.0 110.648 174.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.76 129.23 40.44 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 123.438 0.695 . . . . 0.0 110.226 173.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.1 m -81.17 3.45 23.58 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.281 1.432 . . . . 0.0 113.363 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 78.7 mt -134.71 -33.72 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.614 1.565 . . . . 0.0 110.364 -169.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER 73.06 -46.05 0.64 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 128.78 2.832 . . . . 0.0 115.235 170.341 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.519 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.3 OUTLIER -125.44 149.12 48.5 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.588 1.555 . . . . 0.0 109.24 -175.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.4 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 82.6 m-85 -149.69 157.88 43.65 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.945 1.298 . . . . 0.0 108.832 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -89.11 144.6 26.01 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.378 0.609 . . . . 0.0 111.174 -172.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -56.57 -8.24 0.53 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.421 2.288 . . . . 0.0 114.245 169.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.86 -7.69 8.43 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.827 1.251 . . . . 0.0 112.297 174.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 10.6 m -77.28 -3.15 38.4 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.044 0.838 . . . . 0.0 112.938 168.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 12.7 p -131.11 -0.44 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 126.091 1.757 . . . . 0.0 110.857 169.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.46 29.33 74.97 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.208 1.385 . . . . 0.0 113.174 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.6 mt -64.59 -48.53 74.61 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.307 1.043 . . . . 0.0 112.362 -171.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.4 m 63.65 -13.63 0.08 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.878 2.071 . . . . 0.0 114.118 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.8 p -144.73 168.99 18.88 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.18 1.792 . . . . 0.0 110.361 -173.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -67.25 128.82 93.83 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-O 118.373 -0.822 . . . . 0.0 108.804 170.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -73.53 -67.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.599 2.199 . . . . 0.0 111.749 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 24.9 ttp85 -173.1 -173.99 1.0 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.63 1.972 . . . . 0.0 108.666 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -75.62 6.53 31.26 Favored Glycine 0 CA--C 1.539 1.567 0 CA-C-O 118.731 -1.039 . . . . 0.0 113.875 169.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -158.04 119.85 3.63 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 125.175 1.39 . . . . 0.0 108.593 175.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.1 t90 -136.2 160.0 40.03 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.08 2.152 . . . . 0.0 109.852 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -139.82 142.43 36.64 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.012 0.925 . . . . 0.0 110.096 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.0 p -70.83 164.96 51.36 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.574 0.75 . . . . 0.0 111.347 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -73.76 31.5 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.047 3.165 . . . . 0.0 113.096 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -136.18 -36.85 0.73 Allowed 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.386 1.474 . . . . 0.0 109.937 176.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 18.8 m -79.21 -30.83 43.5 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 127.354 2.262 . . . . 0.0 112.011 173.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 17.9 t -74.62 -19.24 60.37 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.653 1.181 . . . . 0.0 112.303 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 21.9 tm0? -55.85 -35.9 66.96 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.59 1.556 . . . . 0.0 112.754 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.58 -31.54 62.28 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.543 1.537 . . . . 0.0 113.118 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -116.74 33.42 5.6 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.486 1.514 . . . . 0.0 111.524 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -121.18 32.11 6.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.45 1.5 . . . . 0.0 111.045 178.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -80.49 38.53 0.43 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.112 1.765 . . . . 0.0 111.294 169.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt . . . . . 0 C--O 1.25 1.117 0 C-N-CA 127.097 2.159 . . . . 0.0 111.135 -169.169 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 99.0 mmm . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -144.3 30.71 1.25 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.433 1.093 . . . . 0.0 111.366 -167.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 23.9 ptm -133.67 54.68 13.31 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.416 1.087 . . . . 0.0 113.585 -169.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -68.86 138.47 40.86 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.387 2.058 . . . . 0.0 110.348 170.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 91.0 t -144.64 119.47 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -147.39 147.57 28.67 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.491 1.116 . . . . 0.0 110.404 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -81.74 46.18 2.16 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 125.133 3.889 . . . . 0.0 110.954 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -129.51 -0.87 4.97 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.968 1.307 . . . . 0.0 113.312 -168.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -70.91 125.8 92.05 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 118.857 0.753 . . . . 0.0 110.129 175.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.09 128.77 11.68 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.052 2.501 . . . . 0.0 110.362 174.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 78.5 p -149.27 135.31 18.98 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.615 1.566 . . . . 0.0 108.735 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -156.83 -39.0 0.07 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 115.901 -2.0 . . . . 0.0 115.194 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.502 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.7 OUTLIER -52.86 173.79 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 122.218 2.281 . . . . 0.0 112.438 171.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.6 mt -62.88 -6.71 4.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.691 1.596 . . . . 0.0 111.216 171.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.8 m -98.53 -11.31 22.35 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 126.14 1.776 . . . . 0.0 112.712 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.2 p80 45.75 48.92 11.63 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.401 2.28 . . . . 0.0 112.424 -174.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -163.76 148.97 10.8 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.457 1.503 . . . . 0.0 107.548 176.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 205' ' ' SER . 1.1 t -133.83 172.03 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 127.225 2.21 . . . . 0.0 110.635 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.511 ' H ' HG12 ' A' ' 204' ' ' VAL . 13.2 t 64.66 61.53 0.82 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.869 2.068 . . . . 0.0 113.3 -174.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.82 111.07 1.52 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.396 1.878 . . . . 0.0 108.558 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.5 -163.18 23.44 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-O 123.171 1.428 . . . . 0.0 112.575 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.9 pm0 -65.61 147.27 53.68 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 112.233 -1.983 . . . . 0.0 111.1 169.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.8 mtm -148.98 153.71 38.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.208 1.803 . . . . 0.0 109.743 -168.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.9 tp -137.96 -134.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.346 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -173.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 149.35 132.06 2.03 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 126.232 1.872 . . . . 0.0 112.788 -169.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 47.6 t -64.35 125.35 24.31 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.29 -0.955 . . . . 0.0 108.678 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.8 -0.32 2.14 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.484 1.514 . . . . 0.0 113.245 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -72.97 116.83 54.39 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 124.501 1.121 . . . . 0.0 108.466 168.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.02 4.21 5.97 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.288 2.658 . . . . 0.0 113.217 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -114.78 5.01 15.11 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.766 1.626 . . . . 0.0 110.526 174.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.98 130.13 45.52 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 122.987 0.515 . . . . 0.0 110.4 171.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.0 m -74.03 1.62 10.59 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.785 1.634 . . . . 0.0 113.868 -176.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 19.1 mt -134.07 -32.82 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 126.091 1.756 . . . . 0.0 110.359 -172.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.77 -37.51 0.38 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 128.366 2.666 . . . . 0.0 115.78 172.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.504 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.5 OUTLIER -130.14 148.77 52.02 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.371 1.868 . . . . 0.0 108.985 -176.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.411 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 82.5 m-85 -147.27 155.12 41.77 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.849 0.86 . . . . 0.0 108.868 -175.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -82.05 143.19 31.71 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.922 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -58.97 -7.27 1.0 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.789 1.636 . . . . 0.0 113.827 170.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -118.83 -5.26 10.63 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.412 1.085 . . . . 0.0 112.417 172.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.0 m -78.55 -0.77 30.95 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.903 0.774 . . . . 0.0 112.855 168.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.0 -9.67 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.845 2.058 . . . . 0.0 111.943 173.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 73.14 36.98 55.93 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.575 1.084 . . . . 0.0 112.993 -177.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 21.9 mt -70.3 104.37 2.65 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.854 0.827 . . . . 0.0 109.919 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 71.0 p -73.81 -18.7 60.92 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.224 1.01 . . . . 0.0 112.446 172.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 55.5 p -147.56 167.38 24.68 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.546 1.938 . . . . 0.0 109.616 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -59.95 129.07 87.81 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.781 0.833 . . . . 0.0 110.081 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.51 166.24 30.41 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.043 2.496 . . . . 0.0 112.042 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -73.84 166.35 23.49 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.45 1.1 . . . . 0.0 109.605 169.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -60.8 158.06 29.5 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 123.3 0.476 . . . . 0.0 112.5 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? 52.74 63.84 2.08 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.135 1.374 . . . . 0.0 111.568 -173.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -84.79 159.57 20.42 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.018 1.327 . . . . 0.0 109.468 172.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -139.76 141.66 36.82 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.313 1.045 . . . . 0.0 109.491 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.1 p -67.2 165.58 26.92 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 123.586 0.755 . . . . 0.0 112.109 174.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -72.97 34.84 0.33 Allowed 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.978 3.119 . . . . 0.0 113.274 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -139.11 -37.45 0.51 Allowed 'General case' 0 C--N 1.343 0.324 0 C-N-CA 125.02 1.328 . . . . 0.0 110.275 169.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 19.7 m -72.47 -35.15 68.14 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.934 2.094 . . . . 0.0 112.025 172.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 t -73.11 -34.0 65.89 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.585 1.154 . . . . 0.0 111.201 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -64.96 -30.14 71.11 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.216 1.407 . . . . 0.0 111.68 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.62 -9.82 39.44 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.213 1.805 . . . . 0.0 113.622 175.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 33.9 ttt85 -143.36 30.71 1.38 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.248 1.019 . . . . 0.0 112.018 -170.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 10.8 mtpm? -68.18 96.52 0.64 Allowed 'General case' 0 C--N 1.344 0.336 0 C-N-CA 125.339 1.456 . . . . 0.0 110.229 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -132.31 36.65 3.59 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.222 1.809 . . . . 0.0 110.114 175.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? . . . . . 0 C--O 1.25 1.123 0 C-N-CA 125.791 1.636 . . . . 0.0 109.524 174.654 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 1.2 tmt? . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -157.86 153.0 25.65 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.803 1.241 . . . . 0.0 109.445 176.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 21.0 ptt? -155.99 62.58 3.14 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.324 1.45 . . . . 0.0 110.126 -176.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.3 -40.75 1.5 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.27 2.647 . . . . 0.0 113.565 -169.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . 0.264 9.9 p 44.93 135.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 130.857 3.663 . . . . 0.0 116.576 -175.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -142.65 150.63 54.69 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.841 1.257 . . . . 0.0 110.514 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.76 -40.51 3.7 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.178 2.585 . . . . 0.0 112.327 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 59.5 t30 47.74 27.72 1.14 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.662 1.985 . . . . 0.0 114.228 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -127.47 83.69 65.38 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.657 1.183 . . . . 0.0 110.41 -171.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.84 131.72 17.45 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.413 2.742 . . . . 0.0 111.026 175.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 70.4 p -149.54 138.42 21.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.964 1.706 . . . . 0.0 108.786 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -156.49 -37.98 0.08 Allowed 'General case' 0 C--N 1.35 0.625 0 CA-C-O 115.728 -2.082 . . . . 0.0 115.958 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.52 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 1.1 t -53.65 174.11 0.05 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 122.49 2.405 . . . . 0.0 111.851 170.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.1 mt -62.33 -7.29 4.12 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.953 1.701 . . . . 0.0 111.283 170.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 69.7 m -97.11 -12.4 23.19 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.989 1.716 . . . . 0.0 112.711 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.4 p80 45.32 49.33 10.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.173 2.189 . . . . 0.0 112.437 -173.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -164.02 148.06 9.97 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.417 1.487 . . . . 0.0 107.864 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -133.86 176.1 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 127.179 2.192 . . . . 0.0 110.81 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.552 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.0 t 63.69 61.85 0.96 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.692 1.997 . . . . 0.0 112.803 -175.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.96 110.08 1.22 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.334 1.853 . . . . 0.0 109.001 -173.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 60.06 -158.78 24.9 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-O 123.21 1.45 . . . . 0.0 113.247 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.8 pm0 -65.49 145.17 56.45 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.098 2.159 . . . . 0.0 111.317 169.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.3 mtm -151.52 156.68 41.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.294 1.838 . . . . 0.0 109.863 -168.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 7.5 tp -138.03 -133.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 124.258 1.023 . . . . 0.0 109.204 -175.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 146.37 136.08 2.85 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 126.466 1.984 . . . . 0.0 113.285 -169.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.532 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 7.0 t -65.14 125.62 25.55 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 114.622 -0.789 . . . . 0.0 109.324 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.2 0.29 0.65 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.589 1.156 . . . . 0.0 112.758 170.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -63.49 111.4 5.07 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 127.783 2.433 . . . . 0.0 107.844 167.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -78.58 11.5 2.44 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.374 2.716 . . . . 0.0 113.031 -176.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -129.23 9.04 5.61 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.161 1.784 . . . . 0.0 109.787 174.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 25.8 t -55.58 124.11 16.25 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.636 0.732 . . . . 0.0 112.403 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 15.8 m -74.34 1.14 12.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.703 2.001 . . . . 0.0 113.271 -177.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 12.5 mt -131.48 -34.55 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 126.382 1.873 . . . . 0.0 109.574 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.13 -25.3 0.16 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 128.017 2.527 . . . . 0.0 115.78 169.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.521 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.6 OUTLIER -143.6 148.06 35.31 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.855 1.662 . . . . 0.0 109.178 -178.433 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -145.96 155.87 43.13 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.168 0.987 . . . . 0.0 108.825 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -80.91 143.16 32.86 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.901 -175.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.99 -2.4 0.41 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.297 1.839 . . . . 0.0 114.12 171.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.61 -7.59 7.42 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.26 1.424 . . . . 0.0 112.166 172.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.6 m -77.27 -2.16 33.35 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.154 0.888 . . . . 0.0 112.678 168.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.77 -5.59 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 127.444 2.298 . . . . 0.0 111.266 172.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.34 36.58 91.85 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.894 1.235 . . . . 0.0 112.885 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.9 -58.64 5.62 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.727 0.811 . . . . 0.0 111.452 -178.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 25.7 m 62.26 -22.22 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.229 2.211 . . . . 0.0 114.58 -172.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 71.1 p -142.01 157.79 44.52 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.687 1.995 . . . . 0.0 109.528 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -65.18 127.19 92.63 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 123.557 0.743 . . . . 0.0 110.986 -173.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.81 174.44 12.58 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.449 2.766 . . . . 0.0 112.091 176.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -69.05 168.71 13.28 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.949 0.9 . . . . 0.0 109.593 167.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -61.03 161.12 25.26 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 123.224 0.44 . . . . 0.0 112.354 173.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.6 tptp 54.7 56.09 7.15 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.102 1.361 . . . . 0.0 112.645 -173.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -74.46 156.11 37.3 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.44 0.696 . . . . 0.0 109.22 172.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.532 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 71.8 m-85 -134.77 135.97 42.25 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.831 0.852 . . . . 0.0 110.655 -176.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 31.2 p -65.96 164.42 28.55 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.311 1.044 . . . . 0.0 112.237 172.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.88 30.84 0.25 Allowed 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.244 3.296 . . . . 0.0 113.664 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -133.67 -36.4 0.96 Allowed 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.545 1.538 . . . . 0.0 110.041 170.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 3.6 m -71.78 -38.19 70.36 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.158 1.783 . . . . 0.0 112.156 169.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 17.6 t -81.39 -27.99 34.55 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.826 1.251 . . . . 0.0 111.155 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -65.21 -31.62 72.89 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.451 1.5 . . . . 0.0 111.46 173.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.74 -27.48 68.76 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.9 1.68 . . . . 0.0 112.584 175.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 64.2 ttt-85 33.79 70.47 0.12 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 128.407 2.683 . . . . 0.0 114.049 172.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -70.66 -175.43 1.07 Allowed 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.458 1.903 . . . . 0.0 111.066 -176.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -79.22 34.58 0.25 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.645 2.378 . . . . 0.0 111.531 169.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 83.8 tttt . . . . . 0 C--O 1.252 1.21 0 C-N-CA 127.493 2.317 . . . . 0.0 110.806 -168.479 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 66.7 ttp . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -73.5 -48.66 31.57 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.739 0.816 . . . . 0.0 111.403 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 14.0 tpt 19.79 68.79 0.25 Allowed Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 129.233 3.013 . . . . 0.0 114.305 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.06 -41.9 2.39 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.681 2.254 . . . . 0.0 112.809 -170.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . 0.259 1.3 p 49.19 145.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 130.656 3.582 . . . . 0.0 115.727 -174.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 29.3 t70 43.12 76.81 0.49 Allowed Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 126.518 1.927 . . . . 0.0 112.599 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -65.48 136.08 45.13 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.951 2.434 . . . . 0.0 111.626 -172.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -132.75 19.13 4.21 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.385 1.474 . . . . 0.0 111.078 -176.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -57.3 129.72 80.02 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.278 1.431 . . . . 0.0 111.766 -171.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.07 118.07 5.44 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.147 2.565 . . . . 0.0 110.261 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 82.0 p -149.24 132.13 16.11 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.751 1.62 . . . . 0.0 108.409 176.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -156.55 -46.56 0.07 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 117.861 -1.066 . . . . 0.0 113.804 -175.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.506 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -39.38 170.05 0.0 OUTLIER 'General case' 0 C--N 1.349 0.578 0 C-N-CA 126.375 1.87 . . . . 0.0 114.064 168.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -71.08 -6.74 41.44 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.118 168.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.506 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 95.7 m -95.89 -14.31 23.26 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 123.633 0.773 . . . . 0.0 111.792 174.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.1 p80 46.25 52.34 10.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.304 2.242 . . . . 0.0 112.899 -173.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -170.36 141.62 2.03 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 126.091 1.756 . . . . 0.0 107.95 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 205' ' ' SER . 1.6 t -126.47 171.11 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 125.488 1.515 . . . . 0.0 111.18 -176.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.505 ' H ' HG12 ' A' ' 204' ' ' VAL . 43.2 m 68.72 62.81 0.33 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.267 2.227 . . . . 0.0 113.387 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.65 113.45 1.29 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.595 1.958 . . . . 0.0 108.531 -174.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 63.26 -168.68 20.12 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-O 122.708 1.171 . . . . 0.0 112.06 -173.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -69.02 150.53 47.55 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 113.273 -1.463 . . . . 0.0 110.651 168.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.9 mtm -143.63 152.57 41.53 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.929 1.692 . . . . 0.0 109.824 -166.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.6 tp -135.5 -138.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.304 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 151.86 132.4 1.85 Allowed Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 125.906 1.717 . . . . 0.0 112.151 -169.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 40.7 t -63.61 125.55 24.63 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 114.074 -1.063 . . . . 0.0 108.249 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -68.9 6.16 0.96 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.54 1.136 . . . . 0.0 113.559 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -74.42 114.11 30.47 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 166.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -77.65 9.11 3.06 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.328 2.685 . . . . 0.0 113.059 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -124.21 8.74 8.55 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.888 1.675 . . . . 0.0 110.248 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.6 129.97 44.23 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 118.306 0.503 . . . . 0.0 109.924 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -73.59 4.36 5.05 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.755 1.622 . . . . 0.0 113.404 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.2 mt -132.54 -35.17 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 126.268 1.827 . . . . 0.0 109.938 -175.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.7 -38.72 0.43 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.762 2.425 . . . . 0.0 115.27 170.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.47 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -131.43 148.67 52.67 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.899 2.08 . . . . 0.0 108.646 -174.215 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -148.62 146.72 28.35 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -73.22 149.61 42.7 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.793 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -60.29 -6.28 1.43 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.74 1.216 . . . . 0.0 113.641 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -120.36 -0.56 10.36 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.33 1.052 . . . . 0.0 112.611 170.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.5 m -72.61 -5.99 41.11 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.901 0.773 . . . . 0.0 111.301 166.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.1 p -137.48 -12.48 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.765 2.026 . . . . 0.0 112.388 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.97 38.84 55.62 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.348 0.975 . . . . 0.0 112.86 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.7 111.12 3.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 117.82 0.81 . . . . 0.0 109.796 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 73.6 p -78.04 -15.69 58.7 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.44 1.096 . . . . 0.0 112.565 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 15.1 t -155.59 172.29 18.53 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.759 1.623 . . . . 0.0 109.822 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -66.74 127.04 93.27 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 124.599 1.16 . . . . 0.0 109.948 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.04 170.65 19.66 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.149 2.566 . . . . 0.0 112.121 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 50.6 ttp85 -63.71 168.87 4.47 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.208 1.403 . . . . 0.0 111.15 172.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -60.92 -1.5 2.02 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.92 1.724 . . . . 0.0 116.169 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -139.3 116.95 11.45 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.744 1.618 . . . . 0.0 107.361 169.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -130.57 156.17 45.28 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.54 2.336 . . . . 0.0 109.245 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -140.12 143.21 36.11 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.2 1.0 . . . . 0.0 108.755 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 17.1 p -68.12 163.37 51.99 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-O 118.808 -0.615 . . . . 0.0 111.633 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.25 33.81 0.32 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.965 3.11 . . . . 0.0 112.891 178.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -138.26 -35.7 0.61 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 125.988 1.715 . . . . 0.0 109.964 173.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 15.7 m -75.36 -35.8 61.07 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.774 2.03 . . . . 0.0 111.591 170.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 8.2 t -81.36 -5.97 58.42 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.272 1.429 . . . . 0.0 112.781 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -73.49 -40.18 64.3 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.962 0.905 . . . . 0.0 111.497 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -58.3 -47.74 82.7 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.868 1.667 . . . . 0.0 111.85 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 50.09 32.91 6.29 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.553 1.941 . . . . 0.0 114.822 170.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 56.3 tttm 50.45 56.46 7.92 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.081 1.753 . . . . 0.0 111.593 -174.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -138.7 30.76 2.3 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.119 1.368 . . . . 0.0 111.695 -172.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 83.4 tttt . . . . . 0 C--O 1.252 1.205 0 C-N-CA 127.65 2.38 . . . . 0.0 112.647 178.439 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 58.0 tpp . . . . . 0 N--CA 1.475 0.805 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -81.68 17.28 1.5 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.51 1.524 . . . . 0.0 113.024 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 25.5 ttt -57.73 -46.92 99.71 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-O 116.856 -1.545 . . . . 0.0 113.816 -177.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -75.63 142.5 26.07 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.042 1.828 . . . . 0.0 110.032 169.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 88.8 t -66.86 -52.96 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.621 0.769 . . . . 0.0 110.185 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -166.62 -55.39 0.01 OUTLIER Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.942 1.697 . . . . 0.0 110.145 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -72.97 131.58 17.07 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.045 1.83 . . . . 0.0 110.638 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -156.85 23.67 0.32 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.765 1.226 . . . . 0.0 111.178 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.85 118.22 27.4 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.445 1.498 . . . . 0.0 111.535 -172.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -88.54 26.23 0.59 Allowed 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 124.119 3.212 . . . . 0.0 113.557 -173.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.6 p -141.75 140.07 32.99 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.954 1.702 . . . . 0.0 109.361 -173.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -156.28 -38.91 0.08 Allowed 'General case' 0 C--N 1.35 0.623 0 CA-C-O 115.764 -2.065 . . . . 0.0 115.725 -174.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.516 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.8 OUTLIER -53.1 174.2 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 122.449 2.386 . . . . 0.0 112.145 172.035 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.0 mt -62.65 -6.3 3.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.734 1.614 . . . . 0.0 111.275 170.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 82.6 m -99.32 -12.1 20.63 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 126.193 1.797 . . . . 0.0 112.699 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.0 p80 45.19 49.03 10.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.189 2.196 . . . . 0.0 112.357 -174.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -164.15 148.16 9.8 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 125.572 1.549 . . . . 0.0 108.045 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -132.26 175.51 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 127.244 2.218 . . . . 0.0 110.253 178.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.504 ' H ' HG12 ' A' ' 204' ' ' VAL . 16.8 t 61.93 63.1 1.15 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.377 1.871 . . . . 0.0 113.292 -175.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -161.12 112.58 1.81 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.333 1.853 . . . . 0.0 109.165 -173.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.48 -110.02 3.24 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 125.232 1.396 . . . . 0.0 109.872 -172.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.14 165.9 24.64 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.84 2.056 . . . . 0.0 111.332 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -138.72 157.16 46.62 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.742 1.217 . . . . 0.0 111.063 -168.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.421 HG12 ' H ' ' A' ' 211' ' ' GLY . 9.5 tt -134.48 -136.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 174.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 147.59 132.08 2.2 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 125.167 1.365 . . . . 0.0 113.113 -170.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.5 t -65.86 123.44 19.81 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.9 0.88 . . . . 0.0 108.777 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.34 -1.8 3.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.71 1.604 . . . . 0.0 113.574 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -66.93 116.29 33.97 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 168.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.93 5.15 5.15 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.409 2.739 . . . . 0.0 113.009 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -117.69 6.16 12.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.902 1.681 . . . . 0.0 110.424 174.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 41.8 t -59.01 130.23 46.03 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 122.973 0.509 . . . . 0.0 110.378 172.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.3 t -76.07 3.21 10.92 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.732 1.613 . . . . 0.0 113.617 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 19.6 mt -134.42 -35.02 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.995 1.718 . . . . 0.0 110.279 -172.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.22 -40.95 0.49 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.992 2.517 . . . . 0.0 115.38 172.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.516 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.5 OUTLIER -126.56 147.67 49.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.135 1.774 . . . . 0.0 108.837 -177.683 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -146.89 157.48 43.66 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.39 1.076 . . . . 0.0 108.794 -175.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -84.16 141.82 30.78 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.793 -175.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.73 -8.55 1.35 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.574 1.949 . . . . 0.0 113.096 169.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -118.01 -7.06 10.91 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.823 1.249 . . . . 0.0 112.189 174.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 4.6 m -77.9 -2.1 35.09 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.94 0.791 . . . . 0.0 112.306 168.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 14.3 p -130.86 -6.31 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 126.955 2.102 . . . . 0.0 111.481 173.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.67 35.32 89.65 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.735 1.16 . . . . 0.0 113.176 -176.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.7 mt -66.29 155.54 36.91 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.366 1.083 . . . . 0.0 111.315 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 90.6 m -134.46 -12.58 2.37 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.758 1.623 . . . . 0.0 110.924 -176.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 9.9 t -148.49 165.09 32.22 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 125.649 1.579 . . . . 0.0 109.859 174.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -79.63 119.51 77.1 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.33 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.06 172.14 16.67 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.434 2.756 . . . . 0.0 111.46 176.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -146.11 153.54 40.8 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.066 0.946 . . . . 0.0 109.897 174.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 109.56 -82.55 0.3 Allowed Glycine 0 C--N 1.338 0.686 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -175.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -168.92 139.56 2.38 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.732 2.013 . . . . 0.0 107.491 168.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . 0.4 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 91.4 t90 -106.35 162.65 13.5 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.277 1.831 . . . . 0.0 110.256 177.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -139.02 141.13 38.29 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.864 1.266 . . . . 0.0 109.125 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . 0.4 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 17.6 p -66.88 162.87 48.85 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.302 0.641 . . . . 0.0 112.071 173.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -73.63 35.99 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 124.006 3.137 . . . . 0.0 112.888 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -138.46 -35.68 0.59 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.868 1.667 . . . . 0.0 109.935 170.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 17.6 m -72.34 -34.87 68.36 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.424 1.89 . . . . 0.0 111.832 169.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 10.5 t -80.33 -14.92 57.97 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.086 1.354 . . . . 0.0 112.873 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -67.11 -19.51 65.64 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.81 0.844 . . . . 0.0 113.006 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -58.76 -27.26 64.8 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.504 1.922 . . . . 0.0 113.82 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 40.2 mtp180 -136.01 43.44 2.54 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.388 1.075 . . . . 0.0 111.345 -170.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -68.45 86.94 0.3 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.319 1.848 . . . . 0.0 110.917 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -135.5 28.08 3.36 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.901 1.68 . . . . 0.0 111.21 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? . . . . . 0 C--O 1.251 1.171 0 C-N-CA 127.481 2.313 . . . . 0.0 111.502 -169.803 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 68.4 mtt . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -66.48 143.75 56.9 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.493 1.117 . . . . 0.0 110.843 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 73.3 mtm -142.7 73.56 19.5 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 124.883 1.273 . . . . 0.0 108.975 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -78.94 21.93 0.7 Allowed 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 124.678 3.586 . . . . 0.0 113.418 -175.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.7 t -128.53 40.26 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.378 1.471 . . . . 0.0 109.319 -171.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -142.52 151.5 57.71 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.502 1.521 . . . . 0.0 110.132 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.45 126.45 13.53 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.315 2.677 . . . . 0.0 110.81 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -153.77 35.74 0.45 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.577 1.151 . . . . 0.0 110.809 -174.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -135.24 80.29 47.22 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.885 1.274 . . . . 0.0 109.391 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.02 126.96 11.66 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.504 2.803 . . . . 0.0 111.115 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.8 p -147.43 141.66 26.19 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.078 1.751 . . . . 0.0 108.841 -174.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -155.42 -47.14 0.08 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -173.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.495 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -38.6 170.11 0.0 OUTLIER 'General case' 0 C--N 1.351 0.635 0 C-N-CA 126.557 1.943 . . . . 0.0 114.607 169.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.3 mt -70.57 -6.7 38.44 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 113.32 -1.764 . . . . 0.0 110.044 168.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.495 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 84.9 m -96.77 -14.18 22.13 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 123.646 0.778 . . . . 0.0 111.784 174.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.8 p80 45.46 52.27 9.16 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.224 2.21 . . . . 0.0 112.915 -173.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -169.9 140.7 2.1 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.934 1.694 . . . . 0.0 108.269 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.499 HG12 ' H ' ' A' ' 205' ' ' SER . 0.9 OUTLIER -125.0 174.1 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.675 1.59 . . . . 0.0 110.634 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.499 ' H ' HG12 ' A' ' 204' ' ' VAL . 13.7 t 66.36 62.05 0.57 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.721 2.009 . . . . 0.0 113.413 -174.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.75 110.87 1.98 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.174 1.79 . . . . 0.0 108.977 -175.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 66.81 -109.51 2.95 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 125.283 1.421 . . . . 0.0 110.438 -172.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.61 168.64 19.35 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.123 2.169 . . . . 0.0 111.139 -174.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -140.35 158.89 43.33 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.719 0.808 . . . . 0.0 112.748 -168.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.451 HG13 ' H ' ' A' ' 211' ' ' GLY . 7.2 tp -133.18 -138.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.401 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.451 ' H ' HG13 ' A' ' 210' ' ' ILE . . . 145.43 134.6 2.73 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 126.165 1.84 . . . . 0.0 111.714 -169.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.419 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 41.4 t -63.18 126.38 27.21 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.75 -4.29 3.0 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.376 1.47 . . . . 0.0 113.545 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -71.72 118.85 70.32 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.458 1.103 . . . . 0.0 109.071 169.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.36 3.76 6.02 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.362 2.708 . . . . 0.0 113.283 176.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -115.04 6.11 15.14 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.912 1.685 . . . . 0.0 110.495 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 50.8 t -58.18 128.37 36.78 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 123.174 0.59 . . . . 0.0 109.905 171.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.9 t -74.14 1.74 10.52 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.7 1.6 . . . . 0.0 113.442 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.5 mm -134.33 -35.08 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.848 1.659 . . . . 0.0 110.126 -170.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.92 -38.34 0.4 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.117 2.567 . . . . 0.0 115.201 169.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.451 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.0 OUTLIER -135.8 148.91 48.92 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.936 1.694 . . . . 0.0 109.168 -174.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -149.15 148.13 29.28 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -72.15 150.89 43.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.264 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -59.03 -4.6 0.51 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.884 1.674 . . . . 0.0 113.027 166.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.86 -3.69 8.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.237 1.415 . . . . 0.0 112.647 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 18.8 m -72.92 -6.2 43.59 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.107 0.867 . . . . 0.0 111.645 167.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.22 -4.76 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 126.179 1.792 . . . . 0.0 111.709 172.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 68.69 32.57 74.56 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.753 1.168 . . . . 0.0 113.117 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.6 mt -66.53 -51.07 60.6 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.375 1.07 . . . . 0.0 112.048 -175.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . 0.278 2.6 t 46.69 8.98 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 128.549 2.74 . . . . 0.0 116.263 -169.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 75.1 p -147.4 162.97 37.92 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.319 1.848 . . . . 0.0 110.228 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -68.13 121.61 80.78 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 124.103 0.961 . . . . 0.0 109.259 172.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.64 164.38 20.9 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.229 2.619 . . . . 0.0 112.042 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -67.09 159.4 28.89 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.76 0.824 . . . . 0.0 109.77 169.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -57.9 155.14 21.52 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.836 0.731 . . . . 0.0 112.883 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt 53.06 64.77 1.73 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.341 1.456 . . . . 0.0 111.56 -170.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.1 t90 -81.83 152.7 26.78 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 113.168 -1.833 . . . . 0.0 109.044 169.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.419 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 93.3 m-85 -140.49 140.89 35.39 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.826 0.851 . . . . 0.0 109.506 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 242' ' ' CYS . 6.0 p -70.16 167.36 25.91 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.118 0.967 . . . . 0.0 112.174 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -69.59 9.32 0.58 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 123.463 2.776 . . . . 0.0 114.42 -176.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -133.41 27.03 4.11 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.188 1.795 . . . . 0.0 111.504 176.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 239' ' ' CYS . 3.7 t -152.16 -32.26 0.14 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.11 1.764 . . . . 0.0 110.768 -173.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 76.0 p -70.32 -29.98 66.84 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.395 1.478 . . . . 0.0 112.2 170.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -67.61 -34.23 76.58 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.385 1.474 . . . . 0.0 112.294 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -57.02 -50.9 71.31 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.867 1.667 . . . . 0.0 111.888 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 52.22 27.95 5.14 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.648 1.979 . . . . 0.0 114.823 172.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt 47.72 43.76 17.06 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.069 1.748 . . . . 0.0 111.691 -171.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.1 tptm 59.84 118.62 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.326 2.65 . . . . 0.0 112.042 -167.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? . . . . . 0 C--O 1.251 1.161 0 CA-C-O 116.427 -1.749 . . . . 0.0 107.313 170.387 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -68.68 156.63 37.85 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.937 0.895 . . . . 0.0 111.465 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 64.6 mtt -139.17 74.47 35.99 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.675 1.59 . . . . 0.0 108.191 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.56 164.18 36.56 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.639 2.893 . . . . 0.0 112.35 -174.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.479 HG12 ' H ' ' A' ' 192' ' ' ASP . 0.6 OUTLIER -141.07 -173.25 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 125.953 1.701 . . . . 0.0 107.961 -176.127 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.479 ' H ' HG12 ' A' ' 191' ' ' VAL . 26.1 m-20 68.33 154.71 0.14 Allowed Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 128.183 2.593 . . . . 0.0 112.916 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.43 144.88 63.11 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.635 2.224 . . . . 0.0 111.403 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -65.8 -19.57 65.94 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.623 1.169 . . . . 0.0 112.824 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -144.94 83.1 9.6 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.949 1.3 . . . . 0.0 108.452 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.09 121.16 7.99 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.275 2.65 . . . . 0.0 110.48 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.7 p -148.81 135.55 19.73 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.909 1.684 . . . . 0.0 108.615 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -156.41 -37.92 0.08 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 115.935 -1.983 . . . . 0.0 115.759 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.512 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.9 OUTLIER -53.82 174.11 0.05 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 122.352 2.342 . . . . 0.0 111.97 169.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.3 mt -62.52 -7.46 4.66 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.869 1.668 . . . . 0.0 111.278 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 67.0 m -96.62 -12.54 23.8 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.943 1.697 . . . . 0.0 112.68 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.8 p80 45.16 49.27 9.83 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.262 2.225 . . . . 0.0 112.371 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -163.92 148.29 10.24 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.352 1.461 . . . . 0.0 107.825 175.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -134.66 174.48 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 127.274 2.23 . . . . 0.0 110.796 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.547 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.0 t 63.64 62.04 0.96 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.653 1.981 . . . . 0.0 112.727 -174.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.88 108.74 1.16 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.546 1.938 . . . . 0.0 108.716 -173.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 60.48 -160.14 24.17 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-O 123.296 1.498 . . . . 0.0 113.172 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.8 pm0 -65.6 147.24 53.72 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.337 2.255 . . . . 0.0 111.63 170.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.6 mtm -150.57 158.83 44.6 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.186 1.794 . . . . 0.0 110.218 -168.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 9.2 tp -139.35 -133.87 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.247 1.019 . . . . 0.0 109.219 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 147.29 136.01 2.75 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 126.456 1.979 . . . . 0.0 113.14 -169.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.516 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 7.1 t -64.59 124.98 23.27 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 114.642 -0.779 . . . . 0.0 109.124 177.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.45 1.59 0.52 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.631 1.173 . . . . 0.0 113.105 170.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -63.73 111.65 5.69 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 127.622 2.369 . . . . 0.0 107.951 167.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -78.7 11.46 2.49 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.455 2.77 . . . . 0.0 112.916 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -128.95 9.08 5.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.087 1.755 . . . . 0.0 109.798 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 20.8 t -56.65 123.21 14.1 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-O 121.542 0.687 . . . . 0.0 112.131 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 39.7 m -74.5 0.35 15.03 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.537 1.935 . . . . 0.0 113.321 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 14.5 mt -129.14 -34.76 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.436 1.894 . . . . 0.0 109.425 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.75 -25.63 0.15 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.144 2.578 . . . . 0.0 115.77 169.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.52 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.6 OUTLIER -142.45 148.59 38.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.957 1.703 . . . . 0.0 109.041 -177.503 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -147.03 156.61 43.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.095 0.958 . . . . 0.0 108.511 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -82.74 143.58 30.78 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.43 0.633 . . . . 0.0 110.203 -175.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.17 -4.36 0.51 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.675 1.99 . . . . 0.0 114.056 170.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.1 -8.92 7.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.364 1.466 . . . . 0.0 112.215 173.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.5 m -76.68 -2.57 33.53 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.102 0.865 . . . . 0.0 112.81 168.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.2 p -131.43 -1.62 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 126.675 1.99 . . . . 0.0 110.931 170.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 62.45 34.12 88.43 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.112 1.339 . . . . 0.0 113.003 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.76 -53.76 41.97 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 117.859 0.829 . . . . 0.0 111.524 -174.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 36.1 p 48.67 10.32 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.976 2.51 . . . . 0.0 116.118 -173.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 11.0 t -156.84 165.05 37.32 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 125.829 1.652 . . . . 0.0 110.328 174.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -61.27 118.54 37.62 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.84 1.656 . . . . 0.0 108.756 177.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.58 169.76 21.58 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.393 2.729 . . . . 0.0 113.194 -174.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.53 172.31 4.24 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.267 1.027 . . . . 0.0 110.239 168.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -60.42 148.29 44.34 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.374 0.512 . . . . 0.0 111.974 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 46.1 tttp 43.93 82.13 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.284 2.234 . . . . 0.0 113.845 -175.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 86.7 t90 -81.55 157.53 24.75 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.039 0.935 . . . . 0.0 109.66 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.516 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 88.7 m-85 -135.92 136.65 40.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.942 0.897 . . . . 0.0 110.592 -176.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 30.6 p -69.8 164.53 50.35 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 124.259 1.023 . . . . 0.0 112.163 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.28 28.85 0.26 Allowed 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 124.352 3.368 . . . . 0.0 113.817 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -132.15 -30.22 1.56 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.722 2.009 . . . . 0.0 110.079 174.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 2.0 m -81.49 -31.0 33.1 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.301 2.24 . . . . 0.0 112.312 169.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.5 t -70.09 -19.54 63.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.216 1.406 . . . . 0.0 112.393 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.52 -38.48 91.15 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.945 1.298 . . . . 0.0 111.1 170.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 246' ' ' ARG . 0.9 OUTLIER -71.83 179.77 3.02 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.919 1.688 . . . . 0.0 112.114 173.327 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.415 ' H ' ' CD ' ' A' ' 245' ' ' GLU . 32.4 ttm105 55.12 64.29 1.84 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.228 1.811 . . . . 0.0 111.258 -176.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -80.94 -156.3 0.13 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.556 1.942 . . . . 0.0 109.721 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.24 126.09 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 128.488 2.715 . . . . 0.0 111.565 -173.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.481 ' HA ' ' HE2' ' A' ' 249' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.062 0 C-N-CA 127.917 2.487 . . . . 0.0 112.902 -174.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 33.3 t70 62.64 159.49 0.07 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.044 2.137 . . . . 0.0 113.425 -170.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.0 ttt -152.08 89.56 3.96 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.254 1.422 . . . . 0.0 107.997 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.0 156.74 59.57 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.977 2.452 . . . . 0.0 111.486 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.0 -34.79 72.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.405 1.082 . . . . 0.0 111.616 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 28.4 t70 40.75 73.57 0.85 Allowed Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 126.368 1.867 . . . . 0.0 112.469 -171.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -67.23 88.6 0.32 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 124.304 3.336 . . . . 0.0 109.54 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -152.9 48.69 0.72 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.847 1.659 . . . . 0.0 109.054 -167.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -118.61 91.47 42.01 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.098 1.359 . . . . 0.0 109.159 -171.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.33 141.61 29.02 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.092 2.528 . . . . 0.0 110.856 177.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.8 p -148.47 141.17 24.54 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.996 1.718 . . . . 0.0 108.789 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -155.34 -44.47 0.08 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.504 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -38.86 169.84 0.0 OUTLIER 'General case' 0 C--N 1.349 0.578 0 C-N-CA 126.299 1.839 . . . . 0.0 114.257 168.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.6 mt -71.05 -6.34 38.28 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 113.417 -1.72 . . . . 0.0 110.129 168.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.504 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 86.9 m -96.69 -14.2 22.24 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 123.617 0.767 . . . . 0.0 111.819 174.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.9 p80 45.87 52.7 9.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.21 2.204 . . . . 0.0 112.779 -173.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.42 140.39 2.27 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 125.818 1.647 . . . . 0.0 107.958 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 205' ' ' SER . 1.4 t -129.34 171.02 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.368 1.467 . . . . 0.0 111.069 -176.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.511 ' H ' HG12 ' A' ' 204' ' ' VAL . 7.8 t 67.04 64.75 0.44 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.033 2.133 . . . . 0.0 113.048 -174.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.15 113.63 1.21 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.468 1.907 . . . . 0.0 108.48 -175.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.36 -162.68 23.8 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 123.181 1.434 . . . . 0.0 112.769 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.456 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.7 pm0 -67.61 145.05 55.23 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 112.223 -1.988 . . . . 0.0 110.829 169.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.4 mtm -146.45 152.89 39.75 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.166 1.787 . . . . 0.0 109.858 -168.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 9.7 tp -138.98 -137.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.36 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 -174.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 152.92 133.01 1.83 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 125.938 1.732 . . . . 0.0 112.375 -169.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 43.9 t -63.08 124.39 21.03 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.081 -1.059 . . . . 0.0 108.395 175.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.63 4.87 1.22 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.353 1.461 . . . . 0.0 113.426 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -74.95 114.59 36.35 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 167.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.31 9.07 2.97 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.384 2.722 . . . . 0.0 113.009 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -123.89 8.76 8.74 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.798 1.639 . . . . 0.0 110.34 175.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.79 130.88 48.69 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 118.293 0.497 . . . . 0.0 109.951 172.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.5 t -73.48 3.86 5.55 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.794 1.638 . . . . 0.0 113.578 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 30.7 mt -132.96 -34.61 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 126.274 1.829 . . . . 0.0 110.035 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.79 -39.54 0.45 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.624 2.369 . . . . 0.0 115.415 170.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.473 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -130.7 148.6 52.5 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.923 2.089 . . . . 0.0 108.371 -174.283 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -148.63 145.9 27.97 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -175.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -71.64 149.78 45.25 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.634 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.38 -6.04 1.39 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.742 1.217 . . . . 0.0 113.389 168.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -121.66 0.1 9.79 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.454 1.102 . . . . 0.0 112.588 170.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 11.1 m -72.1 -6.77 44.87 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.946 0.794 . . . . 0.0 111.252 166.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.12 -12.67 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 126.376 1.87 . . . . 0.0 112.627 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.22 36.61 34.44 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.422 1.011 . . . . 0.0 113.113 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 17.0 mt -68.62 104.3 1.93 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.309 1.044 . . . . 0.0 109.838 174.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.7 t -71.89 -17.82 62.09 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.46 1.104 . . . . 0.0 112.575 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 14.1 t -152.66 174.56 13.83 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.679 1.592 . . . . 0.0 110.017 176.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -65.98 131.03 94.48 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.457 1.103 . . . . 0.0 110.085 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.26 176.94 9.42 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.38 2.72 . . . . 0.0 112.011 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -61.66 170.94 1.72 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.924 1.29 . . . . 0.0 111.677 171.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -68.21 8.77 1.86 Allowed Glycine 0 CA--C 1.539 1.546 0 C-N-CA 125.281 1.42 . . . . 0.0 115.063 177.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -150.46 112.33 4.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.165 1.386 . . . . 0.0 107.443 170.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 87.4 t90 -128.07 157.82 39.66 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.226 1.81 . . . . 0.0 109.745 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -140.08 140.01 36.01 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.204 1.001 . . . . 0.0 109.093 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 16.6 p -68.94 164.69 44.84 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 123.614 0.765 . . . . 0.0 112.187 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.47 35.3 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.291 3.327 . . . . 0.0 113.071 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -139.55 -28.65 0.76 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.622 1.569 . . . . 0.0 111.032 169.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 7.5 m -88.27 -29.63 20.26 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 127.521 2.328 . . . . 0.0 112.18 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 16.1 t -73.41 -20.11 60.82 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.133 0.973 . . . . 0.0 112.159 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 17.0 mp0 -69.9 -25.67 63.8 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.453 1.501 . . . . 0.0 112.078 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -11.81 31.64 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.739 1.616 . . . . 0.0 113.253 172.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -130.84 31.77 4.45 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.691 1.597 . . . . 0.0 110.967 -175.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -63.77 93.93 0.09 Allowed 'General case' 0 C--N 1.345 0.38 0 C-N-CA 125.731 1.612 . . . . 0.0 109.819 169.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -137.81 68.19 1.41 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.288 2.235 . . . . 0.0 106.827 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt . . . . . 0 C--O 1.251 1.17 0 C-N-CA 126.882 2.073 . . . . 0.0 110.15 -168.347 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 119.255 -0.402 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -148.17 158.38 44.04 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.861 1.265 . . . . 0.0 110.463 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -156.39 99.19 2.11 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 124.271 1.028 . . . . 0.0 108.619 175.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.68 132.9 16.41 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.722 2.281 . . . . 0.0 109.269 169.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 48.9 t -83.64 -89.5 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.457 ' H ' ' HD2' ' A' ' 193' ' ' PRO . 12.8 m-20 -154.87 -54.3 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 125.487 1.515 . . . . 0.0 111.399 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.457 ' HD2' ' H ' ' A' ' 192' ' ' ASP . 73.3 Cg_endo -77.89 -40.96 0.34 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 CA-C-N 122.037 1.763 . . . . 0.0 113.18 -175.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 47.13 32.88 2.17 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.519 1.528 . . . . 0.0 112.871 -169.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -128.04 84.58 62.87 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.172 1.389 . . . . 0.0 109.907 -169.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -81.81 164.7 18.03 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 124.377 3.385 . . . . 0.0 111.889 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.1 p 64.54 144.44 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.869 2.467 . . . . 0.0 112.472 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -155.55 -41.53 0.08 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -166.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.514 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.7 p -38.56 170.15 0.0 OUTLIER 'General case' 0 C--N 1.347 0.49 0 C-N-CA 126.392 1.877 . . . . 0.0 113.973 168.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.1 mt -70.68 -6.17 35.17 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.149 168.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.514 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 93.4 m -96.38 -14.14 22.7 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 123.659 0.784 . . . . 0.0 111.705 174.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.2 p80 46.38 50.92 12.06 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.903 2.081 . . . . 0.0 112.388 -174.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -168.26 141.63 3.16 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 125.068 1.347 . . . . 0.0 108.035 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -124.84 -177.39 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.618 1.567 . . . . 0.0 110.293 177.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.475 ' H ' HG12 ' A' ' 204' ' ' VAL . 10.6 t 62.16 57.59 1.99 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.294 2.238 . . . . 0.0 114.449 -169.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . 0.433 ' H ' ' CE ' ' A' ' 209' ' ' MET . 0.1 OUTLIER -164.04 113.85 1.24 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.574 1.95 . . . . 0.0 109.834 -177.008 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 66.09 -174.23 21.72 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 122.888 1.271 . . . . 0.0 114.099 176.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -62.05 151.3 35.78 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.474 1.91 . . . . 0.0 111.846 169.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.433 ' CE ' ' H ' ' A' ' 206' ' ' TYR . 26.0 mtt -145.14 160.6 41.18 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.625 1.17 . . . . 0.0 112.724 -166.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . 0.265 9.6 tp -138.33 -139.21 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 145.73 135.22 2.78 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 126.486 1.993 . . . . 0.0 111.787 -168.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 238' ' ' PHE . 6.6 t -65.1 123.18 18.83 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 124.447 0.734 . . . . 0.0 109.208 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.68 1.99 0.52 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.851 1.26 . . . . 0.0 113.11 171.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -62.59 112.43 6.57 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 127.903 2.481 . . . . 0.0 107.658 166.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -78.28 12.17 2.15 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.363 2.709 . . . . 0.0 112.953 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -129.8 9.49 5.42 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.081 1.752 . . . . 0.0 109.811 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 15.4 t -57.88 117.89 4.76 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-O 121.647 0.737 . . . . 0.0 111.669 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.7 t -74.49 -2.37 25.34 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.571 1.948 . . . . 0.0 112.571 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.0 mm -117.6 -37.03 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.041 1.736 . . . . 0.0 109.05 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.51 -30.26 0.21 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.25 2.62 . . . . 0.0 115.462 168.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.474 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.0 OUTLIER -144.46 150.15 37.16 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.19 1.796 . . . . 0.0 109.03 -174.576 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -148.12 148.17 30.32 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -71.57 150.41 44.75 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.413 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -60.16 -4.61 0.84 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.904 1.281 . . . . 0.0 113.595 168.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -120.87 -2.5 9.77 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.765 1.226 . . . . 0.0 112.485 170.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 21.2 m -73.36 -5.05 37.2 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.863 0.756 . . . . 0.0 111.606 167.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.5 p -138.91 -9.4 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 126.986 2.114 . . . . 0.0 112.187 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.0 37.13 60.49 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.409 1.004 . . . . 0.0 112.941 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 24.6 mt -68.05 111.27 4.35 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 117.819 0.81 . . . . 0.0 109.909 175.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 66.9 p -79.85 -13.6 59.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.268 1.027 . . . . 0.0 112.525 173.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 14.3 t -158.27 172.83 17.66 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.337 1.455 . . . . 0.0 110.493 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.92 115.7 30.89 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.739 1.616 . . . . 0.0 109.065 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.3 170.42 20.04 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.366 2.711 . . . . 0.0 112.822 -173.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -63.87 165.87 8.1 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.874 0.87 . . . . 0.0 110.898 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -58.87 160.08 16.05 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.117 0.865 . . . . 0.0 113.159 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 43.5 tttp 45.88 69.42 0.46 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.474 1.91 . . . . 0.0 113.164 -170.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -75.7 156.7 34.47 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.97 0.908 . . . . 0.0 109.255 173.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . 0.522 ' HA ' ' SG ' ' A' ' 212' ' ' CYS . 75.1 m-85 -133.03 135.81 45.62 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.926 0.89 . . . . 0.0 110.298 -176.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 30.8 p -65.6 163.08 37.23 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 123.821 0.848 . . . . 0.0 111.599 170.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.28 28.85 0.26 Allowed 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 124.31 3.34 . . . . 0.0 113.529 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -134.17 -34.85 0.95 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.694 1.998 . . . . 0.0 109.377 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 1.5 m -74.87 -33.42 62.08 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.602 1.961 . . . . 0.0 112.104 169.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.5 t -67.02 -33.38 75.43 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.964 0.906 . . . . 0.0 111.148 173.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 16.9 tm0? -68.93 -37.52 78.95 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.346 1.059 . . . . 0.0 111.247 173.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.11 -30.0 65.94 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.633 1.573 . . . . 0.0 112.968 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 35.71 61.56 0.7 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.516 2.727 . . . . 0.0 114.491 168.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -79.37 64.03 4.15 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.406 1.082 . . . . 0.0 111.668 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt 46.53 53.91 9.32 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.771 2.028 . . . . 0.0 112.703 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.089 0 C-N-CA 126.485 1.914 . . . . 0.0 110.651 -174.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 73.5 mtm . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -128.34 103.01 6.92 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 124.25 1.02 . . . . 0.0 109.427 -170.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.2 ttt -150.13 81.58 6.77 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.939 1.295 . . . . 0.0 108.433 179.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.47 78.81 2.93 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 124.348 3.365 . . . . 0.0 110.663 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 97.1 t -137.56 -40.48 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.667 1.587 . . . . 0.0 109.332 -175.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -71.16 151.65 94.65 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.475 1.11 . . . . 0.0 110.745 172.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.64 135.43 33.22 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.096 2.531 . . . . 0.0 110.724 177.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -152.23 34.62 0.52 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.476 1.111 . . . . 0.0 110.825 -173.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -135.63 73.91 60.51 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 124.75 1.22 . . . . 0.0 109.747 -175.036 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.11 102.23 1.32 Allowed 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.861 3.041 . . . . 0.0 110.465 177.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 55.3 p -144.45 137.58 27.07 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.939 1.696 . . . . 0.0 108.603 -174.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -155.45 -38.5 0.09 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 115.739 -2.077 . . . . 0.0 115.92 -168.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.523 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.8 OUTLIER -53.48 174.29 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 122.551 2.432 . . . . 0.0 112.169 170.554 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.0 mt -62.47 -6.74 3.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.607 1.563 . . . . 0.0 111.212 171.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 89.1 m -98.22 -12.53 21.56 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 126.186 1.794 . . . . 0.0 112.71 179.29 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.8 p80 44.97 48.29 9.39 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.219 2.208 . . . . 0.0 112.368 -173.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -162.94 147.16 11.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.461 1.504 . . . . 0.0 108.047 176.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.497 HG12 ' H ' ' A' ' 205' ' ' SER . 0.6 OUTLIER -132.62 175.44 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 127.157 2.183 . . . . 0.0 110.109 178.682 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.497 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.6 t 59.82 65.91 1.06 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.347 1.859 . . . . 0.0 112.824 -174.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.62 102.89 1.36 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.344 1.858 . . . . 0.0 109.163 -173.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 68.45 -98.4 0.52 Allowed Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.386 1.47 . . . . 0.0 110.392 -172.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.26 170.67 15.55 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.401 1.88 . . . . 0.0 111.731 -174.036 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -143.97 160.19 41.26 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.903 1.281 . . . . 0.0 111.364 -169.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.421 HG13 ' H ' ' A' ' 211' ' ' GLY . 4.6 tp -133.42 -135.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.372 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 169.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 148.19 133.7 2.35 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 125.434 1.493 . . . . 0.0 112.478 -172.297 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 53.6 t -64.89 119.32 10.46 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.366 -0.917 . . . . 0.0 109.055 174.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -70.01 5.28 1.66 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.695 1.598 . . . . 0.0 113.874 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -68.8 119.78 71.58 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 168.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.95 5.88 4.16 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.317 2.678 . . . . 0.0 113.312 178.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.86 6.06 12.23 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.657 1.583 . . . . 0.0 110.608 174.216 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 42.5 t -60.53 129.06 39.7 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 123.584 0.753 . . . . 0.0 110.442 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 20.2 m -79.91 4.47 16.66 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.496 1.518 . . . . 0.0 113.333 -176.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.6 mm -135.1 -36.27 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.787 1.635 . . . . 0.0 110.348 -169.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.45 -41.65 0.51 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.84 2.856 . . . . 0.0 115.201 170.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.523 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -129.08 148.09 50.99 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.738 1.615 . . . . 0.0 109.276 -176.057 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -149.38 157.54 43.4 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 124.94 1.296 . . . . 0.0 108.84 -175.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -88.24 144.11 26.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.304 0.573 . . . . 0.0 111.098 -171.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -57.43 -7.2 0.56 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.292 2.237 . . . . 0.0 114.265 170.078 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.22 -8.29 8.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.029 1.332 . . . . 0.0 112.207 174.228 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 10.0 m -77.11 -2.51 34.63 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.07 0.85 . . . . 0.0 112.87 168.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 12.9 p -131.72 -2.03 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 126.435 1.894 . . . . 0.0 111.116 170.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.2 34.38 89.77 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.938 1.256 . . . . 0.0 112.894 -177.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.2 mt -66.34 -52.33 48.17 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.183 0.993 . . . . 0.0 111.919 -174.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 17.5 m 61.92 -9.83 0.08 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.82 2.048 . . . . 0.0 114.47 -175.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 13.0 t -150.0 173.27 14.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.85 1.66 . . . . 0.0 110.659 178.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -68.3 125.39 91.54 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.773 1.229 . . . . 0.0 109.487 177.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.7 -69.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.539 2.159 . . . . 0.0 110.755 177.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 -175.96 176.14 1.84 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.897 2.879 . . . . 0.0 107.074 -176.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -72.67 15.28 2.24 Favored Glycine 0 CA--C 1.541 1.709 0 CA-C-O 118.935 -0.925 . . . . 0.0 113.374 168.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt -152.67 112.73 3.99 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 125.806 1.642 . . . . 0.0 108.99 176.204 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 90.5 t90 -140.83 162.47 35.35 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.581 2.352 . . . . 0.0 109.832 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -140.67 141.78 34.99 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.275 1.03 . . . . 0.0 110.348 178.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.7 p -70.37 165.61 42.9 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.082 0.953 . . . . 0.0 111.731 174.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.47 29.32 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.994 3.13 . . . . 0.0 113.569 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -135.58 -33.8 0.86 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.664 1.586 . . . . 0.0 110.091 174.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.9 m -78.28 -31.78 49.14 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 126.554 1.941 . . . . 0.0 111.99 170.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.8 t -71.67 -24.94 61.92 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.2 1.4 . . . . 0.0 112.085 175.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 17.8 tm0? -62.62 -35.27 79.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.483 1.113 . . . . 0.0 111.913 176.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -52.06 -42.49 63.19 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.242 1.817 . . . . 0.0 112.966 -178.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.8 111.23 3.7 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.994 1.318 . . . . 0.0 107.516 174.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -128.06 -153.94 0.6 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.358 1.863 . . . . 0.0 108.742 -170.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -108.35 33.0 4.39 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.683 1.593 . . . . 0.0 110.849 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 65.2 tttm . . . . . 0 C--O 1.25 1.099 0 C-N-CA 126.224 1.81 . . . . 0.0 109.245 178.376 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 18.3 ptp . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -145.55 135.99 24.12 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.094 0.958 . . . . 0.0 109.725 -168.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 48.8 ttm 35.11 62.86 2.2 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 127.082 2.153 . . . . 0.0 113.541 -176.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.17 112.3 2.72 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.185 2.59 . . . . 0.0 110.162 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 95.4 t -140.68 92.83 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.2 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 -178.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -137.6 63.82 41.83 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.919 1.288 . . . . 0.0 109.332 -170.534 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.71 145.99 71.4 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.319 2.679 . . . . 0.0 111.754 -175.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -148.3 45.21 1.06 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.939 1.296 . . . . 0.0 109.734 -179.108 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -129.87 70.09 81.91 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.474 1.509 . . . . 0.0 108.854 -179.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.3 165.96 25.05 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.55 2.833 . . . . 0.0 111.507 176.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 57.6 p -137.07 142.52 42.38 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.283 1.433 . . . . 0.0 110.709 -167.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -156.33 -39.95 0.08 Allowed 'General case' 0 C--N 1.353 0.735 0 CA-C-O 115.621 -2.133 . . . . 0.0 115.207 -169.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.5 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 0.7 OUTLIER -51.53 175.47 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 122.01 2.186 . . . . 0.0 112.953 176.538 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.9 -5.11 3.92 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.082 -1.417 . . . . 0.0 111.21 170.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 88.6 m -99.32 -15.95 18.63 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 125.976 1.711 . . . . 0.0 112.548 176.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 51.12 46.82 25.9 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.723 2.009 . . . . 0.0 111.628 -177.142 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -164.51 147.27 8.85 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.764 1.626 . . . . 0.0 107.621 179.112 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.472 HG12 ' H ' ' A' ' 205' ' ' SER . 0.5 OUTLIER -132.35 -178.14 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 127.355 2.262 . . . . 0.0 109.553 175.654 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.472 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.2 t 60.16 58.32 2.69 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.93 1.692 . . . . 0.0 113.08 -172.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.89 114.48 2.58 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.944 2.098 . . . . 0.0 109.122 -175.202 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.86 -109.34 2.48 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 125.571 1.558 . . . . 0.0 110.827 -175.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.78 169.11 18.36 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.627 1.971 . . . . 0.0 111.546 -173.618 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -141.69 161.26 38.38 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.146 0.978 . . . . 0.0 112.627 -167.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.428 HG13 ' H ' ' A' ' 211' ' ' GLY . 7.5 tp -135.78 -135.32 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 168.341 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 145.61 130.47 2.2 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 125.559 1.552 . . . . 0.0 112.096 -170.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 41.0 t -63.82 122.66 16.97 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.239 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.78 -2.12 2.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.692 1.597 . . . . 0.0 113.506 -179.216 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -69.25 116.25 40.39 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.277 1.031 . . . . 0.0 108.518 168.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -78.08 8.58 3.44 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.036 2.491 . . . . 0.0 112.916 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -121.37 6.4 10.15 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.727 1.611 . . . . 0.0 110.145 174.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.9 t -60.98 129.95 43.96 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 118.683 0.674 . . . . 0.0 109.589 171.124 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.3 t -74.94 6.31 4.22 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.708 1.603 . . . . 0.0 113.188 -176.275 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.3 mm -134.45 -36.81 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 126.134 1.774 . . . . 0.0 109.776 -171.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . 0.251 0.0 OUTLIER 71.06 -43.88 0.57 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.355 2.662 . . . . 0.0 115.497 169.737 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.5 ' CZ2' ' HB2' ' A' ' 199' ' ' CYS . 0.4 OUTLIER -125.33 148.77 48.6 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.469 1.908 . . . . 0.0 108.511 -178.383 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.43 ' HA ' ' SG ' ' A' ' 199' ' ' CYS . 72.9 m-85 -147.89 154.51 40.48 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.147 0.979 . . . . 0.0 108.804 -175.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -84.58 144.08 28.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.447 0.641 . . . . 0.0 110.499 -175.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -57.0 -7.12 0.43 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.363 2.265 . . . . 0.0 114.413 169.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.58 -8.02 8.55 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.877 1.271 . . . . 0.0 112.184 173.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 14.4 m -77.61 -2.26 34.95 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.088 0.858 . . . . 0.0 113.051 168.716 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.5 p -129.53 -4.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 126.447 1.899 . . . . 0.0 111.039 169.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.29 35.4 91.48 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.938 1.256 . . . . 0.0 112.82 -175.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.4 mt -66.84 -54.21 24.77 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.863 0.865 . . . . 0.0 111.326 -176.385 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 21.8 m 61.2 -11.22 0.06 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.929 2.091 . . . . 0.0 114.338 -174.138 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.7 p -143.97 167.04 23.29 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.33 1.852 . . . . 0.0 110.027 -175.088 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -64.7 126.45 90.9 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 123.789 0.836 . . . . 0.0 109.995 177.342 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.3 169.95 19.33 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.371 2.714 . . . . 0.0 112.138 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 31.1 ttt85 -67.84 158.06 33.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.87 0.868 . . . . 0.0 109.477 168.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -58.5 152.82 29.55 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 123.504 0.574 . . . . 0.0 113.171 -178.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? 50.68 68.86 0.71 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.176 1.79 . . . . 0.0 111.533 -174.016 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -76.42 162.98 27.4 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.799 1.239 . . . . 0.0 110.241 177.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -139.29 139.1 37.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.312 1.445 . . . . 0.0 108.375 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 13.4 p -68.2 165.87 29.7 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 123.143 0.577 . . . . 0.0 111.9 172.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.26 31.6 0.31 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.327 3.351 . . . . 0.0 113.389 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -136.36 -37.81 0.69 Allowed 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.494 1.517 . . . . 0.0 109.816 169.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 18.3 m -72.03 -26.48 62.23 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 126.565 1.946 . . . . 0.0 112.721 173.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.454 ' HA ' ' HE ' ' A' ' 246' ' ' ARG . 3.2 t -96.25 -17.45 20.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.511 1.125 . . . . 0.0 112.388 172.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -65.33 -36.7 84.85 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.113 0.965 . . . . 0.0 111.666 -175.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.36 -12.53 59.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.449 1.099 . . . . 0.0 113.569 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.454 ' HE ' ' HA ' ' A' ' 243' ' ' SER . 35.1 mtm180 -87.13 54.93 3.34 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.883 1.273 . . . . 0.0 110.768 -173.737 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -85.28 -142.68 0.09 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.478 1.911 . . . . 0.0 110.001 -175.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 248' ' ' LYS . 6.0 mmpt? -126.79 87.08 2.6 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.21 1.804 . . . . 0.0 108.068 -179.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.251 1.162 0 C-N-CA 126.116 1.766 . . . . 0.0 109.012 -176.808 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 66.4 ttp . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -145.47 -43.51 0.22 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.491 0.717 . . . . 0.0 111.795 -169.057 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.52 157.58 16.82 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.74 1.216 . . . . 0.0 111.005 -176.405 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.18 50.72 3.15 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 124.892 3.728 . . . . 0.0 112.088 -179.433 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.8 t -121.34 90.99 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.671 1.189 . . . . 0.0 108.376 -175.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.481 ' H ' ' HD2' ' A' ' 193' ' ' PRO . 18.6 t70 -153.64 -52.03 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.655 1.582 . . . . 0.0 110.652 176.208 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.481 ' HD2' ' H ' ' A' ' 192' ' ' ASP . 95.5 Cg_endo -77.04 161.28 32.89 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.28 1.986 . . . . 0.0 111.716 174.041 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -76.78 5.57 7.5 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.166 1.386 . . . . 0.0 113.51 178.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -138.57 75.02 38.78 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.801 1.24 . . . . 0.0 110.035 -173.166 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.78 160.13 46.88 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.528 2.819 . . . . 0.0 111.424 174.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 2.7 p 62.48 143.78 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.247 2.619 . . . . 0.0 113.285 -173.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -156.17 -45.61 0.08 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -168.459 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.482 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 2.0 p -40.25 170.28 0.0 OUTLIER 'General case' 0 C--N 1.349 0.586 0 C-N-CA 126.091 1.757 . . . . 0.0 114.252 169.136 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -71.3 -6.14 37.63 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.137 168.327 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.482 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 95.1 m -97.03 -13.36 22.32 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 123.499 0.72 . . . . 0.0 111.776 175.021 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.9 p80 46.37 53.38 9.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.862 2.065 . . . . 0.0 112.755 -174.006 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -171.0 142.12 1.79 Allowed 'General case' 0 C--N 1.347 0.474 0 C-N-CA 125.652 1.581 . . . . 0.0 108.114 177.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 205' ' ' SER . 1.1 t -123.79 168.92 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 125.606 1.562 . . . . 0.0 110.933 177.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.446 ' H ' HG12 ' A' ' 204' ' ' VAL . 10.5 t 70.81 61.06 0.19 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.144 2.178 . . . . 0.0 113.389 -176.248 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -162.72 108.95 1.2 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.986 2.115 . . . . 0.0 107.403 -176.513 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 65.44 -168.94 29.89 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 122.643 1.135 . . . . 0.0 110.761 -168.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -72.79 164.3 26.78 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.06 1.344 . . . . 0.0 111.978 169.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -138.54 155.46 48.36 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.693 1.597 . . . . 0.0 110.652 -169.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 10.0 tp -131.6 -139.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 149.11 130.76 1.91 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 125.812 1.673 . . . . 0.0 112.428 -169.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 40.6 t -62.73 123.19 17.78 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.468 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.1 0.18 1.4 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.027 1.331 . . . . 0.0 113.529 -179.332 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -70.4 115.05 30.93 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 167.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.56 9.14 3.02 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.304 2.669 . . . . 0.0 113.017 -179.412 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -124.02 8.29 8.65 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.988 1.715 . . . . 0.0 110.206 175.178 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.7 t -60.45 129.23 40.56 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 118.605 0.639 . . . . 0.0 109.558 170.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -73.4 3.41 6.01 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.999 1.72 . . . . 0.0 113.368 -175.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 26.6 mt -132.01 -34.22 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 126.37 1.868 . . . . 0.0 109.965 -175.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.99 -37.35 0.39 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.357 2.263 . . . . 0.0 115.76 170.341 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.478 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -132.58 148.57 52.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.864 2.065 . . . . 0.0 108.785 -174.945 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -148.02 148.52 30.79 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -177.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -73.02 150.15 42.65 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.895 178.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -60.96 -4.27 0.98 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.369 1.467 . . . . 0.0 113.417 167.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.2 -1.63 9.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.771 1.228 . . . . 0.0 112.558 170.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.4 m -72.43 -7.48 50.04 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.96 0.8 . . . . 0.0 111.296 167.031 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 2.8 p -134.38 -13.98 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 127.283 2.233 . . . . 0.0 112.016 179.197 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.86 37.46 44.36 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.592 1.091 . . . . 0.0 112.934 -176.154 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 20.6 mt -66.76 111.05 3.51 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.732 0.813 . . . . 0.0 110.235 176.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 26.3 m -72.12 -27.32 62.55 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.511 1.125 . . . . 0.0 111.464 174.355 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 14.5 t -153.25 175.4 13.11 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.704 1.602 . . . . 0.0 110.065 177.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -61.62 126.39 86.7 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 124.814 1.246 . . . . 0.0 110.256 -177.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.73 170.2 20.57 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.111 2.541 . . . . 0.0 111.967 179.185 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 68.0 mtm180 -69.98 169.79 12.61 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.936 0.894 . . . . 0.0 110.181 169.058 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -60.41 159.2 25.73 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.276 0.465 . . . . 0.0 112.308 172.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 15.0 tptp 51.99 57.38 6.56 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.192 1.397 . . . . 0.0 112.363 -172.264 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -74.97 159.64 31.54 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.611 0.764 . . . . 0.0 109.702 171.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.01 142.13 34.28 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.337 1.055 . . . . 0.0 109.199 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 2.4 p -63.03 165.37 10.45 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 123.72 0.808 . . . . 0.0 112.026 175.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.95 23.96 0.34 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.543 2.828 . . . . 0.0 113.643 -173.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -134.54 -33.07 0.99 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 125.687 1.595 . . . . 0.0 110.472 174.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.6 m -71.9 -36.5 70.03 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.72 2.008 . . . . 0.0 111.533 169.315 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 21.2 t -73.13 -19.4 61.14 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.758 1.623 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -60.59 -24.84 65.78 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -178.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -50.58 -46.47 57.8 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.209 1.804 . . . . 0.0 112.438 177.085 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -144.92 81.57 1.65 Allowed 'General case' 0 C--N 1.343 0.295 0 C-N-CA 125.688 1.595 . . . . 0.0 107.344 171.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -75.59 24.5 0.11 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.749 1.62 . . . . 0.0 114.408 -169.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -80.14 61.27 3.92 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.845 1.658 . . . . 0.0 109.682 169.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.131 0 C-N-CA 126.619 1.968 . . . . 0.0 110.227 -176.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 97.8 mtp . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 62.93 147.63 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.515 2.326 . . . . 0.0 113.806 -173.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 78.0 mtm -151.59 154.92 33.86 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.029 1.332 . . . . 0.0 110.344 -177.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -71.59 168.78 22.68 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.617 2.878 . . . . 0.0 111.835 170.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.8 p -108.32 -4.1 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.275 1.43 . . . . 0.0 111.87 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -57.23 -43.97 99.45 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-O 117.119 -1.42 . . . . 0.0 113.214 170.214 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.74 165.64 29.83 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.358 2.039 . . . . 0.0 111.499 170.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 52.66 56.08 8.14 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.42 1.488 . . . . 0.0 112.016 -177.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -126.12 84.32 61.75 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.479 1.511 . . . . 0.0 108.619 -176.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.09 120.41 6.31 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.831 3.021 . . . . 0.0 111.178 -175.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.1 p -147.24 140.51 25.33 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.903 1.681 . . . . 0.0 108.722 -176.471 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -154.72 -47.43 0.09 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -173.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.505 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -38.29 169.62 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 0 C-N-CA 126.401 1.881 . . . . 0.0 114.444 168.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.72 -6.69 39.23 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.198 168.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.505 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 89.7 m -96.08 -14.51 22.84 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 123.602 0.761 . . . . 0.0 111.71 174.456 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.2 p80 45.73 52.85 9.24 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.211 2.204 . . . . 0.0 112.759 -173.382 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.17 140.88 2.47 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 125.866 1.666 . . . . 0.0 107.889 179.178 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.519 HG12 ' H ' ' A' ' 205' ' ' SER . 1.4 t -129.2 172.72 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.336 1.454 . . . . 0.0 111.051 -176.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.519 ' H ' HG12 ' A' ' 204' ' ' VAL . 13.0 t 66.16 60.73 0.63 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.769 2.027 . . . . 0.0 113.208 -174.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.02 112.52 1.83 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.566 1.946 . . . . 0.0 108.318 -175.218 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.85 -163.45 24.42 Favored Glycine 0 C--N 1.34 0.759 0 CA-C-O 123.314 1.508 . . . . 0.0 112.931 -176.503 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.515 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.6 pm0 -67.88 146.13 53.94 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.028 2.131 . . . . 0.0 111.074 169.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 78.0 mtm -146.85 155.58 42.44 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.198 1.799 . . . . 0.0 110.461 -167.078 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 211' ' ' GLY . 8.2 tp -138.89 -138.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.41 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -175.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 152.22 133.93 2.02 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 126.239 1.876 . . . . 0.0 112.46 -169.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.25 123.59 20.36 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 114.179 -1.011 . . . . 0.0 109.398 177.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.19 0.14 2.18 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.314 1.846 . . . . 0.0 114.86 178.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -68.44 118.91 64.35 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.57 1.148 . . . . 0.0 108.592 169.627 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.26 7.27 3.43 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.413 2.742 . . . . 0.0 113.242 178.185 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -123.04 9.84 9.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.044 1.738 . . . . 0.0 110.358 174.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 42.6 t -58.65 128.87 39.34 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 123.494 0.718 . . . . 0.0 110.607 173.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.6 t -78.19 1.44 21.41 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.668 1.587 . . . . 0.0 113.072 -177.369 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.4 mm -132.7 -36.2 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 125.484 1.513 . . . . 0.0 110.375 -169.432 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.9 -39.16 0.42 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.415 2.686 . . . . 0.0 115.63 170.526 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.475 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.0 OUTLIER -134.16 149.07 51.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.176 1.791 . . . . 0.0 108.803 -174.569 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -149.34 147.01 27.82 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -176.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -73.11 150.49 42.2 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.771 0.796 . . . . 0.0 111.189 178.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -60.52 -4.02 0.81 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.374 1.47 . . . . 0.0 113.304 168.014 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -124.12 -2.03 8.18 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.074 1.35 . . . . 0.0 112.556 171.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.2 m -71.34 -8.11 51.57 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.043 0.838 . . . . 0.0 111.394 167.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.7 p -136.02 -4.1 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.084 1.753 . . . . 0.0 111.863 174.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 69.3 30.24 71.61 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.848 1.213 . . . . 0.0 112.909 -175.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.89 -47.93 83.78 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.662 1.185 . . . . 0.0 112.043 -172.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 m 64.4 -18.83 0.07 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.379 2.272 . . . . 0.0 114.755 -179.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 74.8 p -143.84 163.64 32.79 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.926 1.69 . . . . 0.0 110.605 -173.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -64.23 119.94 60.32 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 124.939 1.295 . . . . 0.0 108.925 177.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.31 166.86 28.52 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.213 2.609 . . . . 0.0 113.019 -175.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -67.39 170.98 6.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.216 1.006 . . . . 0.0 111.242 171.209 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -49.64 114.34 2.28 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.483 1.516 . . . . 0.0 112.416 -179.564 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 49.0 mttm 58.54 124.17 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 128.33 2.652 . . . . 0.0 114.1 -169.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -116.88 153.88 31.76 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.394 1.877 . . . . 0.0 109.652 175.054 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -139.59 136.4 34.35 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.638 0.775 . . . . 0.0 110.03 -177.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 10.8 p -66.95 164.07 38.31 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.125 0.97 . . . . 0.0 111.871 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -72.49 22.69 0.28 Allowed 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 123.94 3.094 . . . . 0.0 114.054 -177.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 -134.21 6.19 3.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.441 1.497 . . . . 0.0 112.027 172.097 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 5.2 m -128.96 -28.78 2.37 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 128.128 2.571 . . . . 0.0 110.01 -175.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 88.8 p -79.25 -29.77 42.81 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 124.688 1.195 . . . . 0.0 111.549 172.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -72.99 -38.34 66.69 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 125.017 1.327 . . . . 0.0 111.028 179.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -58.43 -40.96 83.94 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 126.439 1.896 . . . . 0.0 111.856 173.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 54.52 23.6 4.71 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.35 1.86 . . . . 0.0 114.31 172.423 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 51.1 tttm 46.59 55.01 8.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.227 1.811 . . . . 0.0 111.915 -172.05 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -130.7 35.69 3.98 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.027 1.331 . . . . 0.0 111.617 -169.455 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 83.7 tttt . . . . . 0 C--O 1.252 1.19 0 C-N-CA 127.157 2.183 . . . . 0.0 112.653 176.442 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -59.56 157.03 12.24 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.46 1.504 . . . . 0.0 112.02 170.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 94.4 mtp -140.4 72.4 31.61 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 124.705 1.202 . . . . 0.0 109.727 -173.181 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.38 152.83 71.31 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.329 2.686 . . . . 0.0 111.491 177.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.82 64.62 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.065 1.346 . . . . 0.0 107.987 -175.554 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.44 -48.97 85.72 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-O 117.286 -1.34 . . . . 0.0 112.778 173.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.85 -179.14 5.1 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.782 2.322 . . . . 0.0 111.3 171.391 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 61.2 t30 57.85 61.66 2.32 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.266 1.427 . . . . 0.0 112.273 178.135 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -114.82 98.38 49.74 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.943 1.297 . . . . 0.0 108.324 177.234 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.73 132.1 16.77 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.225 2.617 . . . . 0.0 111.24 -178.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 73.8 p -149.22 140.16 22.87 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.112 1.765 . . . . 0.0 108.914 -174.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -155.12 -44.7 0.08 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -175.457 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.505 ' HB2' ' H ' ' A' ' 201' ' ' CYS . 1.8 p -39.23 170.2 0.0 OUTLIER 'General case' 0 C--N 1.35 0.615 0 C-N-CA 126.273 1.829 . . . . 0.0 114.216 168.667 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.89 -6.62 39.7 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 113.425 -1.716 . . . . 0.0 110.115 168.172 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.505 ' H ' ' HB2' ' A' ' 199' ' ' CYS . 85.3 m -96.79 -14.22 22.09 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 123.7 0.8 . . . . 0.0 111.725 174.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.9 p80 45.73 53.18 8.95 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.138 2.175 . . . . 0.0 112.811 -173.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -169.74 140.77 2.18 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 125.858 1.663 . . . . 0.0 107.911 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 205' ' ' SER . 1.5 t -128.93 170.04 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.364 1.465 . . . . 0.0 111.105 -175.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.508 ' H ' HG12 ' A' ' 204' ' ' VAL . 8.1 t 65.89 66.1 0.51 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.083 2.153 . . . . 0.0 113.09 -174.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.24 111.3 1.08 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.566 1.946 . . . . 0.0 108.336 -175.496 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 61.47 -163.45 22.6 Favored Glycine 0 C--N 1.34 0.778 0 CA-C-O 123.254 1.474 . . . . 0.0 112.592 -174.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 1.7 pm0 -65.71 149.06 50.74 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 112.237 -1.981 . . . . 0.0 111.193 169.436 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 77.0 mtm -147.41 156.9 43.31 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.138 1.775 . . . . 0.0 110.067 -167.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.446 HG13 ' H ' ' A' ' 211' ' ' GLY . 4.9 tp -141.01 -138.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.369 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.447 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 221' ' ' TRP . . . 151.49 132.88 1.94 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 126.11 1.814 . . . . 0.0 112.629 -169.783 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 46.6 t -64.35 125.64 25.26 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.064 0.946 . . . . 0.0 108.814 177.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.08 -2.74 2.16 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.533 1.533 . . . . 0.0 114.068 178.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -70.44 116.08 41.47 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 124.136 0.975 . . . . 0.0 108.387 169.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -76.99 4.4 5.79 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.315 2.677 . . . . 0.0 113.103 179.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -117.49 7.09 12.63 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.896 1.678 . . . . 0.0 110.36 174.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 48.7 t -58.42 127.82 34.04 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 123.113 0.565 . . . . 0.0 110.005 170.459 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.8 t -74.5 2.48 9.52 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.796 1.639 . . . . 0.0 113.207 -176.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 30.2 mt -132.19 -33.78 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.069 1.748 . . . . 0.0 110.247 -173.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.69 -37.64 0.4 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.006 2.522 . . . . 0.0 115.305 170.313 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.478 ' HA ' ' HA2' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -133.06 148.96 52.2 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 126.777 2.031 . . . . 0.0 108.677 -174.032 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -148.44 146.62 28.5 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -176.272 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -70.63 150.61 45.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.942 0.877 . . . . 0.0 110.884 178.183 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -60.63 -5.06 1.09 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.073 1.349 . . . . 0.0 113.727 168.3 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -122.47 -0.84 9.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.656 1.182 . . . . 0.0 112.372 170.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 12.8 m -71.69 -7.19 46.46 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.892 0.769 . . . . 0.0 111.531 167.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 p -137.39 -11.51 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.809 1.244 . . . . 0.0 113.269 173.037 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 80.39 41.28 11.74 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.514 1.054 . . . . 0.0 113.54 -175.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 24.0 mt -65.98 160.88 22.64 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.295 1.047 . . . . 0.0 111.439 171.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 87.8 m -136.39 -16.81 1.57 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.986 1.714 . . . . 0.0 111.001 178.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 10.0 t -148.42 169.53 20.01 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.129 1.771 . . . . 0.0 109.368 174.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -65.84 122.86 82.98 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 174.277 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -73.43 164.3 35.46 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.823 2.349 . . . . 0.0 111.293 177.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 24.8 mtp-105 -142.33 161.76 37.19 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.117 1.367 . . . . 0.0 109.763 -178.175 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 73.09 22.24 79.17 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-O 118.929 -0.928 . . . . 0.0 113.444 -177.071 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? 72.2 126.54 0.03 OUTLIER 'General case' 0 C--N 1.346 0.42 0 C-N-CA 128.441 2.696 . . . . 0.0 111.821 -173.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -99.77 158.34 15.86 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.333 1.453 . . . . 0.0 110.305 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -141.06 139.78 34.13 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.184 0.994 . . . . 0.0 109.2 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.5 p -66.69 165.11 27.38 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.674 0.789 . . . . 0.0 111.957 177.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.5 31.93 0.28 Allowed 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 123.908 3.072 . . . . 0.0 113.413 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -135.97 -38.09 0.72 Allowed 'General case' 0 C--N 1.345 0.373 0 C-N-CA 125.584 1.554 . . . . 0.0 109.689 171.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 26.6 m -71.96 -34.61 69.11 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.585 1.954 . . . . 0.0 111.888 171.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 15.9 t -85.27 -21.39 29.05 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.061 1.344 . . . . 0.0 112.117 175.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.86 -33.72 76.23 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.896 1.278 . . . . 0.0 111.287 -179.299 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.81 -33.14 55.16 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.069 1.747 . . . . 0.0 113.343 178.16 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 33.35 63.48 0.35 Allowed 'General case' 0 C--N 1.345 0.412 0 C-N-CA 128.971 2.908 . . . . 0.0 113.917 169.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -81.44 56.27 2.88 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.365 1.066 . . . . 0.0 110.77 176.609 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -155.66 126.94 7.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 127.423 2.289 . . . . 0.0 106.852 177.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt . . . . . 0 C--O 1.25 1.117 0 CA-C-O 116.736 -1.602 . . . . 0.0 109.493 -172.712 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_